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Abstract 
 Post-septic encephalopathy is a poorly understood condition in survivors of 
sepsis that is characterised by cognitive and affective impairments. This thesis sought to 
understand this condition by undertaking a comprehensive behavioural and cognitive 
assessment of mice who had previously survived sepsis. Mice were treated with a septic 
dose of lipopolysaccharide and one month after this assessed on a battery of tests. Post-
septic animals were found to display significant levels of depressive-like and anxiety-
like behaviour but no cognitive impairments were found. The hippocampus and 
amygdala, two key brain areas for affective and cognitive functioning, were also 
examined in post-septic animals. Significant microglial activation was found in the 
hippocampus 24 hours post-sepsis and this remained upregulated at two months post-
treatment. Other neuroimmune factors were also affected in the post-septic 
hippocampus and amygdala such as neural precursor cell production and the production 
of proteins important to long-term potentiation.  
In order to investigate whether pharmacological intervention could ameliorate 
these post-septic changes NF-κB inhibitor pyrrolidine dithiocarbamate was 
administered prior to sepsis induction which significantly improved outcomes in post-
septic mice. To examine whether any intervention after sepsis onset could improve 
outcomes another experiment was conducted investigating the effects of chronic 
fluoxetine administration to post-septic mice. This treatment significantly improved 
affective behaviours and had anti-inflammatory effects in post-septic mice. In order to 
further examine what may be leading to the behavioural and neuroimmune changes in 
post-septic mice it was also examined whether these mice were “primed” for excessive 
inflammatory responses to secondary insults and whether aspects of hippocampal 
circadian rhythmicity were altered in these mice. Mice were not found to be primed, 
xvi 
 
although circadian parameters were disrupted post-sepsis. In summary it is 
demonstrated that LPS-induced sepsis produces long-lasting, but ameliorable, affective 
changes in mice, accompanied by significant inflammation in the hippocampus. These 
findings contribute new knowledge which may aid the comprehension of this poorly 
understood condition. 
 
  
1 
 
Chapter 1. General Introduction 
1.1 Systemic Inflammatory Response Syndrome, Sepsis, and Sepsis Associated 
Encephalopathy 
Systemic inflammatory response syndrome (SIRS) refers to a severe 
inflammatory response co-occurring with alterations in at least two of the following 
parameters - body temperature, heart rate, respiratory rate and white blood cell count 
(Robertson & Coopersmith, 2006). Where this occurs as a result of infection patients are 
said to have sepsis. During sepsis, a complication known as septic encephalopathy (or 
sepsis-associated encephalopathy) develops in up to 70% of patients (Papadopoulos, 
Davies, Moss, Tighe, & Bennett, 2000). While altered mental state is the key diagnostic 
criterion of septic encephalopathy, those who develop this encephalopathy may 
experience a full spectrum of cognitive symptoms, from confusion to delirium and coma 
(Jacob, Brorson, & Alexander, 2011). The pathogenesis of septic encephalopathy, 
although poorly understood, is thought to be multi-factorial – involving blood-brain 
barrier disruption, reduced cerebral blood flow, an upregulation of inflammatory cells 
and cytokines, edema, altered synaptic transmission and of particular importance, 
inflammation (Jacob, et al., 2011). These structural and neuroinflammatory alterations 
often lead to impaired cognitive and emotional function, and are hypothesised to lead to 
an increased susceptibility to the development of neurodegenerative diseases (such as 
Alzheimer’s disease) in survivors for many years following recovery (Hopkins, Ely, & 
Jackson, 2007; Lazosky, Young, Zirul, & Philips, 2010; Semmler, et al., 2013; 
Widmann & Heneka, 2014; Winters, et al., 2010; Ziaja, 2013), which is often referred 
to as post-septic encephalopathy.  
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Though some research has been done on the neurological pathology present in 
sepsis associated encephalothy and post-septic encephalopathy the aetiology of neither 
is currently well understood, and there are no successful treatments available. During 
systemic sepsis, sepsis-associated encephalopathy can manifest as a relatively mild 
symptomatology, or may develop into irreversible brain damage (Wilson & Young, 
2003). Given the heterogeneous nature of sepsis itself, categorising the neurological and 
cognitive problems which follow during, and after, recovery is a difficult task. A 
pathology involving ischemic lesions in the cerebral cortex is common in sepsis-
associated encephalopathy (Chelazzi, Consales, & De Gaudio, 2008), and imaging 
studies have provided evidence that blood-brain barrier permeability, influxes of 
inflammatory cells, neuronal death and subsequent neurotransmitter level alterations 
and endothelial activation are also likely to play a role (Stubbs, Yamamoto, & Menon, 
2013). To what extent this damage is resolved or unresolved in the post-septic brain is 
not yet known, although the persistent neurological symptoms present in post-septic 
encephalopathy can include reduced hippocampal volume and altered EEG frequency 
(Semmler, et al., 2013). This imaging and neuropsychological data implicates the 
hippocampus as an important area in the pathology of post-septic encephalopathy – 
although it is not affected in isolation. 
1.1.1 Cognitive Symptoms in Post-Septic Patients 
 The cognitive and affective symptoms which affect post-septic patients are not 
surprising given the severe brain pathology they experience. Cognitive deficits appear to 
be the key symptoms which occur due to the persistent neurological damage present in 
post-septic encephalopathy, and importantly, these are newly acquired after sepsis 
(Widmann & Heneka, 2014). Although only a small number of assessments of post-
septic encephalopathy in survivors exist, the majority support cognitive dysfunction as a 
3 
 
core symptom at various timepoints following hospital discharge. In comparison to 
survivors of severe cardiac illness, more sepsis survivors reported cognitive problems 
such as difficulty with problem solving, concentration and memory 1-4 years after 
hospital discharge (Lazosky, et al., 2010). This suggests that these problems are specific 
to sepsis and not just a product of an ICU stay. Likewise, six to twenty four months 
after hospital discharge sepsis survivors show significant verbal learning and memory, 
working memory, attention and phonetic verbal fluency deficits compared to other ICU 
survivors (Semmler, et al., 2013). Older patients also show increased cognitive 
dysfunction following sepsis; with a three year follow-up showing post septic patients 
were three times more likely to develop cognitive impairment than other age matched 
hospital survivors (Iwashyna, Ely, Smith, & Langa, 2010). Similarly, paediatric patients 
who survive sepsis also show significantly impaired cognition compared with 
population norms several years after hospital discharge (Bronner, et al., 2009). 
Survivors of sepsis may also be at an increased risk for developing later 
neurocognitive diseases.  A study over ten years which included survivors of severe 
sepsis showed that they had an increased hazard ratio for the later development of 
dementia (1.38-3.77) while 12% experienced severe cognitive decline and 25.3% 
experienced minimal cognitive decline (Shah, et al., 2013).  In a study of American ICU 
survivors 21.7% of those who developed severe sepsis subsequently developed 
dementia within 3 years of hospital discharge, with an adjusted hazard ratio of 1.28-1.53 
for those with severe sepsis as compared with other patients who received intensive care 
(Guera, Linde-Zwirble, & Wunsch, 2012). The neuroinflammatory aspect of post-septic 
encephalopathy may predispose survivors to the development of dementia – of which 
inflammation is often an important, although not necessarily causal, aspect (Enciu & 
Popescu, 2013). 
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1.1.2 Affective Disorders in Post-Septic Patients 
 There have been a number of studies examining affective changes in post-septic 
patients in the last decade with mixed findings. Survivors of intensive care units (ICUs) 
are already a high risk group for depression with one longitudinal study showing over 
30% of patients reporting at least mild depression 12 months after ICU discharge 
(Jackson, et al., 2014). Survivors of sepsis are prone to developing a cluster of affective 
problems including anxiety, depression and post-traumatic stress disorder – in addition 
to the cognitive and somatic issues associated with post-septic encephalopathy (Jones & 
Griffiths, 2013; Ziaja, 2013). Indeed hospitalisation for any infection, including sepsis, 
increases one’s relative risk of subsequent mood disorder diagnosis by 62%, with sepsis 
patients actually showing twice the incidence rate ratio for mood disorders relative to 
people without a hospital contact with infection (Benros, et al., 2013). Approximately 
two thirds of patients who survived severe sepsis subsequently reported post-traumatic 
symptoms, while close to 40% reported depressive and anxious symptoms in a study of 
German sepsis survivors (Jaenichen, Brunkhorst, Strauss, & Rosendahl, 2012). In 
another study, 44% of patients reported being at least moderately anxious or depressed 
at 6 months after sepsis, although this was actually lower than other ICU survivors 
(Granja, Dias, Costa-Pereira, & Sarmento, 2004). In a Dutch cohort one year following 
abdominal sepsis 22% were classified as mildly depressed, 7% as moderately depressed 
and 5% as severely depressed while 28% displayed moderate PTSD and 10% displayed 
severe PTSD symptoms (Boer, et al., 2008).  Survivors of sepsis reported greater 
difficulty with emotional behaviour and psychosocial functioning relative to survivors 
of myocardial infarction suggesting that in some cases survivors of sepsis may suffer 
worse neuropsychological problems than other ICU survivors (Lazosky, et al., 2010), 
but only when analysing those who had not yet retired from work. This raises the 
possibility that affective changes may be magnified when post-septic patients are 
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confronted, and have difficulty, with more complex tasks such as those found in the 
workplace.   
In other studies, however, post septic patients have shown only slightly lowered 
mental functioning relative to population norms (Cuthbertson, et al., 2013). Using the 
same measurement Hofhuis et al. (2008) showed that while mental component score 
showed a decline just after ICU discharge it had recovered by 6 months post-discharge, 
although the role emotional and mental health components remained significantly lower 
than population norms at this timepoint. although depressive symptoms may be higher 
in survivors of sepsis it has also been suggested that this depression, in contrast to 
cognitive diffciulties, may be present before sepsis onset in older populations and 
simply mainted after recovery from sepsis (Davydow, Hough, Langa, & Iwashyna, 
2013). Thus, although cognitive and physical impairment seem to be common following 
sepsis, affective changes may only be present at certain timepoints or when survivors 
experience certain difficulties such as returning to work. It may be that the 
neuroinflammatory changes present post-sepsis can serve as a risk factor which 
predisposes individuals towards developing depression following stressful life 
experiences. 
1.1.3 Animal Models of Sepsis and Post-Septic Encephalopathy 
The aetiology of sepsis associated encephalopathy and post-septic 
encephalopathy can be difficult to study in human populations. During septic incidents 
patients require intensive care and are treated with a variety of drugs which affect 
neurological and inflammatory measures such as norepinephrine, corticosteroids and 
vasopressin (Verceles, et al., 2012).  A significant portion (~35%) of septic patients do 
not survive hospitalization (Daniels, 2011) and significantly elevated mortality levels 
are present in those who survive their hospital stay for years after discharge (Winters, et 
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al., 2010). This means that post-mortem studies may be influenced by bias towards 
those suffering from the most severe sepsis, while long-term studies of survivors may 
include those who suffered more moderate septic incidents. Another problem is that 
sepsis in humans is a heterogeneous condition which can originate due to a wide variety 
of infectious challenges and as such the subsequent neurological issues present in 
survivors are likely to differ significantly. In an effort to categorise the physiological 
and behavioural sequelae of sepsis a number of animal models have therefore been 
developed. 
Sepsis is commonly induced via cecal ligation and puncture (Imamura, et al., 
2011), specifically termed polymicrobial sepsis, which leads to a potent systemic 
inflammatory response, dysfunction in multiple organs, and often death (Rittirsch, 
Huber-Lang, Flierl, & Ward, 2008). Another common model involves the 
intraperitoneal or intravenous injection of a high dose of lipopolysaccharide (LPS) (Doi, 
Leelahavanichkul, Yuen, & Star, 2009). This stimulates the release of numerous pro-
inflammatory cytokines such as tumour necrosis factor-α (TNF- α), interleukin-1 (IL-1) 
and interleukin-6 (IL-6) in addition to septic shock.  In our model, mice are treated with 
5mg/kg LPS from escherichia coli which induces systemic shock within hours of 
treatment, followed by a recovery period of several days, with a morbidity rate of 
around 10% (O'Callaghan, Anderson, Moynagh, & Coogan, 2012). This treatment has 
previously shown to upregulate pro-inflammatory factor TNF- α and increase the 
number of microglia active throughout the whole brain for up to 10-months post-
treatment (Qin, et al., 2007). As with human studies of post-septic encephalopathy, in 
terms of animal models there has been significant differences in the time left between 
sepsis induction and behavioural testing – with measurements occurring anywhere from 
10 days (Cassol-Jr, et al., 2011) to several months (Semmler, et al., 2007). 
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1.1.4 The Present Model – Lipopolysaccharide Induced Sepsis 
While sepsis in humans is a heterogeneous condition, for the present research 
the intraperitoneal injection of a high dose of the bacterial endotoxin lipopolysaccharide 
(LPS) was selected due to its common use in modelling sepsis (Buras, Holzmann, & 
Sitkovsky, 2005; Doi, et al., 2009). Peripheral administration of high-dose LPS leads to 
a potent inflammatory response, via Toll-like receptor-4 (TLR-4) binding and 
subsequent Nuclear Factor-κB (NF- κB) pathway activation. This septic dose of LPS 
mimics many of the clinical features of sepsis and results in a hyper-inflammatory 
response, accompanied by depressed EEG rhythmicity, low blood pressure, oxidative 
stress, multiple organ failure and a significant mortality rate (Chang, Tsai, Sheu, Hsieh, 
& Chiang, 2013; Lin, Chen, Lee, Chen, & Yang, 2010; Okazaki, Tachibana, Koga-
Ogawa, & Takeshita, 2013). Following recovery from the acute effects of LPS-induced 
sepsis, an increased level of microglial activation persists in the CNS, accompanied by 
prolonged over-expression of pro-inflammatory cytokines and inducible nitric oxide 
synthase (iNOS) as well with time and dose dependent neuronal degeneration (Bossú, et 
al., 2012; Qin, et al, 2007;  Semmler, et al., 2007; Weberpals, et al., 2009). 
 In addition to persistent neuroimmunological changes, there have been a number 
of studies examining cognitive and affective parameters following recovery from both 
LPS-induced, and CLP-induced sepsis. There is considerable variance in the 
behavioural changes present in post-septic animals depending on both the method of 
sepsis induction and the latency to test behaviour following recovery from sepsis. 
Within the domain of learning and memory, post-septic animals have shown cognitive 
impairments across tasks such as the step-down passive avoidance task, the radial arm 
maze, and novel object recognition tasks (Barichello, et al., 2007; Cassol-Jr, et al., 
2010; Cassol-Jr, et al., 2011; Semmler, et al., 2007; Weberpals, et al., 2009). Ten 
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months after LPS-induced sepsis rats show no differences in the elevated plus maze or 
Morris watermaze, although they exhibit reduced exploration and recognition of a novel 
object in the open field test (Bossú, et al., 2012). Post-septic animals have also been 
shown to display increased levels of depressive-like behaviour including both 
anhedonia and behavioural despair (Comim, et al., 2010; Tuon, et al., 2008) as well as 
anxiety-like behaviour in the elevated plus maze ten days after CLP (Calsavara, et al., 
2013). These affective changes may be linked to the growing evidence for a 
neuroimmune basis to mood disorders such as major depressive disorder (Berk, et al., 
2013; Miller, Maletic, & Raison, 2009). The wide variation in methodology used to 
study sepsis and its behavioural consequences illustrate the need for a comprehensive 
examination of these effects in a single model.   
1.2 Neuroimmune Signalling in the CNS 
1.2.1 LPS from the Periphery to the Brain 
In order to understand how a peripheral dose of LPS may affect brain function in 
this model it is first necessary to describe how peripherally administered LPS can exert 
effects on the central nervous system (CNS). Minimal amounts of peripherally injected 
LPS may cross the blood-brain barrier and the CNS does contain many cells which 
recognise and respond to LPS. Despite this, evidence suggests that peripherally 
administered LPS does not, except at the highest doses, directly affect the CNS but 
rather mediates its effects indirectly via a number of mechanism (Banks & Robinson, 
2010; Singh & Jiang, 2004). Therefore, while Banks and Robinson (2010) suggest that a 
5mg/kg dose of LPS may be enough to affect the most LPS-sensitive parameters of the 
brain via brain endothelial cells, it is also necessary to consider the other mechanisms 
through which peripheral LPS administration exerts such potent effects on the CNS. 
These are illustrated in Figure 1.1. 
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It is known that cytokines in the periphery, which are upregulated in response to 
LPS administration (Juskewitch, et al., 2012; Qin, et al., 2007), can affect brain 
cytokine levels via a number of different mechanisms (Dantzer, 2001). Firstly, LPS is 
known to stimulate the sensory pathways of the vagus nerve, representing one pathway 
through which immune signals can be transmitted from the periphery to the brain (Wan, 
Wetmore, Sorensen, Greenberg, & Nance, 1994). Afferent vagal fibers transmit 
information to the nucleus tractus solitaries which projects to sites such as the 
paraventricular nucleus of the hypothalamus (Arkrout, Sharshar, & Annane, 2009; 
Bailey, Hermes, Whittier, Aicher, & Andresen, 2007). While signalling via this pathway 
is important for peripheral LPS to induce neuroinflammation, vagotomy fails to block 
increased levels of IL-1β in the rodent brain following high doses of LPS (Van Dam, et 
al., 2000), indicating the importance of other pathways in eliciting the CNS response to 
systemic LPS.   
Secondly, cytokines themselves, while too large to passively cross the blood-
brain barrier, can enter the brain via the circumventricular organs which lack a blood-
brain barrier (Arkrout et al., 2009). Both toll-like receptors and cytokine receptors are 
present within the circumventricular organs (Dantzer, 2004). From the 
circumventricular organs, cytokines may then move towards deeper structures such as 
the hippocampus.  
Apart from entering passively via the circumventricular organs, cytokines may 
also be actively transported across the blood-brain barrier (McCusker & Kelley, 2013). 
While specific transporter systems for all cytokines have not yet been identified, blood 
to CNS transporter systems have been isolated for TNF-α, IL-6 and IL-1β (Banks, 
Kastin, & Broadwell, 1995; Pan & Kastin, 2002; Quan & Banks, 2007). LPS itself 
induces cell death in the endothelial cells which make up the blood-brain barrier by 
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activating microglia (Kacimi, Giffard, & Yenari, 2011), disrupting blood-brain barrier 
stability and increasing its permeability. 
The fourth mechanism involves cytokines and LPS itself interacting with brain 
endothelial cells, causing them to produce their own cytokines (including IL-1, IL-6 and 
TNF) which can then activate microglia within deeper brain structures (Verma, 
Nakaoke, Dohgu, & Banks, 2006; Quan & Banks, 2007). Once activated, microglia 
within the CNS actively produce pro-inflammatory factors. This pathway is thought to 
primarily be mediated via the synthesis of prostaglandins, particularly prostaglandin E2, 
driven by cyclooxygenase (COX)-2 (Engblom, et al., 2002). 
 
 
 
 
 
 
 
 
Figure 1.1 Pathways via which peripheral LPS may act on the CNS. CVO = 
circumventricular organs, CRF = Corticotrophin Releasing Factor, AVP = 
Vassopressin. Red represents activating signals while blue represents 
immunosuppressive signals. Adapted from Arkrout,et al., (2009). 
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1.2.2 LPS Signalling Cascade 
LPS is a component of all gram-negative bacteria. Located on the outer 
membrane of the cell, LPS elicits a potent innate immune response – which can lead to 
endotoxic shock (Bryan, Spring, Gangloff, & Gay, 2010). The primary mammalian 
receptor responsible for the recognition of LPS is TLR-4 (Poltorak, et al., 1998). As 
illustrated in Figure 1.2, there are several proteins necessary for TLR-4’s recognition of 
LPS however. Firstly, plasma protein LPS binding protein (LBP) binds directly to the 
lipid A domain of LPS forming a complex which can then bind to the surface antigen 
CD14, which is present on monocytes and macrophages of the innate immune system 
(Schumann, et al., 1990; Wright, Ramos, Tobias, Ulevitch, & Mathison, 1990). Another 
protein involved is myeloid differentiation factor (MD)-2. Soluble MD-2 non-
covalently associates with TLR-4 and is necessary for the proper recognition of LPS 
(Nagai, et al., 2002). Once bound to LPS via LBP, CD14 then allows for the transfer of 
LPS to a hydrophobic pocket of the MD-2 component of the TLR4/MD-2 complex (Lu, 
Yeh, & Ohashi, 2008; Tissières, et al., 2008).   
Once LPS has bound to the TLR-4-MD-2 complex two different pathways may 
become activated involving four separate adaptor proteins  - TIR-domain-containing 
adapter-inducing interferon-β (TRIF), translocating chain-associating membrane 
(TRAM), myelin and lymphocyte (MAL) and myeloid differentiation primary response 
88 (MyD88) (O'Neill & Bowie, 2007). One pathway involves the adaptor protein pair 
TRAM-TRIF, while the other involves the MAL-MyD88 pair. The TRAM and MAL 
proteins have been referred to as bridging adaptors - associating with the MD2-TLR4 
complex and recruiting TRIF and MYD88 respectively (O'Neill & Bowie, 2007). It has 
been suggested that the MAL-MyD88 pathway induces proinflammatory cytokine 
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expression while the TRAM-TRIF pathway activates Type I interferons and interferon-
inducible genes (Lu et al, 2008). 
The primary function of MyD88 is to induce rapid NF-κB activation. Once 
recruited by MAL, MyD88 subsequently activates IL-1R-associated kinase (IRAK)-4 
via a death domain-death domain interaction which in turn can phosphorylate IRAK-1 
(Li, Strelow, Fontana, & Wesche, 2002). Downstream tumor-necrosis-factor-receptor-
associated factor 6 (TRAF6) is then activated – recruiting transforming-growth-factor-
β-activated kinase 1(TAK1) and TAK1-binding protein 2(TAB2), as well as ubiquitin-
conjugating enzyme E2 variant 1 (UEV1A) and ubiquitin-conjugating enzyme 13 
(UBC13) (O'Neill & Bowie, 2007). It is this complex which then activates IκB kinase 
(IKK) and mitogen-activaed protein kinase (MAPK) pathways which lead to the 
induction of p38 and JUN N-terminal kinase (JNK). Phosphorylated by IKKα, IKKβ 
and IKKγ, inhibitor of κ light chain gene enhancer in B cells (IκB) subsequently 
degrades allowing for the translocation of NF-κB to the nucleus, which is typically 
bound in a inactive state with IκB in the cytosol, stimulating the production of several 
proinflammatory cytokines (Lu, Yeh, & Ohashi, 2008). In addition to this, MAPK 
pathway activation induces the activation of the transcription factor activator-protein 
(AP)-1 which is involved in a wide range of functions including cellular proliferation, 
death and differentiation (Shaulian & Karin, 2002). MyD88s – a spliced variant of 
MyD88 may inhibit NF-κB, but not JNK, activation by interfering with IRAK4 
recruitment (O'Neill & Bowie, 2007). 
Unlike the MAL-MyD88 heterodimer, the TRAM-TRIF protein pair induce later 
phase NF-κB induction following TLR-4 activation, in addition to type I interferon 
activation via interferon regulatory factor(IRF)-3 and IRF-7 (Fitzgerald, et al., 2003). 
Upon phosphorylation of TRAM, TRIF is recruited which in turn activates TRAF-
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family-member-associated NF-κB-activator-binding kinase 1(TKB1) leading to IRF3 
and IRF7 activation. TRAF6 is also activated inducing NF-κB production via IKK 
phosphorylation (O'Neill & Bowie, 2007). Type I interferons induced by IRF3 and IRF7 
are important primarily for responding to viral infections, but are also modulators of the 
immune response to bacterial infection (González-Navajas, Lee, David, & Raz, 2012). 
Importantly, TRAM-TRIF may also induce apoptosis by activating receptor interacting 
protein (RIP)1, a key regulator of cell survival and death (Festjens, Vanden Berghe, 
Cornelis, & Vandenabeele, 2007).    
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Illustration of the key stages in LPS recognition by TLR-4 and subsequent 
NF-κB induction. Adapted from Guo & Friedman (2010) 
1.2.3 The NF-κB Pathway 
NF-κB is a transcription factor composed of a family of five proteins – NF-κB1 
(p50), NF-κB2 (p52), c-Rel, RelA (p65) and RelB. Depending on the stimulus and 
context in which NF-κB is activated each of these five factors forms either hetero- or 
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homodimers (Hoesel & Schmid, 2013). Once liberated from IκB, NF-κB translocated 
from the cytoplasm to the nucleus binds with to DNA and can begin to regulate 
transcription of hundreds of target genes (Karin & Ben-Neriah, 2000). Depending on 
which NF-κB family members compose a hetero- or homodimer different genes will be 
regulated by NF-κB activation (Cao, Zhang, Edwards, & Mosser, 2006). LPS induces 
NF- κB activation via the canonical pathway (as described above) and this is typically 
thought to be associated with heterodimers containing RelA (p65) or c-Rel (Lawrence, 
2009). NF-κB target genes are involved in a wide range of functions relating to 
inflammation and immune responses. These include cytokines, chemokines, cell 
adhesion molecules, interferons, IEGs and others. In addition to this, many of the genes 
which are upregulated by NF-κB lead to the activation of NF-κB themselves (Barnes & 
Karin, 1997). 
 Though the genes upregulated following the binding of NF-κB vary depending 
on the context of activation and cell type in which it is active, among the relevant genes 
regulated by NF-κB are the chemokines monocyte chemoattractant protein (MCP)-1, 
chemokine (C-C) motif ligand (CCL)5 (Jang & Lee, 2000) and IL-8 (Lokensgard, Hu, 
van Fenema, Sheng, & Peretson, 2000; Martin, Cardarelli, Parry, Felts, & Cobb, 1997); 
cytokines such as IL-1β (Greten, et al., 2007; Hiscott, et al., 1993), IL-6 (Libermann & 
Baltimore, 1990), IL-10 (Cao, et al., 2006), TNFα (Shakhob, Collart, Vassalli, 
Nedospasov, & Jongeneel, 1990; Qiutang & Verma, 2002); adhesion molecules such as 
intercellular adhesion molecule (ICAM)1 (Bunting, et al., 2007); enzymes inducible 
nitric oxide synthase (iNOS) and cyclooxygenase(COX)-2 (Arias-Salvatierra, 
Silbergeld, Acosta-Saavedra, & Calderon-Aranda, 2011; Kim, et al., 2007; Nadjar, et 
al., 2005); both pro-apoptotic factors such as Fas ligand (FasL) (Kasibhatla, et al., 1998) 
and inhibitor of apoptosis family members (xiap, hiap1, and hiap2) (Stehlik, et al., 
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1998) and immediate early genes such as EGR-1 (Chapman & Perkins, 2000; Choi, 
Park, Do, Yang, & Moon, 2012). Some of these factors also positively (e.g. IL1β, 
TNFα)  or negatively (e.g. EGR-1) regulate NF-κB transcription themselves. As this 
pathway represents the primary route through which LPS activates an immune response 
in sepsis an understanding of its mechanisms and the consequences of its activation and 
disruption are important for modelling and understanding septic pathologies. 
1.3 The Hippocampus 
 The hippocampus was chosen as the primary brain region for investigation in the 
present study due to its susceptibility to damage during sepsis (Semmler, et al., 2013) 
and its importance in both cognition and emotion (Fanselow & Dong, 2010). The rodent 
hippocampus is a large brain structure that stretches rostro-caudally and dorso-ventrally 
from the septal nuclei within the basal forebrain (dorsal) to the temporal lobe (ventral) 
(Tanti & Belzung, 2012). Within humans, the hippocampus has rotated and shifted in 
location close to the base of the brain due to the extensive development of neocortical 
regions (Kempermann, 2012). When comparing human and rodent hippocampal areas 
the septal pole of the rodent hippocampus corresponds to the posterior section of the 
human hippocampus, while the temporal pole corresponds to the anterior hippocampus 
of humans (Tanti & Belzung, 2012). The hippocampus itself is an anatomically 
heterogeneous region and it has long been thought that this heterogeneity gives rise to 
functional dissociation between hippocampal structures (Grant & Jarrard, 1968; Moser 
& Moser, 1998). Following decades of work, this dissociation of function is now 
thought to exist between dorsal, intermediate and ventral regions, and also among the 
various hippocampal subfields encompassing the dentate gyrus and Cornus Ammonus 
(CA) regions 1 to 3 (Bast, Wilson, Witter, & Morris, 2009; Fanselow & Dong, 2010). 
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Here the functional and anatomical characteristics of each hippocampal area and the 
contribution of the region to both cognition and affective behaviour will be reviewed.  
1.3.1 Dentate Gyrus  
 One of the most basic divisions within the hippocampus is between the dentate 
gyrus and CA1-3 regions. Anatomically, the dentate gyrus consists of several distinct 
layers, shown in Figure 1.3. Two blades of densely packed granule cell somata make up 
the granular layer, with axonal projections, known as mossy fibers, expanding into the 
hilus (polymorphic cell layer) and innervating the mossy cells there, while their 
dendrites expand to the molecular cell layer (Amaral, Scharfman, & Lavenex, 2007; 
Scharfman & Myers, 2013; Scorcioni, Bouteiller, & Ascoli, 2002). Sensory input is 
primarily transmitted to the dentate gyrus via the entorhinal cortex through the perforant 
pathway, with granule cells of the dentate then transmitting signals exclusively, in 
rodents, to the CA3 (Neves, Cooke, & Bliss, 2008). The molecular cell layer, granule 
cell layer and polymorphic cell layer each contain a variety of different cell types and 
each serve a different function within the dentate gyrus and hippocampus as a whole.  
1.3.1.1 Molecular Cell Layer 
 The molecular cell layer, comprised of three sub-layers, is primarily composed 
of dendrites from granule cells as well as pyramidal basket cells and polymorphic layer 
cells, and its outer layer receives the principal sensory input to the hippocampus from 
layer II of the entorhinal cortex (Amaral, Scharfman, & Lavenex, 2007). It also receives 
other input originating outside the entorhinal cortex – for example cholinergic input 
from the septum (Guthrie, Tran, Baratta, Yu, & Robertson, 2005) and hypothalamic 
projections (Dent, Galvin, Stanfield, & Cowan, 1983). The area is also sparsely 
populated by a number of other neurons, for example GABAergic interneurons which 
signal to the subiculum (Ceranik, et al., 1997) as well as other cells which may control 
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granule cell activity such as molecular layer perforant pathway (MOPP) cells which 
have recently been shown to play a role in functionally incorporating newborn granule 
cells via feed forward inhibition (Li, et al., 2013). This control of granular and 
subsequent mossy cell activation has been referred to as “gating” – such that only 
specific signals are sent beyond the dentate gyrus (Walker, Pavlov, & Kullmann, 2010).  
A) 
 
 
 
B) 
 
 
 
 
 
Figure 1.3 Dentate gyrus neuroanatomy A) Photomicrograph showing each layer of 
the mouse dentate gyrus, B) Diagram adapted from Scharfman & Myers, 2013 showing 
a granule cell and its dendritic projections from the granular layer through the three 
sections of the molecular layer as well as mossy fibre expansion to the 
hilus/polymorphic cell layer. 
1.3.1.2 Granule Cell Layer 
 The granule cell layer of the dentate gyrus contains the tightly packed cell 
bodies of a large number of granule cells and is divided into two “blades” – the 
Molecular Layer 
Granular Layer 
Granular Layer 
Molecular Layer 
Polymorphic Layer 
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suprapyramidal and infrapyramidal blades (Amaral, et al., 2007). These granule cells 
are excitatory in nature and project both to the polymorphic cell layer (Jinde, Zsiros, & 
Nakazawa, 2013) and the CA3 (Szabadics & Soltesz, 2009) via specialised axons 
known as “mossy fibers”. Granule cells transmit spatial information to the CA3, 
showing environmentally selective firing (Jung & McNaughton, 1993) and Arc 
expression (Chawla, et al., 2005). Brief spatial learning alone is sufficient to promote 
survival of newborn granule cells – highlighting the specialised nature of these cells 
(Feng, et al., 2010). Aside from spatial information, granule cells can also be affected 
by emotional experiences. Maternal deprivation has been shown to subtly affect granule 
cells, significantly lowering the cell density in the granule cell layer as well as altering 
cell morphology (Oomen, et al., 2011). 
 The granule cell layer becomes home to a large number of newborn neurons 
throughout adult life. In rats for example, roughly 9,000 cells are created each day 
(Cameron & McKay, 2001), and by the late stages of aging adult-born granule cells 
make up about 40% of the population of the granule cell layer (Snyder & Cameron, 
2012). As only a small number of granule cells fire in response to a given situation, 
there has been speculation that mature granule cells may in fact be “retired” – with the 
more excitable newer neurons assuming their function (Alme, et al., 2010). It has been 
shown however that specific ablation of mature adult-born granule cells only interferes 
with memory recall when it takes place after training, rather than beforehand (Arruda-
Carvalho, Sakaguchi, Akers, Josselyn, & Frankland, 2011). This indicates that while 
newborn granule cells are heavily involved in memory consolidation, mature granule 
cells are likely not retired despite their sparse activity. It has also been suggested that 
these older granule cells may be differentially activated in situations involving high 
19 
 
emotional salience, given the differential stimulation of these two types of granule cell 
by the amygdala (Wosiski-Kuhn & Stranahan, 2013).  
1.3.1.3 Polymorphic Cell Layer 
 Positioned between both blades of the granule cell layer is the polymorphic cell 
layer of the hippocampus. While a variety of cell types inhabit this area, the principal 
neuron is the mossy cell. These cells feature large cell bodies and dendrites which 
project extensively throughout the polymorphic layer and sometimes to the molecular 
layer through the granule cell layer (Amaral, Scharfman, & Lavenex, 2007). They are 
primarily excitatory and can activate both granule cells and inhibitory interneurons in 
the dentate gyrus. (Scharfman, 1995). These mossy cells are characterised by large, 
complex spines known as thorny excrescences which are present on their dendrites 
(Buckmaster, Strowbridge, & Schwartzkroin, 1993) and receive input from the mossy 
fibers of granule cells (Henze & Buzsáki, 2007). Morphofunctional differences exist 
between dorsal and ventral mossy cells – dorsal mossy cells show more compact 
dendritic fields and more complex and numerous thorny excrescences while more 
ventral cells show a wider dendritic spread but smaller thorny excrescences (Fujise, Liu, 
Hori, & Kosaka, 1998). Mossy cells can also be stimulated via perforant pathway 
signals through their dendrites extended to the molecular layer. (Scharfman, 1991).  It 
has been suggested that these mossy cells, given their ability to project to 
septotemporally distant dentate gyrus neurons, may function to pass on information 
from granule cells at one level of the hippocampus to those in distal areas (Amaral, et 
al., 2007). 
 Aside from mossy cells, the polymorphic layer is also home to a variety of 
interneurons. although many of these are not yet well understood, two of the best 
characterised are the hilar perforant path-associated cell (HIPP) and the hilar 
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commissural-associational pathway-related cell (HICAP) (Amaral & Lavenex, 2007). 
Sik, Penttonen, & Buzsáki (1997) conducted detailed physiological characterization of 
these interneurons using electrophysiology and electronmicroscopy. They described 
HIPP cells as responding to perforant pathway stimulation via granule cell activation, 
with their axons in turn extending both to the outer two thirds of the molecular layer and 
both blades of the granular layer. These spiny neurons expand extensively through the 
septotemporal axis of the hippocampus, as well as to the contralateral hippocampus, 
with a single cell making as many as 1355 synaptic contacts. While HIPP cells may 
modulate perforant pathway input by innervating the outer areas of the molecular layer, 
HICAP cells have axons located primarily in the inner third of the molecular layer, with 
roughly one quarter projecting to the granular layer and a small number also remaining 
within the polymorphic layer (Sik, Penttonen, & Buzsáki, 1997). These cells are 
GABAergic and their axonal projections are thought to be involved in feed forward 
inhibition of commissural and associational pathways.  
 Inhabiting the border between the granule cell layer and the polymorphic layer 
are pyramidal basket cells.  These are the chief inhibitory neurons of the dentate gyrus 
(Amaral, et al, 2007). Primarily GABAergic, these cells receive input from mossy fibres 
although they also extend dendrites throughout the dentate, and most commonly signal 
to granule cells (Ribak & Seress, 1983).  They are therefore thought to form an integral 
part of the dentate gyrus’ inhibitory feedback loop, although they may also be involved 
in feed forward inhibition via their connections with the perforant path (Ribak, 1992). 
Basket cells vary in number across the extent of the dentate gyrus, with a higher ratio at 
the temporal pole relative to septal levels (Seress & Pokorny, 1981). 
 It is here in the subgranular zone that adult neurogenesis takes place (Kaplan & 
Hinds, 1977). Here, neural precursor cells (NPCs) become mature granule cells and may 
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then be incorporated into existing hippocampal networks – a process key for both 
cognitive and affective functioning (Ransome, Renoir, & Hannan, 2012). Multipotent 
neural stem cells exist within both the subgranular zone of the hippocampus and 
subventricular zone (Guo, Patzlaff, Jobe, & Zhao, 2012) and have the potential to 
develop into oligodendrocytes, astrocytes or granule neurons (Duan, Kang, Liu, Ming, 
& Song, 2008). These neural stem cells (NSCs) can be categorised as either quiescent or 
active – with some suggesting that active stem cells, which are highly proliferative and 
responsive to external input, may act as an intermediary between quiescent NSCs and 
more developed progenitors (Wang, Plane, Jiang, Zhou, & Deng, 2012). The process of 
neuronal differentiation, survival and incorporation is highly susceptible to pathological 
and environmental stimuli (Lugbert, et al., 2010) regulated through a variety of 
pathways and is spread across several developmental stages with a number of critical 
periods (Ming & Song, 2011).  
The first stage of neurogenesis involves the proliferation of quiescent and active 
radial and horizontal neural stem (type 1) cells which leads to the generation of transit-
amplifying progenitors (type 2A/B), also known as intermediate progenitor cells, which 
may then produce neuroblasts that can differentiate to form either granule cells or 
astrocytes in the dentate gyrus (Hsieh, 2012). Fate determination (neuronal vs. 
astrocytic) appears to occur in type 2 cells (Duan et al., 2008), and Type 2B cells are 
identifiable as the first stage to express doublecortin (DCX), a marker for immature 
neurons (Hsieh, 2012). The transition from type 2B cells to neuroblasts (type3) is the 
first critical period during which the majority of newborn cells undergo apoptosis 
followed by phagocytosis by nearby microglia (Sierra, et al., 2010). Interestingly, it has 
recently been shown that mature astrocytes, at least in the SVZ, can actually be 
reprogrammed to become neuroblasts – and subsequently develop into neurons, by the 
22 
 
administration of the transcription factor SOX2 (Niu, et al., 2013). Neuroblasts then go 
on to develop into immature granule neurons which, over the course of about 4 weeks, 
migrate to the granule cell layer and develop first GABAergic synaptic inputs, then 
glutamatergic inputs and finally a mature phenotype expressing NeuN, and exhibiting 
an axon projecting to the polymorphic cell layer, dendrites within the molecular layer 
and fast perisomatic GABAergic contacts (Espósito, et al., 2005). During this immature 
neuronal developmental a second critical survival period occurs regulated by input to 
the cells’ NMDA receptors (Tashiro, Sandler, Toni, Zhao, & Gage, 2006). 
In terms of overall functionality, the dentate gyrus has long been suggested to be 
responsible for pattern separation of entorhinal cortex input and transmitting this 
information to the CA3 region of the hippocampus (Newman & Hasselmo, 2014). 
Pattern separation in this context refers to the dentate’s involvement in reducing the 
complexity and potential for overlap, via sparse activation patterns, in signals passed on 
from the entorhinal cortex which must then be stored by the CA3 (Myers & Scharfman, 
2011). The dentate gyrus therefore responds to even moderate environmental change 
with significant shifts in activity patterns – even though these may involve some 
overlapping entorhinal input (Neunuebel & Knierim, 2014). As with the dentate gyrus 
anatomy however, functionality of this area is also believed to vary along the 
dorsoventral axis. Using optogenetic manipulation of granule cells at varying levels of 
the dentate gyrus Kheirbek and colleagues (2013) demonstrated that activation of dorsal 
granule cells led to large increases in exploration of novel environments while 
inhibition of these cells led to a disruption in the encoding of novel contexts. Activation 
of ventral granule cells on the other hand led to suppressed anxiety with inhibition 
failing to alter context encoding – interestingly, stimulation and inhibition of 
intermediate areas appeared to produce a hybrid effect. The ventral hippocampus may 
23 
 
however be important in some forms of memory processesing with Kesner, Hunsaker, 
& Ziegler (2011) showing that the ventral hippocampus exclusively contributes to 
olfactory working memory.  
1.3.2 CA3 
 The primary output of the dentate gyrus is to the CA3 region via mossy fibers – 
and unlike the pattern separation which occurs in the dentate, the CA3 is thought to be 
responsible for pattern storage and pattern completion by recreating stored outputs 
following the transmission of, at least partially, similar patterns from the dentate 
(Neunuebel & Knierim, 2014). The CA3 does not only receive “pre-processed” signals 
from the dentate gyrus however, also receiving direct input from layer II of the 
entorhinal cortex (Neves, Cooke, & Bliss, 2008).  As with the dentate gyrus, the CA3 is 
organised in a laminar fashion, inhabited by numerous neuronal types and can be 
separated into a number of sub-regions based on their heterogeneous anatomy and 
function (Hunsaker, Rosenberg, & Kesner, 2008). The laminar organisation of the 
hippocampus varies only slightly between areas CA1, CA2 and CA3 – moving from the 
outermost layer the alveus, to the stratum oriens, followed by the principal layer the 
pyramidal layer, then unique to the CA3 is the stratum lucidum, the stratum radiatum is 
again common to all three divisions and is followed by the innermost stratum 
lacunosum-moleculare (Paxinos & Watson, 2007). Beginning proximally to CA2 the 
CA3 area has also been subdivided into area CA3a which encompasses the initial 
curved section, CA3b which extends up to the beginning of the granular cell blades of 
the dentate, and finally CA3c which refers to the area which extends into the 
polymorphic cell layer (Hunsaker, Rosenberg, & Kesner, 2008). These laminar and 
transverse distinctions are illustrated below in Figure 1.4. 
24 
 
 The most well studied neuron type within the CA3 region are the pyramidal 
neurons which inhabit the pyramidal cell layer. Receiving input from both the perforant 
pathway as well as DG mossy fibers, these cells have a pyramidal shaped soma, with 
dendrites from the base extending into the stratum oriens, while the apex extends 
dendrites to the stratum radium and stratum lacunosum-moleculare, but not stratum 
lucidum, in CA3a/b and to the stratum radium alone in CA3c (Amaral & Lavenex, 
2007). At ventral levels, additional segregation is possible based on the neuron’s 
location either close to the stratum radium (inner) or close to the stratum oriens (outer) – 
with each subpopulation expressing different gene profiles (Thompson, et al., 2008). 
The most striking feature of these neurons although is their ability to project axons 
through as much as two thirds of the septotemporal axis of both the ipsilateral and 
contralateral hippocampus (Amaral & Lavenex, 2007). Characterised in vivo in the 
early 90s (Li, Somogyi, Ylinen, & Buzsáki, 1994), these projections form the Schaffer 
collateral pathway to the CA1 region, the associational commissural pathway to other 
neighbouring CA3 pyramidal neurons, and also more specified output to mossy cells 
and the septal nuclei.  
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Figure 1.4 Organisation of the hippocampal subregions Microphotograph coloured to 
illustrate the laminar and transverse subdivisions of the dorsal hippocampus in rodents. 
Adapted from (Ropireddy, Bachus, & Ascoli, 2012). 
1.3.2.1 Schaffer Collaterals 
The schaffer collateral connection to the CA1 forms the final part of the classical 
DG-CA3-CA1 trisynaptic circuit. CA3 pyramidal neurons extend their axons to both the 
stratum radiatum and stratum oriens of the CA1 where they innervate CA1 pyramidal 
cell dendrites via glutamatergic transmission (Sun & Kapur, 2012). These projections 
are commissural, innervating both the ipsilateral and contralateral CA1 region (Witter, 
2007). Although all CA3 cells project both septally and temporally, these projections 
exhibit topographical organisation with CA3c (proximal) neurons projecting mainly to 
more septal CA1 neurons and CA3a/b (distal) neurons projecting more to temporal CA1 
neurons (Brivanlou, Dantzker, Stevens, & Callaway, 2004; Ishizuka, Weber, & Amaral, 
1990). The origin of the CA3 pyramidal neuron also dictate how deeply the axon tends 
to innervate the CA1 – with CA3c neurons tending to project axons to more distal CA1 
regions and innervating mainly superficial levels of the stratum radiatum, while CA3b 
neurons project axons which terminate deeper in the stratum radiatum and penetrate the 
stratum oriens while CA3a neurons project to CA1 neurons closer to the CA2 and 
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innervate the deep stratum radiatum and stratum oriens dendrites. Although a single 
CA3 neuron can project a significant distance along the length of the hippocampus, 
making potentially tens of thousands of synapses (Li, Somogyi, Ylinen, & Buzsáki, 
1994), it is still unknown how many CA1 neurons a single CA3 cell typically 
innervates.   
1.3.2.2 Associational Connections 
One of the key aspects to CA3 episodic memory storage is thought to be its 
autoassociative nature. This is facilitated by the extensive interconnections between 
CA3 pyramidal neurons, and allows for the recall of an episodic memory by the 
presentation of any part of that memory – for example a place or object (Rolls & 
Kesner, 2006). This pathway is known as the commissural-associational pathway 
(Hagenal & Manahan-Vaughan, 2011) and, involving similar topographical complexity 
to the Schaffer collaterals, features both ipsilateral and contralateral projections from 
proximal CA3c pyramidal neurons to other proximal CA3c pyramidal neurons, while 
projections from mid and distal CA3 pyramidal neurons innervate a larger expanse 
along both the septotemporal and transverse axes of the CA3 (Amaral & Lavenex, 
2007). Projections from proximal CA3 project more towards cells dorsal from the origin 
of the cell, while projections from distal CA3 project more towards ventral areas, while 
mid CA3 neurons project to both areas equally (Witter, 2007).  These pyramidal 
neurons also form synapses on CA3 stratum lucidum interneurons (Banke & McBain, 
2006) which in turn inhibit pyramidal neurons, allowing for further modulation of 
synaptic strength in CA3 circuits. This auto-associative network is thought to be 
particularly important for learning associative memories. Gilbert and Kesner (2003), for 
example, showed that, relative to rats with CA1 and DG lesions, CA3 lesioned rats 
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could not perform a stop-go learning task involving the reinforcement of either paired-
associate learning of either object-place or odor-place couplings.  
1.3.2.3 Other CA3 Outputs 
Aside from the Schaffer collaterals and associational pathway the CA3 also 
outputs to the dentate gyrus (Scharfman, 2007; Shi, Ikrar, Olivas, & Xu, 2014) as well 
as to the septal nuclei (Risold & Swanson, 1997). The “backprojection” to the dentate 
gyrus involves output from pyramidal neurons to dorsal polymorphic layer mossy cells 
as well as dentate gyrus interneurons, while ventrally these axons reach the granule 
layer itself and even the inner molecular layer (Myers & Scharfman, 2011). CA3 
pyramidal cells may therefore inhibit their own firing not only by innervating CA3 
interneurons, but also via inhibition of the granular cells which activate them originally. 
Output to the lateral septal nuclei may also eventually influence hippocampal 
functioning by signalling from the lateral septum to the medial septum which innervates 
the subiculum which may subsequently signal to the entorhinal cortex (Gilbert & 
Brushfield, 2009). CA3 output signals to the lateral septum may also then travel to the 
ventral tegmental area forming a circuit which has been shown to be responsible for 
context-reward associations – illustrating a potential role for the CA3 in processing 
context and subsequent motivational behaviours (Luo, Tahsili-Fahadan, Wise, Lupica, 
& Aston-Jones, 2011).  
 1.3.2.4 CA3 Interneurons 
 While the pyramidal cells are the most studied neurons of the CA3, the region is 
also home to a host of heterogeneous, and far less characterised, interneurons. Already 
noted are the stratum lucidum interneurons which receive mossy fibre and CA3 
pyramidal cell input and in turn inhibit both pyramidal neurons and themselves (Banke 
& McBain, 2006).  Other interneurons are generally found throughout all CA1/2/3 
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areas, although they may vary slightly in function or morphology according to the 
specific subfield they inhabit (Amaral & Lavenex, 2007). A second kind of GABAergic 
CA3 interneuron is the oriens lacunosum-moleclare cell (Katona, Acsády, & Freund, 
1999) which project to pyramidal cell neurons in the distal stratum lacunosum-
moleclare while their soma and dendrites may occupy any other stratum in the CA3 
region (Amaral & Lavenex, 2007). Other important interneuron types in the CA3 region 
include the basket cells – GABAergic cells which have their cell bodies close to the 
pyramidal layer and extend dendrites both to the stratum lacunosum-moleclare and the 
stratum oriens receiving input from mossy fibers, pyramidal cells and the entorhinal 
cortex, while innervating pyramidal cells themselves (Tukker, et al., 2013). Also present 
in the CA3 region are axo-axonic interneurons which receive unique septal input and 
function by targeting the axon initial segment of CA3 pyramidal neurons (Viney, et al., 
2013) and interneuron selective neurons which are unique in that their axons only 
innervate other interneurons (Amaral & Lavenex, 2007). These complex cellular circuits 
allows for finely tuned responses to CA3 input and facilitate its role in pattern 
completion and the transmission of information to the CA1.  
1.3.3 CA2 
The CA2 is a small area which lies between CA3 and CA1 and has received 
relatively little attention compared to other hippocampal regions. Although it is 
similarly structured to the neighbouring CA3 and CA1 regions, CA2 is known to show a 
unique expression pattern of various cellular markers, is the sole hippocampal region to 
receive input from the supramammillary body, and its principal pyramidal cells display 
many characteristics which differentiate it from its neighbours (Caruana, Alexander, & 
Dudek, 2012; Mercer, Trigg, & Thomson, 2007). Traditionally, one of the main 
distinctions between CA2 and CA3 pyramidal cells was thought to be the absence of 
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DG mossy fibre input to the former (Amaral, et al, 2007). The CA2 was also found to 
receive entorhinal layer II & III input via distal dendrites and input from neighbouring 
CA3 pyramidal neurons (Chevaleyre & Siegelbaum, 2010). CA2 axons in turn project 
preferentially to the stratum oriens, but also stratum radiatum, of the CA1 (Tamamaki, 
Abe, & Nojyo, 1988) and also engages in reciprocal inhibition with CA3 pyramidal 
neurons, forming inhibitory synapses with proximal CA3 neurons (Kohara, et al., 2014). 
Very recent optogenetics work however has challenged these ideas, showing that 
granule cells actually can project to the CA2, while entorhinal cortex layer III does not 
(Kohara, et al., 2014). These authors propose that the conceptualization of a novel 
trisynaptic circuit from entorhinal cortex layer II to the deep CA1, via the granule cells 
and the CA2 which may regulate “overlearning” by the traditional trisynaptic circuit.  
Aside from differences in pyramidal neurons, CA2 is also unique in aspects of 
its interneuron population. First, the CA2 region contains a higher density of 
interneuron than its neighbouring CA3 and CA1 (Piskorowski & Chevaleyre, 2013). As 
in the CA3 region, basket cells are present here with dendrites extending to the stratum 
oriens/alveus and via the stratum radiatum to the stratum lacunosum moleclare 
(therefore receiving entorhinal cortex input) with axons innervating the pyramidal layer 
– although two functional subtypes exist. The first type are more similar to CA1 basket 
cells – aspiny and extending only within the CA2 region, while the second subtype 
show a small number of spines and extend axons and dendrites throughout CA1, CA2 
and CA3 (Mercer, Trigg, & Thomson, 2007). Another interneuron type identified by 
Mercer et al (2007) were bistratisfied cells – whose cell bodies occupied the pyramidal 
cell layer with dendrites extended to the stratum radiatum and stratum oriens (thereby 
receiving schaffer collateral but not entorhinal input) primarily of the CA2 and CA1. 
Interneurons in the CA2 region therefore have the potential for both feedforward 
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inhibition in CA1 and feedback inhibition in CA3 which may again contribute to the 
suggestion of CA2’s involvement in the management of “overlearning” by other 
hippocampal regions (Kohara, et al., 2014).  
 In functional terms, recent studies have shown that the CA2 likely plays a role in 
social learning and contextual change. The CA2 has been shown to be especially 
involved in perceiving even minor changes to context and environment – often showing 
a complete remapping of activity following small changes in environmental context and 
may compare the context being experienced with one’s internal representation (Wintzer, 
Boehringer, Polygalov, & McHugh, 2014). Mice knocked out for vasopressin 1b 
receptor (Avpr1b), which is preferentially expressed in the CA2 region, show reduced 
sociability and impaired social recognition – as well as impaired object recognition and 
temporal memory (DeVito, et al., 2009). Optogenetic inactivation of dorsal CA2 
pyramidal neurons does not lead to impairments in spatial or fear memory, but it does 
prevent mice from forming social memories – without affecting sociability or olfactory 
function (Hitti & Siegelbaum, 2014).  The CA2 is also thought to be particularly 
susceptible to dysfunction in schizophrenic and bipolar patients (Jones & McHugh, 
2011).  Several studies have shown that there is a loss of inter neurons in the CA2 
region of schizophrenic and bipolar patients (Benes, Kwok, Vincent, & Todtenkopf, 
1998; Knable, Barci, Webster, & Torrey, 2004) – with people suffering from 
schizophrenia typically showing significant social dysfunction (Goldberg & Schmidt, 
2001). Although relatively small, CA2 clearly deserves consideration as a functionally 
and anatomically distinct region of the hippocampus rather than simply an intermediate 
between CA3 and CA1. One area which has not yet been researched however is whether 
the dorsal and ventral CA2 are functionally different as is seen in other hippocampal 
subregions. 
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1.3.4 CA1 
 The CA1 region forms the final part of the traditional trisynaptic DG-CA3-CA1 
circuit. As previously mentioned it is innervated by CA3 via the Schaffer collaterals, as 
well as by CA2 pyramidal cells and interneurons. The CA1 also receives strong 
excitatory innervations from layer III of the entorhinal cortex (Brun, et al., 2008). As 
with the other hippocampal sub-regions, CA1 is laminar and contains principal 
pyramidal neurons as well as at least sixteen types of GABAergic interneurons 
(Somogyi & Klausberger, 2005). The CA1 can also be subdivided into regions 
CA1a/b/c in a similar fashion to the CA3 – Although here CA1a (distal) refers to the 
area closest to the subiculum, with CA1c (proximal) closest to the CA2, and CA1b 
referring to the intermediate area (Ropireddy, Scorcioni, Lasher, Buzsáki, & Ascoli, 
2011).  Additionally, functional and anatomical differences exist along the dorsoventral 
axis of the CA1 in a similar manner to other hippocampal regions (Marcelin, et al., 
2012).  
1.3.4.1 CA1 Principal Pyramidal Neurons 
 As with the other CA regions, pyramidal cells are considered the principal cells 
of the CA1 region. Similar to the CA3, pyramidal neurons may be segregated into 
different lamina in which they show varying anatomical and functional features – which 
are somewhat more characterised than in the CA3 region. Although some 
morphological differences were identified in early anatomical studies (Bannister & 
Larkman, 1995), gene mapping originally delineated a number of strata of pyramidal 
neurons, with Dong, Swanson, Chen, Fanselow and Toga (2009) dividing the pyramidal 
layer into the superficial, deep, and middle pyramidal sublayers – although there is 
variation along the dorsoventral extent of the hippocampus.  Further 
electrophysiological and anatomical characterization of CA1 pyramidal layers then 
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revealed that although they had many similarities deep (close to stratum oriens) 
pyramidal cells contain more place fields, have higher firing rates, and show alternate 
theta and gamma phase preference during maze exploration and REM sleep (Mizuseki, 
Diba, Pastalkova, & Buzsáki, 2011). As with the CA3 pyramidal subdivision, the 
behavioural consequences of these distinct populations is as of yet unknown.  
 CA1 pyramidal cells are typically smaller than CA2/3 neurons, with dendrites 
that extend both to the stratum oriens and also downwards towards the stratum radiatum 
and eventually the stratum lacunosum-moleclare (Amaral & Lavenex, 2007). As 
previously discussed the CA1 can be divided along a transverse axis, and entorhinal 
input is separated along this axis with distal CA1 neurons receiving lateral entorhinal 
cortex input and proximal neurons receiving input from medial entorhinal cortex 
neurons via the stratum lacunosum-moleclare (Amaral & Lavenex, 2007). As the final 
part of the trisynaptic circuit, CA1 neurons in turn project hippocampal information to a 
variety of extra-hippocampal areas. The primary output of the dorsal CA1 is to the 
subiculum – which in turn activates the entorhinal cortex layers V and VI (MacDougall 
& Howland, 2013). Study of axonal projections from the ventral CA1 reveal three major 
routes – the primary connection to the subiculum, another projection to the amygdaloid 
complex, amygdalopiriform-transition area and parahippocampal regions,  and a third 
projection which travels to the septum, hypothalamus, ventral striatum and olfactory 
regions (Arszovski, Borhegyi, & Klausberger, 2014). These projections make sense 
given what is known about the ventral hippocampus’ preferential role in odour memory 
and emotional processing.  
 Aside from its function as an output to extra-hippocampal areas, the CA1 also 
fulfils other roles. While pattern separation and completion are attributed to the DG and 
CA3 respectively, it has been hypothesised that CA1 may bring together these CA3 
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representations leading to the recall of an episodic memory (Rolls, 2013). Temporal 
aspects of episodic memory recall have also been attributed to CA1 with dorsal CA1 
lesioned animals unable to recalling the order in which objects have been presented to 
them (Hoge & Kesner, 2007). Dorsal CA1 electrophysiology and lesion studies also 
implicate the area in the acquisition and consolidation of contextual fear memory 
(Daumas, Halley, Francés, & Lassalle, 2005; Ognjanovski, Maruyama, Lashner, 
Zochowski, & Aton, 2014; Wang, et al., 2012). This indicates that the dorsal CA1 does 
not only encode spatial information but is also involved in processing emotional 
memories. Ventral CA1 is also highly involved in spatial memory performance as well 
as object recognition – despite a growing trend for the attribution of emotional rather 
than spatial processing to the ventral hippocampus (Beer, Chwiesko, & Sauvage, 2014). 
In terms of the transverse axis it has been suggested that proximal CA1 neurons are 
tasked with processing large spatial information while distal neurons deal with olfactory 
and detailed object representations (Igarashi, Ito, Moser, & Moser, 2014).  
1.3.4.2 CA1 Interneurons   
As in CA3 and CA2, interneurons play an important role in CA1 functioning. 
although many interneurons have similar properties across the CA1/2/3 region, there are 
also many discrete differences (Amaral & Lavenex, 2007). Oriens lacunosum-moleclare 
interneurons are also present in the CA1 region, although unlike in the CA3 region, here 
their soma and dendrites occupy only the stratum oriens (Amaral & Lavenex, 2007). 
Basket cells are present as well within the CA1 region but display some differences to 
the CA3 counterparts – namely their dendritic trees are located much more in the 
stratum radiatum than the stratum lacunosum-moleclare and receive much less 
entorhinal input (Tukker, et al., 2013). Parvalbumin-positive CA1 inhibitory 
interneurons, which are compromised in diseases such as schizophrenia, have been 
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shown to be essential for spatial working, but not reference, memory (Murray, et al., 
2011). CA1 interneurons appear to innervate all strata and have also been found which 
backproject to the CA3 (Sik, Penttonen, Ylinen, & Buzsáki, 1995).   
1.3.5 Hippocampal Place cells 
 Place cells, originally discovered in 1971 (O’Keefe & Dostrovsky, 1971), are 
present within all hippocampal subregions, are neurons which fire in isolation when an 
animal enters a certain spatial location – referred to as that cell’s “place field” (Park, 
Dvorak, & Fenton, 2011). These neurons fire again in the same patterns after spatial 
exploration is completed – during sleep or immobility, thereby facilitating consolidation 
of this information (O'Neill, Senior, & Csicsvari, 2006). Place cells gain directional 
specificity as animals become more familiar with an environment (Navratilova, Hoang, 
Schwindel, Tatsuno, & McNaughton, 2012), and can be remapped following both 
changes to spatial context (Solstad, Yousif, & Sejnowski, 2014), or emotional context 
(Moita, Rosis, Zhou, LeDoux, & Blair, 2004) of an environment. Place cell field sise 
has been shown to vary along the dorsoventral axis of the CA1 region, as occurs in CA3 
(Keinath, et al., 2014). These authors also show that despite spatial memory typically 
being attributed to the dorsal hippocampus, ventral CA1 neurons do show detailed place 
fields.  
1.3.6 Long-term Potentiation – Molecular Mechanisms of Memory Formation and 
Consolidation 
 While appreciating the gross anatomy of the hippocampus is essential to 
understanding its function, the cellular processes which contribute to this functioning 
must also be considered. The most important concept to consider in the cellular 
mechanisms for memory formation and consolidation is that of synaptic plasticity. 
Synaptic plasticity refers to the brain’s ability to modify the strength of a synaptic 
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connection either by brief, high frequency stimulation – long-term potentiation (LTP), 
or by prolonged low frequency stimulation – long-term depression (LTD) (Purves, et 
al., 2001). LTP and LTD typically occurs in glutamatergic neurons, and takes place at 
many important connections within the hippocampus (e.g. Schaffer Collaterals, 
perforant pathway) (Collingridge, Peineau, Howland, & Wang, 2010). The best 
characterised forms of LTP and LTD depend on N-methyl-D-aspartate (NMDA) 
glutamate receptors (Lüscher & Malenka, 2012) – although some forms of NMDA-
independent LTP and LTD can also occur. LTP is now known to take place in the 
hippocampus as a result of many different forms of behavioural learning – inhibitory 
avoidance (Whitlock, Heynen, Shuler, & Bear, 2006), spatial learning (Liu, et al., 2014) 
and emotional learning (Schulz & Korz, 2010). Although LTD involves the weakening 
of synaptic strength, it is not simply functionally opposite to LTP, and is also required 
during learning (Sacai, et al., 2014) and behavioural flexibility (Nicholls, et al., 2008). 
Like LTP, LTD has also been implicated in emotional memory (Diamond, Park, 
Campnell, & Woodson, 2005). Despite decades of research however a comprehensive 
mechanism by which LTP/LTD actually form memories within the hippocampus is still 
elusive.  
1.4 Contribution of non-neuronal cells to CNS functions 
 Though hippocampal neuroanatomy has primarily been discussed here in terms 
of neuronal populations and circuits – other cell types are also key to proper 
functioning. Many of the cognitive impairments observed in post-septic encephalopathy 
necessitate the hippocampus, and indeed significant neurological alterations are seen in 
this area in post-septic patients (Semmler, et al., 2013). It is therefore pertinent to 
consider the hippocampus not just in terms of its neuronal population, but also in terms 
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of the immune cells which reside there and are essential both to normal functioning, as 
well as orchestrating the response to infectious events such as sepsis.   
1.4.1 Microglia, Astrocytes and immunity within the brain 
Astrocytes and microglia are two types of glial cells which are involved both in 
brain immune function as well as in the maintenance and regulation of synaptic 
plasticity – a key process in learning and memory. Microglia are macrophages which 
reside within the CNS and are involved in phagocytosis of both pathogens and 
unnecessary synapses (Kaushik & Basu, 2013; Marin & Kipnis, 2013). Astrocytes also 
react to brain insult, releasing inflammatory mediators, and when necessary forming 
glial scars which surround injured tissue isolating it from healthy tissue (Wanner., et al., 
2013). Astrocytes are involved in synaptic plasticity during both development and 
normal adult functioning, releasing both glutamate and ATP to alter activity at 
presynaptic glutamatergic terminals (Stipursky, Romão, Tortelli, Neto, & Gomes, 
2011). Given astrocytes close proximity to the synapse and their ability to both act as 
receptors for, and release, neurotransmitters it is thought that they regulate synaptic 
functioning via bidirectional signalling with neurons (Allen & Barres, 2009). Due to the 
importance of perisynaptic astrocytes the concept of a “tripartite” synapse is now 
replacing the traditional idea of communication existing only between a presynaptic and 
postsynaptic neuron, with perisynaptic astrocytes present at the majority of rat 
hippocampal synapses (Ota, Zanetti, & Hallock, 2013; Witcher, Kirov, & Harris, 2007).  
While both microglia and astrocytes are crucial for host response to both injury 
and pathogens, there is growing evidence to suggest that their prolonged activation can 
be detrimental to many aspects of normal CNS functioning. Microglia undergo various 
phenotypic and morphological changes in response to pro- or anti-inflammatory stimuli 
in their environment (Michelucci, Heurtaux, Grandbarbe, Morga, & Heuschling, 2009). 
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These are represented in Figure 1.5. Upon the detection of activating signals or the 
cessasation of “deactivating” signals such as CD200 (Kettenmann, Hanisch, Noda, & 
Verkhratsky, 2011) microglia move from a ramified state (also referred to as a “resting” 
or “surveilent” state) where they monitor and support normal synaptic functioning 
(Morris, Clark, Zinn, & Vissel, 2013) to a deramified or “active” state accompanied by 
an increase in pro-inflammatory cytokine release. As described above, in sepsis this 
changes is primarily driven by NF-κB activation following LPS recognition by TLR-4. 
This response is necessary to deal with infection and/or injury, but microglia may also 
stay chronically activated and subsequently neurotoxic by a self-propelling mechanism 
if this active state is not properly resolved. It is thought inducible reactive oxide species, 
nitric oxide and cytokines released by activated microglia may maintain microglia 
themselves in an activated state which ultimately becomes harmful (Lijia, Zhao, Wang, 
Wu, & Yang, 2012). 
 
 
 
 
 
 
 
Figure 1.5 Microglial morphology in the CNS Illustration of the morphological 
changes microglia undergo when shifting to an activated state. Adapted from 
Karperien, Ahammer, & Jelinek, 2013. 
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Given their requirement during normal functioning, if microglia remain 
activated within the brain then deleterious changes are likely to occur. It is now 
becoming accepted that a neuron-microglia-astrocyte triad is necessary for normal brain 
function (Cerbai, et al., 2012). Indeed  neuroinflammation and cytokine signalling are 
implicated in the  pathogenesis of several neuropsychiatric disorders such as major 
depression (Miller, Maletic, & Raison, 2009) and schizophrenia (Na, Jung, & Kim, 
2012) as well as other neurological disorders such as Parkinson’s disease (Collins, 
Toulouse, Connor, & Nolan, 2012). It is therefore probable that activated microglia play 
a deleterious role in the post-septic brain where they may affect proper neuronal 
function. 
1.4.2 Cytokines and synaptic transmission 
Cytokines, produced by immune cells both in the periphery and the CNS, 
function as messenger proteins which are essential for an appropriate response to 
injury/pathogenic invasion (Stow & Murray, 2013) in addition to being necessary for 
normal synaptic function. Synaptic scaling, a homeostatic process through which cells 
in a system alter their firing rate by uniformly revising the strength of all their synapses 
is dependent on glial produced TNF-α (Stellwagen & Malenka, 2006). Apart from 
homeostatic synaptic regulation, cytokines also show specific and regional effects on 
LTP and LTD (Pribaiag & Stellwagen, 2014). Recently, Il-1β, IL-6 and IL-18 (but not 
TNFα) have been shown to be induced by LTP in the rat hippocampus (Del Rey, 
Balschun, Wetzel, Randolf, & Besedovsky, 2013). The authors also showed that IL-1β, 
IL-6 and IL-18 were upregulated following spatial training, with a difference between 
ventral and dorsal as well left and right hippocampi. In other experiments Il-1β has been 
shown to be induced by, and necessary for LTP maintenance in the hippocampus 
(Yirmiya & Goshen, 2011). IL-6 on the other hand may be necessary for the termination 
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of LTP – with the blockade of IL-6 inducing prolonged LTP and improved hippocampal 
dependant long-term memory (Balschun, et al., 2004). TNFα also appears to have an 
inhibitory effect on long-term potentiation in the hippocampus (Butler, O'Connor, & 
Moynagh, 2004). 
Examination of hippocampal inflammation in the context of experimental 
autoimmune encephalomyelitis, an experimental multiple sclerosis, has shown that 
impairments of GABAergic transmission by activated microglia in vitro depends on IL-
1β, being rescued by treatment with IL-1β receptor antagonist (Nisticò, et al., 2013).  
The application of IL-1β (but not TNFα or IL-10) to cell cultures containing 
hippocampal primary neurons significantly reduces the phosphorylation and surface 
expression of AMPA receptor subunit GluR1 (Lai, Swayze, El-Husseini, & Song, 
2006). Interestingly, researchers investigating the effects of peripheral inflammation 
induced via treatment with Freund’s adjuvant and mycobacteria found increased 
hippocampal microglia expression and impaired LTP in the absence of an increase in 
either hippocampal TNFα or IL-1β levels (Di Filippo, et al., 2013). 
Given their necessity for normal synaptic functioning, it follows that over- or 
under-expression of these cytokines can affect normal neurotransmission. Psychiatric 
illnesses are increasingly being recognised not only as brain disorders, but as involving 
neuroimmune components in their pathophysiology (Müller, 2009). Cytokines such as 
IL-1β and TNF-α are known to influence both serotonergic (Baganz & Blakely, 2013) 
and dopaminergic signalling (Felger & Miller, 2012), two neurotransmitters strongly 
implicated in affective disorders. The examination of the effects of glia and cytokines 
on synaptic plasticity, neurogenesis and apoptosis therefore represent a valuable target 
for understanding how neurobehavioural deficits in post-septic encephalopathy, and 
other neuroimmune disorders, may develop and persist. 
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1.5 Hippocampal Neuroimmune Interactions and Affective Disorders 
1.5.1 Adult Neurogenesis in Immune and Affective Disorders 
Though cognitive impairment may be more demonstrable in post-septic patients, 
it has also been outlined that affective changes may also be present in some sepsis 
survivors. While the hippocampus has long been studied in terms of its contribution to 
memory and learning, newer research has also been assessing its role in depression and 
anxiety. Impaired neurogenesis has been one of the most important factors implicated in 
many of the main animal models of depression such as olfactory bulbectomy in mice 
(Islam, Moriguchi, Tagashira, & Fukunaga, 2014) and rats (Jaako-Movits, Zharkovsky, 
Pedersen, & Zharkovsky, 2006), maternal immune activation  (Lin & Wang, 2014; 
Meyer, et al., 2006), and unpredictable chronic mild stress (Tanti, Rainer, Minier, 
Surget, & Belzung, 2012; Nollet, et al., 2012). Indeed, human studies have also shown 
that hippocampal volume is reduced in sufferers of unipolar depression (Videbech & 
Ravnkilde, 2004). In fact, hippocampi from unmedicated depressed patients show 
reduced granule neurons in the dentate gyrus compared with controls and medicated 
depressed patients (Boldrini, et al., 2013). Importantly however, while anti-depressants 
increase NPC proliferation in patients with depression, untreated depressed patients do 
not show significantly lower NPC levels relative to controls (Boldrini, et al., 2009) 
Early research suggested that hippocampal neurogenesis may actually be 
required for the behavioural effects of antidepressants such as fluoxetine (Santarelli, et 
al., 2003). Increased adult neurogenesis is not always a requirement for fluoxetine to 
exert its anti-depressant effects however. For example, in cyclin D2 (CD2) knock-out 
(KO) mice which show almost no adult neurogenesis, fluoxetine reversed depressive-
like behaviour following stress despite having no effect on adult neurogenesis in KO 
mice (Jedynak, Kos, Sandi, Kaczmarek, & Filipkowski, 2014). It has also been 
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suggested that neurogenesis may be required for anti-depressant effects only in certain 
models/paradigms such as the novelty suppressed feeding test, but not others such as the 
forced swim test & open field behaviour (David, et al., 2009).  
1.5.2 Brain Derived Neurotrophic Factor in Immune and Affective Disorders 
Aside from adult hippocampal neurogenesis, the neurotrophin brain derived 
neurotrophic factor (BDNF) has also been implicated both in depression and the 
mechanism of action of anti-depressants such as fluoxetine (Jiang & Salton, 2013). 
BDNF binds to the receptor TrkB and is involved in a number of key processes within 
the hippocampus including both synaptic transmission and long-term potentiation 
(Murray & Holmes, 2011), as well as promoting neurogenesis (Scharfman, Goodman, 
Macleod, Antonelli, & Croll, 2005) and the differentiation to (Babu, Ramirez-
Rodriguez, Fabel, Bischofberger, & Kempermann, 2009) and survival of newborn 
neurons (Sossin & Barker, 2007). Intact BDNF-TrkB signalling is also required for the 
integration of these adult-born neurons into existing hippocampal networks (Bergami, et 
al., 2008). 
Given the important role of BDNF in synaptic plasticity and neuronal survival, 
and the potential for these processes to be disrupted in affective disorders a number of 
studies have investigated a possible role of BDNF in the neurobiology of depression. 
Reduced mRNA and protein expression of BDNF as well as protein levels of TrkB have 
been shown to be present in post-mortem hippocampus and prefrontal cortex of suicide 
victims (Banjerjee, Ghosh, Ghosh, Bhattacharyya, & Mondal, 2013; Dwivedi, et al., 
2003). A later study showed that, in suicide victims, hippocampal BDNF was 
significantly lower in people who had an antemortem diagnosis of major depressive 
disorders who were not receiving medication, and that this effect was absent in those 
who had a diagnosis of depression but were taking antidepressant medication at the time 
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(Karege, Vaudan, Schwald, Perroud, & La Harpe, 2005).  BDNF gene and protein 
levels are also reported to be significantly lower in the lymphocytes and platelets of 
drug-free sufferers of major depression (Pandey, et al., 2010). Interestingly, serum 
BDNF levels are decreased in bipolar patients and unipolar major depressed patients 
during both depressive and manic episodes, with levels negatively correlating with the 
severity of symptoms in both cases (Cunha, et al., 2006; Karege, et al., 2002). 
Anti-depressant medications have been shown to upregulate BDNF levels 
relative to untreated patients in post mortem hippocampal tissue (Chen, Dowlatshahi, 
MacQueen, Wang, & Young, 2001). Importantly, anti-depressants have actually been 
shown to increase serum BDNF levels in patients after chronic treatment to drug-free 
baseline levels (Aydemir, Deveci, & Taneli, 2005; Gonul, et al., 2005), although this 
effect may only be present in responders to anti-depressant treatment (Yoshimura, et al., 
2007). There is also evidence that other treatments such as electroconvulsive therapy 
may lead to increased serum BDNF in patients who do not respond well to 
pharmacological antidepressants (Bocchio-Chiavetto, et al., 2006). In animal models 
BDNF administration itself leads to anti-depressive effects (Shirayama, Chen, 
Nakagawa, Russell, & Duman, 2002), while physical exercise which is known to have 
anti-depressant effects also increases hippocampal BDNF (Baj, et al., 2012).  
As with neurogenesis however, the restoration of altered BDNF levels may not 
always be essential to anti-depressant activity. Ninan, Shelton, Bao and & Guico-Pabia 
(2014) for example found that a 12 week treatment with desvenlafaxine (SNRI) did not 
significantly increase serum BDNF levels despite eliciting a significant anti-depressant 
effect, although a larger increase was present in severely depressed patients than those 
with less severe symptoms. Interestingly 28-day administration of fluoxetine at a 
5mg/kg dose did not increase hypothalamic BDNF mRNA despite attenuating pro-
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inflammatory cytokine production (Alboni, et al., 2013). Most likely, changes in BDNF 
levels among those treated with anti-depressants depend on the type of treatment 
received and the severity of as well as specific symptoms present (Deuschle, et al., 
2013; Hellweg, Ziegenhorn, Heuser, & Deuschle, 2008).  
1.5.3 Cognitive Disruptions in Mood Disorders 
Further evidence for the involvement of the hippocampus in depression comes 
from studies which involve the measurement of functions known to require the 
hippocampus in patients suffering from affective disorders. Evidence from human 
studies of patients with both unipolar and bipolar depression suggested hippocampal 
dysfunction, with inferior spatial navigation in virtual reality tasks as compared with 
healthy controls (Cornwell, et al., 2010; Gould, et al., 2007). Therefore rather than 
framing depression as a consequence or symptom of hippocampal dysfunction it may be 
wise to consider how affective disorders can impact on other aspects of hippocampal 
functioning. As has been discussed, although emotional functioning is more commonly 
attributed to the ventral than dorsal hippocampus there is significant interconnectivity 
between these two areas. Therefore mnemonic and emotional information may be 
transmitted across hippocampal axes and it would not be surprising if disorders which 
involve disruption to the physiology or function of one hippocampal subregion affect 
that of other subregions. In a stress-induced model of depression, behavioural despair 
has for example been shown to involve glutamatergic DG to CA3 signalling along the 
entire dorsoventral axis of the hippocampus (Wang, Zhang, & Lu, 2014). Given the 
complex circuitry within the hippocampus it can be seen how disturbances to even one 
layer or type of cell may have follow on effects throughout the whole system. 
Disruption to interneurons for example may cause over stimulation of primary neurons 
– while a lack of newborn granule neurons may lead to a heightened threshold for CA3 
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activation via mossy fibers and subsequent CA1 activation disrupting hippocampal 
output to other areas. 
1.5.4 Other Key Affective Areas – Amygdala and Prefrontal Cortex 
 Though the hippocampus is an important area in processing emotion the 
contributions of areas such as the amygdala and medial prefrontal cortex (mPFC) 
cannot be ignored. The amygdala, shown in Figure 1.6, is actually a collection of 
distinct nuclei which can be broadly divided into five areas – the basolateral, lateral and 
basomedial/accessory basal nucleus as well as the central nucleus and the medial 
nucleus (Soma, et al., 2009).  
  A)                                                                  B)           
 
 
 
 
Figure 1.6 Location and anatomy of the amygdala Photomicrographs showing A) the 
macroscopic organization of the rodent amygdala and B) its position in relation to the 
hippocampus - * represents the intercalated cell clusters of the amygdala. Adapted from 
(Pape & Pare, 2010) (A) and (Brinks, van der Mark, de Kloet, & Oitzl, 2007) (B). LA – 
Lateral Amygdala, BL – Basolateral Amygdala, AB – Accessory Basal 
Amygdala/Basomedial Nucleus, CE – central amygdala, ME – medial amygdala. 
This region is particularly important for mediating social and emotional 
behaviour, as well as pairing neutral stimuli with emotionally-salient information (for 
example during fear conditioning paradigms) (Manning, Martin, & Meng, 2003). The 
amygdala, most significantly, the basolateral nucleus, is known to input to the ventral 
hippocampus CA3 and CA1 stratum oriens and radiatum thereby glutamatergically 
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innervating pyramidal neurons (Pikkarainen, Rönkkö, Savander, Insausti, & Pitkänen, 
1999) with recent optogenetic work illustrating the control this connection exerts over 
anxiety (Felix-Ortiz, et al., 2013) and social behaviour (Felix-Ortiz & Tye, 2014). 
Electrophysiological work has also shown that this nucleus can induce LTP in the 
dentate gyrus (Vouimba & Richter-Levin, 2013). Studies in humans reveal functional 
and morphological abnormalities in  anxiety disorders – for example under-activation of 
the amygdala in generalised anxiety disorder (Yassa, Hazlett, Stark, & Hoehn-Saric, 
2012) amygdala hyperactivity in obsessive-compulsive disorder (Simon, Adler, 
Kaufmann, & Kathmann, 2014), and hyperactivity with impaired functional 
connectivity in social anxiety disorder (Hahn, et al., 2011) and hyper-activation. One 
fMRI study in unipolar depression patients has shown that the amygdala shows reduced 
functional connectivity with many other areas – an effect the authors suggest may be 
relative to the anhedonia and dulling of emotions experienced in depression (Benson, et 
al., 2014).  
Though the amygdala is often referred to as a unitary structure, the five nuclei 
mentioned above appear to serve distinct roles and relate to fear processes in different 
ways. The basolateral and lateral nuclei receive input both from sensory regions as well 
as the hippocampus and prefrontral cortex, and it is suggested that these regions are 
involved in assessing the emotional significance of these inputs (Rosen & Donley, 
2006). The central amygdala in turn receives input from the lateral and basolateral 
nuclei (Wilensky, Schafe, Kristensen & LeDoux, 2006), and is key both for the 
consolidation and expression of fear. Due to its projections to areas such as the 
brainstem and hypothalamus, the central nuclei are thought to be important in driving 
our behavioural and physiological responses to fear (Kalin, Shelton & Richardson, 
2004). The medial amygdalar nucleus is functionally connected to olfactory areas in 
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rodents, though it is suggested that this area is also important for more unconditioned 
emotional responses (Keshavarzi, Sullivan, Ianno & Sah, 2014). While most studies 
delineating the differential functioning of amygdala nuclei have been done in rodents, 
there is also evidence that similar divisions exist within humans – though these are far 
less studied (Ball, Rahm, Eickhoff, Schulze-Bonhage, Speck & Mutschler, 2007). 
The medial prefrontal cortex and its neighbouring anterior cingulate cortex also 
play a key role in regulating our emotions and, as with the hippocampus, are often 
divided into dorsal and ventral portions (Etkin, Egner, & Kalisch, 2011). The rodent 
medial prefrontal cortex is actually a point of convergence for axons of the 
hippocampus and amygdala, receiving input from both the BLA and CA1 pyramidal 
neurons (Ishikawa & Nakamura, 2003) and in turn projects to the BLA (Sesack, Deutch, 
Roth, & Bunney, 1989). Apart from its role in emotional functioning, the prefrontal 
cortex also works synergistically with the hippocampus during memory-based tasks. In 
particular, the prefrontal cortex is important for working-memory based tasks (Yoon, 
Okada, Jung & Kim, 2008). Inputs from the ventral hippocampus to the medial 
prefrontal cortex are suggested to be essential not just for emotional behaviour but also 
for cognition (Parent, Wang, Su, Netof & Yuan, 2010).  
While the amygdala is usually studied in the context of fear and anxiety, the 
mPFC may be more involved in positive affect – controlling positive emotional learning 
in a rat model (Burgdorf, et al., 2011). In humans the medial prefrontal cortex is 
involved in high level emotional processing and the recall of emotional 
autobiographical memories (Oddo, et al., 2010).  Patients with damage to this area 
suffer from an inability to correctly regulate their emotional expression (Anderson, 
Barrash, Bechara, & Tranel, 2006) and also to interpret the intent (harmful or otherwise) 
behind the actions of others (Young, et al., 2010).  Damage to the human prefrontal 
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cortex also affects the autonomic response to stressful situations such as cortisol release 
and heart rate (Buchanan, et al., 2010). These patients also show dysregulation of 
amygdala activity, with increased reactivity in the area to aversive stimuli implicating 
the mPFC in the pathogenesis of anxiety and mood disorders (Motzkin, Philippi, Wolf, 
Baskaya, & Koenigs, 2014).  
Aside from its connections with the hippocampus, the amygdala is also 
functionally connected to the prefrontral cortex, and it has been suggested that 
hippocampal-prefrontal-amygdalar connectivity is key to the consolidation of 
conditioned fear (Moustaga, Gilbertoson, Orr, Herzallah, Servatius & Myers, 2013). 
During fear conditioning, the amygdala outputs from the BLA to the hippocampus, 
which in turns signals from ventral hippocampal neuros to the medial prefrontal cortex 
(Marek, Strobel, Bredy & Sah, 2013). In humans, the strength of amygdala to prefrontal 
connections, assessed using diffusion tensor imaging, has been shown to predict trait 
anxiety levels – with higher connectivity predicting lower anxiety (Kim & Whalen, 
2009). Post-traumatic stress disorder patients also show excessive amygdala activity but 
reduced medial prefrontal cortex size and responsivity highlighting the importance of 
these pathways not just in learning fear, but also in fear extinction (Shin, Rauch & 
Pitman, 2006). Untreated patients suffering from MDD also show dampened amygdala 
to medial prefrontal cortex signalling, when asked to process emotionally-salient 
information, illustrating how the importance of these connections in emotions other than 
fear (Kong et al, 2013). 
1.6 Outstanding Questions 
Despite a handful of good studies which have described some of the long-lasting 
neurological and behavioural effects of a septic dose of LPS (Bossù, et al., 2012; Fan, et 
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al., 2012; Qin, et al., 2007; Semmler, et al., 2007; Weberpals, et al., 2009) 
comprehensive examination of the long-term effects of LPS on a wide variety of 
cognitive and affective behaviours in a single model has yet to be carried out. Given that 
the hippocampus is of central importance in both cognitive and affective functioning, 
and that sepsis survivors show neuroinflammatory (Lemstra, et al., 2007) and 
hippocampal morphometry (Semmler, et al., 2013) changes it was also decided to 
examine the state of the hippocampus both shortly following LPS administration and 
during the chronic state of post-septic encephalopathy. In this regard a wide range of 
cytokines, glial markers, apoptotic markers, immediate early genes and investigated cell 
proliferation within the hippocampus were examined to build a profile of the 
neurological changes which accompany behavioural impairments. Although recent 
research has critiqued both CLP and LPS-administration models of sepsis (Seok, et al., 
2013; Zofaghari, Pinto, Dyson, & Singer, 2013) and their relevance to the human 
condition  there are obvious limitations to research in human post-septic encephalopathy 
and as of yet the entire scope of effects produced during LPS-induced sepsis remains 
undescribed.  
 In light of the poor understanding at present of the aetiology of post-septic 
encephalopathy and the lack of available treatments, following the characterisation of 
the neuroimmunological and behavioural profile of this mouse model of post-septic 
encephalopathy, the aim was to answer questions about the mechanisms by which long-
term alterations may be elicited by systemic LPS administration and whether there are 
any treatments which might be useful. Since the hippocampus of post-septic mice 
displays elevated levels of microglial markers without over-expression of pro-
inflammatory cytokines it was hypothesised that microglia may be “primed”. This was 
investigated by examining the response of post-septic mice to another small dose of 
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LPS, mimicking a secondary inflammatory insult following recovery from sepsis. As 
NF-κB is known to be a key driver of the immune response to LPS I investigated 
whether inhibition of this pathway might rescue animals from some of the long-lasting 
effects of LPS administration. Although NF-κB has previously been investigated in 
relation to its effects on acute LPS treatments, no long-term investigation of its 
inhibition has been carried out. I also sought to investigate the potential of the SSRI 
fluoxetine to alleviate some of the changes present in post-septic mice given its utility in 
affective disorders and anti-inflammatory properties.  
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Chapter 2. Cognitive and Affective Behaviour in post-septic mice 
Abstract 
The aim of this chapter was to characterise the behavioural alterations present in 
post-septic mice. Mice were administered a septic dose of LPS and then left to recover 
for one month before testing. Behavioural tests were then conducted within both the 
affective and cognitive domain. Unlike previous research which showed cognitive 
problems in post-septic mice, here no deficits were present in tasks assessing either 
long-term or short-term memory – although there are some changes to novel object 
exploration. Within the affective domain post-septic mice show increased anxiety-like 
and depressive-like behaviours in some taks (elevated plus maze, tail suspension test, 
sucrose preference test), but no changes in others. It is also shown that an acute 
treatment with fluoxetine can reduce this depressive-like behaviour in the tail 
suspension test. Finally it is also demonstrated that single versus group housing does not 
affect behaviours in the marble burying or forced swim test. It is concluded that 
although these post-septic mice do not show cognitive deficits in the tests selected, they 
do show some affective changes which are also a common symptom in patients 
recovering from sepsis.   
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2.1 Introduction 
2.1.1 Memory and Learning Deficits in Sepsis survivor rodents 
Analagous to patients who have recovered from sepsis, sepsis-survivor rodents 
have been shown to exhibit distinct cognitive impairment and behavioral changes 
following recovery from the acute effects of sepsis. Ten days after the induction of 
sepsis via cecal ligation and puncture (CLP), a time point at which animals are known 
to be free from infection (Comim, et al., 2010) rats have been shown to have impaired 
memory in the step down passive avoidance task (Cassol-Jr, et al., 2010). In addition to 
altered open field test exploration patterns, memory impairment has also been shown 
both 10 and 30 days after CLP in rats in a continuous multiple-trials step-down 
inhibitory avoidance task (Barichello, et al., 2007). Short-term and long-term novel 
object recognition have also been shown to be impaired in sepsis survivor rats 10 days 
after CLP, indicating non-spatial and non-aversive memory disruption (Cassol-Jr, et al., 
2011). 15 days post-CLP rats have shown impaired fear memory and Morris watermaze 
performance, which was protected against by genetic and pharmacological inhibition of 
oxidative stress (Hernandes, et al., 2014) 
Cognitive impairments have also been shown in sepsis models using an i.p. 
administration of LPS rather than CLP. Male Wistar rats administered a 10mg/kg dose 
of LPS have been found to have impaired performance in an 8-arm radial maze 
following recovery, as well as altered open field exploration patterns (Semmler, et al., 
2007). These animals spent longer in the corner squares and the wall corridor, as well as 
a reduced time in the centre square - behaviour which is thought to be indicative of 
anxiety. Interestingly however, unlike rats who underwent CLP in other studies, these 
rats did not display impaired learning in a passive avoidance test, although the apparatus 
used was different.  A 5mg/kg dose of LPS given to C57BL/6 mice was found not to 
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produce any locomotor or behavioural alterations in an open-field test 2 months post-
treatment, but signficantly increased both working and reference memory errors on an 
eight-arm radial maze test, as well as significantly increasing the number of trials 
necessary to complete the task (Weberpals, et al., 2009). These results indicate that 
while there are some differences between the models in terms of the specific memory 
deficits which follow recovery, cognitive processes are negatively affected to a large 
degree in the absence of sickness behaviour or locomotor effects in both models. The 
amount of time which has passed since the induction of sepsis may also factor in the 
results obtained in these cognitive tests.  
2.1.2 Memory and Learning in the Presence of Chronic Neuroinflammation 
Neuroinflammation is one of the most central pathophysiological aspects of 
post-septic encephalopathy, and as such, models involving chronic neuroinflammation 
are particularly relevant to the understanding of cognitive deficits which follow sepsis 
recovery. Chronic neuroinflammation has previously been shown to affect multiple 
forms of memory accross several models of central nervous system (CNS) disorders. 
For example, in the Morris water maze (Morris, 1981), a task which requires animals to 
learn the location of an invisible platform based on the position of external spatial cues 
sustained interleukin-1β over-expression for 14 days in a transgenic mouse line has 
been found to disrupt acquisition and long-term memory retention in mice in a Morris 
water maze task (Moore, Wu, Shafter, Graham, & O'Banion, 2009). Chronic infusion of 
LPS into the 4
th
 ventricle has also been shown to significantly impair rats’ performance 
in the watermaze (Cui, et al., 2008; Rosi, et al., 2006) and induce alterations in the T-
maze, but not novel object recognition (Hauss-Wegrzyniak, Vannucchi, & Wenk, 
2000). In addition to long-term spatial memory disruption, chronic infusion of LPS 
(0.25 µl/hr)  into the 4
th
 ventricle of Wistar rats has been found to disrupt spatial 
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working memory, an effect which was reversed by daily administration of the non-
steroidal anti-inflammatory drug dexibuprofen (Jin, et al., 2008). 
 Non-spatial memory is also known to be affected by chronic neuroinflammation. 
In a contextual fear-conditioning paradigm, mice who over express the pro-
inflammatory cytokine 1L-1β display significantly impaired long-term contextual 
memory (Hein, et al., 2010). Auditory conditioning was not impaired however, 
indicating an effect on hippocampus-dependent, but not independent learning. Injections 
of IL-1β itself have also been shown to impair contextual fear learning in Sprague-
Dawley rats (Hein, et al., 2007). Peripheral LPS injection has also been shown to 
disrupt contextual but not auditory fear conditioning when given after the conditioning 
session had finished, suggesting it disrupts consolidation processes which occur after 
the learning event has taken place (Pugh, et al., 1998). Microglial activation appears to 
be the key factor in producing long-term cognitive deficitis following CLP, as its 
inhibition with minocycline protects sepsis-survivor rats from oxidative stress in the 
hippocampus and rescues cognitive ability in the step-down inhibitory avoidance task 
(Michels, et al., 2014)  
Further evidence for a role of the immune system in learning and memory comes 
from the fact that severe combined immune deficitent (scid) mice display impaired 
cognitive performance relative to wild-type controls (Brynskikh, Warren, Zhu, & 
Kipnis, 2008). These mice are deficient in both T cells and B cells, and have been 
shown to display impaired learning in the Morris water maze, the radial arm water maze 
test, and the Barnes maze (Brynskikh, et al., 2008; Kipnis, Cohen, Cardon, Ziv, & 
Schwartz, 2004). These impairments can then be saved by T cell vacination with 
glatiramer acetate. This provides evidence that while inflammatory factors may 
adversely affect learning in some contexts, they are also required for learning in others. 
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although heterogeneous in terms of the models used, this literature illustrates clearly the 
necessity of a functioning immune system for several phases and types of memory 
processessing, as well as the deficits which follow where the immune system becomes 
dysregulated.  
2.1.3 Affective Changes in Post-septic Animal Models 
Affective changes are also present in a number of studies involving animal 
models of post-septic encephalopathy. Ten months after LPS-induced sepsis rats show 
no differences in the elevated plus maze or Morris watermaze, although they exhibit 
reduced exploration and recognition of a novel object in the open field test (Bossú, et 
al., 2012). Post-septic animals have also been shown to display increased levels of 
depressive-like behaviour including both anhedonia and behavioural despair (Comim, et 
al., 2010; Petronilho, et al., 2012; Tuon, et al., 2008) as well as anxiety-like behaviour 
in the elevated plus maze ten days after CLP (Calsavara, et al., 2013). Similarly to post-
septic affective changes in humans, affective behavioural change here seems to be 
affected by the time since sepsis onset as well as the precise construct being measured. 
2.1.4 Affective States in Populations with Chronic Neuroinflammation 
 A large comorbidity exists between mood disorders and anxiety disorders. Those 
who are diagnosed with an anxiety disorder are 12 times more likely to suffer with 
depression than those who do not, while those diagnosed with depression are eight 
times more likely to be diagnosed with generalised anxiety disorder in the next 12 
months (Ross, 2009). Studies in both clinical, and non-clinical, populations have 
revealed a link between the inflammatory state and affective disorders. As previously 
noted, sepsis survivors sometimes display more emotional problems than patients who 
were chronically hospitalised for other serious conditions. Studying the interaction 
between the inflammatory system and affective states in other populations may provide 
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clues as to how post-septic encephalopathy contributes to an altered affective state 
above and beyond that experienced following life-threatening illnesses in general. 
In a study involving 453 men, and 400 women anxiety levels as rated by the 
Spielberger State Anxiety Questionnaire higher anxiety levels were found to correlate 
significantly with C-reactive protein (CRP), TNF-α and IL-6 levels in men, as well as 
CRP and IL-6 levels in women (Pitsavos, et al., 2006), all of which are upregulated 
during neuroinflammation. A randomised-control trial of omega-3 and omega-6 
polyunsaturated fatty acids in a non-clinical population revealed that a reduced omega-
3:omega-6 ratio led to lower LPS-stimulated IL-6 and TNF-𝛼 levels along with reduced 
anxiety symptoms (Kiecolt-Glaser, Belury, Andridge, Malarkey, & Glaser, 2011). The 
relationship between pro-inflammatory factors and anxiety does not appear to be 
universal however. One study of elderly, non-demented participants found no 
significant relationship between 10 markers of systemic inflammation – including CRP, 
IL-6 and TNF-α, and anxiety levels, although a significant correlation was found 
between between IL-6 and IL-8 and depressive symptoms at baseline, increasing IL-8 
and depressive symptoms after 2 years, and an association between plasminogen 
activator inhibitor-1 and remitting depressive symptoms (Baune, et al., 2012).  
 Further support for this association comes from a birth cohort study of 2688 
males and 2837 females in Finland which found that anxiety symptoms alone doubled 
the probability of elevated CRP levels in males, while comorbid anxiety and depressive 
symptoms predicted a 1.7-fold increase in probability of elevated CRP levels 
(Liukkonen, et al., 2011). An Irish study of both clinically anxious and non-clinical 
participants found significantly higher levels of IL-6, and significantly lower morning 
levels of the stress hormone cortisol, with no difference between sexes, ages or 
depressive symptoms (O'Donovan, et al., 2010). Interestingly, there was no between 
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groups difference in CRP levels. These results indicate an increase in low-grade 
inflammation among males with anxiety and comorbid anxiety with depression but not 
females, indicating that there may be sex differences, as well as inter-region differences 
in the relationship between inflammatory factors and anxiety levels.   
Interferon-α is a key component of the immune system, employed as a treatment 
for a variety of illnesses. Treatment with interferon-α however commonly leads to the 
development of depression, following which patients are often required to cease 
treatment. Treatment with interferon-α has been shown to correlate with depressive and 
anxious symptoms in numerous human populations, such as chronic hepatitis C patients 
(Bonaccorso, et al., 2001), multiple sclerosis (Loftis & Hauser, 2004) and systemic 
mastocytosis (Casassus, et al., 2002). Many of these studies do not employ a control 
treatment group however making it difficult to discern whether the increased depressive 
and anxious symptoms were caused soley by treatment or whether the progression of 
illness may play a role. 
Although depression is most likely a result of an interaction between the 
environment and many genes (Wong & Licinio, 2001), there have been some links 
between particular immune genes and the disorder. In Caucasian patients with major 
depression, diminished efficacy of antidepressant treatment and as well as altered 
amygdala and anterior cingulate cortex response during emotional processing has been 
shown to associated with a genotype of two single nucleotide polymorphisms of the IL-
1β gene (Baune, et al., 2010). Single nucleotide polymorphisms in two genes necessary 
for T-cell function have been shown to be predictive of Major Depressive Disorder 
among Mexican Americans (Wong, Dong, Maestre-Mesa, & Licinio, 2008). An 
association was found to exist between patients’ response to antidepressant and multiple 
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SNPs which support the T-cell functioning (Wong, Dong, Maestre-Mesa &Licinio, 
2008). 
2.1.5 Affective Behaviour in Rodent Models of Neuroinflammation 
 Research in rodents has generally pointed towards increased anxiety- and 
depressive-like behaviours in the presence of elevated immune activity. A 4-week 
administration of the pro-inflammatory cytokine interferon-α (IFN-α) led to increased 
anxiety like behaviour in the elevated plus maze in otherwise healthy male Wistar rats, 
accompanied by increased anhedonia in the sucrose preference test and behavioural 
despair in the forced swim test (Fahey, Hickey, Kelleher, O'Dwyer, & O'Mara, 2007). 
The acute administration of LPS and IL -1β have also been shown to induce anxiety like 
behaviour in a dose-dependent manner in male CD-1, virus antibody free mice 
(Swiergiel & Dunn, 2007). Importantly however, the dose required to induce these 
changes led to decreased locomotor activity – a common problem in the case of studies 
of acutely induced neuroinflammation. Relatively few studies however examine the 
chronic effects of neuroinflammation on anxiety. In another model of anxiety-like 
behaviour in Sprague-Dawley rats, repeated IL-1β (5µg/kg) administration for 7 days 
was found to increase latency to escape shocks in the shuttle box test (Bonaccorso, 
Maier, Meltzer, & Maes, 2003).  
 Other studies however have shown an opposite effect. IL-1β administration has 
been shown to reduce or increase time spent in the open bars of an elevated plus-maze 
in a dose dependant fashion 20 minutes following ICV injection to adult Wistar rats 
(Montkowski, Landgraf, Yassouridis, Holsboer, & Schöbitz, 1997). The authors found 
that a 0.1ng dose increased the amount of time spent in an open arm, while a 100ng 
dose significantly reduced it, although other doses ranging from 0.001 to 10.0 had no 
effect. These doses both significantly reduced locomotor activity under basal conditions 
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0-6 hours post-treatment, but not in animals who had previously been exposed to a 
novel environment until 6-12 hours post-injection.   
 As in human populations, a link between depression and neuroinflammation has 
been uncovered in many animal models. Chronic unpredictable mild stress (CUMS) for 
example, although not a model of neuroinflammation, increases depressive-like 
behaviours as well as serum IL-1β levels relative to controls (Wang, et al., 2011). Rats 
undergoing CUMS have also been found to have significantly higher levels of 
interleukin-1β and TNF-α mRNAs in the cortex, as well as significantly higher levels of 
TNF-α and IL-18 in the hippocampus. (You, et al., 2011). An 830µg/kg dose of LPS has 
been shown to significantly increase time spent immobile in the forced swim test, as 
well as to decrease sucrose preference, but not affect the tail suspension test, in the 
absence of locomotor impairment in mice 24 hours after injection, indicating test-
specific effects (Frenois, et al., 2007).  
Other studies however have found that chronic activation of the immune system 
does not always lead to increased behavioural despair. Five days of IL-1β (2µg) 
administration for example has been found not to decrease immobility time in the forced 
swim test in rats, despite a loss of weight which may have been indicative of anorexia 
(Wilhelm, Murphy-Crews, Menasco, Huckans, & Loftis, 2012). Overall, although 
limited work has been done on affective behaviour in rodents with chronic 
neuroinflammation in the absence of sickness behaviour, there seems to be an 
interaction between the two systems. This is clearly influenced by a number of factors 
however, including the test being used, how the inflammation is produced, and the 
amount of time that has passed since the induction of inflammation. 
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2.1.6 Drug Treatments 
Adding support to the idea of an interaction between factors which contribute to 
affective disorders and the inflammatory system is a body of evidence indicating that 
drugs which act on inflammatory pathways may ameliorate some affective behaviour, 
while several anti-depressants exert anti-inflammatory properties. Experimentally 
induced neuroinflammation by daily administration of a low dose of LPS (100mg/kg) 
has also been shown to block the effects of selective serotonin reuptake-inhibitor 
fluoxetine (10mg/kg) in reducing depressive behaviour (forced swim, novelty 
suppressed feeding and sucrose preference) in rats undergoing an unpredictable chronic 
mild stress paradigm (Wang, et al., 2011). The authors also found that 
neuroinflammation blocked an increase in hippocampal neurogenesis produced by 
fluoxetine treatment in non-neuroinflammed rats. In fact, fluoxetine was found to 
decrease the levels of serum IL1-β in animals administered LPS, suggesting an interplay 
between the anti-depressant effects of fluoxetine and the inflammatory system.  
 In an experiment involving an acute treatment with 100µg/kg LPS, 4 hours post-
LPS treatment, there was a reduction in line crossing and rearing in the open field test 
compared with saline-treated animals. Line crossings were not rescued by fluoxetine 
administration, while fluoxetine administration abolished the difference between saline 
and LPS-treated mice in terms of rearing. The fluoxetine treatment also attenuated the 
reduction in food consumption over the 24 hours following LPS treatment, indicating an 
effect on LPS induced anorexia (Yirmiya, et al., 2001). The effects of acute LPS 
treatment (20µg/kg) on reward behaviour – an effect the authors attribute to anhedonia 
rather than anorexia, have also been shown to be reversed by a treatment with the non-
steroidal anti-inflammatory drug diclofenac (De La Garza II, Fabrizio, Radoi, Tudor, & 
Asnis, 2004). This treatment also reduced the levels of corticosterone produced. 
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 In patients receiving interferon-α for the treatment of malignant melanomas, pre-
treatment with the SSRI paroxetine was found to significantly reduce the likelihood of 
patients developing depressive symptoms compared to a control group receiving 
interferon-α and a placebo (Musselman, et al., 2001). Treatment with paroxetine is 
effective in reducing symptoms of depression, anxiety, cognitive impairment and pain 
while patients do not respond as well in terms of fatigue and anorexia (Capuron, et al., 
2002). Another study of 8131 adults however has found that treatment with anti-
depressants, in particular tricyclic anti-depressants, correlates with increased C-reactive 
protein levels independent of mental state (Hamer, Batty, Marmot, Singh-Manoux, & 
Kivimäki, 2011).  
 Relatively little work has been done on the effects of drug treatments on chronic 
models of neuroinflammation. In rats which have undergone CLP ten days prior to 
behavioural testing, a single i.p. injection of the tricyclic antidepressant imipramine has 
been shown to reverse an increase in time spent immobile during a forced swim test 
(Tuon, et al., 2007). A 10mg/kg dose of the Alzheimer’s drug memantine, an NMDA-
receptor antagonist has been found to protect spatial learning and the induction of the 
learning-related immediate early gene Arc from disruption during the chronic infusion 
of LPS into the 4
th
 ventricle over for 28 days (0.25µl/hr). These results indicate that 
both the chronic and acute effects of neuroinflammation on cognitive and affective 
behaviour are treatable with a variety of drugs. 
2.1.7 Aims 
Given the lack of research into the behavioural effects of LPS-induced sepsis, 
the aim of these experiments is to categorise the behavioural and cognitive deficits 
present post-sepsis in mice administered 5mg/kg doses of LPS. In certain experiments 
the effects of single and group housing were examined, as housing condition is thought 
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to contribute to behavioural alterations. Also examined is whether the serotonin 
reuptake inhibitor fluoxetine could reverse behavioural changes induced in post-septic 
mice. 
In order to investigate the effects of our treatment on cognition and behaviour a 
total of 12 different behavioural tasks were carried out investigating a diverse range of 
functioning. Constructs targeted included working memory, long-term spatial memory, 
behavioural despair and anxiety. Memory tasks were chosen as it is known that immune 
factors are heavily involved in the neural processes of learning and memory, and while 
the immune system is affected by physiological/psychological events (Yirmiya & 
Goshen, 2011) such as during post-septic encephalopathy. Thus long-term spatial 
memory was investigated using the Morris water maze (Vorhees & Williams, 2006), 
working spatial memory using the Morris watermaze and the radial arm maze (Levin, et 
al., 2009). Non-spatial working memory was also tested using a 5 trial novel object task. 
As there are has been mounting evidence of a possible role of neuroinflammation in 
affective disorders such as major depression (Dowlati, et al., 2010; Mössner, et al., 
2007), and anxiety (Pitsavos, et al., 2006) several tasks aimed at measuring depressive- 
and anxiety-like behaviour were also conducted. 
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2.2 Materials and Methods 
2.2.1 Animals 
Male C57BL/6 mice between 8 and 12 weeks old were used for the purpose of 
all experiments. Group-housed animals were housed two to four per group in plastic 
cages (12cm x 9cm x 9 cm) with wire lids containing wood-chip bedding and shredded 
paper for environmental enrichment. Singly-housed animals were housed in the same 
conditions. All animals had ad libitum access to water at all times, and ad libitum access 
to food except during food restriction protocols. Animals were kept in a 12:12 light:dark 
cycle at 200lux and 21±1°C and 50±5% relative humidity. Unless otherwise stated, all 
animals were group housed. Where an animal was moribund and deemed unlikely to 
recover he was removed from the sample and euthanised. No animals was used for more 
than 3 experiments, and no more than one experiment deemed to be stressful (Tail 
Suspension Test, Forced Swim Test, Watermaze) to the animal. Experiments were 
conducted in order from least stressful to most stressful. 
2.2.2 Drug Treatments 
 Mice were allowed to acclimatise to the housing facility for at least two weeks 
prior to injection. All saline and LPS injections were made up fresh on the treatment 
day, and given intraperitoneally in a final injection volume of 0.125ml.  0.9% sterile 
saline was made up fresh for control injections, while lipopolysaccharide (Sigma 
Aldrich, Escherichia Coli 0114b) was made up to a 5mg/kg dose in sterile saline. 
Injections were given between zeitgeber time (ZT) 05 and 06. Animals were allowed to 
recover for at least 1 month prior to behavioural testing. 
 Treatments of 20mg/kg fluoxetine were made up in sterile saline on the day of 
treatment. 20mg/kg fluoxetine and corresponding control injections were given in a 
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final volume of 0.25ml – a dose which has previously been shown to be effective in 
C57bl/6 mice (Holmes, et al., 2005).  
2.2.3 Marble Burying Task 
Animals were placed in an isolated testing arena (26cm length x 20cm width x 
27 cm high) filled with roughly 6cm of wood chip bedding for thirty minutes with 
marbles arranged in four rows of three, evenly spaced from each other and the sides of 
the test cage  (Deacon, 2006). After thirty minutes mice were removed and marbles 
were considered buried where at least 2/3 of their surface was covered with woodchip. 
As mice may bury novel objects which they find anxiety-inducing the number of 
marbles buried during the test functioned as the dependent measure of anxiety. 
2.2.4 Open Field Test  
Open field testing occurred in a circular arena of diameter 100cm. Trial length 
was 300 seconds during which distance moved, velocity in cm/sec and time spent 
moving as well as time in the inner and outer 50% were automatically tracked with 
Ethovision 3.1 software (Ethovision 3.1; Noldus Information Technology, Leesburg, 
VA). Here, as animals tend to avoid open spaces (Ennaceur, Michalikova, van 
Rensburg, & Chazot, 2006) time spent in the inner corridor versus the outer corridor of 
the arena is a measure of anxiety-like behaviour while distance, velocity and time spent 
moving are indexes of general locomotor behaviour. 
2.2.5 Hyponeophagia Test 
Testing occurred in a large transparent plexiglass container (26 length x 20 
width x 13.5 cm high) placed on a white surface using existing methodology with 
chocolate as the novel food (Deacon, 2011). Animals, which were not subject to food 
deprivation, were placed in the testing arena where the novel food covered the floor and 
were given up to three trials of four minutes with latency to eat the dependent measure 
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of anxiety. Data shown represents the sum of these trials. After three trials testing for 
that animal stopped and they were given a score of 720 seconds if they had not yet 
eaten.  
2.2.6 Forced Swim Test 
Animals were placed singly in a 2 litre clear plexiglass beaker (12.5cm diameter 
x 23.5cm height) filled to a height of 12cm with 1.25l water (25°C) such that their tails 
could not touch the bottom of the beaker. Following the method of Porsolt et al. (1997) 
each test lasted six minutes, with the immobility (absence of movement except leg kicks 
to stay afloat) scored in the final four minutes only. This test measures depressive-like 
behaviour with immobility taken as the dependent measure of behavioural despair. 
2.2.7 Sucrose Preference Test 
 Following a method set out in Strekalova et al (2004) bottles were filled with 
either animals’ standard drinking water or 1% sucrose in the animals standard drinking 
water, lids securely taped in place to minimise spillage and weighed. Cages were 
modified to accommodate two bottles, and food was placed in both sides. Mice were 
then given a free choice between either tap water, or a 1% sucrose in tap water solution 
for 24 hours. After 12 hours had passed, the position of the two bottles were switched, 
in order to control for a side preference in drinking behaviour. After 24 hours had 
passed, the bottles were then weighed to measure how much liquid was consumed, and 
sucrose preference was calculated as [sucrose consumed / (water consumed + sucrose 
consumed)] for each mouse. This sucrose preference functions as the dependent 
measure of anhedonia. The data of animals were removed if they were found to have 
liquid in their cages.  
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2.2.8 Tail Suspension Test  
According to a previously used protocol (Steru et al, 1985) mice were attached 
to a support raised to a height of 121cm using tape placed 1cm from the tip of their tales 
for six minutes. Mice were suspended for six minutes each, with immobility (complete 
absence of movement) being recorded throughout the entire six minutes. This is a test of 
depressive-like behaviour with immobility taken as the dependent measure of 
behavioural despair.  
2.2.9 Tail Suspension Test (Fluoxetine) 
On the experimental day 1 animals were injected with 0.9% sterile saline 90 
minutes before undergoing the tail suspension test. Two weeks later on experimental 
day 2 animals were injected with 20mg/kg fluoxetine dissolved in sterile saline 90 
minutes prior to repeating the test. Mice were removed from the home cage and singly 
attached to a support raised 121cm above a cage containing woodchip bedding by tape 
placed 1cm from the tip of their tales for six minutes. Mice were suspended for six 
minutes each, with immobility being recorded throughout the entire six minutes. 
Immobility was defined as the complete absence of movement.  
2.2.11 Novel Object Recognition Test  
Animals were first habituated to a circular arena of 50cm. Each animal 
underwent 5 trials lasting two minutes each. During the first four trials, animals were 
habituated to two objects. Between each trial the animal was removed while the objects 
and arena were cleaned with 70% ethanol solution. On the fifth trial one familiar object 
was replaced with a novel object. The objects had previously been examined for 
preference with no differences being observed. These objects were pseudo-randomised 
so that each object could function as either a familiar object or the novel object in any 
given session. This randomization was balanced across each group. Animals were 
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measured on their time touching, and number of nose touches for each object during 
each trial. This is typically a test of working memory with novel object recognition, the 
dependent variable, calculated as [time exploring the novel object / (time exploring the 
novel object + time exploring the familiar object)] or [number of touches on the novel 
object / (number of touches on the novel object + number of touches on the familiar 
object)] (Anderson, Commins, Moynagh, & Coogan, 2014). In this experiment time 
touching and number of touches on the familiar and novel objects were also taken as 
measures of exploratory behaviour. 
2.2.12 Radial 8-arm Maze 
Animals were placed on an 80% restricted diet for five days before the first day 
of experimental testing followed by a 60% restricted diet throughout the duration of the 
experiment. The maze consisted of a centre area of diameter 13.5cm, from which 8 arms 
extended of length 34.5cm, width 5cm and height 13.5cm. Similar to previously used 
methodology (Janitzky et al., 2011), all eight arms of the maze were baited with a food 
reward (chocolate). Trials were of five minutes length, unless the animals successfully 
consumed all of the bait. The apparatus was wiped down with 70% ethanol between all 
trials to remove the previous animals’ odour. Each animal underwent one trial per day, 
for fourteen days. Entrances to an arm were counted when all four of the mouse’s paws 
were within the arm. The trial was ended once the animal either consumed all rewards 
or once five minutes had passed. The dependent variables were latency to complete the 
maze, a measure of learning, and the number of repeat entries to arms where bait was 
already consumed, taken as a measure of working memory errors. 
2.2.13 Working Memory Watermaze 
Testing followed the protocol of Vorhees & Williams (2006) in a circular pool 
of diameter 100cm, with water 21±1°C. A rectangular white card (55x81cm) to the west 
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of the pool was visible to the mouse, and there were lights in the northeast and 
southeast. Each animal underwent twenty eight sixty-second trials over seven sessions 
(4 trials/session). Two sessions took place per day such that there was four hours 
between the first and second session, then twenty hours between the second and third 
session and so on. Each mouse was placed into the pool at the northeast, northwest, 
southeast and southwest positions in a pseudo-random order. In session one an invisible 
platform of diameter 9cm was submerged 0.5cm below water-level in the north-western 
quadrant of the pool. This platform was moved clockwise from quadrant to quadrant on 
each subsequent session. The mouse was returned to a cage for 10 seconds between 
trials. Escape latency was defined as the time it took the mouse to mount the hidden 
platform. All experiments were tracked using a video camera and Ethovision 3.1 
software (Ethovision 3.1; Noldus Information Technology, Leesburg, VA). Escape 
latency, distance travelled and velocity (cm/second) were measured throughout the 
trials. Escape latency was the primary dependent variable of interest functioning as a 
measure of working memory.  
2.2.14 Long-term memory Watermaze 
Testing occurred in the same maze conditions previously described in the 
section above. Each animal underwent 4 trials per session for 6 sessions. Two sessions 
took place per day such that there was four hours between the first and second session, 
then twenty hours between the second and third session and so on. Each mouse was 
placed into the pool at the northeast, northwest, southeast and southwest positions in a 
pseudo-random order. In all sessions an invisible platform of diameter 9cm was 
submerged 0.5cm below water-level in the North-Eastern quadrant of the pool where it 
remained throughout testing. The mouse was returned to a cage for 10 seconds between 
trials. Escape latency, distance travelled and velocity (cm/second) were measured 
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throughout the trials. Escape latency was the primary dependent variable of interest 
functioning as a measure of spatial memory acquisition. During the retention trial, 
conducted 24 hours after the final trial, each animal was allowed to swim for sixty 
seconds in the pool with no platform present.   
2.2.15 Elevated Plus Maze 
 The elevated plus maze was conducted in accordance with the protocol set out 
by (Walf & Frye, 2007). The maze consisted of a centre area of diameter 13.5cm, from 
which four arms extended of length 34.5cm, width 5cm. The maze was raised 20cm 
from the ground. Two arms were open without walls, while the other two were enclosed 
by high walls. Entrance to an arm was counted where all four of an animals’ paws were 
within the arm. Animals underwent one five-minute testing session each. This test 
assesses anxiety-like behaviour by measuring time spent in the open arms and number 
of entries to the open arms as dependent variables.  
2.2.16 Statistical Analyses 
 All results were analysed in IBM SPSS Statistics version 20. The type of test 
used is indicated in the results section for each experiment, with the appropriate test 
chosen based on fulfilling normality criteria. P levels below 0.05 were considered 
significant for all tests. Where data violated statistical assumptions adjusted values are 
presented. All data are presented as means ± standard error of the mean (SEM). * 
represents p<0.05, ** represents p<0.01 and *** represents p<0.001.  
 
 
 
 
69 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Cohorts and timelines for behavioural experiments  
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2.3 Results 
2.3.1 Anxiety-like behaviour 
2.3.1.1 Marble Burying Test 
A two-way ANOVA was used to determine whether or not there was an effect 
of housing or treatment on the number of marbles buried during the task.  It was found 
that there was no main effect of housing, with the single housed animals (n=16) burying 
on average 9±0.51 marbles, and the group housed animals (n=16) burying 9.06±0.72 
marbles (F₁,₂₈=0.032, p=0.859). There was also no effect of treatment, with saline-
treated animals (n=17) burying 9.06 ± 0.55 marbles, and LPS-treated animals (n=15) 
burying 9±.71 marbles (F₁,₂₈=0.007, p=0.933). There was no significant interaction 
effect between treatment and housing (F₁,₂₈=2.711, p=0.11). These results are 
represented in and Figure 2.2.  
 
   
 
 
 
 
 
Figure 2.2 Post-septic mice do not show altered marble burying behaviour Bar graph 
illustrating the effect of treatment and housing on the number of marbles buried during 
a 30 minute trial.  Error bars represent ± 1 SEM. N=8 group-housed controls, n=9 
single-housed controls, n=8 group-housed LPS-treated mice, n=7 single-housed LPS-
treated mice. 
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2.3.1.2 Open Field Test 
As shown in Table 1 there was no effect of treatment on any parameter 
examined in the small arena.  In the small arena saline-treated (n=8) animals travelled 
an average of 889.73±37.35cm while LPS-treated mice (n=7) travelled 804.78±48.79cm 
(t₁₃=1.402, p=0.184). Saline mice travelled at a velocity of 8.0263±.36cm per second 
while LPS mice travelled at 8.33±.56cm per second (t₁₃=-0.455, p=0.657). Saline 
animals spent 112.6±1.74 seconds moving while LPS animals moved for 113.37±2.4 
seconds (t₁₃=-0.265, p=0.795).  Saline animals spent 30±4.58 seconds in the centre of 
the arena while LPS animals spent 27.66±4.98 seconds there (t₁₃=0.347, p=0.734).  
In the large arena there (Table 2) was also no effect of treatment with saline-
treated animals moving 909±28.51cm while the LPS animals moved 827.71±56.22cm 
(t₁₃=1.35, p=0.2). Saline animals (n=8) moved at a velocity of 7.99±0.29cm per second 
while LPS animals (n=7) moved at 8.28±0.28cm per second (t₁₃=-0.728, p=0.479). 
Saline treated mice moved for 113.5±1.75 seconds while LPS-treated animals moved 
for 113.43±1.34 seconds (t₁₃=0.032, p=0.975). Saline-treated animals spent 19.15±3.87 
seconds in the centre of the arena while LPS animals spent 20.029±7.74 seconds there 
(t₁₃=-0.159, p=0.876.  
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Table 1 Open field exploration in a small arena (50cm
2
) 
Treatment Distance Velocity Time Moving Time in Centre 
Saline 889.73±37.35cm 8.0263±.36cm/s 112.6±1.74s 30±4.58s 
LPS 804.78±48.79cm 8.33±.56cm/s 113.37±2.4s 27.66±4.98s 
 
 
Table 2 Open field exploration in a large arena 
Treatment Distance Velocity Time Moving Time in Centre 
Saline 909±28.51cm 7.99±0.29cm/s 113.5±1.75s 19.15±3.87s 
LPS 827.71±56.22cm 8.28±0.28cm/s 113.43±1.34s 20.029±7.74s 
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2.3.1.3 Hyponeophagia 
An independent t-test was carried out to investigate whether or not there was a 
main effect of treatment on the latency to eat. There was no effect of treatment 
observed, with saline animals (n=8) displaying a mean latency to eat of 513±67.64 
seconds, and LPS-treated animals (n=8) eating after 415.25±92.67 seconds (t₁₄=0.856, 
p=0.406). These results are illustrated in Figure 2.3.  
 
 
 
 
 
 
 
 
Figure 2.3 Post-septic mice do not exhibit hyponeophagia. Error bars represent ± 1 
SEM.N=8 per group. 
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2.3.1.4 Elevated Plus Maze 
 In order to test for the effects of LPS induced sepsis on anxiety-like behaviour in 
the elevated plus maze the number of open arm entries, closed arm entries and total 
visits were investigated using independent t-tests. Similarly, time spent in open arms, 
closed arms and the centre of the maze were also compared using independent t-tests. 
As seen in Figure 2.4, animals who had received LPS (n=12) made significantly fewer 
entries to the open arms of the maze than controls (n=12) (5.55±0.87 vs. 9.08±0.9) 
t₂₁.₉₄=2.82, p=0.01. They also made significantly fewer total visits (t₂₂=2.81, p=0.009), 
while there was no significant difference in the number of closed arm entries between 
groups (t₂₂=0.89, p=0.38).  
 There was no difference between groups in the amount of time spent in the 
various areas of the maze. LPS-treated animals spent 81.36±16.36 seconds in the open 
arms, while saline-treated animals spent 100.08±11.07 (t₂₂=0.97, p=0.34). LPS-treated 
animals spent 119.09±14.46 seconds in the closed arms, while saline-treated animals 
spent 110.31±9.46 seconds in these arms (t₂₂=0.52, p=0.61). LPS-treated animals spent 
99.54±8.46 seconds in the centre of the maze, while saline-treated animals spent 
89.62±6.29 seconds in the centre (t₂₂=0.96, p=0.35). 
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Figure 2.4 Post-septic mice show reduced elevated plus maze exploration Bar graph 
illustrating a significant reduction in the number of open arm entries among post-septic 
mice in the elevated plus maze. Error bars represent ±1 standard error of the mean, * 
represents p<0.05 in independent t-tests. N=12 per group.  
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2.3.2 Depressive-like behaviour 
2.3.2.1 Forced Swim Test 
A two-way ANOVA was run in order to determine whether or not there was a 
main effect of either housing or treatment, or an interaction effect between the two 
variables. There was no main effect of housing, with the single housed animals (n=16) 
spending an average of 135.06±7.67 seconds immobile, and the group-housed animals 
(n=16) spending an average of 143.93±4.35 seconds immobile (F₁‚₃₂=0.89, p =0.35). 
There was also no main effect of treatment with saline-treated animals (n=17) spending 
an average of 136.23±6.88 seconds  immobile, and the LPS-treated animals (n=15) 
spending an average of 142.6±5.94 seconds immobile (F₁‚₃₂=0.458, p=0.5). There was 
no interaction effect between the two variables (F₁‚₃₂=0.004, p=0.95). These results are 
illustrated in Figure 2.5. 
 
 
 
 
 
 
 
Figure 2.5 Post-septic mice show no changes in the forced swim test Bar graph 
illustrating the effect of treatment and housing on time spent immobile in the forced 
swim test. Error bars represent ±1 standard error of the mean. N=8 group-housed 
controls, n=9 single-housed controls, n=8 group-housed LPS-treated mice, n=7 single-
housed LPS-treated mice.  
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2.3.2.2 Sucrose Preference Test 
As shown in Figure 2.6 an independent t-test revealed a significantly higher 
sucrose preference among the saline-treated animals (n=10) at 77.9 ±1.6% than the LPS 
group (n=11) at 68.9±3.5% (t₁₈=2.34, p=0.031). In addition, a chi-squared test revealed 
that a significantly higher portion of the LPS-treated animals could be classes as 
“anhedonic” according to a 65% cut off for sucrose preference suggested by Strekalova 
et al (2004) (x²₁=5, p=0.025). 
 
 
Figure 2.6 Post septic mice show anhedonia in the sucrose preference test Bar graph 
illustrating a significant difference between post-septic and control mice in sucrose 
preference. Error bars represent ±1 standard error of the mean, * represents p<0.05 in 
an independent t-test. N=10 for saline-treated mice, n=11 for LPS treated mice. 
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2.3.2.3 Tail Suspension Test  
An independent t-test was conducted in order to examine whether or not there 
was a main effect of treatment on time spent immobile. LPS-treated animals (n=15) 
spent a significantly longer amount of time immobile than saline-treated (n=16) animals 
(t₂₉=-3.948, p<0.0001). Saline animals spent an average of 158.69 ± 9.76 seconds 
immobile, while LPS animals spent 210.8 ± 8.8 seconds immobile. This is illustrated in 
Figure 2.7. 
                                                         
 
 
 
 
 
 
 
 
Figure 2.7 Post-septic mice show behavioural despair in the tail suspension test 
Error bars represent ±1 standard error of the mean, *** represents p<0.001 in an 
independent t-test. N=16 for control mice, n=15 for LPS-treated mice. 
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2.3.2.4 Tail Suspension Test with Fluoxetine 
Repeated measures t-tests were conducted in order to examine whether or not 
the fluoxetine treatment had an effect on time spent immobile in either group. There 
was no effect of fluoxetine treatment in the saline group (n=10, t₉=0.546, p=0.598) with 
them spending and average of 140.1±16.34 seconds immobile after treatment with 
saline, and 151±13.64 seconds immobile after a treatment with fluoxetine. In the LPS-
treated group, fluoxetine did significantly reduce the time spent immobile however 
(n=10, t₈=2.476, p=0.038). Treatment with fluoxetine reduced the time spent immobile 
from 167.78±14.29 seconds to 132.89±13.03 seconds. Independent t-tests revealed no 
significant difference between the groups following the administration of saline (t₁₇=-
1.262, p=0.222) or fluoxetine (t₁₈=1.278, p=0.218). This effect is illustrated in Figure 
2.8. 
 
 
 
 
 
 
 
 
Figure 2.8 Fluoxetine ameliorates behavioural despair in the tail suspension test 
Error bars represent ±1 standard error of the mean, * represents p<0.05 in dependent 
t-test. N=10 per group. 
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2.3.3 Learning and Memory 
2.3.3.1 Novel Object Recognition 
Significant differences were found on several parameters between the saline 
(n=20) and LPS-treated (n=18) mice. There were no differences in the amount of time 
spent exploring, or number of nose touches on either object between the groups in any 
of the four habituation trials, nor in the total time spent exploring (t36=1.097, p=0.28), or 
total nose touches over all five trials (t36=1.914, p=0.064). Exploration in each trial is 
illustrated in Figure 2.9. 
In the fifth trial, where the novel object was introduced, it was found that saline 
animals spent a significantly longer amount of time exploring the novel object, and 
touched it more than LPS-treated animals. Saline animals spent 2.43±0.47 seconds 
exploring the object while the LPS-treated animals spent 1.08±0.22 seconds exploring it 
(t27.1=9.189, p=0.014). Saline animals touched the novel object 3.35±0.43 times, while 
LPS-treated animals touched it 2.17±0.35 times (t36=1.791, p=0.042). Saline animals 
also explored more overall in trial 5 in terms of both time spent exploring (t30.984=5.372, 
p=0.019), and number of nose touches (t36=0.748, p=0.027).  
Both the saline-treated animals and the LPS-treated animals did explore the 
novel object more than the old object in trial five however, illustrated in Figure 2.10. 
Saline animals spent 1.96 ± 0.48 seconds longer with the novel object (t₂₀.₈₄=4.09, 
p=0.001), and touched it 2.05±0.5 times more (t₃₀.₆₆= 4.11, p<0.0005). LPS-treated 
animals spent 0.81 ± 0.26 seconds longer exploring the novel object (t₃₄=3.05, 
p=0.004), and touched it 1.56±4.15 times more than the familiar object (t₃₄=3.75, 
p=0.001). Important results are laid out in Table 3. 
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Table 3 Differences in object exploration in post-septic mice 
Measure Saline LPS p-value 
Time Exploring 
Old object in Trial 
5 
0.48 ± 0.1s 0.27  ± 0.6s 0.248 
Time Exploring 
Novel Object in 
Trial 5 
2.43  ± 0.47s 1.08  ± 0.22s 0.014 
Trial 5 Exploration 
Time 
2.91 ± 0.54 1.35 ± 0.33 0.019 
Trial 5 Nose 
Touches 
4.65 ± 0.61 2.78 ± 0.52 0.027 
Difference 
between old object 
in time touching 
trial 4 and new 
object in trial 5 
1.73 ± 0.41s 0.28 ± 0.18 0.003 
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 Figure 2.9 Habituation of mice to objects across 5 trials Line graph illustrating 
differences in the amount of time spent exploring objects throughout all five trials. 
Error bars represent ±1 SEM. * represents p<0.05 in independent t-tests. N=20 saline-
treated mice, n=18 LPS-treated mice. 
 
 
 
 
 
 
 
Figure 2.10 No deficit in object recognition in post-septic mice Bar graph illustrating 
the difference in the amount of time spent exploring a familiar object in trial 4 versus a 
novel object in trial 5.Error bars represent ±1 SEM. ** represents p<0.01 in 
independent t-tests. N=20 saline-treated mice, n=18 LPS-treated mice.  
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2.3.3.2 Radial Arm Maze 
When analysing the latency to complete the maze there was no interaction effect 
between treatment and time (n=8 per group, F₁₃,₂₈₆=0.46, p=0.943). There was a main 
effect of time (F₁₃,₂₈₆=11.05, p<0.0001). There was no main effect of treatment 
(F₁‚15=0.408, p=0.53). These results are illustrated in Figure 2.11. The number of trials 
before an animal made its first error (returning to an arm where the bait had already 
been consumed) was also analysed. Here, as illustrated in Figure 2.12, there was a main 
effect of time (F₁₃,₂₀ =5.561, p<0.0001). There was no significant interaction between 
treatment and time on the first error committed (F₁₃,₂₀₈=0.758, p=0.7). There was also 
no significant difference between the groups (F₁‚₁₆=0.526, p=0.48).  
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 Figure 2.11 No change in time taken to complete radial arm maze in post-septic mice. Error bars represent ±1 SEM. N=8per 
group 
 
 
 
 
Figure 2.12 No increase in errors made by post-septic mice Error bars represent ±1 SEM.N=8 per group  
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2.3.3.3 Working Memory Watermaze 
As each trial is a unique test of working memory due to the platform being 
moved between trials, an independent t-test was done to examine whether there was a 
difference between the average escape latencies across all trials for saline and LPS 
animals. There was no significant difference between the groups, with saline-treated 
animals (n=8) displaying a mean escape latency of 14.78±1.85, while LPS animals 
(n=7) displayed a mean escape latency of 14.54±2.20 (t₈₈=0.092, p=0.927). 
Independent t-tests also revealed no significant differences between groups within any 
session (4 trials) – all p>0.05, see Figure 2.13. 
In order to examine whether or not there might be a difference in the escape 
latencies following a 4 hour, or 24 hour delay since the previous trial, a two-way 
between groups ANOVA was carried out examining the effects of treatment and delay. 
This revealed no significant main effect of treatment (F₁‚₆₁=0.913, p=0.343), or delay 
(F₁‚₆₁ = 0.257, p =0.614), and no interaction effect was found (F₁‚₆₁=1.774, p=0.188). 
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Figure 2.13 Post-septic mice show no working memory deficits in the watermaze Error bars represent ±1 SEM. N=8 saline-
treated mice, n=7 LPS-treated mice.  
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2.3.3.4 Reference Memory Watermaze 
In order to assess whether or not learning took place throughout the trials, both 
groups (n=8 for saline-treated controls, n=7 for LPS-treated mice) were compared using 
3 two way mixed between-within ANOVAs comparing trial number with escape 
latency, distance swam, and velocity. There was a significant main effect of trial on 
escape latency (F₅,₆₅=27.416, p<0.0001), although there was no main effect of 
treatment (F₁,₁₃=0.493, p=0.495), or an interaction between the two (F₅,₆₅=1.013, 
p=0.417). This is illustrated in Figure 2.14. There was also a main effect of session on 
the distance swam during trials (F₅,₆₅=24.916, p<0.0001), but no main effect of 
treatment (F₁‚₁₃=0.399, p=0.538) or interaction between the variables (F₅,₆₅=1.124, 
p=0.356). There was also a main effect of session on velocity across the sessions 
(F₂.₈₅‚₆₅=3.972, p=0.016), but no effect of treatment (F₁‚₁₃=0.059, p=0.812) or 
interaction between the variables (F₂.₈₅‚₆₅=1.971, p=0.138).  
 
 
 
 
 
 
 
Figure 2.14 Post-septic mice show no reference memory deficits in the watermaze 
Error bars represent ±1 SEM. N=8 for saline-treated mice, n=7 for LPS-treated mice. 
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Independent t-tests were also conducted to examine whether or not there was a 
difference between groups in time spent in the North-Eastern quadrant/area where the 
platform had previously been located, and whether or not there was any difference 
between groups in terms of the time spent in the outer versus the inner quadrant. There 
was no difference between groups in the amount of time spent in the North-Eastern 
quadrant (t₁₃ = 0.131, p = 0.898) or area (t₁₃ = 1.175, p = 0.261). These differences are 
illustrated in Figure 2.15. There was also no between-groups difference in the amount of 
time spent in the inner section of the pool (t₁₃ = 1.504, p = 0.157).  
 
 
 
 
 
 
 
 
 
Figure 2.15 Post-septic mice show no differences in spatial retention Bar graph 
illustrating no significant between groups differences in the amount of time spent in 
each area during the retention trial. Error bars represent ±1 SEM. N=8 for saline-
treated mice, n=7 for LPS-treated mice. 
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2.4 Discussion 
2.4.1 Anxiety-like Behaviour in Post-septic Mice 
 Post-septic mice did not show any discernible differences in anxiety-like 
behaviour in either the marble burying test or the open field test relative to treatment 
with saline. Saline and LPS-treated animals buried near-identical numbers of marbles in 
the first task, which is thought to reflect rodents’ anxious or compulsive reaction to 
novel objects. It has also been argued however that this burying, while a possible 
predictor of anxiolytics’ efficacy (Li, Morrow, & Witkin, 2005), may be simply a 
measure of digging behaviour which results in the unintentional burying of marbles 
(Deacon, 2006; Londei, Valentini, & Leone, 1998). Given that treatment with LPS did 
not induce significantly more thigmotaxic behaviour in the open-field test, it would 
seem that there was no effect of treatment on the anxious state of the animals in this 
test.  
 Interestingly, there was also no effect of housing condition on anxiety-like 
behaviour in the marble burying task. Some authors have argued that group housing of 
males may lead to social stress for non-dominant males as they are exposed to territoreal 
hostility (Arndt, et al., 2009; Karolewicz & Paul, 2001). Others however argue that 
single housing represents a kind of social deprivation, and group-housed mice have 
been shown to display significantly less anxiety-like behaviours in the dark-light box 
test and open field test (Chourbaji, Zacher, Sanchis-Segura, Spanagel, & Gass, 2005). 
Our results do not support either hypothesis, with no effect of housing on any measure, 
and no interaction between housing and treatment.  
 In the hyponeophagia test, which examines an animals’ latency to eat a novel 
food in a novel environment, there was no difference between groups. Two preliminary 
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trials were run (data not shown) using different environments and food rewards, as well 
as shorter trials and inter-trial times and it was found that a high number of both the 
control and sepsis-survivor animals did not eat within the allotted time. Therefore it is 
possible that, at least using our paradigm, a ceiling effect exists whereby the latency to 
eat among control animals is already so high, that any effect of LPS treatment on this 
measure is difficult to distinguish without further methodological alterations. 
As previously discussed, the literature on chronic neuroinflammation and post-
septic encephalopathy anxiety-like behaviour is sparse and at times contradictory. These 
results, however, are in agreement with Weberpals et al (2009) who found no effect of a 
5mg/kg dose of LPS on open field behaviour in mice 2 months after treatment. Our 
measures of time moving, distance and velocity also reveal no adverse locomotor 
effects of LPS treatment one month after recovery in the open field test. This provides 
evidence that all of our sepsis-survivor mice had fully recovered at this time, and any 
behavioural alterations are in fact due to cognitive and/or affective changes present in 
post-sepsis mice, rather than altered locomotion. 
 Post-septic animals did however exhibit heightened anxiety in the elevated plus 
maze. Animals surviving CLP-induced sepsis show similarly increased anxiety-like 
behaviours in the elevated plus maze at 10 days (Calsavara, et al., 2013), and somatic 
anxious (and depressive) symptoms have been shown to be associated with elevated 
levels of inflammatory factors among healthy adults (Pitsavos, et al., 2006), clinical 
populations (Hoge, et al., 2009).  This is in contrast to the lack of  anxious symptoms 
present in the hyponeophagia test or marble burying task. Although behavioural tests 
used to assess affective changes in animals are typically noted as targetting broad 
categories of behaviour (e.g. anxiety, depression) it is clear that  within these categories 
functional and mechanistic differences are present between the type of test used 
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(Bourin, Petit-Demoulière, Dhonnchadha, & Hascöet, 2007; Renard, Dailly, David, 
Hascoet, & Bourin, 2003). Post-septic mice may therefore only be affected in one 
subset of anxiety-like behaviours.  
2.4.2 Depressive-like Behaviour in Post-Septic Mice 
 Previous research in both humans who have recovered from sepsis and sepsis-
survivor rodents has pointed towards and altered emotional processing and increased 
depressive-like behaviour following recovery from sepsis (Cassol-Jr, et al., 2010; 
Comim, et al., 2010; Lazosky, Young, Zirul, & Philips, 2010). In accordance with these 
studies, an increase in the time spent immobile in the tail suspension test was also 
found, a commonly used model of behavioural despair, following recovery from LPS 
treatment as compared with saline-treated animals and an decrease in sucrose preference 
indicative of anhedonia. These increases in anhedonia and behavioural despair represent 
two key features of major depressive disorder (American Psychiatric Association, 
2013). 
Importantly, this effect was reversed by treatment with the selective serotonin 
reuptake inhibitor fluoxetine in the LPS-treated mice. This contributes to the predictive 
validity of our model. Although other studies have shown that acute neuroinflammation 
may block the anti-depressant effects of fluoxetine (Wang, et al., 2011), these results 
provide evidence that fluoxetine can, at least where an acute treatment is concerned,  
reverse behavioural despair in post-septic mice. It is necessary however to examine the 
effects of chronic fluoxetine treatment after LPS administration, as in human 
populations there is a significant latency between beginning treatment with SSRIs such 
as fluoxetine and a reduction in depressive symptoms (Önder & Tural, 2003).  
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Confounding these results  is the fact that, at baseline, 90 minutes following the 
administration of saline there was no significant difference in immobility between the 
saline-treated and sepsis-survivor mice. This suggests that the tail suspension test may 
be particularly susceptible to acute stressors as has been suggested before (Dunn & 
Swiergiel, 2008). This cohort of mice had also undergone rather different behavioural 
testing than those which completed the tail suspension test with no acute treatment – 
including a food restriction protocol,which may have contributed to high baseline 
immobility among the saline group. 
The forced swim test revealed no effect of LPS treatment on behavioural 
despair, in addition to no effect of housing condition. Although both the forced swim 
test and the tail suspension test claim to measure behavioural despair, it is likely that the 
underlying biology involved in animals’ responses to both tests are quite different, with 
nicotine for example exerting opposite results in the two tests in female C57BL/6J mice 
(Andreasen & Redrobe, 2009), while many SSRIs which reduce immobility in the tail 
suspension test fail to do so reliably in the forced swim test (Bai, Li, Clay, Lindstrom, & 
Skolnick, 2001; Duman & Monteggia, 2006). Furthermore, the forced swim test has 
been shown to produce alterations in the levels of dopamine, its metabolite DOPAC, 
and serotonin in male Swiss mice where the tail suspension test does not (Renard, 
Dailly, David, Hascoet, & Bourin, 2003). Therefore the septic encephalopathy which 
follows recovery from sepsis in our mice may interfere with the pathways responsible 
for behavioural despair in the tail suspension test, but not those which control the 
response in the forced swim test. Our results, when taken together with the absence of 
locomotor reduction in the LPS-treated mice, suggest that the tail suspension test is not 
more affected by locomotor responses than the forced swim test as some authors have 
claimed (Hascoët, Bourin, & Bradwej, 1991). 
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2.4.3 Learning and Memory in Post-Septic mice 
Our 5-trial novel object recognition task yielded a number of interesting results. 
Important to note is that there was no difference between groups in any of the first four 
habituation trials, or in the amount of time spent exploring either of the two objects, 
indicating that baseline exploration was similar in both groups of mice, and that there 
was no object preference among either group. There was a key difference however in 
that saline-treated animals explored the novel object significantly more than their LPS-
treated counterparts. They also explored the item significantly more than they did a 
familiar object in trial 4, where the LPS animals did not. They had significantly higher 
levels of exploratory behaviour across the trial as a whole (where no such difference 
existed in the previous four trials), and had a significantly greater preference for the 
novel object in terms of the amount of time they spent exploring it than the LPS-treated 
animals.  
All of these results would typically point towards impaired working memory 
function in the sepsis-survivor mice, as has been previously shown following recovery 
from sepsis induced via CLP (Cassol-Jr, et al., 2011). The LPS mice did in fact examine 
the novel object more than the familiar object during the trial however, indicating that 
the effect is probably not due to a working memory deficit. This result may agree with 
findings that chronic LPS-infusion into the 4
th
 ventricle does not induce short- or long-
term working memory deficits in rats (Hauss-Wegrzyniak, Vannucchi, & Wenk, 2000). 
It is therefore probable that deficits in another process led to the behaviour of LPS-
treated mice observed during the novel object recognition test. Acute LPS treatment has 
been shown to reduce exploratory behaviour towards a novel object hours after 
locomotor decreases have subsided (Haba, et al., 2012), an effect the authors contribute 
to a possible decrease in motivation in their mice. Given the reduced exploration in 
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general in the fifth trial, it is possible that reduced motivation to explore the novel 
object, although it was correctly recognised as novel. As there was no such effect during 
the 4 habituation trials, it would seem that this effect is context-dependent.  
Supporting the idea that this alteration in the novel object recognition task is not 
an effect on working memory per se, is the fact that no deficits were found in the LPS-
treated mice relative to controls in either the radial arm maze, or the working memory 
watermaze. Although these tests examine spatial working memory, where the novel 
object recognition task is non-spatial, LPS-treated mice performed just as well as their 
saline-treated counterparts in all aspects of both tests. There was no increase in errors, 
time to complete the trials, or any effect on the latency to commit a first error in the 
radial arm maze, and no effect on escape latencies in the watermaze, while velocity 
remained the same indicating equivalent locomotor abilities. 
It is possible that the working memory deficits observed by Cassol-Jr et al 
(2011) were unique to the CLP model of septic encephalopathy, or perhaps there is a 
time dependent effect on working memory. Given that their experiments were carried 
out 10 days post-sepsis, and other deficits resulting from sepsis have shown to be 
present after 10 days, but not 30 or 60, that our experiments which were carried out over 
thirty days later may have missed a possible effect. Although Semmler et al. (2007) and 
Weberpals et al. (2009) both found working memory deficits in rats and mice 
respectively in the radial arm maze roughly 2 months after treatment suggesting that 
methodological factors may play an important role. For example, Weberepals and 
colleagues (2009) examined radial arm maze behaviour during animals’ active phase 
(subjective night) and used ten minute trials with only 4 out of eight arms baited per 
trial. Semmler et al. (2007) conducted their experiment with rats, three months post-
sepsis, and again used ten minute trials.  
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In the reference version of the watermaze both groups learned at almost identical 
rates, indicating that spatial nevigation and memory is conserved in the presence of 
post-septic encephalopathy. In addition, there was no difference during the retention 
trial in the length of time spent in the correct quadrant between the groups. This is 
surprising given the body of research which shows that both acute and chronic 
neuroinflammation typically lead to deficits in watermaze performance in rodents. In 
the CLP model of post-septic encephalopathy mice  show significant watermaze 
impairment 15 days after sepsis induction (Hernandes, et al., 2014), although these mice 
show severe oxidative damage in the hippocampus.  It is probable that the chronic 
neuroinflammation which results from the i.p. dose of LPS is functionally different to 
that induced via chronic infusion to the 4
th
 ventricle which has previously been shown 
to disrupt watermaze performance (Cui, et al., 2008, Rosi, et al., 2006). Relevant 
hippocampal areas may have recovered sufficiently one month post-LPS administration 
in order to carry out successful spatial learning and memory consolidation in our model, 
whereas the more aggressive chronic infusion of LPS may lead to a more sustained 
inflammatory response which interupts spatial memory.  
2.4.4 Conclusion 
In conclusion, the i.p. administration of LPS does not appear to lead to gross 
alterations in locomotion or memory deficits one month after recovery. There are 
significant changes in affective behaviour, some of which is reversible with the acute 
administration of fluoxetine. Also present are alterations in novel object exploration 
which may be indicative of altered motivation. Our results are somewhat at odds with 
the existing literature on sepsis-survivor rodents and chronic neuroinflammation, 
however a number of key differences may explain this. Many of the tests used have 
been shown to be strain and sex dependent, and were previously carried out using 
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different doses or different models. Some of the effects seen in other papers may have 
been specific to certain models, doses or strains, or even particular methodological 
variations. In addition to this it seems likely that the time since recovery may play an 
important role in the deficits seen following sepsis.  
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Chapter 3. Immunohistochemical Analysis of the Post-Septic 
Hippocampus 
Abstract 
This chapter sought to assess the extent to which peripheral administration of a 
septic dose of LPS could produce long-lasting changes within the hippocampus and 
amygdala. Animals which had previously undergone LPS administration and 
behavioural testing were sampled and hippocampal and amygdala sections were stained 
for a protein expression using immunohistochemistry. It is shown that post-septic mice 
show an upregulation of microglial markers within the hippocampus at both 24 hours 
and 2 months after LPS treatment. There are also changes to immediate early gene 
expression at both acute and long-term timepoints. IEG expression is also dampened in 
the post-septic amygdala. There was no change in astroglial markers and little change in 
cytokine expression profiles in the hippocampus. To examine hippocampal adult cell 
proliferation BrdU was administered 24 hours before sampling to one cohort – with 
findings suggesting a reduced number of BrdU-positive cells in the post-septic 
subgranular zone. By fourteen months post-sepsis expression levels of microglial 
markers CD11b and F4/80 match those of controls. It is concluded that peripheral LPS 
administration has the potential to stimulate long-lasting inflammation within the 
hippocampus, affect NPC proliferation and alter immediate early gene expression 
patterns.  
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3.1 Introduction 
As outlined in chapter 1, the hippocampus is a brain region known to play a key 
role in both memory and emotional processing (MacQueen, et al., 2003), both of which 
may be impaired in patients suffering from post-septic encephalopathy (Lazosky, et al, 
2010; Semmler, et al., 2013; Winters, et al., 2010; Ziaja, 2013). Sepsis survivors show 
hippocampal atrophy (Semmler, et al., 2013) and hippocampal neurons are particularly 
susceptible to the effects of chronic neuroinflammation (Rosi, Ramirez-Amaya, Hauss-
Wegrzyniak, & Wenk, 2004). Given its importance in the behaviours previously 
described in post-septic mice the aim was to assess the extent to which our systemic 
administration of LPS affected the hippocampus of sepsis-survivor animals. As LPS is 
used to induce potent immune responses in a variety of other models, and there are 
relatively few studies detailing animal models of sepsis, it is also pertinent to consider 
its effects across this body of literature. 
3.1.1 Acute Immune Responses Triggered by LPS Administration 
 LPS can elicit a variety of effects depending on the dose, method and timing of 
application and investigation, as well as the types of cells or specific area of the brain 
targeted. Peripheral administration of high-dose LPS leads to a potent inflammatory 
response, via the NF-κB pathway, mimicking some of the clinical features of sepsis and 
resulting in depressed EEG activity, low blood pressure, oxidative stress, multiple organ 
failure and a significant mortality rate (Chang, Tsai, Sheu, Hsieh, & Chiang, 2013; Lin, 
Chen, Lee, Chen, & Yang, 2010; Okazaki, Tachibana, Koga-Ogawa, & Takeshita, 
2013). The hippocampus in particular is highly sensitive to the effects of LPS-induced 
sepsis in rodents (Semmler, Okulla, Sastre, Dumitrescu-Ozimek, & Heneka, 2005). Two 
hours following 10mg/kg i.p. LPS administration serum TNFα, IL-6 and IL-10 are 
significantly upregulated (Zheng, et al., 2012), similarly, 6 hours following 10mg/kg i.p. 
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LPS administration to C57BL/6J mice TNF-α and IL-1β are greatly upregulated in 
serum (Chang et al, 2013). In Sprague-Dawley (SD) rats a 10mg/kg dose of LPS has 
also been shown to significantly upregulate hippocampal, cortical and hypothalamic 
TNF-α, IL-1 and IL6 as well as H202 while decreasing anti-oxidant markers (Chen, et 
al., 2014). 5mg/kg i.p. administration led to a significant increase in hippocampal IL-1β, 
but not TNFα mRNA levels in C57BL/6 mice 24 hours post-treatment (Diz-Chavez, 
Astiz, Bellini, & Garcia-Segura, 2013). In the same study, immunohistochemical 
analysis of microglial marker Iba-1 also showed that while the absolute number of 
microglia did not change, a significantly higher percentage of microglia demonstrated a 
reactive morphology in the DG and CA1, with no increase in GFAP immunoreactivity. 
8mg/kg LPS administered intravenously to SD rats resulted in a large increase in 
cerebral iNOS levels at 1hour, with this increase diminishing at 2 and 3 hours and 
subsequently returning to high levels at 6 hours post-treatment (Pei, et al., 2013).  
LPS can also increase mRNA for cytokine receptors in the brain with a 30µg 
doses of LPS triggering an increase in hippocampal IL-1RI, IL-6R and TNFαR six 
hours post treatment (Utsuyama & Hirokawa, 2002). 10mg/kg LPS i.p. has been shown 
to have peak cytokine (TNFα, IL-6) and chemokine (KC, MIP-2) at 1 – 4 hours post-
treatment, with a decline or plateau occurring by 8 hours post-treatment (Remick, 
Newcomb, Bolgos, & Call, 2000). A 10mg/kg i.p. dose of LPS given to male Wistar 
rats has also been shown to reduce cerebral glucose uptake in an area-dependent 
fashion, accompanied by increased TNF-α, IL-1β and iNOS transcription and reduced 
hippocampal NeuN expression 24 hours post-treatment (Semmler, et al., 2008). Rats 
treated with 8mg/kg doses of LPS showed significantly higher levels of plasma IL-1 β, 
IL-6 or TNFα 24 hours or six days post-treatment, with significantly increased IL-1β 
but no change in IL-6, TNFα or apoptotic cells in cerebral cortex tissue at six days post-
100 
 
treatment (Plaschke, Bent, Wagner, Zorn, & Kopitz, 2014). LPS (2.25µg/brain) injected 
intracerebroventricularly results in upregulated TNFα, IL-6 and MCP-1 in the 
hippocampus at 1 and 4 hours, with levels dropping by 10 hours and close to baseline 
by 16 hours, while F4/80 expression, indicative of microglial activation, peaked at 2 
days post-treatment when cytokine production had ceased to be detectable (Lund, et al., 
2006). Overall it appears that systemic administration of LPS leads to rapid 
upregulation of pro-inflammatory factors and microglial activation within the CNS – 
although there is evidence for differential susceptibility among brain regions. 
3.1.2 Chronic Immune Responses to LPS Administration 
Fewer studies have examined the long lasting effects of LPS administration – 
either through repeated low-dose LPS administration or at a later timepoint following a 
septic administration of LPS. There is considerable variation between the results of 
these studies, and indeed between the brain regions studied in each experiment. An 
early study on the effect of a systemic 5mg/kg dose of LPS found that TNF-α protein 
remained upregulated in the whole brain of mice up to 10 months following treatment – 
accompanied by persistent microglial activation (Qin, et al., 2007).  A repeated i.p. 
administration of 750-1250µg/kg LPS to female C57BL/6 mice over four months 
induced anhedonic behaviour accompanied by a reduction in IL-10 and IFN γ and an 
increase in superoxide and corticosterone – with these effects ameliorated by chronic 
treatment with fluoxetine (Kubera, et al., 2013). Male Wistar rats treated with 5mg/kg 
i.p. exhibited significantly higher levels of hippocampal and frontal cortex TNF-α at 7 
days post-treatment, with elevated TNF-α persisting at 10 months post-treatment 
accompanied by an elevated expression of IL-18 (Bossù, et al., 2012).  Increased 
microglial activation and morphological alterations have been seen in the whole brains 
of C57BL/6 mice 28 days after a dose of only 0.5mg/kg, although this was not 
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accompanied by significant changes in cytokine expression (Konda, Kohsaka, & Okabe, 
2011). Interestingly, an upregulation of CD11b, TNFα and IL-1β expression was seen in 
the frontal cortex, but not hippocampus, of C57BL/6 mice two months following LPS 
administration (Weberpals, et al., 2009). Although increased microglial activation was 
present, there were no changes in GFAP or NeuN levels indicating that there was no 
long-term neuronal cell loss or change in astrocyte function or number. Fan et al (2012) 
report sustained microglial activation in the abscence of astrocytic activation or 
heightened expression of cytokines TNF-α or IL-1β in the hippocampus one week 
following LPS-induced sepsis in C57 mice using a 5mg/kg dose. Together these 
findings demonstrate the potential for chronic overactivation of microglia in response to 
peripheral doses of LPS – although the cytokines which peak rapidly following 
treatment may not always remain upregulated at later time-points. 
3.1.3 The Inflammatory Response to Sepsis 
Similar to animal models of LPS-induced sepsis, patients suffering from sepsis 
also show a hyperinflammatory state with a huge upregulation of proinflammatory 
cytokines – although this may be slower than that seen in animal models. They then 
however also show a secondary state of immunosupression characterised by increased 
apoptosis of immune cells, lower levels of human leukocyte antigen-DR molecule 
expression on monocytes and macrophages, anti-inflammatory cytokine production, 
reduced monocyte phagotocytosis and a reduction in the number of pro-inflammatory 
cytokines released from immune cells (Hutchins, Unsinger, Hotchkiss, & Ayala, 2014; 
Schefold, Hasper, Volk, & Reinke, 2008; Venet, Lukaszewicz, Payen, Hotchkiss, & 
Monneret, 2013). It is often during this later immunosuppressed phase of sepsis that 
patients die – due to second or third infections occurring in conjunction with an 
impaired immune system.  
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3.1.4 Immediate Early Genes in the CNS 
Immediate early genes are rapidly produced in the CNS in response to a wide 
variety of stimuli and are thought to be key factors in regulating cellular activities 
necessary for neuronal plasticity (Pérez-Cadahía, Drobic, & Davie, 2011). Three of the 
most characterised IEGs include activity-regulated cytoskeleton-associated protein 
(Arc), early growth response protein-1 (egr-1), and c-fos. Arc encodes an effector 
protein which directly influences cell function, egr1 and c-fos on the other hand are 
classified as regulatory transcription factors, with both genes influencing cells in a more 
indirect fashion via effects on the transcription of specific downstream genes 
(Guzowski, Setlow, Wagner, & McGaugh, 2001). Egr-1 and arc are both of central 
importance to long-term plasticity and memory (Bozon, Davis, & Laroche, 2003; Soulé, 
et al., 2008), with egr-1 also implicated in the induction of late-phase arc transcription 
(Penke, Chagneau, & Laroche, 2011). Arc has been shown to be both up-regulated, and 
down-regulated in response to neuroinflammation, with differences emerging between 
models of inflammation, age of the animals, whether basal arc expression or learning-
stimulated arc is measured and the time at which arc measurement takes place (Rosi, 
2011).   
Though less research exists on the interplay between egr-1 expression and 
neuroinflammatory pathways, egr-1 has been shown to play a role in LPS induced 
neuroinflammation in addition to its involvement in memory consolidation/formation. 
Egr-1 has been shown to bind to the promoter region of TNF-α in human monocytic 
cells following LPS administration (Yao, Mackman, Edgington, & Fan, 1997). In 
models of cerebral ischemia EGR-1 expression is increased while egr-1 knockout mice 
exhibit improved neurological function and reduced inflammatory gene expression (Yi, 
Park, Kapadia, & Vemuganti, 2007).  Little work to date has been done on egr-1 
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expression in the hippocampus following the administration of inflammatory stimuli. It 
has however been found that a 5µg intracerebroventricular injection of LPS does not 
increase expression of egr-1 or arc expression in the hippocampus, although both were 
significantly lower in the cortex (Bonow, Aïd, Zhang, Becker, & Bosetti, 2009).  
c-fos is a transcription factor known to be induced by a number of noxious 
stimuli (Pérez-Cadahía, Drobic, & Davie, 2011), and has been shown to be acutely 
upregulated across multiple brain regions upon LPS administration (Wanner, et al., 
2013) with levels falling by 24 hours (Frenois, et al., 2007). Owing to its rapid induction 
in neurons following stimulation c-fos has been widely used in neuroscience research as 
a marker of neuronal activation (Avi, 1997; Cruz, et al., 2013; Kovács, 1998).  
3.1.5 Aims 
 The aim of this chapter was therefore to examine neuroimmune parameters 
highly relevant to both human sepsis and the behavioural alterations which were 
previously shown in post-septic mice. Based on previous studies indicating the ability of 
septic doses of LPS to induce long-lasting neuroinflammatory changes within the 
hippocampus, it was hypothesised that the peripheral administration of LPS would lead 
to a chronic activation of microglia and the upregulation of pro-inflammatory factors 
within our model. It was also hypothesised that these inflammatory changes would 
affect factors essential to normal hippocampal functioning such as immediate early gene 
expression and adult cell proliferation. As the amygdala is also a key area in processing 
emotion c-Fos levels were also examined here to assess neuronal activation in the 
region.  
Immunohistochemical analysis was carried out to examine both the acute and 
long-term effects of LPS treatment in the hippocampus. Microglial and astrocytic 
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activation were investigated using the microglial markers cluster of differentiation 
molecule 11B (CD11b), F4/80 and ionised calcium-binding adaptor (IBA1) in addition 
to the astrocytic marker glial fibrillary acidic protein (GFAP). The cytokines 
interleukin(IL)-6, IL-1β and tumor necrosis factor-α (TNF-α) were also examined as 
well as the enzyme inducible nitric oxide synthase (NOS2/iNOS). Given the importance 
of the NF-κB pathway in driving LPS-induced inflammation, components of NF-κB 
signalling phosphorylated (p)-IKK, and p-IκB were then assessed. In addition to these 
immune factors IEG protein product expression levels, namely ARC, EGR-1 and c-Fos 
were assessed. C-Fos was also measured in the amygdala at this timepoint. Finally, 
apoptotic marker cleaved caspase-3 was examined 24 hours post-LPS administration 
and cell proliferation was assessed using bromodeoxyuridine (BrdU).  
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3.2 Methods & Materials 
3.2.1 Animals 
Male C57BL/6 mice between 8 and 12 weeks old were used in all experiments. 
Animals were housed two to four per group in plastic cages (12cm x 9cm x 9 cm) with 
wire lids containing wood-chip bedding and shredded paper for environmental 
enrichment. All animals had ad libitum access to water at all times, and ad libitum 
access to food. Animals were kept in a 12:12 light:dark cycle at 200lux and 21±1°C and 
50±5% relative humidity. Where an animal was moribund and deemed unlikely to 
recover, as occurred in approximately 10% of cases, he was removed from the sample 
and euthanised.  
3.2.2 Drug Treatments 
All saline and LPS injections were made up fresh on the treatment day, and 
given intraperitoneally in a final injection volume of 0.125ml.  0.9% sterile saline was 
made up fresh for control injections, while lipopolysaccharide (serotype0111.B4, Sigma 
Ireland; Qin et al, 2007) was made up to a 5mg/kg dose in sterile saline. Injections were 
given intraperitoneally between zeitgeber time (ZT) 06 and 08, where ZT0 is defined as 
lights on. For the examination of neural precursor cell proliferation BrdU (50mg/kg, 
Sigma Aldrich) was administered i.p. to animals 24 hours before euthanasia in a volume 
of 0.3ml.  
3.2.3 Perfusion and Tissue Preparation 
Mice were anaesthetised with 0.1ml sodium pentobarbital (Euthatal, Merial 
Animal Health, UK), following which they were perfused transcardially with 0.9% 
saline, and then 4% paraformaldehyde (PFA, Sigma) in 0.1M phosphate buffer (PB), 
pH 7.4 at 4˚C. Brains were subsequently removed and placed overnight in the same 
fixative at 4˚C, followed by immersion in 0.1 M PB containing 30% sucrose at 4˚C until 
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sunk. Following cryoprotection, the brains were then taken from sucrose, cerebellums 
were removed, and the brains were frozen and sectioned coronally at 30µm in series of 
4 using a microtome (Leica, UK), with sections stored in 0.1M PB with 0.1% sodium 
azide.  
3.2.4 Immunohistochemistry 
Immunohistochemistry followed a standard Avidin-Biotin Complex/Nickel 
DAB colourmetric protocol (O'Callaghan, Anderson, Moynagh, & Coogan, 2012). 
Following two ten minute washes in 0.1 M PB and one ten minute wash in 0.1 M PB 
with 0.3% Triton X (PBX), sections were washed for 20 minutes in 0.1 M PB with 
1.5% hydrogen peroxide to inactivate endogenous peroxidases. After a further three ten 
minute washes (2 x PB, 1 x PBX) sections were blocked with 5% normal horse serum 
(NHS) or normal goat serum (NGS) for 60 minutes at room temperature. Sections were 
then incubated with primary antibody in 0.1M PBX containing 2% normal horse serum 
overnight at 4˚C (primary antibody information given in table 4). The following day 
sections were once again washed (2 x PB, 1 x PBX) before development with the 
appropriate biotinylated secondary antibody (1:400) in 0.1M PBX containing 2% NGS 
or NHS for 70 minutes. During secondary antibody incubation and all subsequent steps 
sections and solutions were protected from light.  Following 3 subsequent ten minute 
washes (2 x PB, 1 x PBX) sections were developed in ABC for 90 minutes (0.4%; 
Vector Laboratories, Peterborough, Cambridgeshire, UK). After two more PB washes, 
and one ten minute wash in 0.1 M Sodium Acetate (Ph 6, Sigma) sections were reacted 
with 1ml of nickel-enhanced diaminobenzidine, (3, 3’-diaminobenzidene with 
ammonium nickel chloride, NiDAB, PH6) and 60µl glucose oxidase (5mg/ml) as a 
catalyst to visualise the protein products of interest. To control for inter-run variability 
all sections for individual anti-bodies were reacted in the same run, for an equal amount 
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of time. Once sufficient staining had developed, sections were washed in 0.1M sodium 
acetate (Ph6) followed by two washes in 0.1M PB (Ph7.4). Sections were subsequently 
mounted on gelatine coated slides (1% gelatine, 0.05% chromium potassium sulphate) 
and allowed to dry for 24-48 hours. Slides were then dehydrated via three 3 minute 
washes in 70%, 90% and 100% ethanol and delipified with three 3 minute washes in 2% 
Histoclear (National Diagnostics, UK). Slides were then coverslipped with Eukitt 
(Fluka Analytical). 
Table 4. Primary antibodies used in immunohistochemical analysis 
Antibody  Dilution  Raised in  Supplier  Product 
Code  
Arc (H-300) 1:500 Rabbit Santa Cruz 
Biotechnology 
sc-15325 
Egr-1 (C-
19) 
1:3000 Rabbit Santa Cruz 
Biotechnology 
sc-189 
CD11b 1:1000 Rat AbD Serotec, 
Oxford, UK 
MCA74GA 
F4/80 1:100 Rat AbD Serotec, 
Oxford, UK 
MCA497GA 
IBA-1 1:3000 Rabbit Wako, 
Denmark 
019-19741 
GFAP 1:1000 Rabbit Sigma, St. 
Louis, MO, 
U.S.A 
G4546 
TNF- α 1:75 Rat AbD Serotec, 
Oxford, UK 
MCA1488 
IL-1β 1:50 Rabbit Peprotech, 
U.S.A. 
500-P51 
IL-6 (M-19) 1:200 Goat Santa Cruz  
Biotechnology 
sc-1265 
NOS2 (M-
19) 
1:100 Rabbit Santa Cruz 
Biotechnology 
sc-650 
p-IKK α/β 
(Ser 180/ 
Ser 181)-R  
1:200 Rabbit Santa Cruz 
Biotechnology 
sc-23470-R 
p-IkB- α 
(Ser32/36) 
1:200 Rabbit Santa Cruz 
Biotechnology 
sc-101713 
BrdU 1:200 Rat  AbD Serotec, 
Oxford, UK 
MCA2060 
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Cleaved 
Caspase-3 
(Asp175) 
1:200 Rabbit Cell signalling 
technology, 
Danvers, MA, 
USA 
#9661 
 
Photomicrographs of sections were taken using a digital camera connected to an 
Olympus BX-51 light microscope at 40x or 100x magnification under constant light 
intensity. Morphology and number of active microglia stained with IBA1 were assessed 
by eye under 400x magnification, while for nuclear staining (Cleaved Caspase-3, ARC, 
and c-FOS) the number of clearly stained immunoreactive cells per area per section 
were counted via microscope at 100x magnification, and for all other antibodies (except 
IBA1) image analysis software (ImageJ 1.43, NIH, USA) was used to calculate 
integrated optical density for photomicrographs of sections of interest. 
Microphotographs are presented in text with scale bars representing 100µm unless 
otherwise noted. For each method between 4 and 6 sections of the mid dorso-ventral 
level of the hippocampus were analysed. Hippocampal sections were assessed across 
five areas of interest – the dentate gyrus granule cell layer, the dentate gyrus 
polymorphic cell layer, CA1, CA2 and CA3, with the entire region of interest analysed 
for each section (Franklin & Paxinos, 1997). Amygdala sections were analysed in an 
identical manner in the lateral and basolateral nuclei (Franklin & Paxinos, 1997). 
3.2.5 Assessment of the Acute Effects of LPS-induced Sepsis 
10 week old behaviourally naïve mice were treated with either 5mg/kg LPS or 
0.9% sterile saline (n=5 per group) at ZT6. 24 hours later these animals were then 
administered 0.1ml sodium pentobarbital and transcardially perfused as previously 
described. Sections from these animals were then processed for microglial activation 
(CD11b, F4/80), astroglial  activation (GFAP), as well as IL-6, cleaved caspase-3 and 
Arc expression. 
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3.2.6 Assessment of the Long-lasting Effects of LPS-induced Sepsis 
 For all experiments animals were treated with either 5mg/kg LPS or 0.9% sterile 
saline and allowed to recover for one month. Animals then underwent up to three 
behavioural tasks and were terminally anaesthetised and perfused no sooner than one 
week following the cessation of the final task. For the analysis of the effects of LPS 
induced sepsis at 12 months animals were treated at age 8-12 weeks and subsequently 
allowed to recover. They then underwent a tail suspension test 12 months later and one 
week subsequent to this they were terminally anaesthetised and transcardially perfused. 
All perfusions were carried out at ZT6, and brains were then analysed via 
immunohistochemistry for microglial (CD11b, F4/80, IBA1) and astroglial (GFAP) 
activation, IEG expression (Egr-1, Arc, c-Fos), cytokine levels (TNF-α, IL-1β, IL-6), as 
well as iNOS levels, IKK and IκB expression. Table 5 details which behavioral cohort 
(as described in chapter 2) mice had been part of prior to perfusion for 
immunohistochemical analysis. 
Table 5. Behavioural cohorts subsequently involved in immunohistochemical analysis. 
Cohort Antibodies examined 
Cohort A CD11b 
Cohort B F4/80. TNFα, GFAP 
Cohort C c-Fos, EGR-1, ARC, iNOS 
Cohort D IL-6, IL-1β, p-IKK, p-IκB 
Cohort E BrdU 
 
3.2.7 Statistical Analysis 
Data for each experiment was collated and analysed with IBM SPSS (version 
20). For all experiments independent t-tests were conducted with p values of < 0.05 
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accepted as significant. All data are presented as means ± standard error of the mean 
(SEM). * represents p<0.05, ** represents p<0.01 and *** represents p<0.001 in 
independent t-tests. Scale bars on microphotographs represent 100µm for photos at 40x 
and 100x magnification and 50µm for photos at 400x magnification. Where Levene’s 
assumption of homogeneity of variance was violated p values and degrees of freedom 
were corrected. Red arrows show staining considered positive for each antibody.  
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3.3 Results 
3.3.1 Acute effects of LPS-induced sepsis in mice 
3.3.1.1 CD11b 
CD11b is expressed on the surface of microglia. Shown in Figure 3.1, there was 
a main effect of LPS treatment on CD11b IOD scores between saline (n=3) and LPS 
(n=3) treated mice in the DgGr (0.32±0.12 vs. 1.56±.0.29), t₄=3.938, p=0.017. A 
significant difference was also present in the DgPo (0.80±0.19 vs. 3.63±0.24), t₄=9.189, 
p=0.001. In the CA1 region there was again a significant difference (0.29±0.04 vs. 
2.17±0.26), t₂.₀₈=6.738, p=0.019. There was also a significant difference in the CA2 
region (0.36±0.07 vs. 3.24±0.29), t₄=9.81, p=0.001. Lastly there was a significant 
difference between saline and LPS-treated animals in the CA3 region (0.58±0.14 vs. 
5.1±0.167), t₄=20.931, p<0.0001. 
 
 
 
 
 
Figure 3.1 Upregulated CD11b expression 24 hours post-sepsis Bar graph illustrating 
IOD values for each area of the hippocampus in saline (n=3) and LPS (n=3) treated 
mice. */**/*** represents p<0.05/0.01/0.001 respectively in independent t-tests, error 
bars represent ± 1 SEM. Representative photomicrographs illustrating CD11b 
expression in the hippocampus at 40x magnification. 
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3.3.1.2 F4/80 
 There was an upregulation of F4/80 – another microglial and macrogphage 
marker, across all areas of the hippocampus in response to LPS (n=4) compared to 
saline (n=4) at 24 hours as shown in Figure 3.2. Microglia notably assumed an 
amoeboid morphology (red arrows) in response to this high dose of LPS. In the dentate 
gyrus saline-treated animals had a mean IOD score of 1.35±0.27 while LPS-treated 
animals had a mean score of 11.67±1.95, t₃.₁₂ = 5.24, p = 0.012. In the DgPo saline-
treated animals had a mean score of 2.12±0.32 while LPS-treated animals had a mean 
score of 23.99±2.4, t₃.₁=9.03, p=0.003. In the CA1 region saline-treated animals had a 
mean IOD score of 0.94±0.26 while LPS animals had a mean score of 9.93±1.58, 
t₃.₁₆=5.61, p=0.012. In the CA2 region saline-treated animals had a mean score of 
1.52±0.33 while LPS-treated animals had a mean score of 10.81±1.79, t₆=5.11, 
p=0.002. In the CA3 region saline animals had a mean score of 1.4±0.33 vs. 15.66±0.88 
for LPS-treated mice (t6=15.24, p<0.0005). 
 
 
 
 
 
 
Figure 3.2 Upregulated F4/80 expression 24 hours post-sepsis Bar graph illustrating 
mean IOD values for each area of the hippocampus in saline (n=4) and LPS (n=4) 
treated animals with */**/*** representing p<0.05/0.01/0.001 in independent t-tests, 
error bars represent ± 1 SEM. Representative photomicrographs illustrating F4/80 
expression in the hippocampus at 40x and 100x magnification. 
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3.3.1.3 GFAP 
 There was no changes to astrocytes as measured by GFAP IOD in any area of 
the hippocampus of LPS-treated mice (n=4) in comparison to saline-treated mice (n=4) 
as shown in Figure 3.3. In the DgGr saline-treated animals had a mean IOD score of 
3.51±0.37 while LPS-treated animals had a mean score of 2.81±0.91, t₆=0.71, p=0.507. 
In the DgPo there was a mean score of 3.15±0.28 for saline-treated animals and 
5.07±0.99 for LSP treated mice, t₆=1.87, p=0.111. In the CA1 region saline-treated 
animals had a score of 2.13±0.11 while LPS-treated mice had a mean score of 
1.73±0.52, t₃.₂₆₈=0.76, p=0.477. In the CA2 region saline-treated mice had an IOD 
score of 5.34±0.51 while LPS-treated mice had a mean score of 5.05±0.91, t₆=0.28, 
p=0.792. In the CA3 region saline-treated mice had a mean score of 5.11±0.84 while 
LPS-treated mice had a mean score of 7.19±1.45, t₆=1.38, p=0.218.  
 
 
 
 
 
Figure 3.3 Unaltered GFAP expression 24 hours post-sepsis Bar graph illustrating 
IOD values for each area of the hippocampus for saline (n=4) and LPS (n=3) treated 
animals. * represents p<0.05, error bars represent ± 1 SEM. Representative 
photomicrographs illustrating GFAP expression in the hippocampus at 40x 
magnification.  
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3.3.1.4 IL6 
 When expression of the pro-inflammatory cytokine IL-6 was measured 24 hours 
post-treatment a significant difference was seen only in the DgGr. As seen in Figure 3.4, 
in the DgGr saline-treated animals (n=5) had a mean IOD score of 0.45±0.13 while 
LPS-treated animals (n=5) had a mean score of 1.04±0.09, t₈=3.727, p=0.006. In the 
DgPo saline-treated animals had a mean IOD score of 0.80±0.25 while LPS-treated 
animals had a mean score of 1.3±0.22, t₈=1.52, p=0.167. In the CA1 region saline 
animals scored 1.5±0.35 while LPS-treated animals scored 1.27±22, t₈=0.55, p=0.596. 
In the CA2 region saline-treated animals scored 1.86±0.58 while LPS-treated mice 
scored 1.22±0.18, t₄.₈=1.07, p=0.335. Lastly, in the CA3 region saline-treated mice 
scored 2.71±0.72 while LPS-treated mice scored 1.63±0.11, t4.19=1.47, p=0.212.  
 
 
 
 
 
 
Figure 3.4 Unaltered IL-6 expression 24 hours post-sepsis Bar graph illustrating IOD 
values for each area of the hippocampus in saline (n=5) and LPS(n=5) treated mice 
with ** representing p<0.01 in independent t-tests, error bars represent ± 1 SEM. 
Representative photomicrographs illustrating IL6 expression in the hippocampus at 40x 
magnification. 
 
0
0.5
1
1.5
2
2.5
3
3.5
4
Dg Gr Dg Po CA1 CA2 CA3
IL
-6
 I
O
D
 S
co
re
 
Saline
LPS
Saline 
  LPS 
** 
115 
 
3.3.1.5 Cleaved Caspase-3 
 There was a significant upregulation of apoptotic marker cleaved caspase-3 
expression in the subgranular zone of the hippocampus 24 hours following LPS 
administration as can be seen in Figure 3.5. While there was negligible expression of 
cleaved caspase-3 positive cells in the hippocampus following saline treatment 
(0.125±0.07, n=5), there was a robust expression of cells positive for cleaved caspase-3 
in the LPS-treated animals (10.75±2.33, n=5), t4.007=4.561, p=0.01.  
 
 
Figure 3.5 Upregulated cleaved caspase-3 expression 24 hours post-sepsis Cleaved 
caspase-3 expression in the subgranular zone of the hippocampus at 24 hours post 
treatment. Bar graph illustrating average number of Cleaved Caspase-3
+
 cells in the 
SGZ  per hippocampal section in saline (n=5) and LPS (n=5) treated mice with ** 
representing p<0.01 in independent t-tests, error bars represent ± 1 SEM. 
Representative photomicrographs illustrating Cleaved Caspase-3 expression in the 
hippocampus at 100x magnification. 
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3.3.1.6 ARC 
 As shown in Figure 3.6, there was a significant reduction in neurons positive for 
ARC – a key IEG for neuronal plasticity in the dentate gyrus of the hippocampus 24 
hours following LPS administration. Saline-treated animals (n=5) had an average of 
54.25±3.75 Arc positive cells while LPS-treated animals (n=5) had an average of 
23.55±3.054 ARC positive cells in the dentate gyrus t₈=6.34, p<0.0005. Arc expression 
was negligible in hippocampal areas CA1, CA2 and CA3 and is therefore not illustrated. 
 
 
 
 
 
 
 
 
Figure 3.6 Altered ARC expression 24 hours post-sepsis Bar graph illustrating 
average ARCc+ cells per dentate gyrus section in both saline (n=5) and LPS (n=5) 
treated mice. *** represents p<0.001 in an independent t-test, error bars represent ± 1 
SEM. Representative photomicrographs illustrating Arc expression in the hippocampus 
at 40x magnification. 
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3.3.2 Long-lasting effects of LPS induced sepsis in mice 
3.3.2.1 CD11b 
 Microglial activation measured by CD11b indicated an upregulated expression 
in the DgGr, DgPo, and CA1 of the hippocampus, shown in Figure 3.7. In the DgGr 
there was a mean IOD score of 1.16±0.23 for saline-treated animals (n=8) and 
2.78±0.45 for LPS-treated animals (n=7), t13=3.343, p=0.005. In the DgPo saline-treated 
animals had a mean score of 3.68±0.8 while LPS-treated animals had a mean score of 
6.98±0.63, t13=3.156, p=0.008. In the CA1 region saline-treated animals had a mean 
score of 1.56±0.38 while LPS-treated animals had a mean score of 3.46±0.7, t13=2.467, 
p=0.028. There was no difference between saline-treated and LPS-treated animals in the 
CA2 region (1.76±0.38 vs. 2.37±0.39, t13=1.12, p=0.283) or the CA3 (2.67±0.51 vs. 
2.47±0.35, t13=0.314, p=0.759). 
 
 
 
 
 
 
Figure 3.7 Upregulated CD11b expression 2 months post-sepsis Bar graph illustrating 
IOD values for each area of the hippocampus in saline (n=8) and LPS (n=7) treated 
mice with */** representing p<0.05/0.01 in independent t-tests, error bars represent ± 1 
SEM. Representative photomicrographs illustrating CD11b expression in the 
hippocampus at 40x magnification. 
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3.3.2.2 F4/80 
 F4/80 was upregulated throughout the hippocampus 2 months following LPS 
administration, as can beseen in Figure 3.8. In the DgGr saline-treated animals (n=8) 
had a mean IOD score of 1.7±0.21 while LPS-treated animals (n=7) had a mean score of 
3.82±0.56, t7.76=3.55, p=0.008. In the DgPo saline-treated animals had a mean score of 
2.57±0.29 while LPS-treated animals had a mean score of 6.51±1.08, t6.89=3.52, 
p=0.002. In the CA1 region saline-treated mice had a mean score of 1.22±0.17 while 
LPS-treated animals had a mean score of 3.41±0.49, t7.48=7.48, p=0.003. In the CA2 
region saline-treated animals had a mean score of 2.23±0.25 while LPS-treated animals 
had a mean score of 5.87±0.75, t7.39=7.39, p=0.002. Lastly, in the CA3 region saline-
treated mice had a mean score of 1.91±0.19 while LPS-treated animals had a mean 
score of 4.37±0.72, t6.82=3.28, p=0.014. 
 
 
 
  
 
 
Figure 3.8 Upregulated F4/80 expression 2 months post-sepsis. Bar graph illustrating 
IOD values for each area of the hippocampus in saline (n=7) and LPS (n=8) treated 
mice. */** represent p<0.05/0.01 in independent t-tests, error bars represent ± 1 SEM. 
Representative photomicrographs illustrating F4/80 expression in the hippocampus at 
40x magnification. 
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3.3.2.3 IBA1 
 When microglia in the hippocampus were morphologically examined using 
IBA1, which is expressed on the surface of all microglia, an increased number of 
activated microglia (characterised by withdrawn processes and/or enlarged cell bodies, 
as shown in Figure 3.9) were found in sepsis-survivor animals (n=4) than controls 
(n=4). In the DgGr saline-treated animals had an average of 6.3±0.52 activated 
microglia while LPS-treated animals had an average of 10.01±0.64, t6=4.49, p=0.004. In 
the DgPo saline-treated animals had an average of 5.01±0.64 activated microglia while 
LPS-treated animals had an average of 7.74±0.69, t6=2.9, p = 0.027. In the CA1 region 
LPS-treated animals also had a larger number of activated microglia (10.92±1.54 vs. 
20.26±2.94), t6=2.81, p=0.031. In the CA2 region saline-treated mice had an average of 
0.85±0.05 activated microglia while LPS-treated animals had an average of 1.48±0.29, 
t6=2.1, p=0.081. In the CA3 region saline-treated animals had an average of 8.26±0.95 
activated microglia while LPS-treated animals had 12.75±1.3, t6=2.8, p=0.031. 
 
 
 
 
 
 
Figure 3.9 Upregulation of activated microglia 2 months post-sepsis Bar graph 
illustrating cell counts values for each area of the hippocampus of saline (n=4) and 
LPS (n=4) treated mice. */** represent p<0.05/0.01 in independent t-tests, error bars 
show ± 1 SEM. Photomicrographs illustrating IBA1 expression in the hippocampus at 
400x magnification, scale bar represents 50µm.Red circles denote activated microglia. 
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3.3.2.4 GFAP 
 As illustrated by Figure 3.10, there was no significant difference in GFAP levels 
– expressed on the surface of astrocytes, between saline (n=4) and LPS (n=4) treated 
animals after two months. In the DgGr saline-treated animals had mean IOD scores of 
5.32±1.69 while LPS-treated animals had scores of 4.53±0.58, t3.71=0.44, p=0.67. In the 
DgPo saline-treated animals had a mean score of 2.17±0.39 while LPS-treated animals 
had a mean score of 2.92±0.23, t6=1.66, p = 0.148. In the CA1 region saline-treated 
animals had a mean score of 1.5±0.37 while LPS-treated animals had a mean score of 
2.08±0.55, t6=0.88, p=0.411. In the CA2 region saline-treated animals had a mean score 
of 2.83±0.65 while LPS-treated animals had a mean score of 4.56±0.43, t6=2.2 p=0.07. 
In the CA3 region saline-treated animals had a mean score of 7±1.69 while LPS-treated 
animals had a mean score of 9.30±0.77, t6=1.24, p=0.263. 
 
 
 
 
 
 
 Figure 3.10 Unaltered GFAP expression 2 months post-sepsis Bar graph illustrating 
IOD values for each area of the hippocampus in saline (n=4) and LPS (n=4) treated 
mice. * represents p<0.05 in independent t-tests, error bars represent ± 1 SEM. 
Photomicrographs illustrating GFAP expression in the hippocampus at 40x 
magnification. 
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3.3.2.5 TNFα 
 As Figure 3.11 shows, there were no significant differences between groups in 
the expression of proinflammatory cytokine TNFα at two months post-treatment. In the 
DgGr saline-treated animals (n=4) had a mean IOD score of 0.57±0.13 while LPS-
treated animals (n=4) had a mean score of 1±0.16, t6=2.12, p=0.078. In the DgPo saline-
treated animals had a mean score of 1.82±0.41 while LPS-treated animals had a mean 
score of 2.91±0.19, t6=2.41, p=0.052. In the CA1 region saline-treated animals had a 
mean score of 0.98±0.23 while LPS-treated animals had a mean score of 1.46±0.43, 
t6=0.98, p=0.36. In the CA2 region saline-treated animals had a mean score of 
0.72±0.25 while LPS-treated animals had a mean score of 0.55±0.14, t6=0.6, p=0.573. 
In the CA3 region saline-treated animals had a mean score of 0.68±0.25 while LPS-
treated animals had a mean score of 0.66±0.28, t6=0.28, p=0.943.  
 
 
 
 
 
 
Figure 3.11 Unaltered TNFα expression 2 months post-sepsis Bar graph illustrating 
IOD values for each area of the hippocampus for saline (n=4) and LPS (n=4) treated 
mice with * representing p<0.05 in independent t-tests, error bars represent ± 1 SEM. 
Photomicrographs illustrating TNFα expression in the hippocampus at 40x 
magnification. 
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3.3.2.6 IL-1β 
 Levels of the pro-inflammatory cytokine IL-1β were measured in the 
hippocampus 2 months post treatment with a significant difference between saline (n=4) 
and LPS (n=4) treated animals present only in the CA3 region area, illustrate in Figure 
3.12. In the DgGr saline-treated animals had a mean IOD score of 69±10.66 while LPS-
treated animals had a mean score of 88.81±6.84, t6=1.52, p=0.18. In the DgPo there was 
no significant difference between saline and LPS-treated animals (13.29±2.22 vs. 
17.97±1.59), t6=1.71, p=0.132. In the CA1 region saline-treated mice had a mean score 
of 17.62±2.43 while LPS-treated mice had a mean score of 19.42±1.52, t6=0.63, p=0.55. 
In the CA2 region saline-treated animals had a mean score of 18.59±1.63 while LPS-
treated animals had a mean score of 23.89±1.74, t6=2.23, p=0.068. In the CA3 region 
saline-treated animals had a mean score of 21.52±1.76 while LPS-treated animals had a 
mean score of 27.58±1.35, t6=2.73, p=0.034. 
 
 
 
 
 
 
Figure 3.12 IL-1β expression 2 months post-sepsis Bar graph illustrating IOD values 
for each area of the hippocampus for saline (n=4) and LPS (n=4) treated mice. * 
represents p<0.05 in independent t-tests, error bars represent ± 1 SEM. 
Photomicrographs illustrating IL-1β expression in the hippocampus at 40x 
magnification. 
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3.3.2.7 IL-6 
 When expression of pro-inflammatory cytokine IL-6 was measured via 
immunohistochemistry there were no significant differences between saline (n=4) and 
LPS (n=4) treated animals in any area of the hippocampus, illustrated in Figure 3.13. In 
the DgGr saline-treated animals had a mean score of 1.15±0.17 while LPS-treated 
animals had a mean score of 1.09±0.277, t6=0.2, p=0.849. In the DgPo saline-treated 
animals had a mean score of 0.8±0.13 while LPS-treated animals had a mean score of 
0.70±0.26, t6=0.35, p=0.736. In the CA1 region saline-treated animals had a mean score 
of 1.47±0.31 while LPS-treated animals had a mean score of 1.19±0.17, t6=0.8, 
p=0.455. In the CA2 region saline-treated mice had a mean score of 1.55±0.34 while 
LPS-treated mice had a mean score of 1.69±0.28, t6=0.31, p=0.769. In the CA3 region 
saline-treated mice had a mean score of 1.71±0.28 while LPS-treated mice had a mean 
score of 1.32±0.31, t6=0.91, p=0.396. 
 
 
 
 
 
 
Figure 3.13 Unaltered IL-6 expression 2 months post-sepsis Bar graph illustrating 
IOD values for each area of the hippocampus in saline (n=4) and LPS (n=4) treated 
mice. * represents p<0.05, error bars represent ± 1 SEM. Photomicrographs 
illustrating IL-6 expression in the hippocampus at 40x magnification. 
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3.3.2.8 p-IKK 
 Analysis of p-IKK levels, an upstream component of the NF-κB pathway, 
revealed no differences between saline (n=4) and LPS (n=3) treated animals in any area 
of the hippocampus as can be seen in Figure 3.14. In the DgGr saline-treated animals 
had a mean score of 2.97±0.22 while LPS-treated animals had a mean score of 
1.99±0.42, t5=2.24, p=0.076. In the DgPo saline-treated animals had a mean score of 
4.8±1.26 while LPS-treated animals had a mean score of 2.79±01.23, t5=1.34, p=0.237. 
In the CA1 region saline-treated animals had a mean score of 1.89±0.23 while LPS-
treated animals had a mean score of 1.78±0.81, t2.34=0.12, p=0.911. In the CA2 region 
saline-treated animals had a mean score of 5.3±1.17 while LPS-treated animals had a 
mean score of 4.5±1.05, t5=0.48, p=0.649. In the CA3 region saline-treated animals had 
a mean score of 7.7±1.38 while LPS-treated animals had a mean score of 6.39±1.31, 
t4.47=0.834, p=0.447. 
 
 
 
 
 
 
Figure 3.14 Unaltered p-IKK expression 2 months post-sepsis Bar graph illustrating 
IOD values for each area of the hippocampus for salinie (n=4) and LPS (n=3) treated 
animals. * represents p< 0.05 in independent t-tests, error bars represent ± 1 SEM. 
Photomicrographs illustrating p-IKK expression in the hippocampus at 40x 
magnification. 
0
1
2
3
4
5
6
7
8
9
10
Dg Gr Dg Po CA1 CA2 CA3
p
-I
K
K
 I
O
D
 s
c
o
re
 
Saline
LPS
Saline 
 LPS 
125 
 
3.3.2.9 p-IκB 
 There were no differences in p-IκB levels, which are elevated during NF-κB 
activation, between saline (n=4) and LPS (n=4) treated animals in the hippocampus at 2 
months post-treatment, illustrated in Figure 3.15. In the DgGr saline-treated animals had 
a mean IOD score of 15.6±1.26 while LPS-treated animals 15.42±1.16, t6=0.1, p=0.921. 
In the DgPo saline-treated animals had a mean score of 6.37±1.32 while LPS-treated 
animals had a mean score of 7.07±0.63, t4.283=0.48, p=0.655. In the CA1 region region 
saline-treated animals had a mean score of 10.21±1.79 while LPS-treated animals had a 
mean score of 11.87±1.6, t6=0.78, p=0.46. In the CA2 region region saline-treated 
animals had a mean score of 13.86±1 while LPS-treated animals had a mean score of 
15.67±2.08, t4.32=047, p=0.474. In the CA3 region saline-treated animals had a mean 
score of 17.73±0.89 while LPS-treated animals had a mean score of 19.75±1.2, t6=1.35, 
p=0.226.  
 
 
 
 
 
 
Figure 3.15 Unaltered p-IκB expression 2 months post-sepsis Bar graph illustrating 
IOD values for each area of the hippocampus for saline (n=4) and LPS (n=4) treated 
mice. * represents p<0.05 in independent t-tests, error bars represent ± 1 SEM. 
Photomicrographs illustrating p-IκB expression in the hippocampus at 40x 
magnification. 
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3.3.2.10 iNOS 
 Immunohistochemical analysis revealed no significant differences between 
saline (n=4) and LPS (n=3) treated animals in inducible nitric oxide synthase levels in 
any area of the hippocampus, as shown in Figure 3.16. In the DgGr saline-treated 
animals had a mean IOD score of 0.15±0.07 while LPS-treated animals had a mean IOD 
score of 0.11±0.03, t5=0.49, p=0.646. In the DgPo saline-treated animals had a mean 
score of 0.29±0.04 while LPS-treated animals had a mean score of 0.38±0.1, t6=0.95, 
p=0.38. In the CA1 region saline-treated animals had a mean IOD score of 0.76±0.1 
while LPS-treated animals had a mean score of 0.83±0.21, t5=0.29, p=0.78. In the CA2 
region saline-treated animals had a mean score of 3.62±0.67 while LPS-treated animals 
had a mean score of 5.27±1.54, t5=1.09, p=0.325. In the CA3 region saline-treated 
animals had a mean score of 0.93±0.23 while LPS-treated animals had a mean score of 
1.58±0.17, t5=2.15, p=0.084. 
 
 
 
 
 
 
Figure 3.16 Unaltered iNOS expression 2 months post-sepsis Bar graph illustrating 
IOD values for each area of the hippocampus for saline (n=4) and LPS (n=3) treated 
mice. * represents p< 0.05 in independent t-tests, error bars represent ± 1 SEM. 
Photomicrographs illustrating iNOS expression in the hippocampus at 40x 
magnification. 
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3.3.2.11 BrdU 
 In order to examine whether or not any alterations in cell proliferation were 
present in post-septic animals BrdU positive cells were counted in the subgranular zone 
of the hippocampus 2 months post-treatment. As can be seen in Figure 3.17 cell 
proliferation appeared reduced in post-septic mice.  In saline-treated animals (n=5) there 
were an average of 13.24±0.79 BrdU
+
 cells while in the LPS-treated animals (n=6) there 
was an average of 7.99±1.15 BrdU
+
 cells per hippocampal section, t9=3.61, p=0.006. 
 
 
 
 
 
 
 
 
Figure 3.17 Reduced BrdU incorporation 2 months post-sepsis Bar graph illustrating 
average number of BrdU
+
 cells per hippocampal in both saline (n=5) and LPS (n=6) 
treated animals. ** represents p<0.01 in an independent t-test, error bars represent ± 1 
SEM. Representative photomicrographs illustrating BrdU expression in the 
hippocampus at 100x magnification. 
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3.3.2.12 c-Fos 
 Immunohistochemical analysis of neurons positive for activation marker c-Fos 
in the hippocampus revealed no significant differences between saline (n=8) and LPS-
treated animals (n=8) 2 months after treatment, illustrated in Figure 3.18. In the DgGr 
saline-treated animals had an average of 36.32±3.29 positive cells while LPS-treated 
animals had an average of 30.79±4.9, t14=0.936, p=0.365. In the DgPo saline-treated 
animals had an average of 1.46±0.45 c-Fos positive cells while LPS-treated animals had 
an average of 0.87±0.4, t14=0.97, p=0.348. In the CA1 region saline-treated animals had 
an average of 8.44±2.35 c-Fos positive cells while LPS-treated animals had an average 
of 6.92±1.72, t14=0.52, p=0.61. In the CA2 region region saline-treated animals had an 
average of 1.59±0.47 c-Fos positive cells while LPS-treated animals had an average of 
0.94±0.26, t14=1.216, p=0.244. In the CA3 region saline-treated animals had an average 
of 11.54±3.88 c-Fos positive cells while LPS-treated animals had an average of 
11.45±3.06, t14=0.02, p=0.984. 
 
 
 
 
 
Figure 3.18 Unaltered c-Fos expression 2 months post-sepsis Bar graph illustrating 
average number of c-Fos
+
 cells per hippocampal section for each area of the 
hippocampus in saline (n=8) and LPS (n=8) treated mice. * represents p<0.05 in 
independent t-tests, error bars represent ± 1 SEM. Representative photomicrographs 
illustrating c-Fos expression in the hippocampus at 40x magnification. 
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3.3.2.13 EGR-1 
 Analysis of the immediate early gene EGR-1 expression in the hippocampal 
neurons of sepsis-survivor mice revealed reduced expression in a number of areas 2 
months post treatment, shown in Figure 3.19. In the DgGr saline-treated animals (n=4) 
had a mean IOD score of 3.92±0.53 while LPS-treated animals (n=4) had a mean score 
of 1.61 ±0.8, t6=4.29, p=0.005. In the DgPo saline-treated animals had a mean IOD 
score of 0.94±0.21 while LPS-treated animals had a mean score of 0.55±0.04, 
t3.21=1.822, p=0.16. In the CA1 region saline-treated animals had a mean score of 
113.43±12.93 while LPS-treated animals had a mean score of 71.47±7.37, t6=2.82, 
p=0.03. In the CA2 region saline-treated animals had a mean score of 32.97±4.73 while 
LPS-treated animals had a mean score of 18.28±3.56, t6=2.48, p=0.048. In the CA3 
region saline-treated animals had a mean score of 11.26±2.47 while LPS-treated 
animals had a mean score of 6.56±0.77, t6=1.81, p=0.12. 
 
 
 
 
 
 
Figure 3.19 Reduced EGR-1 expression 2 months post-sepsis Bar graph illustrating 
average number of EGR-1
+
 cells per hippocampal section for each area of the 
hippocampus in saline (n=4) and LPS (n=4) treated mice. * represents p<0.05 in 
independent t-tests, error bars represent ± 1 SEM. Representative photomicrographs 
illustrating EGR-1 expression in the hippocampus at 40x magnification. 
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3.3.2.14 ARC 
 ARC expression was measured in the dentate gyrus of post septic (n=3) and 
saline-treated animals (n=4). It was found that there were significantly more Arc
+
 cells 
in the dentate gyrus of control animals (25.14±4.47) than sepsis-survivor mice 
(9.6±1.7), t5=2.84, p=0.036. This is illustrated in Figure 3.20.  
 
 
 
 
 
 
 
 
Figure 3.20 Reduced ARC expression 2 months post-sepsis Bar graph illustrating 
average number of ARC
+
 cells per dentate gyrus section in saline (n=4) and LPS (n=3) 
treated mice. * represents p<0.05 in independent t-tests, error bars represent ± 1 SEM. 
Representative photomicrographs illustrating Arc expression in the hippocampus at 40x 
magnification. 
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3.3.2.15 Amygdala c-Fos 
 Analysis of c-Fos in neurons of the lateral and basolateral amygdala was also 
conducted. Here it was found that post-septic animals (n=8) had significantly lower 
levels of c-Fos protein product than controls (n=7) in both the lateral (t13=2.275, 
p=0.041) and basolateral regions of (t13=2.624, p=0.021). These changes are shown in 
Figure 3.21. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21 Decreased Amygdala c-Fos expression 2 months post-sepsis Bar graph 
illustrating average number of c-Fos
+
 cells per amygdala section in saline (n=8) and 
LPS (n=7) treated mice with * representing p<0.05 in independent t-tests, error bars 
represent ± 1 SEM. Representative photomicrographs illustrating c-Fos expression in 
the amygdala at 100x magnification. 
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3.3.3 Microglial activation 12 months post-LPS administration 
3.3.3.1 CD11b 
No differences existed between post-septic (n=7) and control (n=7) animals in any area 
of the hippocampus at 12 months post-treatment, as can be seen in Figure 3.22. In the 
DgGr saline-treated animals had a mean IOD score of 3.45±0.53 vs. 4.03±0.75 for LPS-
treated mice, t12=0.625, p=0.544. In the DgPo saline-treated animals had a mean score 
of 10.05±1.3 while LPS-treated animals had a mean score of 8.3±1.2, t12=0.99, p=0.343. 
In the CA1 region saline-treated animals had a mean score of 5.49±1.22 while LPS-
treated animals had a mean score of 4.52±0.64, t12=0.71, p=0.494. In the CA2 region 
saline-treated animals had a mean score of 9.47±2.71 while LPS-treated animals had a 
mean score of 6.6±0.92, t12=1, p=0.336. In the CA3 region saline-treated animals had a 
mean score of 10.57±2.04 while LPS-treated animals had a mean score of 9.11±1.34, 
t12=0.603, p=0.558.  
 
 
 
 
 
 
Figure 3.22 Unaltered CD11b expression 12 months post-sepsis Bar graph illustrating 
IOD values for each area of the hippocampus in saline (n=7) and LPS (n=7) treated 
mice. * represents p<0.05 in independent t-tests, error bars represent ± 1 SEM. 
Photomicrographs illustrating CD11b expression in the hippocampus at 40x 
magnification. 
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3.3.3.2 F4/80 
 There was no significant difference in F4/80 levels, illustrated in Figure 3.23,  in 
any region of the hippocampus at 12 months post LPS administration. In the DgGr 
saline-treated (n=7) animals had a mean score of 7.46±0.91 while LPS-treated animals 
(n=7) had a mean score of 7.88±0.88, t12=0.333, p=0.745. In the DgPo saline-treated 
animals had a mean score of 13.56±1.47 while LPS-treated animals had a mean score of 
12.69±1.19, t12=0.456, p=0.657. In the CA1 region saline-treated animals had a mean 
score of 6.44±1.1 while LPS-treated animals had a mean score of 10.65±3.24, t12=1.232, 
p=0.242. In the CA2 region saline-treated animals had a mean score of 7.33±1.19 while 
LPS-treated animals had a mean score of 9.25±1.26, t12=1.11, p=0.287. In the CA3 
region saline-treated animals had a mean score of 2.92±1.11 while LPS-treated animals 
had a mean score of 7.56±1.16, t12=1.17, p=0.265.  
 
Figure 3.23 Unaltered F4/80 expression 12 months post-sepsis Bar graph illustrating 
IOD values for each area of the hippocampus in saline (n=7) and LPS (n=7) treated 
mice. * represent p<0.05 in independent t-tests, error bars represent ± 1 SEM. 
Photomicrographs illustrating F4/80 expression in the hippocampus at 40x 
magnification. 
0
2
4
6
8
10
12
14
16
DgGr DgPo Ca1 Ca2 Ca3
F
4
/8
0
 I
O
D
 S
co
re
 
Saline
LPS
Saline 
 LPS 
134 
 
Table 6 Protein expression across experimental timepoints 
Antibody  24 Hours  Long-term 14 months  
Arc  Down-regulated in 
LPS (DgGr) 
Down-regulated 
in LPS (DgGr) 
Not examined 
Egr-1  Not examined Down-regulated in 
LPS (DgGr, CA1, 
CA2) 
Not examined 
c-Fos Not examined No changes in 
hippocampus, down-
regulated in 
amygdala. 
Not examined 
CD11b Up-regulated in LPS 
(all areas) 
Up-regulated in LPS 
(DgGr, DgPo, CA1) 
No changes 
F4/80 Up-regulated in LPS 
(all areas) 
Up-regulated in LPS 
(all areas) 
No changes 
IBA-1 Not examined Up-regulated in LPS 
(all areas except 
CA2) 
Not examined 
GFAP No changes No changes Not examined 
TNF- α No changes No changes Not examined 
IL-1β  Up-regulated in LPS 
(CA3) 
Not examined 
IL-6  Upregulated iin LPS 
(DgGr) 
No changes Not examined 
NOS2  Not examined No changes Not examined 
p-IKK α/β  Not examined No changes Not examined 
p-IkB- α  Not examined No changes Not examined 
BrdU Not examined Down-regulated in 
LPS (DgGr) 
Not examined 
Cleaved Caspase-3 
 
Up-regulated in LPS 
(SGZ) 
Not examined Not examined 
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3.4 Discussion 
 These results indicate that a 5mg/kg dose of LPS is sufficient to produce a 
potent inflammatory response accompanied by possible apoptosis in the hippocampus at 
24 hours post-treatment, leading to sustained microglial activation, altered IEG 
expression, and a reduction in neural precursor cell proliferation up to two months later 
– with microglial activation appearing to return to baseline levels by 14 months post-
treatment. Hippocampal cytokine levels at both 24 hours, and two months post-
treatment appear to be close to those of control animals.  
3.4.1 The Acute Response to LPS-induced Sepsis 
 At 24 hours post-treatment there is a significant upregulation of activated 
microglia (F4/80, CD11b) in the hippocampus, accompanied by increased cleaved 
caspase-3 expression and a reduction in the production of Arc. These microglia assume 
an amoeboid morphology typical of acutely activated microglia. There was no 
upregulation in astrocytes (GFAP) and IL-6 production was upregulated only within the 
granule cell layer.  Since the typical profile of activated microglia assumes the 
production of certain pro-inflammatory cytokines such as IL-1β, TNF-α and IL-6 
(Huang, He, Chen, Zhang, & Chen, 2013; Kao, et al., 2011; Lund, et al., 2006; Smith, 
Das, Ray, & Banik, 2012), it was surprising that increased IL-6 was present only within 
the granule cell layer and not other areas of the hippocampus at 24 hours post-treatment, 
despite the large upregulation of activated microglia throughout the hippocampus. 
Several studies show however that in vivo administration of LPS leads to peak cytokine 
levels at much earlier timepoints than 24 hours. For example i.cv. administration of LPS 
leads to peak cerebral IL-6 and TNFα levels between 1-4 hours (Lund, et al., 2006; 
Zujovic, Schussler, Jourdain, Duverger, & Taupin, 2001), while i.p. administration of a 
100µg/kg dose to SD rats induced upregulated hippocampal cytokine production at 2 
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hours with levels generally dropping by 4 hours (Roche, Diamond, Kelly, & Finn, 2007) 
and a 2.5mg/kg i.p. administration leads to increased cytokine levels at 2 and 6 hours 
post-LPS but not 24 hours later in whole-brain samples from male NMRI mice 
(Buiesmans, et al., 2013). Although our dose of LPS is higher than these studies it may 
still elicit a cytokine response which peaks earlier than 24 hours.  
 In addition to microglial activation an acute reduction in basal Arc expression is 
also seen within the hippocampus of post-septic animals. Aged rats treated with E. coli 
show a reduction in resting levels of hippocampal Arc (but not c-Fos) 24 hours post-
treatment, an effect which was blocked by anti-inflammatory IL-1RA administration 
(Frank, et al., 2010). Mice chronically over-expressing IL-1β have also been shown to 
have significantly reduced basal, and conditioning induced, levels of Arc in the 
hippocampus (Hein, et al., 2010). Newly born activated microglia have been shown to 
negatively correlate with behaviourally induced Arc levels following whole-body 
radiation (Nelson, et al., 2014). Thus it appears that in the acute state of LPS-induced 
sepsis, activated microglia contribute to a reduction in resting levels of Arc in the 
dentate gyrus.  
 There was a large upregulation of cleaved caspase-3 within the granule cell layer 
of the hippocampus of post-septic animals while levels are almost undetectable in the 
control group. Cleaved caspase-3 is typically associated with apoptotic cell death 
(Elmore, 2007: Kim, et al., 2014), indicating that apoptosis may be taking place within 
the hippocampus 24 hours following sepsis induction. TUNEL analysis has also shown 
apoptosis in rats 24 hours after a 10mg/kg dose of LPS (Semmler et al, 2005), although 
cognitive deficits have also been observed in rodents following sepsis induction without 
neuronal cell loss (Weberpals, et al., 2009). Caspase-3 may also play other, non-
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apoptotic, roles in the adaptive immune system however (Yi & Yuan, 2009) which 
could also explain its significant upregulation following LPS administration.  
3.4.2 Long-lasting Changes in Immune Factors Post-Sepsis 
 A large number of immune factors were examined in order to elucidate the long-
lasting effects of LPS-induced sepsis on hippocampal processes. Microglia appear to 
remain upregulated at 2-months post-LPS, showing a deramified morphology compared 
to the ramified microglia present in the control animals and the amoeboid microglia 
present acutely following LPS administration. Similar to the results at 24-hours post-
treatment, no upregulation of astrocytic activity was seen using GFAP staining. Apart 
from increased IL-1β expression in the CA3 region, there were also no changes in 
cytokine levels, NF-κB precursor proteins (p-IKK, p-IκB), or iNOS levels in any area of 
the hippocampus at this timepoint. By 12 months F4/80 and CD11b levels in post-septic 
animals were no different to those of controls. As increased inflammation and 
microglial activation is known to be a factor in normal aging (Liu, Wu, Hayashi, & 
Nakanishi, 2012) it is possible that either LPS-induced inflammation was resolved at 
this timepoint, or that microglial activation in control animals had reached similar levels 
by this age. 
 As other researchers have demonstrated upregulation of TNF-α production at 10 
months after similar doses (Bossù, et al., 2012; Qin, et al., 2007), and Fan, et al. (2012) 
and Konda, Kohsaka, & Okabe (2011) show increases in activated microglia without 
cytokine over-expression at 7 days and 4 weeks post-treatment it is unclear which 
factors lead to prolonged increases in cytokine production following a single 
administration of LPS. It is known that regional variation exists in the expression of 
inflammatory parameters in the brain following systemic LPS administration 
(Weberpals, et al., 2009; Bossù, et al., 2012; Fan, et al., 2012), which may explain why 
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analysis of the whole brain may yield different results to our examination of only the 
hippocampus, see Qin, et al. (2007. Also of note is that while other studies examined 
cytokine levels using ELISA (Bossù, et al., 2012; Konda, et al., 2011; Qin, et al., 2007), 
immunohistochemistry is used in the present work toexamine these factors. It has 
previously been illustrated that, even in near identical samples, large discrepancies can 
exist between immunohistochemistry and ELISA measurements (Ferrier, et al., 1999).  
 Given that there is no upregulation of p-IKK or p-IκB, two upstream 
components of the NF-κB signalling pathway it appears that NF-κB production does not 
remain upregulated at 2 months following LPS administration. This coincides with 
unaltered levels of TNF-α expression, a key driver of the NF-κB pathway (Schütze, 
Wiegmann, Machleidt, & Krönke, 1995) and mirrors results found using the same LPS 
administration model but examining the suprachiasmatic nucleus (O’Callaghan et al., 
2012). There also appears to be no upregulation of iNOS as detected by 
immunohistochemistry in any area of the hippocampus. This is again in contrast to 
Weberpals, et al. (2009) who showed increased iNOS levels at 2 months in whole brain 
samples of animals treated with 5mg/kg dose of LPS, although Fan et al. (2012) showed 
that the same dose elicited increased acute iNOS production which returned to baseline 
by 7 days. Differences may also exist between our study and other experiments due to 
differences in the strain of E. coli from which the LPS was isolated. 
3.4.3 Immediate Early Genes 
 In addition to alterations in inflammatory parameters LPS also induced 
alterations in key IEGs involved in neuronal activity and synaptic plasticity. Similar to 
the acute timepoint, at 2 months post-LPS administration there was a reduction in the 
expression of Arc within the dentate gyrus. There was also a reduction in EGR-1 within 
the DgGr, CA1 and CA2 with no changes present in c-Fos expression in any region. 
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Both Arc and Egr-1 have also been used as markers of neuronal activity and their 
transcription has previously been shown to be altered by various forms of LPS 
administration with differential expression occurring based on animals’ age, activity 
prior to measurement, time of measurement and other factors (Bonow et al, 2009; Rosi, 
2011; Rosi, et al., 2005). Neurons express c-Fos in response to many stimuli and it has 
previously been shown to be upregulated in response to acute treatment with LPS 
(Haba, et al., 2014; Ma, Matsuwaki, Yamanouchi, & Nishihara, 2014). It is likely that c-
Fos expression may only be altered at timpoints closely following LPS administration. 
c-Fos does not appear to be expressed in the hippocampus at 6 or 24 hours after LPS 
administration, although c-Fos expression in several other areas such as the amygdala 
was at the same timepoints (Frenois, et al., 2007). In our examination of the amygdala it 
was found that LPS actually reduced c-Fos levels, possibly mirroring the 
underactivation of the amygdala seen in general anxiety disorder (Yassa, Hazlett, Stark, 
& Hoehn-Saric, 2012). It is difficult to know if this may explain any of the anxiety 
behaviours present in post-septic mice however as rodent anxiety behaviour is more 
typically associated with an overactivation of the amygdala (Duncan, Knapp, & Breese, 
1996). Although it is unclear how LPS affects the expression of these IEGs in this 
model, they illustrate subtle changes in hippocampal function among post-septic mice. 
 Staining with BrdU revealed that post-septic mice show a long-lasting reduction 
in cell proliferation within the hippocampus. Acute and chronic treatments with LPS 
have previously been shown to reduce hippocampal neurogenesis in the rodent 
hippocampus by reducing both cell proliferation (Fukioka & Akema, 2010; Wu, et al., 
2013) and the survival of newborn cells (Bastos, Moriya, Inui, Katura, & Nakahata, 
2008; Ekdahl, Claasen, Bonde, Kokaia, & Lindvall, 2003). Indeed, an inverse 
correlation has been observed between the number of microglia present within the 
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hippocampus and cell proliferation (Gebara, Sultan, Kocher-Braissant, & Toni, 2013). 
Neurogenesis is strongly implicated in the pathology of affective disorders, although the 
experimental interruption of neurogenesis in the rodent hippocampus is not, by itself, 
always sufficient to produce increased anxiety-like and depressive-like symptoms, with 
stress appearing to play an important role (Petrik, Lagace, & Eisch, 2012). As BrdU 
expression was examined after only a single 24 hour pulse it is unknown whether LPS-
induced sepsis affected the survival and differentiation of NPCs or their integration into 
existing hippocampal networks. 
3.4.4 Interactions between glia and synapses – implications for post-septic 
encephalopathy 
 Though these experiments describe acute and long-lasting changes in the 
hippocampus of post-septic animals, the mechanisms through which these changes 
occur remain unclear. The high prevalence of activated microglia in the post-septic 
hippocampus is likely to have a deleterious effect on normal brain functioning in these 
animals. Intact neuron-astrocyte-microglial signalling is essential for normal neuronal 
circuit structure and homeostasis (Cerbai, et al., 2012; Wake, Moorhouse, Miyamoto, & 
Nabekura, 2013) which is likely to be compromised in this model given the elevated 
levels of activated microglia. Although neither cytokine levels nor NF-κB pathway 
activation appeared elevated in the hippocampus of post-septic animals at 2 months 
post-treatment, microglia may also be detrimental to neuronal function via mechanisms 
not measured here such as the production of reactive oxygen species (Hernandes, et al., 
2014), increased indoleamine 2,3-dioxygenase production (Corona, et al., 2013) altered 
chemokine expression (Rivest, 2009) or changes to mitochondrial function (Noh, Jeon, 
& Seo, 2014). LPS treatment is also known to affect blood-brain barrier permeability 
(Jangula & Murphy, 2013) and several aspects of cerebrovascular functioning (Gavins, 
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et al., 2012) which may continue to disrupt normal brain processes long after the acute 
effects of LPS-induced sepsis have passed.  
In other studies a 5mg/kg dose of LPS does not appear to induce long-lasting 
neuronal loss, although pre- and post-synaptic protein levels are altered in the 
hippocampus (Fan, et al., 2012; Weberpals, et al., 2009) and it is shown here that post-
septic mice exhibit reduced levels of IEG proteins essential to synaptic plasticity. 
Although the present experiments show increased cleaved caspase-3 expression in the 
post-septic brain, this is not definitively indicative of apoptosis, with TUNEL analysis 
in the same model showed no signs of apoptosis in the suprachiasmatic nucleus 
(O'Callaghan, Anderson, Moynagh, & Coogan, 2012). The reduction of adult cell 
proliferation in post-septic animals in this study may also contribute to this pathology. 
As adult-born cells are continually produced and incorporated into synaptic networks 
within the hippocampus a disruption, or reduction, of this process may disrupt 
hippocamal functioning.  
3.4.5 Relevance to Human Sepsis 
It is known that the administration of high doses of LPS induces a more rapid, 
and intense, hyper-inflammatory response than that seen in human sepsis (Buras, 
Holzmann, & Sitkovsky, 2005). Another critical component of sepsis in humans is the 
hypo-inflammatory state which follows the initial hyperinflammatory response, 
involving immune factors such as IL-10 and transforming growth factor (TGF)-β. 
Although IL-6 is a key factor in clinical sepsis, and its levels have been positively 
correlated with severity and mortality in septic patients (Hack, et al., 1989), these results 
show elevated hippocampal IL-6 levels 24 hours after LPS administration in the granule 
cell layer only, possibly due to their return to basal levels prior to our sampling time in 
other areas. Neuronal apoptosis as marked by cleaved caspase-3 immunocytochemistry, 
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iNOS expression and microglial activation are present in patients who died from septic 
shock at higher levels than other ICU fatalities (Lamar, Hurley, Hayman, & Taber, 
2011; Sharshar, et al., 2004) which is reflected in some of the changes in our post-septic 
mice. One caveat may also be that while many studies examining neuroimmune changes 
in the brains of septic patients rely on post-mortem tissue, in our experiments those 
animals which survive sepsis-induction are assessed. Although substantial research has 
been done into the immediate neurological alterations present during septic 
encephalopathy, the long-lasting pathophysiology of post-septic encephalopathy in 
humans remains unclear, making direct comparisons difficult. 
3.4.6 Conclusion 
 In conclusion it is shown that a peripheral administration of a septic dose of LPS 
induces a rapid (24 hour) microglial activation in the hippocampus as well as cleaved 
caspase-3 activation and increased IL-6 expression in the granule cell layer. There is 
also a reduction in the immediate early gene Arc, but no changes to astrocytic marker 
GFAP. 2 months after recovery from these acute effects microglia maintain an 
activated, deramified morphology throughout the hippocampus. Save for increased IL-
1β expression in the CA3 region, there is no over-expression of pro-inflammatory 
cytokines. IEGs key to synaptic plasticity (Arc, Egr-1) are downregulated within the 
hippocampus of post-septic animals. There was also a reduction in adult cell 
proliferation in the subgranular zone of the hippocampus which may be contributing to 
disrupted hippocampal functioning. These changes mimic some of the changes seen in 
human cases of sepsis, although it does not mirror the more long-lasting upregulation of 
pro-inflammatory cytokines and inducible nitric oxide expression.  
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Chapter 4. Can Pharmacological Disruption of the NF-κB Pathway 
Reduce Post-Septic Symptoms? 
Abstract 
 In chapters two and three it was demonstrated that LPS administration could 
lead to long-lasting inflammation in the hippocampus, accompanied by reduced cell 
proliferation and IEG expression as well as changes to affective behaviour. The NF-κB 
pathway is known to be highly important in the inflammatory response to LPS. It was 
therefore hypothesised that if this pathway was disrupted prior to sepsis induction the 
subsequent post-septic symptoms may be dampened. PDTC was chosen as our 
pharmacological inhibitor of NF-κB. Animals were treated either with saline or PDTC 
prior to sepsis induction or control treatment and their health was then monitored. After 
one month animals underwent behavioural testing. They then were given a BrDU 
treatment 24 hours to being sampled and processed for immunohistochemistry. LPS 
treatment again induced significant changes to affective behaviour, while PDTC pre-
treatment was shown to protect against post-septic deficits in the novel object and tail 
suspension tests as well as the elevated plus maze. Post-septic mice pre-treated with 
PDTC also show less activated microglia, more BrdU incorporating cells and immediate 
early gene expression than post-septic mice which had not been administered PDTC. It 
is concluded that inhibition of the NF-κB pathway can protect against some of the 
effects of LPS-induced sepsis highlighting the importance of NF-κB signalling in this 
disorder.  
 
 
 
144 
 
4.1 Introduction 
 In previous chapters it has been shown that post-septic animals exhibit 
depressive-like and anxious-like behaviours in addition to elevated levels of microglial 
activation, reduced IEG levels and impaired adult cell proliferation in the hippocampus. 
As previously discussed, LPS is recognised following peripheral administration by 
TLR-4 receptors, leading to a potent inflammatory response in the CNS driven 
primarily by NF-κB. It was therefore hypothesised that pre-treatment with pyrrolidine 
dithiocarbamate (PDTC) could potentially ameliorate some of the deficits seen in post-
septic mice. PDTC is a potent inhibitor of the NF-κB pathway, thought to exert its 
effects by inhibiting IκBα degradation (Liu, Ye, & Malik, 1999), thereby preventing the 
translocation of NF-κB dimers to the cell nucleus and resulting pro-inflammatory gene 
transcription.  
PDTC itself is a metal chelating compound which can act, dose-dependently, as 
a potent anti-oxidant (Moellering, McAndrew, Jo, & Darley-Usmar, 1999) and anti-
inflammatory (Shao, Lee, Huang, Liao, & Lin, 2004) agent. At high levels however it 
can exert pro-oxidative effects as well as induce apoptosis (Erl, Weber, & Hansson, 
2000; Moellering, McAndrew, Jo, & Darley-Usmar, 1999). Preclinical toxicity 
assessment indicates that, although well tolerated at low doses, it has an LD50, intravenous 
of 282.4mg/kg in mice – exerting toxic effects on both the central and peripheral 
nervous system (Chabicovsky, et al., 2010). Its derivative diethyldithiocarbamate has 
been shown to be clinically tolerated in humans (Reisinger, et al., 1990). It therefore 
appears to have high utility as a modulator of the inflammatory response, although only 
at specific doses. 
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Though most researchers attribute its neuroprotective effects to NF-κB 
inhibition, some authors have suggested that PDTC may exert beneficial effects 
independent of, or despite failing to, inhibit NF-κB signalling (Huang, et al., 2008; 
Malm, et al., 2007) such as by activating the metal-activated heat shock factor 1 (HSF1) 
and inhibiting IL-6 activity (Song, et al., 2011). Importantly however in Malm et al. 
(2007) NF-κB was not upregulated in their transgenic Alzheimer’s disease model 
relative to controls and Huang et al. (2007) also hypothesised that NF-κB does not play 
a role in the pathophysiology of their model. If PDTC inhibits NF-κB activation 
primarily in models which involve significant NF-κB overactivation then it is less 
surprising that PDTC did not supress NF-κB activation in the above experiments, but 
exerted its effects through other mechanisms. Song et al. (2011) for example show that, 
apart from it’s effects on NF-κB, PDTC also promotes the activation of a large number 
of cytoprotective genes. Interestingly, in Huang’s (2007) study discrepancies did exist at 
certain timepoints between heightened NF-κB levels despite restored IκBα levels, and 
attenuated NF-κB levels despite reduced IκBα expression suggesting that in some casse 
NF-κB activation may occur independently of IκBα expression.  
4.1.1 The effect of PDTC on microglia and neurons in culture 
Many experiments have reported PDTC’s anti-inflammatory effects on 
microglial and neuronal cell lines. In human endothelial cells PDTC has been shown to 
reduce IL-6 and IL-8 transcription in response to LPS (Muñoz, et al., 1996). In murine 
BV-2 microglia cells LPS treatment leads to an increase of NF-κB protein in the cell 
nucleus versus cytosol, accompanied by increased TNF-α, IL-6 and NO production, an 
effect which is blocked when cells are pre-incubated with PDTC (Yuan, Ren, Liu, 
Wang, & Liu, 2014). This effect is mirrored in rat hippocampal neurons where  PDTC 
has been shown to block the translocation of NF-κB to the cell nucleus upon LPS 
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administration – which also attenuated the transcription of IL-1β and TNF-α (Zhao, 
Zhou, Xu, & Zhang, 2014). In murine BV2 microglial cells PDTC administration has 
been also shown to significantly reduce microglial expression of activation marker 
CD11b (Roy, et al., 2008) as well as production of iNOS following LPS treatment 
(Kumar, et al., 2014). In rat microglial cells PDTC was shown to inhibit LPS induced 
production of COX-2 and Prostaglandin E2 (Bauer, et al., 1997).  
PDTC is clearly therefore a potent inhibitor of NF-κB driven pro-inflammatory 
responses in microglia in vitro. Importantly however, LPS can still induce inflammation 
in rodent microglia via NF-κB independent pathways such as c-Jun N-terminal Kinase 
(JNK) and p38 mitogen-activated protein kinase (p38MAPK) dependent pathways 
(Uesugi, Nakajima, Tohyama, Kohsaka, & Kurihara, 2006). Particularly, TNF-α 
production seems to occur despite NF-κB inhibition with PDTC (Nakajima, Matsushita, 
Tohyama, & Kurihara, 2006).  
4.1.2 The effects of PDTC in system level models of sepsis and other inflammatory 
disorders 
Though PDTC has not been studied in human sepsis, it has been shown to be 
effective in several studies involving the administration of septic doses of LPS. 
Specifically, PDTC has been shown to improve survival rate, protect against multiple 
organ dysfunction and attenuate pro-inflammatory cytokine and iNOS levels following 
septic doses of LPS (Lauzurica, et al., 1999; Meisner, Schmidt, Schywalsky, & 
Tschaikowsky, 2000; Németh, Haskó, & Viz, 1998; Yao, Xu, Yao, Yu, & Sheng, 2006). 
PDTC’s ability to exert powerful anti-inflammatory and antioxidant effects in models of 
LPS-induced sepsis suggest that it may protect against long-lasting behavioural and 
neuroimmune deficits seen in post-septic mice. 
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PDTC has also been examined in animal models of CLP-induced sepsis. A 
100mg/kg dose of PDTC 2 hours prior to CLP inhibited NF-κB activation leading to a 
reduction in renal cytokine and NOS2 production and ultimately reduced hypotension 
and renal failure (Höcherl, Schmidt, Birgül, & Bucher, 2010). PDTC (100mg/kg) has 
also been shown to inhibit NF-κB production and therefore plasma levels of TNF-α, IL-
1β, IL-6, and IFN-γ (Raspé, Höcherl, Rath, Sauvant, & Bucher, 2013).  An early study 
however showed that the same dose of PDTC failed to improve survival rates or 
macrophage function following CLP, although C3H/HeN mice were used here rather 
than the C57/BL6 strain used in later studies (Joshi, et al., 2002). These studies provide 
support for PDTC’s utility as an anti-inflammatory not just in vitro but also in whole 
system models. 
4.1.3 The effects of PDTC on behaviour in inflammatory disease models 
Although PDTC has not previously been shown to protect against LPS-induced 
cognitive or affective impairment, it has been shown to protect against cognitive 
impairment and anxiety-like behaviours in other models involving inflammatory 
components such as acute restraint stress (Sharma, Gilhotra, Dhingra, & Gilhotra, 
2011), diabetes (Zhao, Huang, Wang, & Zhong, 2013), neurosurgery (Zhang, Jiang, & 
Zuo, 2014), maternal immune stimulation (Song, et al., 2011) and neonatal hypoxia-
ischemia (Wang, Zhao, Peng, & Zuo, 2013). In the APP/PS1 transgenic model of 
Alzheimer’s disease a 7-month oral administration of PDTC was found to rescue spatial 
learning (Malm, et al., 2007). Elevated gliosis in APP/PS1 mice was not affected by 
PDTC administration however. In a scopolamine-induced model of dementia PDTC has 
been shown to reduce IL-1β expression, rescue decreased cortical dopamine levels and 
ameliorate cognitive performance in the Y-maze (Abd-El-Fattah, Abdelakader, & Zaki, 
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2014). PDTC therefore appears to be a promising candidate for effecting behavioural 
change in post-septic animals. 
4.1.4 Aims 
 Given PDTC’s ability to improve many of the acute effects of LPS-induced 
sepsis it was hypothesised that it may ameliorate some of the long-lasting effects 
present in our post-septic mice. Although PDTC may have limited clinical utility given 
the necessity of pre-administration to protect against sepsis, this approach may shed 
light on the contribution of NF-κB to the persistent deficits in sepsis-survivors. 
Therefore, control and post-septic animals which either had received saline or PDTC 
were tested on a number of behavioural measures which had previously shown to be 
affected by LPS administration before examining hippocampal levels of microglial 
activation, EGR-1 expression and adult cell proliferation. We also assessed EGR-1 
expression in the amygdala of these mice, given this area’s importance in anxiety-like 
behaviours and the previous results showing reduced c-Fos expression here. 
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4.2 Methods 
4.2.1 Animals 
For the purpose of all experiments male C57BL/6 mice (Charles River, Kent, 
UK) aged between 8 and 16 weeks were used. Animals were group housed in a 12:12 
light:dark cycle for 2 weeks prior to LPS administration. Food and water were available 
ad libitum, temperature was 21 ±1°C and humidity was 50 ±10%. Animals remained 
housed in groups of 2-4 in polypropylene cages (33cm long x 15 cm wide x 13cm high) 
with wood chip bedding and environmental enrichment (shredded paper and cardboard 
tubes). All procedures were approved by the Research Ethics Committee, National 
University of Ireland Maynooth, and were licensed by the Department of Health and 
Children, Ireland under statutory instrument (S.I.) No. 543 of 2012 and the European 
directive 2010/63/EU.   
4.2.2 Drug treatments 
All injections were prepared fresh on the treatment day, and given 
intraperitoneally in a final injection volume of 0.1 – 0.15ml.  0.9% sterile saline was 
made up fresh for control injections, while lipopolysaccharide (serotype 0111.B4, 
Sigma Ireland; Qin et al, 2007) was made up to a 5mg/kg dose in sterile saline. PDTC 
(Sigma Ireland) was administered in a 200mg/kg dose (Liu, et al, 1999) 10 minutes 
before LPS treatment. Animals were once again returned to their homecage and their 
health was scored at 1 hour, 4 hours, 24 hours, 48 hours and 1 week post treatment. 
Animals were scored based on weight reduction, activity in the cage (response to 
stimulus, spontaneous movement), general appearance (e.g. staring coat, hunching, 
shivering), behaviour (motility, alertness), and clinical signs (breathing etc.). To assess 
neural precursor cell proliferation in the hippocampus mice which had one month 
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previously undergone sepsis-induction were injected i.p. with 50mg/kg BrdU (Sigma 
Ireland) and transcardially perfused 24 hours later. 
4.2.3 Behavioural testing 
 One month after the administration of LPS animals were tested the novel object 
recognition task followed by the elevated plus maze and then the tail suspension test 
with one week between tests. They were then singly housed and two days later 
underwent the sucrose preference test. All behavioural tests were carried out as 
previously described in Chapter 2.  
4.2.4 Immunohistochemical analysis 
 One week after the sucrose preference test mice were anaesthetised with 0.1ml 
sodium pentobarbital (Euthatal, Merial Animal Health, UK), following which they were 
perfused transcardially with 0.9% saline, and then 4% paraformaldehyde (Sigma 
Ireland) in 0.1M phosphate buffer (PB), pH 7.4 at 4˚C. Brains were then cryoprotected 
in 0.1M PB containing 30% sucrose, frozen and sectioned coronally at 30µm. 
Immunohistochemistry for IBA-1, Egr-1 and BrdU was then carried out following a 
standard Avidin-Biotin Complex/Nickel DAB colourmetric protocol as previously 
described in Chapter 3. 
4.2.5 Statistical Analysis 
Data were analysed in SPSS version 20 (IBM) with the type of test used 
indicated for each data set. All data are presented as means ± standard error of the mean 
(SEM). * represents p<0.05, ** represents p<0.01 and *** represents p<0.001. Where 
statistical assumptions were violated adjusted values are presented. Scale bars on 
microphotographs represent 100µm for photos at 40x and 100x magnification and 50µm 
for photos at 400x magnification.   
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Figure 4.1 Timeline for PDTC experiments.  
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4.3 Results 
4.3.1 Health Ratings After Sepsis Induction 
  A three-way time x PDTC x sepsis ANOVA revealed a significant main effect 
of time (F4,140=64.082, p<0.0005), sepsis induction (F1,35=157.174, p=0.0005) and 
PDTC treatment (F1,35=33.97, p<0.0005). Significant interaction effects were present 
between all three variables (p<0.0005 in all cases). 
Subsequent analysis with two-way sepsis x PDTC ANOVAs at each timepoint 
indicated there was a main effect of LPS treatment at 4 hours (F₁,₃₅=37.088, p<0.0005), 
24 hours (F₁,₃₅ = 357.854, p <0.0005), 48 Hours (F₁,₃₅=91.182, p<0.0005) and 1 week 
(F₁,₃₅=9.096, p<0.005) but not at one hour post-treatment (F₁,₃₅=0.042, p=0.838). 
There was a main effect of PDTC treatment one hour (F₁,₃₅=186.136, p<0.0005) and 4 
hours (F₁,₃₅=24.827, p<0.0005) with a trend towards significance at 48 hours post-
treatment (F₁,₃₅=3.991, p=0.054). There was no main effect of PDTC treatment at 24 
hours post-treatment (F₁,₃₅=3.187, p=0.085) or one week post-treatment (F=0.364, 
p=0.55). There was an interaction effect between the two treatments at 1 hour 
(F₁,₃₅=15.087, p<0.0005), 4 hours (F₁,₃₅=6.812, p=0.013), 24 hours (F₁,₃₅=4.118, 
p=0.05) but not at 48 hours (F₁,₃₅=2.782, p=0.104) or one week (F₁,₃₅=0.364, p=0.55).  
 Animals who received PDTC exhibited a sharp reduction in mobility and 
irresponsiveness to stimulus lending to a high score at one hour post-treatment (9±0.91 
for animals subsequently treated with saline and 7.11±0.42 for those subsequently 
treated with LPS). By four hours those treated with PDTC followed by saline were 
returning to baseline (4.8±1.04) while those treated with PDTC followed by LPS 
remained elevated at 7±0.44.  While both animals receiving PDTC and saline and saline 
followed by saline were essentially back to normal at 24 hours with scores of 0.5±1.67 
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and 0 respectively, animals who received saline followed by LPS peaked at a score of 
8.6±0.62 while those who received PDTC followed by LPS scored 7.11±0.42. At 48 
hours PDTC+LPS animals scored 4.78±0.83 while Saline+LPS animals scored 7±0.91. 
These numbers are illustrated in Figure 4.2. 
 
 
Figure 2.1 Health ratings following sepsis induction Mean health rating at each 
timepoint following drug administration. Error bars represent ±1 SEM.(S+S= saline & 
saline, P+S = PDTC + Saline, S+L = Saline + LPS, P+L = PDTC + LPS). N numbers 
for each group are as follows – saline/saline (n=10), saline/LPS (n=10), PDTC/saline 
(n=10), PDTC/LPS (n=9). 
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4.3.2 Tail Suspension Test 
As shown in Figure 4.3 a two-way ANOVA showed no main effect of sepsis 
induction on time spent immobile (F₁,₃₄=1.988, p=0.168) and no main effect of PDTC 
treatment (F₁,₃₄=1.824, p=0.186). There was however an interaction effect between the 
two treatments (F₁,₃₄=12.616, p=0.001). Animals who received a saline treatment 
followed by a second saline treatment spent a mean time of 93.3±9.395 seconds 
immobile, those who received PDTC followed by saline spent 115.2±8.799 seconds 
immobile, animals treated with saline and subsequently LPS were immobile for 
142.67±13.25 seconds while those who received PDTC before LPS were immobile for 
93.89±7.75 seconds. Post-hoc analysis with Tukey’s test revealed a significant 
difference between post-septic and control mice (p=0.029) while post-septic mice and 
their counterparts who were pre-treated with PDTC had a p value of 0.051. 
 
 
 
 
 
 
 
Figure 4.3 PDTC protects against increased behavioural despair in post-septic mice 
Mean time spent immobile (seconds) in the tail suspension test. * represents p<0.05 in 
Tukey analysis. Error bars represent ±1SEM. N numbers for each group are as follows 
– saline/saline (n=10), saline/LPS (n=10), PDTC/saline (n=10), PDTC/LPS (n=9). 
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4.3.3 Sucrose Preference Test 
As illustrated in Figure 4.4 there was no main effect of PDTC treatment on the 
percentage of sucrose consumed (F₁,₃₃=3.317, p=0.078). There was a trend towards a 
main effect of LPS treatment on sucrose consumed (F₁,₃₃=4, p=0.054). There was no 
interaction effect between these two variables (F₁,₃₃=0.014, p=0.907). Animals who 
received two saline treatments had a mean sucrose preference percentage of 
76.59±3.06% while those who received PDTC followed by saline had a similar 
percentage of 81.71±1.84%. Post-septic animals who received saline prior to LPS had a 
mean sucrose percentage of 70.22±2, while those who received PDTC prior to LPS had 
a preference of 76.05±4.34%. 
 
Figure 4.4 Anhedonia is unchanged following LPS or PDTC administration. Bar 
graph displaying mean percentage sucrose preference for all groups. Error bars 
represent ±1 SEM. N numbers for each group are as follows – saline/saline (n=10), 
saline/LPS (n=8), PDTC/saline (n=10), PDTC/LPS (n=9). 
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4.3.4 Elevated Plus Maze 
As shown in Figure 4.5, in the elevated plus maze there was no main effect of 
PDTC treatment on any of the four measures. There was a main effect of LPS treatment 
on time spent in the close arm of the maze (F₁,₃₅=4.154, p=0.049), but not on time spent 
in the open arm (F₁,₃₅=2.083, p=0.158). There was an interaction effect present between 
PDTC and LPS treatment on both time spent in the open arms (F₁,₃₅=6.699, p=0.014) 
and time spent in the closed arms (F₁,₃₅=9.178, p=0.005). Post-hoc analysis with 
Tukey’s test for time spent in the open arm showed differences only between post-septic 
mice and saline treated controls (p=0.032). For time spent in the closed arm Tukey’s 
post-hoc test indicated a significant difference again only between post-septic mice and 
saline-treated controls (p=0.005). 
Animals that were treated with two saline treatments (n=10) had an average of 
9.7±0.94 open arm entries and 12.5±1.18 closed arm entries, spending 98.2±13.38 
seconds in the open arms and 115.3±5 seconds in the closed arms. Animals who 
received a PDTC treatment followed by a saline treatment (n=10) had 8±0.99 open arm 
entries and 12.7±0.99 closed arm entries on average, with 72.6±11.6 seconds spent in 
the open arms and 147.2±13.27 spent in the closed arms. Post-septic animals who 
received saline followed by LPS treatments (n=10) had 7.3±0.42 open arm entries and 
12.7±0.76 closed arm entries, spending 56.5±5.38 seconds in the open arms and 
166.3±6.61 seconds in the closed arm. Those who received a PDTC treatment followed 
by an LPS treatment (n=9) had 8.56±0.84 open arm entries and 11.67±1.08 closed arm 
entries, spending 84.44±8.83 seconds in the open arms and 137.22±13.16 seconds in the 
closed arms.  
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Figure 4.5 PDTC protects against increased anxiety in the elevated plus maze in post-
septic mice. Bar graph illustrating time spent  in each arm of the Elevated Plus Maze by 
each group. * represents p<0.05 post-hoc analysis, error bars represent ± 1 SEM. N 
numbers for each group are as follows – saline/saline (n=10), saline/LPS (n=10), 
PDTC/saline (n=10), PDTC/LPS (n=9). 
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4.3.5 Novel Object Recognition 
A mixed between within ANOVA with PDTC and LPS treatments as between 
groups factors and trial number as a within groups variable indicated that from trial 1 to 
trial 4 there was a main effect of trial number on seconds spent exploring both objects 
(F₃,₁₀₅=13.021, p<0.0005), but not of PDTC treatment (F₁,₃₅=0.894, p=0.351) or LPS 
treatment (F₁,₃₅=0.611, p=0.44). There were no interaction effects present indicating 
that all groups habituated to the objects at similar levels.  
When analysing the percent time spent exploring the novel object relative to the 
familiar object in the fifth trial it was observed that there was a main effect of PDTC 
treatment (F₁,₃₅= 5.094, p=0.03), but not LPS treatment or any interaction between the 
two treatments. Animals treated with saline followed by saline had a 76.92±9.26% 
preference for the novel objects, those treated with PDTC followed by saline showed 
90.03±1.66% preference, animals who received saline followed by LPS showed 
71.95±5.42% percent preference, and those treated with PDTC followed by LPS had a 
84.38±2.33% preference.  
As illustrated in Figure 4.6, in terms of total exploration time in the fifth trial 
there was a main effect of LPS treatment (F₁,₃₅=11.153, p=0.002) but not PDTC 
treatment (F₁,₃₅= 2.295, p=0.139) or any interaction effect (F₁,₃₅=0.27, p=0.607). 
Animals receiving two saline treatments had a total exploration time of 8.01±1.31 
seconds, those receiving PDTC followed by saline 9.07±1.25, those receiving saline 
followed by LPS 3.9±5.07 and those receiving PDTC followed by LPS 6.07±0.97. 
Tueky post-hoc tests revealed significant differences between post-septic and control 
mice (p=0.043 and post-septic mice and mice receiving PDTC followed by saline 
(p=0.007).  
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Figure 4.6 PDTC protects against reduced exploration in the novel object recognition 
test in post-septic mice. Bar graph illustrating the effects of both treatments on time 
spent exploring both objects in the fifth trial. ** represents a main effect of LPS 
(p<0.01), #/## represent post-hoc differences (p0.05/0.01), error bars represent ± 1 
SEM. N numbers for each group are as follows – saline/saline (n=10), saline/LPS 
(n=10), PDTC/saline (n=10), PDTC/LPS (n=9). 
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4.3.6 IBA  
There was a main effect of PDTC treatment on IBA1 expression in the granule 
cell layer of the dentate gyrus (F₁,₃₅=45.157, p<0.0005) the CA1 (F₁,₃₅=22.616, 
p<0.0005) and the CA3 (F₁,₃₅=6.145, p=0.016) but not the polymorphic cell layer 
(F₁,₃₅=3.504, p=0.07) or the CA2 (F₁,₃₅=1.928, p=0.174). There was also a main effect 
of LPS treatment in the granule cell layer of the dentate gyrus (F₁,₃₅=27.275, 
p<0.0005), the CA1 (F₁,₃₅=24.447, p< 0.0005) and the CA3 (F₁,₃₅=6.145, p=0.018) but 
again not within the polymorphic cell layer (F₁,₃₅=0.399, p=0.532) or the CA2 
(F₁,₃₅=2.678, p=0.111). As illustrated in Figure 4.7 there were significantly higher 
levels of microglia showing altered cell body shapes and deramification in the post-
septic hippocampus. Finally there was an interaction effect between both treatments in 
the granule cell layer (F₁,₃₅=12.241, p=0.001) the CA1 (F₁,₃₅=22.098, p<0.0005) and 
the CA3 (F₁,₃₅=9.998, p=0.003) but not the polymorphic cell layer (F₁,₃₅=0.173, 
p=0.68) or CA2 (F₁,₃₅=0.02, p=0.889).  
 Post-hoc analysis with Tukey’s test revealed that in the DG and CA1 post-septic 
mice had higher levels of activated microglia than all other groups (p<0.0005 for all 
cases). In the CA3 region post-septic mice had significantly more activated microglia 
than controls (p=0.002), controls pre-treated with PDTC (p=0.002) and mice treated 
with PDTC and then LPS (p=0.005). There were no other significant differences.   
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Figure 4.7 PDTC ameliorates microglial activation in post-septic mice A) 
Representative microphotographs (x400 magnification) illustrating microglia exhibiting 
altered cell body morphology (red circles) in the hippocampus. B) Bar graph 
illustrating the number of activated microglia in the hippocampus of each group. 
**/*** represent significant post-hoc differences with p<0.01/0.001. Error bars 
represent ±1 SEM. N numbers for each group are as follows – saline/saline (n=10), 
saline/LPS (n=10), PDTC/saline (n=10), PDTC/LPS (n=9).  
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4.3.7 EGR-1  
A main effect of PDTC treatment was present within the granule cell layer of the 
dentate gyrus (F₁,₃₅=5.258, p=0.028) and CA3 (F₁,₃₅=6.291, p=0.017), but not the 
polymorphic cell layer (F₁,₃₅=0.265, p=0.61) the CA1 (F₁,₃₅=1.824, p=0.186) or the 
CA2 (F₁,₃₅=0.442, p=0.511). There was also a main effect of LPS treatment in the CA1 
region (F₁,₃₅=26.272, p<0.0005) the CA2 (F₁,₃₅=09.814, p=0.003) and the CA3 
(F₁,₃₅=20.554, p<0.0005) but the granule cell layer did not reach significance 
(F₁,₃₅=3.719, p=0.062) and there was no effect in the polymorphic cell layer 
(F₁,₃₅=1.065, p=0.309). There was a significant interaction effect between the two 
treatments in the granule cell layer (F₁,₃₅=4.699, p=0.037), the polymorphic cell layer 
(F₁,₃₅=4.506, p=0.41), the CA1 (F₁,₃₅=6.486, p=0.015), the CA2 (F₁,₃₅=7.003, 
p=0.012)  and the CA3 (F₁,₃₅=14.516, p=0.001). These results are illustrated in Figure 
4.8. 
 Post-hoc analysis with Tukey’s test revealed significant differences in the DG 
between post-septic mice (n=10) and controls (n=10, p=0.028), post-septic mice and 
controls pre-treated with PDTC (n=10, p=0.023) and post-septic mice and mice given 
PDTC followed by LPS (n=9, p=0.018). In CA1 post-septic mice differed from controls 
(p<0.0005), PDTC treated controls (p<0.0005) and PDTC pre-treated post-septic mice 
(p=0.048). In CA2 post-septic mice differed from controls (p=0.01) and PDTC pre-
treated controls (p=0.047). In CA3 post-septic mice differed from controls (p<0.0005), 
PDTC pre-treated controls (p<0.0005) and PDTC pre-treated post-septic mice 
(p=0.001). 
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Figure 4.8 PDTC ameliorates reduced EGR-1 expression in post-septic mice A) 
Representative micrographs (x400 magnification) illustrating EGR-1 expression in the 
CA1 region. 4) Bar graph illustrating EGR-1 expression in the hippocampus of each 
experimental group. */**/*** represents post-hoc differences with p<0.05/0.01/0.001, 
error bars represent ±1 SEM. N numbers for each group are as follows – saline/saline 
(n=10), saline/LPS (n=10), PDTC/saline (n=10), PDTC/LPS (n=9). 
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4.3.8 Amygdala EGR-1 Expression 
 Amygdala EGR-1 expression was analysed in both the lateral and basolateral 
regions. As illustrated in Figure 4.9, a two way ANOVA indicated a main effect of 
PDTC in the lateral (F1,35=18.245, p<0.0005) but not basolateral (F1,35=0.887, p=0.353) 
regions. There was a main effect of sepsis induction in both the lateral (F1,35=10.546, 
p=0.003) and basolateral (F1,35=44.395, p<0.0005) regions. A significant interaction 
effect was not present in the lateral amygdala (F1,35=2.266, p=0.141) although it was 
present in the basolateral amygdala (F1,35= 5.068, p=0.141).  
 Post-hoc analysis with Tukey’s test revealed a significant difference in the 
lateral amygdala between post-septic mice and controls (p=0.009), post-septic mice and 
PDTC treated controls (p<0.0005) and post-septic mice and those treated with PDTC 
before LPS (p=0.002). In the basolateral amygdala there were differences between post-
septic mice and controls (p<0.0005) and PDTC pre-treated controls (p<0.0005) as well 
as between mice treated with PDTC before LPS and PDTC pre-treated controls 
(p=0.02).  
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Figure 4.9 PDTC alters amygdala EGR-1 expression in post-septic mice A) 
Representative micrographs illustrating Egr-1 expression in the amygdala  B) Bar 
graph illustrating Egr1 expression in the amygdala of each experimental group. 
*/**/*** represent signficicant differences in Tukey post-hoc tests with 
p<0.05/0.01/0.001 Error bars represent ±1 SEM. N numbers for each group are as 
follows – saline/saline (n=10), saline/LPS (n=10), PDTC/saline (n=10), PDTC/LPS 
(n=9). 
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4.3.9 BrdU 
There was no main effect of PDTC treatment on BrdU expression in the 
hippocampus (F₁,₃₅=3.273, p=0.079), there was a main effect of LPS treatment (F₁,₃₅= 
7.195, p=0.011) but no interaction effect between the two variables (F₁,₃₅=0.438, 
p=0.512). Tukey post-hoc analysis revealed a significant difference only between post 
septic animals and those treated with PDTC followed by saline (p=0.014). Animals 
treated with two saline treatments (n=10) had an average of 22.91±2.17 BrdU positive 
cells, those treated with PDTC followed by saline (n=10) had an average of 25.43±2.92 
BrdU positive cells. Post septic animals who received saline followed by LPS (n=10) 
had an average of 15.59±1.63 BrdU positive cells while those who received PDTC prior 
to LPS (n=9) had an average of 21±1.7 BrdU positive cells. These results are illustrated 
in Figure 4.10. 
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Figure 4.10 PDTC may not alter BrdU incorporation in post-septic mice A) 
Representative microphotographs (100x magnification) illustrating BrdU
+
 cells in the 
dentate gyrus. B) Bar graph illustrating number of BrdU positive cells in the SGZ of 
each treatment group. * represents main effect of LPS treatment (p<0.05), # represents 
Tukey post-hoc difference (p<0.05), error bars show ±1 SEM. N numbers for each 
group are as follows – saline/saline (n=10), saline/LPS (n=10), PDTC/saline (n=10), 
PDTC/LPS (n=9). 
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4.4 Discussion 
 These experiments illustrate the effects of PDTC on long lasting behavioural and 
neuroimmune deficits following LPS-induced sepsis. Although PDTC administration 
acutely affected mice one to four hours post-treatment it appeared to lessen the severity 
of sepsis experienced by those also administered LPS by 24 hours and onwards. 
Importantly, PDTC did not completely block the acute effects of LPS administration, 
with all animals still clearly exhibiting symptoms at 48 hours post-treatment. The 
inhibitory effect of PDTC on NF-κB is dose dependent (Liu, Ye, & Malik, 1999; Satoh, 
et al., 1999) – and as it is neurotoxic at high doses it may be impossible to administer a 
dose sufficient to completely block the NF-κB signalling present following large doses 
of LPS. As previously discussed, while LPS elicits potent and rapid inflammatory 
responses via the MAL-MyD88 pathway NF-κB signalling may also be driven by the 
later phase TRAM-TRIF pathway. It is therefore also possible that LPS elicited NF-κB 
signalling via the TRAM-TRIF pathway after PDTC became inactive within the CNS. 
The activation of other transcription factors apart from NF-κB, such as JNK and 
p38MAPK, may also play a role here in driving an inflammatory response.  
4.4.1 Behavioural effects of PDTC pre-treatment during LPS-induced sepsis 
 As in previous experiments, LPS administration led to long-lasting affective 
changes in post-septic mice. Compared with mice treated only with saline, post-septic 
mice showed significantly higher immobility in the tail suspension test, a significant 
reduction in time spent in the open arms of the elevated plus maze and reduced 
exploration during the novel object recognition task with an effect on sucrose preference 
just under significance. Again post-septic mice did not exhibit significantly lower 
preference for the novel object but rather showed lower overall exploration in the fifth 
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trial. This constellation of affective changes is again typical of some of the core 
components of depressive episodes as discussed in previous chapters.  
Though PDTC alone induced acute behavioural changes, possibly symptoms of 
some neurotoxicity, it did not evoke any long-lasting behavioural changes in mice save 
for possibly increasing novel object preference in the novel object recognition task. It is 
unclear exactly why pre-treatment with PDTC could have increased this index above 
control levels. As no other cognitive tests were conducted the effects of PDTC on 
cognitive behaviour in the present model cannot be assessed. Other results are 
consistent with the findings of other behavioural studies using control groups treated 
only with PDTC similarly report it having no effect on behaviour in isolation compared 
with vehicle treated controls (Sharma, et al., 2011; Song, et al., 2011; Zhang, et al., 
2014), even following 7 months of PDTC administration (Malm, et al., 2007)– although 
some do not include control groups treated only with PDTC (Abd-El-Fattah, et al., 
2014; Zhao,et al., 2013; Wang, et al. 2013). It therefore appears that PDTC has no long-
lasting affect, adverse or otherwise, in healthy control animals. 
In the novel object recognition task, the sucrose preference task and the elevated 
plus maze post-septic animals who had received pre-treatment with PDTC appeared to 
show behaviour which was somewhere in between that of post-septic mice and saline-
treated controls, while in the tail suspension test immobility levels were on par with 
non-septic controls. Although PDTC did not completely return behaviour to baseline 
levels, significant differences between post-septic and non-septic animals in the control 
group were greatly diminished in the group pre-treated with PDTC. If, as hypothesised, 
elevated microglial activation plays a role in effecting lost-lasting behavioural changes 
in post-septic mice then the amelioration of this with PDTC may have led to 
improvements in affective behaviours. Also of possible relevance is the fact that PDTC 
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did not fully restore cell proliferation in the subgranular zone of the hippocampus. 
Neurogenesis is hypothesised to play an important, although not necessarily causative, 
role in the pathophysiology of affective states (Petrik, Lagace, & Eisch, 2012). 
4.4.2 Using anti-inflammatories to elicit changes in affective behaviour 
 Though it may initially seem surprising that anti-inflammatory agents could 
elicit a anti-depressive and anxiolytic effects – in fact many currently established 
treatments for affective disorders have been shown to also have anti-inflammatory 
components. For example fluoxetine (Liu, et al., 2011), as well as several other SSRIs 
(Tynan, et al., 2012), attenuate the release of inflammatory molecules in microglia 
stimulated with LPS in vitro. In fact, the commonly used SSRI fluoxetine can increase 
survival rates in mice pre-treated with the drug before a lethal dose (50mg/kg) of LPS 
(Roumestan, et al., 2007). Although there is evidence that fluoxetine exerts anti-
inflammatory effects by inhibiting NF-κB signalling (Zhang, et al., 2012), others have 
demonstrated increased NF-κB and inflammatory activity when microglial cells are 
treated with fluoxetine (Ha, et al., 2006). These findings provide context for the use of 
potent anti-inflammatory treatments in eliciting anti-depressant effects. 
4.4.3 The effects of sepsis and PDTC on neuroimmune parameters in the post-septic 
hippocampus 
 Post-septic animals displayed elevated levels of microglial activation relative 
other groups within the dentate gyrus, CA1 and CA3 areas. These animals displayed a 
greater number of microglial cells featuring deramified processes and/or highly dense or 
elongated cell bodies typical of activated microglia (Walker, et al., 2014). This appeared 
to be ameliorated by the administration of PDTC prior to sepsis induction. PDTC 
administration alone did not lead to any significant changes relative to saline-treated 
controls.  
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 Given the multiple pathways through which peripherally administered LPS may 
affect the CNS, it is possible that PDTC exerted its effects either by inhibiting 
inflammatory signalling within the periphery leading to less severe CNS effects, by 
affecting the CNS directly or both. PDTC is known to cross the blood-brain barrier 
(Chen, Liu, Liang, Lin, & Lin-Shiau, 2000), offering protection against ischemia 
following intraperitoneal administration (Nurmi, et al., 2004a) and reducing microglial 
activation even when administered up to six hours after onset of ischemia (Nurmi, et al., 
2004b). It is therefore likely that in the present model PDTC is affecting the brain 
directly during the acute stages of LPS-induced septic encephalopathy. As PDTC is 
anti-inflammatory, anti-oxidative and in certain conditions neuroprotective 
independently of either of these properties (Song et al, 2011) it is not possible to 
delineate from the data collected here its exact mechanism of action in the present 
model. 
 Microglia are maintained in an active state by their own release of factors such 
as reactive oxide species, nitric oxide and cytokines (Lijia, Zhao, Wang, Wu, & Yang, 
2012). This state can become harmful if unresolved, as may be happening in the post-
septic brain. Given PDTC’s anti-oxidant and anti-inflammatory following endotoxin 
challenge (Németh, Haskó, & Viz, 1998), the reduction in these signalling factors may 
have led to a return to resting state following the acute effects of sepsis rather than the 
prolonged activation seen in post-septic animals who did not receive PDTC. 
Interestingly, in another model PDTC promotes the production of anti-inflammatory 
cytokine IL-10 within the hippocampus (Abd-El-Fattah, et al., 2014). If present here, 
increased IL-10 production could drive anti-inflammatory responses and a quiescence of 
microglial activation (Hu, et al., 1999). The relatively acute timeframe in which PDTC 
is active within the body (Chabicovsky, et al., 2010) indicates that it most likely 
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attenuated the rapid upregulation of inflammatory factors involved in LPS-induced 
sepsis. A timecourse analysis of both the effects of PDTC and LPS on these factors 
would be particularly interesting here.  
 In line with previous results, LPS administration led to a significant reduction in 
EGR-1 expression in the hippocampus, particularly within the Cornus Ammonis region. 
In the granule cell layer this difference just failed to reach significance, despite the 
presence of significantly higher levels of activated microglia as indicated by IBA-1 
staining. PDTC treatment reverted the expression close to normal levels in post-septic 
animals while not exerting an effect in non-septic mice. As Egr-1 is a transcription 
factor with a wide variety of biological functions it is hard to delineate exactly what 
changes in levels of this IEG may represent. For example, although it is often used as a 
marker of neuronal activation and plasticity within the brain  (Guzowski, Setlow, 
Wagner, & McGaugh, 2001; James, Conway, & Morris, 2006), in other contexts it 
functions as a transcription factor involved in cell growth and differentiation, apoptosis 
and TNF-α activation (Calogero, et al., 2001). PDTC has been shown to increase egr-1 
RNA in HL-60 (acute myloid lukemia) cells (Della Ragione, et al., 2002), but it has not 
been examined in terms of its effects on neuronal EGR-1 expression. Here, EGR-1 is 
measured at resting levels rather than in response to any stimuli or learning paradigm. 
Given EGR-1’s rapid induction and degradation (Mokin & Keifer, 2005), and PDTC’s 
terminal elimination half-life of around 20 hours (Chabicovsky, et al., 2010) any effect 
of PDTC on EGR-1 expression either in post-septic or control animals is likely due to 
lasting changes within the hippocampus itself.  
 EGR-1 expression was also decreased within the basolateral and lateral 
amygdala of post-septic mice – areas highly implicated in anxiety like behaviour 
(Duncan, Knapp, & Breese, 1996). Previous studies have shown that EGR-1 expression 
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is induced in the lateral amygdala following footshock training (Malkani & Rosen, 
2000) but not due to predator stress (Rosen, Adamec & Thompson, 2005) indicating 
that Egr-1 in this case may be involved in the learning of an anxiety-inducing task. 
There is a paucity of data however regarding EGR-1 expression in anxious strains of 
mice rather than following anxiety-inducing experiences, and to our knowledge there 
are no other experiments examining the effects of LPS on EGR-1 expression in the 
amygdala. It is therefore difficult to assess the implications of a reduction in amygdala 
EGR-1 expression in the present experiment – although interestingly PDTC pre-
treatment did protect against the reduction in lateral Egr-1 expression.  
 As previously outlined, IEGs such as egr-1 are sometimes suppressed in 
situations involving prolonged neuroinflammation factors (Bonow et al, 2009; Rosi, 
2011; Rosi, et al., 2005). As PDTC ameliorated microglial activation within the 
hippocampus in the current experiments, increased EGR-1 expression in post-septic 
animals given PDTC is likely a downstream consequence of this. Normal microglial 
functioning is essential for proper neuronal activity/plasticity, and in turn behaviour and 
cognition  (Morris, Clark, Zinn, & Vissel, 2013). The upregulation of active microglia 
in the hippocampus of post-septic animals appears to affect neuronal activity as 
measured by EGR-1 – an effect which is ameliorated by the suppression of microglial 
activation via PDTC. This may then be reflected in the return to normal behaviour in 
post-septic animals who were pre-treated with PDTC. The precise mechanisms 
underlying these changes are not clear from the present data however.  
 Post-septic animals in the present study showed a significant reduction in the 
expression of BrdU within the subgranular zone of the hippocampus – a commonly used 
marker of neuronal progenitor cells (Lehner, et al., 2011). In the current experiment, 
utilising a 24 hour pulse with only a single treatment of BrdU, this reduction represents 
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a decrease in the production of adult-born cells but does not inform us about their 
eventual differentiation or integration into existing neural networks. Although PDTC 
attenuated microglial activation in post-septic animals it did not protect against the 
subsequent decrease in cell proliferation. As previously discussed, neurogenesis is 
reduced in the presence of activated microglia – and this reduction is implicated in the 
pathophysiology of mood disorders. One possibility may be that the LPS-induced sepsis 
was not sufficiently attenuated to affect cell proliferation. Therefore it is somewhat 
surprising that affective behaviour was ameliorated in the absence of repaired cell 
proliferation.  
 Though impaired neurogenesis is strongly implicated in affective disorders – 
interruption of neurogenesis is not always sufficient to produce depressive-like or 
anxious-like behaviour in rodents, with stress playing an important role (Petrik, Lagace, 
& Eisch, 2012). As the affective changes in the present study are not the effect of stress, 
it is possible that decreases in cell proliferation are simply co-occurring with – but not 
causative of, these behavioural changes. Although NF-κB signalling itself is a regulator 
of neurogenesis (Bortolotto, Cuccurazzu, Cononico, & Grilli, 2014; Denis-Donini, et 
al., 2008), PDTC treatment alone in the current experiment did not affect cell 
proliferation 2 months post-treatment. It therefore appears that the disruption of NF-κB 
signalling did not have any long-term negative impact on cell proliferation.  
4.4.4 Conclusion  
 In this experiment it is shown that pre-treatment with NF-κB inhibitor PDTC 
protects against some of the long last neuroimmune and affective changes present in the 
post-septic mouse. PDTC pre-treatment reduced the severity of sepsis experienced by 
animals, attenuated microglial activation and prevented decreases in Egr-1 expression 
following LPS administration – although it failed to protect against reductions in adult 
175 
 
cell proliferation. Increased depressive-like and anxious-like behaviour in post-septic 
animals was also significantly improved in animals pre-treated with PDTC despite cell 
proliferation not returning to baseline levels. PDTC itself did not elicit any long lasting 
changes in control mice. These results point towards the involvement of the NF-κB 
pathway in effecting the changes present in post-septic mice and highlight it as a 
potential therapeutic target.  
Though the present experiment both re-affirms the potential of LPS induced 
sepsis to produce long-lasting behavioural and neuroimmune effects and elucidates a 
potential role for NF-κB in that pathophysiology of these effects, it also is not without 
certain limitations. In particular, as no examination of NF-κB levels either at sepsis 
induction or when animals were sampled was conducted, it cannot definitively said that 
inhibition of this pathway is what led to these effects. In addition to this, as post-septic 
encephalopathy is likely a whole brain condition and the present experiment looks only 
at a specific region, differences present within other areas may be contributing 
significantly to the behavioural effects seen here. Elucidating the precise role of 
microglial activation, EGR-1 underexpression and decreased cell proliferation in 
affecting behaviour is also not possible here meaning the results are descriptive in 
nature rather than offering a mechanistic explanation.   
Given the limitations of the current study it would be useful in the future to look 
for example at the timecourse involved in LPS-induced septic encephalopathy and how 
this is affected by PDTC treatment. Also of interest is whether elevated inflammation in 
the hippocampus may influence NPC cells to differentiate at a higher rate to astrocytes, 
and whether the survivability of these cells is compromised in the presence of 
microglial overactivation. Future work should also seek to assess the efficacy of 
potential therapeutics which can be administered after the onset of sepsis. 
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Chapter 5. Investigating the Potential of Fluoxetine in Improving 
Outcomes in Post-Septic Mice 
Abstract 
 Previous chapters demonstrated that LPS-induced sepsis reliably produces long-
lasting changes within the affective domain. These behavioural changes are 
accompanied by significant microglial activation and reduced adult cell proliferation in 
the hippocampus of post-septic mice. Fluoxetine is a common anti-depressant which 
also has potent anti-inflammatory effects. It was hypothesised that chronic treatment 
with fluoxetine could ameliorate the effects of LPS-induced sepsis in mice. 28 days of 
fluoxetine treatment reduced microglial activation and increased levels of BrdU 
expressing cells in post-septic mice. It also increase immediate early gene expression in 
the hippocampus of post-septic and control mice. Fluoxetine improved affective 
behaviour in the tail suspension test, novel object recognition test and elevated plus 
maze among post-septic but not control mice. In the sucrose preference test there was 
no effect of LPS induction and fluoxetine paradoxically lowered preference levels. It is 
concluded that fluoxetine can reduce the inflammation present in the post-septic 
hippocampus as well as improve related depressive-like and anxiety-like behaviours. 
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5.1 Introduction 
Previous chapters have described the long lasting effects of LPS-induced sepsis 
on a variety of neuroimmune parameters as well as a constellation of affective 
behaviours. Excessive microglial activation within the post-septic hippocampus appears 
to play an important role in these changes. It was shown in the preceding chapter that 
inhibition of the NF-κB pathway with PDTC could ameliorate most of the long-lasting 
changes within the post-septic mouse, reducing levels of microglial activation and 
returning behaviour close to control levels. Unfortunately however, owing to the 
necessity to administer PDTC before the onset of sepsis and the potential for neurotoxic 
side effects, it has limited clinical utility. An alternative potential therapeutic was 
therefore sought which could be administered after the onset of sepsis and which is 
clinically tolerated. Given that post-septic mice appear to show changes primarily in 
affective behaviour, as well as excessive microglial activation and inhibited cell 
proliferation, the selective serotonin uptake inhibitor (SSRI) fluoxetine was chosen as a 
potential treatment due to its ability to effect change in all three of these parameters.  
5.1.1 Anti-inflammatory effects of fluoxetine 
Fluoxetine, first approved for use in the 1980s, is now the most commonly 
prescribed anti-depressant medication (Perez-Caballero, Torres-Sanchez, Bravo, Mico, 
& Berrocoso, 2014). Early studies showed fluoxetine’s efficacy as a selective serotonin 
re-uptake inhibitor (Wong, Horng, Bymaster, Hauser, & Molloy, 1974), binding to the 
serotonin transporter and thereby inhibiting the reuptake of serotonin into the 
presynaptic cell which then leads to elevated levels of extracellular serotonin. This was 
in contrast to other monoamine uptake inhibitors available at the time which also 
affected norepinephrine and dopamine levels. The inhibition of serotonin reuptake was 
initially thought to be fluoxetine’s primary mechanism of action. More recently 
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however it has been shown that there is a significant discrepancy between the time 
fluoxetine takes to alter brain serotonin levels - with peak inhibition occurring around 4 
hours (Perez-Caballero, et al., 2014), and the ~4 weeks it takes to produce an anti-
depressive effect in patients (Thompson, 2002). This has led to the investigation of 
alternative neural mechanisms through which chronic fluoxetine treatment may effect 
anti-depressant changes. 
Of primary relevance to the affective changes in post-septic encephalopathy is 
fluoxetine’s ability to module inflammatory responses. In vitro fluoxetine has been 
shown to attenuate microglial activation and the subsequent production of 
proinflammatory cytokines and nitric oxide as well as p38 MAPK phosphorylation and 
NF-κB expression following stimulation of BV2 microglial cells with LPS (Liu, et al., 
2011). Similarly, in cultured rat glial cells fluoxetine protects against LPS induced NF-
κB activation, iNOS expression as well as elevated TNF-α, COX-2 and IL-1β levels 
(Lim, et al., 2009). In primary mixed glial cultures from rat pups fluoxetine also dose-
dependently inhibited the production of TNF-α and IL-1β while inhibiting the 
translocation of NF-κB p65 subunit to cell nuclei (Obuchowicz, Bielecka, Paul-
Samojedny, Pudełko, & Kowalski, 2014). Interestingly, fluoxetine here also prevented 
morphological changes associated with LPS administration in glial cultures. In rat 
neuronglia cultures fluoxetine protects against microglial activation following LPS 
administration and subsequent neurotoxicity (Zhang, et al., 2012). In BV-2 microglial 
cells which are unstimulated by LPS however fluoxetine may actually increase NF-κB 
DNA binding and subsequent TNF-α and IL-6 expression (Ha, et al., 2006). 
Several in vivo studies have also demonstrated an anti-inflammatory and 
neuroprotective role for fluoxetine. In one particularly relevant study researchers 
administered various doses of fluoxetine either preventatively or curatively to BALB/c 
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mice who then received a lethal (50mg/kg) dose of LPS. Although fluoxetine 
administered preventatively significantly increased mortality this effect did not occur 
when the drug was administered after sepsis was induced (Roumestan, et al., 2007). 
Interestingly, the authors also showed that fluoxetine could also inhibit TNF-α 
production in human monocytes – the primary sources of TNF-α production during 
septic shock. In a model of Parkonsinosian symptoms, rats administered intranigral LPS 
injections following 18 doses of fluoxetine (5 or 10mg/kg) show significantly greater 
numbers of dopaminergic neurons and inhibited microglial activation compared with 
controls receiving LPS but not fluoxetine (Chung, et al., 2010). In another model of 
Parkinson’s disease fluoxetine administration attenuated dopamine neuron death, 
microglial activation and ensuing pro-inflammatory cytokine and reactive oxygen 
species production following MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) 
administration (Chung, et al., 2011).  In BALB/c mice acute fluoxetine dose 
dependently increased serum IL-10 and decreased serum TNF-α (Ohgi, Futamura, 
Kikuchi, & Hashimoto, 2013).  
While fewer studies have been done regarding the anti-inflammatory and 
neuroprotective effects of chronic fluoxetine treatments, 28 days of fluoxetine 
administration (5mg/kg, i.p.) led to an anti-inflammatory profile with reduced IFN-γ IL-
6, CXCL1, CX3CL1 expression in the hypothalamus accompanied by an increase in the 
anti-inflammatory cytokine IL-4, but not IL-10 (Alboni, Benatti, Montanari, Tascedda, 
& Brunello, 2013). Although these studies shed light on the anti-inflammatory effects of 
fluoxetine in various cell lines as well as animal models of inflammatory disorders – the 
effects of chronic treatments with fluoxetine on inflammatory parameters within the 
hippocampus is still relatively unclear.  
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5.1.2 Anti-depressive effects of anti-inflammatories – problems when they combine? 
While it could be suspected that anti-inflammatory and anti-depressant 
medications might work synergistically, however the results of investigations into this 
have been mixed. Apart from increasing the risk of gastrointestinal problems (Mort, 
Aparasu, & Baer, 2012), serotonin syndrome (Hersh, Pinto, & Moore, 2007) when used 
in conjunction certain NSAID and anti-depressant combinations have been shown to 
lead to poorer remission rates and anti-depressant effects. One particularly important 
study demonstrated that the administration of ibuprofen significantly inhibited the 
antidepressant effect of fluoxetine, in addition to tricyclic and MAOI antidepressants, in 
a number of behavioural models as well as attenuating the effectiveness of SSRI 
citalopram in humans (Warner-Schmidt, Vanover, Chen, Marshall, & Greengard, 2011). 
There is also some evidence that fluoxetine may impair the anti-inflammatory abilities 
of NSAIDs indomethacin and celecoxib in a rat paw oedema model (Abdel-Salam, 
Baiuomy, & Arbid, 2004). 
The COX-2 selective NSAID celoxib has also been shown to work 
synergistically with the atypical anti-depressant bupropion in an inflammatory model of 
depression (Maciel, Silva, Morrone, Calixto, & Campos, 2013), as well as enhance 
serotenergic output when used in conjunction with fluoxetine (Johansson, Falk, Marcus, 
& Svensson, 2012) and reboxetine with celecoxib actually showed significantly more 
efficacy in ameliorating depressive symptoms in patients  with major depression than 
reboxetine alone  (Müller, et al., 2006). Interestingly, despite inhibiting the effects 
SSRIs, ibuprofen did not affect the antidepressant potency of bupropion in a number of 
behavioural models (Warner-Schmidt, Vanover, Chen, Marshall, & Greengard, 2011). 
While NSAIDs typically exert their effects acting within the periphery and spinal cord – 
rofecoxib, another COX-2 specific drug, may act through the central serotenergic 
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system. This drug does not inhibit the anti-inflammatory effect of fluoxetine to the same 
level as other NSAIDs (Abdel-Salam, et al., 2004).  
Another possible explanation put forward is that it is not the NSAIDs per se that 
impair response to anti-depressants, but rather the disease which the NSAIDs are 
treating (Gallagher, et al., 2012; Shelton, 2012). As comorbidites are associated with 
lower remission rates in depression (Otte, 2008), it may be that those patients required 
to take an NSAID concomitantly with anti-depressants are at a greater risk in general for 
poor treatment outcomes. This does not however explain the differing effects of various 
anti-depressant and NSAID combinations in animal models of depressive-like 
behaviour, although each of these models are different from each other, and different 
from the human condition of affective disorders.  
5.1.3 Inflammation in Affective Disorders 
Several studies have looked at levels of inflammatory cytokines in depressed 
patients. For example, before treatment with fluoxetine a sample of 20 depressed 
patients showed higher serum levels of the inflammatory cytokines IL-1β, IL-6, IFNγ 
and TNFα as well as serotonin transporter 5-HTT than healthy-matched controls. 
Following three months of fluoxetine treatment both IFNγ and 5-HTT levels were 
significantly reduced – although only 8 participants returned for the second analysis 
(Tsao, Lin, Chen, Bai, & Wu, 2006). Other studies have also found elevated levels of 
plasma IL-6 (Maes, et al., 1995), IL-1β (Diniz, Teixeira, Talib, Gattaz, & Forlenza, 
2010) and TNF-α (Lanquillon, Krieg, Bening-Abu-Shach, & Vedder, 2000). 
Interestingly some studies have shown that certain cytokines may be predictive of or 
associated with particular symptoms of affective discords. For example there is an 
association between TNF-α and dissociative symptoms in major depression patients 
while IL-1β can correlate with the severity of depression  and increased suicidality 
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(Bizik, et al., 2014; Lichtblau, Schmidt, Schumann, Kirkby, & Himmerich, 2013; 
Thomas, et al., 2005). Aside from plasma cytokine levels, post-mortem studies in 
suicide victims have shown elevated levels of pro-inflammatory cytokines such as IL-6, 
TNFα and IL-1β in prefrontal cortex (Pandey, et al., 2012) compared with matched 
controls.  
5.1.4 Neurogenesis and BDNF in Sepsis/Inflammatory Disorders 
Though neurogenesis and BDNF levels are both well studied in affective 
disorders, research examining these two factors in models of sepsis and post-septic 
encephalopathy is scarce. One study showed that CLP actually led to an increase in 
neurogenesis within the SVZ, but no change in the SGZ, 24 hours post sepsis-induction 
(Bakirci, Kafa, Uysal, & Kurt, 2011). A sub-septic, although still large, peripheral 
1mg/kg dose of LPS has been shown to lead to a decrease in newborn neurons 7 days 
later, accompanied by significant microglial activation (Monje, Toda, & Palmer, 2003). 
The administration of E. Coli to early postnatal rats (P4) led to an acute decrease in 
BrdU positive cells as well as a sustained reduction in BrdU+NeuN positive cells 
throughout the hippocampus suggesting that this systemic infection both reduced NPC 
proliferation and the survivability of newborn neurons. A 5mg/kg dose of LPS 
administered to female C57BL/6 mice led to significant reductions in the levels of 
newbord neurons (DCX + NeuN positve), but not NPC proliferation, at 7 days 
following LPS treatment as well as significant reductions at 28 days accompanied by a 
net reduction in neurogenesis (Omerod, et al., 2013).  
BDNF levels have been shown to significantly decrease in the hippocampus of 
rats submitted to CLP at 48 hours but not 12 or 24 hours (Comim, et al., 2014). In two 
further studies by the same group BDNF levels are not significantly lower in CLP rats 
than sham operated rats at 10 days post-operation, despite persistent memory deficits 
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(Cassol-Jr, et al., 2011) but were significantly lower at 17 days post-treatment, although 
this effect was reversed by subchronic (14 day) imipramine treatment (Comim, et al., 
2010). Other studies have shown that reduced BDNF expression is present in the 
hippocmapus of CLP survivors up to one month after CLP occurs (Biff, et al., 2013; 
Wu, et al., 2013).  Interestingly, in patients admitted to hospital with sepsis, lower 
plasma BDNF is actually associated with mortality (Ritter, et al., 2012). 
5.1.5 Aims 
The aim of this experiment was therefore to examine whether the long-lasting 
effective changes in post-septic animals could be ameliorated by chronic treatment with 
the SSRI fluoxetine. It was hypothesised that fluoxetine treatment could reduce 
microglial activation in the hippocampus following post-septic encephalopathy 
similarly to its anti-inflammatory effects seen in other models. As neurogenesis is 
thought to be important for the behavioural effects of fluoxetine it was examined 
whether the drug could upregulate cell proliferation in this model.  
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5.2 Materials and Methods 
5.2.1 Animals 
For the purpose of all experiments male C57BL/6 mice (Charles River, Kent, 
UK) aged between 8 and 16 weeks were used. Animals were group housed in a 12:12 
light:dark cycle for 2 weeks prior to LPS administration. Food and water were available 
ad libitum and temperature was 21 ±1°C and humidity was 50 ±10%. Animals remained 
housed in groups of 2-4 in polypropylene cages (33cm long x 15 cm wide x 13cm high) 
with wood chip bedding and environmental enrichment (shredded paper and cardboard 
tubes) except during the sucrose preference test which necessitates single housing. All 
procedures were approved by the Research Ethics Committee, National University of 
Ireland Maynooth, and were licensed by the Department of Health and Children, Ireland 
under statutory instrument (S.I.) No. 543 of 2012 and the European directive 
2010/63/EU.   
5.2.2 Drug treatments 
All injections were prepared fresh on the treatment day, and given 
intraperitoneally in a final injection volume of 0.1 – 0.15ml.  0.9% sterile saline was 
made up fresh for control injections, while lipopolysaccharide (serotype 0111.B4, 
Sigma Ireland; Qin et al, 2007) was made up to a 5mg/kg dose in sterile saline. 
Fluoxetine (10mg/kg, Tocris Bioscience, UK) was administered orally in standard 
drinking water beginning one week after LPS administration. Fresh fluoxetine was 
given every second day and animals and water were weighed to ensure the correct 
dosage was maintained. Animals were given fluoxetine for 28 days before testing began 
and throughout the duration of behavioural testing. To assess adult cell proliferation in 
the hippocampus mice which had one month previously undergone sepsis-induction 
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were injected i.p. with 50mg/kg BrdU (Sigma Ireland) and transcardially perfused 24 
hours later. 
5.2.3 Behavioural testing 
 Five weeks after the administration of LPS animals were tested the novel object 
recognition task followed by the elevated plus maze and then the tail suspension test. 
They were then singly housed and two days later underwent the sucrose preference test. 
All behavioural tests were carried out as previously described in Chapter 2. 
 
Figure 5.1 Timeline of fluoxetine experiments. 
5.2.4 Immunohistochemical analysis 
 One week after the sucrose preference test mice were anaesthetised with 0.1ml 
sodium pentobarbital (Euthatal, Merial Animal Health, UK), following which they were 
perfused transcardially with 0.9% saline, half the brain was then placed in 4% 
paraformaldehyde (Sigma Ireland) in 0.1M phosphate buffer (PB), pH 7.4 at 4˚C. 
Brains were then cryoprotected in 0.1M PB containing 30% sucrose, frozen and 
sectioned coronally at 30µm. Immunohistochemistry for IBA-1, Egr-1 and BrdU was 
then carried out following a standard Avidin-Biotin Complex/Nickel DAB colourmetric 
protocol as previously described in Chapter 3. 
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5.2.5 Statistical Analysis 
 All data were analysed in SPSS version 20 (IBM) with the type of test used 
indicated for each data set. All data are presented as means ± standard error of the mean 
(SEM). * represents p<0.05, ** represents p<0.01 and *** represents p<0.001.Where 
data violated statistical assumptions correcte values are presented. Scale bars on 
microphotographs represent 100µm for photos at 40x and 100x magnification and 50µm 
for photos at 400x magnification.  
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5.3 Results 
5.3.1 Tail Suspension Test 
 Illustrated in Figure 5.2, a two-way between groups ANOVA with sepsis and 
fluoxetine as independent variables revealed a main effect of sepsis induction in the tail 
suspension test F1,37=31.848, p<0.0005. A main effect of fluoxetine administration was 
also present F1,37=13.624, p=0.001 as well as an interaction effect between the two 
variables F1,37=36.61, p<0.0005. Post-hoc analysis via Tukey test revealed a significant 
difference between untreated post-septic animals and the three other groups (p<0.0005) 
but no other significant differences. 
 
 
 
 
 
 
 
 
Figure 5.2 Fluoxetine treatment attenuates behavioural despair in post-septic mice. 
Bar graph illustrating mean time spent immobile in the tail suspension test for each 
group. Error bars represent 1x SEM, *** represent significant post-hoc differences at 
p<0.001. SEM. Saline/Water n=10, Sepsis/Water n=11, Saline/FLX n=10, Sepsis/FLX 
n=10. 
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5.3.2 Sucrose Preference Test  
A two-way ANOVA with sepsis induction and fluoxetine treatment as between groups 
variables revealed no main effect of sepsis induction on sucrose preference F1,37=1.738, 
p=0.196, illustrated in Figure 5.3. There was a main effect of fluoxetine administration 
F1,37=4.603, p=0.039 with no interaction effect between the two variables F1,37=.811, 
p=0.374. Post-hoc tests showed no differences between any groups. 
 
 
 
 
 
 
 
 
 
Figure 5.3 Reduced sucrose preference in fluoxetine administered mice Bar graph 
illustrating sucrose preference % in each group. Error bars represent 1x SEM and * 
represents a main effect of fluoxetine administration (p<0.05). Saline/Water n=10, 
Sepsis/Water n=11, Saline/FLX n=10, Sepsis/FLX n=10. 
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5.3.3 Elevated Plus Maze 
As shown in Figure 5.4, a two-way between groups ANOVAs for sepsis 
induction and fluoxetine treatment were carried out to investigate results in the elevated 
plus maze. There was a main effect of sepsis induction on time spent in the open arms 
(F1,37=7.303, p=0.01) with a trend towards a main effect on number of entries to open 
arms (F1,37=3.829, p=0.058) but not closed entries (F1,37=3.315, p=0.077) or time in 
closed arms (F1,37=0.716, p=0.321). There was a main effect of fluoxetine on closed arm 
entries (F1,37=5.103, p=0.03) but not open entries (F1,37=1.861, p=0.181), time in open 
arms (F1,37=0.163, p=0.689) or closed arms (F1,37=1.01, p=0.953). An interaction effect 
was not present for either open arm (F1,37=1.486, p=0.231), closed arm entries 
(F1,37=0.008, p=0.929), time in open arms (F1,37=1.883, p=0.178) or closed arms 
(F1,37=0.003, p=0.953). 
Post-hoc analysis revealed that there was a significant difference in time spent in 
the open arms between untreated post-septic mice (n=11) and untreated controls 
(p=0.029) while the other groups were not significantly different (n=10 per group). 
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Figure 5.4 Fluoxetine treatment increases elevated plus maze exploration in post-
septic mice. Bar graph illustrating time spent in each arm during the elevated plus 
maze. Error bars represent 1x SEM and * represents significant post-hoc difference 
p<0.05. Saline/Water n=10, Sepsis/Water n=11, Saline/FLX n=10, Sepsis/FLX n=10. 
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5.3.4 Novel Object Recognition 
 A three way mixed between within ANOVA with sepsis induction and 
fluoxetine administration as between groups variables and trial number as a within 
groups variable revealed a significant effect of trial number (F3,111=42.72, p<0.05), but 
not sepsis induction (F1,37=0.511, p=0.479) although there appeared to be a main effect 
of fluoxetine administration (F1,37=6.485, p=0.015). There were no significant 
interaction effects present (p>0.05 in all cases). These effects are illustrated in Figure 
5.5. 
 There was no main effect of sepsis induction (F1,37=2.601, p=0.115), fluoxetine 
treatment (F1,37=, p=0.278) or interaction effect (F1,37=3.681, p=0.063) for percentage 
preference on time exploring the novel object. For total time exploring the novel object 
there was a significant sepsis x fluoxetine interaction (F1,37=11.985, p=0.001),  but not 
main effect of sepsis (F1,37=2.627, p=0.114) or fluoxetine (F1,37=0.266, p=0.609). 
 As illustrated in Figure 5.6 post-hoc analysis with Tukey tests showed that 
untreated post-septic mice (n=11) had significantly lower time spent exploring in the 
fifth trial than both untreated controls (n=10, p=0.003) and fluoxetine treated post-septic 
mice (n=10, p=0.04).  
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 Figure 5.5 Object explorations across all five trials. Line graph displaying habituation 
to both objects over the five trials of the novel object recognition task.  
Figure 5.6 Fluoxetine treatment promotes object exploration in post-septic mice. Time 
spent exploring both objects in the fifth trial. Error bars represent 1xSEM, */** denotes 
p<0.05/0.01 in post-hoc analysis. Saline/Water n=10, Sepsis/Water n=11, Saline/FLX 
n=10, Sepsis/FLX n=10. 
0
1
2
3
4
5
6
7
8
9
10
Water Fluoxetine
S
ec
o
n
d
s 
E
x
p
lo
r
in
g
 B
o
th
 O
b
je
ct
s 
Fluoxetine Treatment 
Saline
LPS
0
1
2
3
4
5
6
7
8
9
10
Trial 1 Trial 2 Trial 3 Trial 4 Trial 5
S
ec
o
n
d
s 
ex
p
lo
r
in
g
 b
o
th
 o
b
je
ct
s 
Trial Number 
No Sepsis + Water
Fluoxetine + No Sepsis
No Fluoxetine + Sepsis
Fluoxetine + Sepsis
** * 
193 
 
5.3.5 EGR-1 
 Two-way mixed between within ANOVA were conducted in order to analyse 
the effects of sepsis and fluoxetine administration on EGR-1 expression throughout the 
hippocampus. Illustrated in Figure 5.7, there was no main effect of sepsis induction in 
the dentate gyrus granule cell layer (F1,37=0.215, p=0.645), polymorphic cell layer 
((F1,37=1.549,  p=0.221), CA1 (F1,37=3.33, p=0.076), CA2 (F1,37=0.065, p=0.801) or 
CA3 (F1,37=1.824, p=0.185). There was a main effect of fluoxetine in all areas of the 
hippocampus – granule cell layer (F1,37=30.2, p<0.0005), polymorphic cell layer 
(F1,37=24.061, p<0.0005), CA1 (F1,37=22.018, p=0.0005), CA2 (F1,37=24.475, p<0.0005) 
and CA3 (F1,37=19.344, p<0.0005). A sepsis x fluoxetine interaction was present within 
the CA1 region (F1,37=6.301, p=0.017), the CA2 (F1,37=4.405, p=0.043) and the CA3 
(F1,37=6.128, p=0.018).  
 Post-hoc analysis with Tukey tests revealed that in the granular layer untreated 
post-septic mice were significantly different to post-septic mice treated with fluoxetine 
(p<0.0005) and controls treated with fluoxetine (p<0.001), while controls treated with 
fluoxetine were also significantly different to untreated controls (p<0.016). Similarly in 
the polymorphic cell layer untreated post-septic mice were significantly different to 
post-septic mice treated with fluoxetine (p<0.001) and controls treated with fluoxetine 
(p<0.0005), while controls treated with fluoxetine were also significantly different to 
untreated controls (p<0.043). In CA1 untreated post-septic mice were significantly 
different to controls (p=0.018), post-septic mice treated with fluoxetine (p<0.0005) and 
controls treated with fluoxetine (p<0.0005). In CA2 untreated post-septic mice were 
siginificantly difference to fluoxetine treated post-septic mice (p<0.0005) and fluoxetine 
treated controls (p=0.004). In CA3 untreated post-septic mice were significantly 
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different to controls (p=0.045), post-septic mice given fluoxetine (p<0.0005) and 
fluoxetine treated controls (p=0.001). 
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Figure 5.7 Fluoxetine treatment increases EGR-1 expression in post-septic and 
control mice A) Representative micrographs (40x magnification) illustrating EGR-1 
expression. B) Bar graph illustrating EGR-1 expression in the hippocampus of each 
experimental group. */**/*** represents main effects, #/##/### represent post-hoc 
differences with p<0.05/0.01/0.001. Error bars represent ±1 SEM. SEM. Saline/Water 
n=10, Sepsis/Water n=11, Saline/FLX n=10, Sepsis/FLX n=10.  
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5.3.6 IBA-1 
 A two-way between groups ANOVA was conducted to analyse the effects of 
sepsis induction and fluoxetine treatment on IBA-1 expression in the hippocampus. 
There was a main effect of sepsis in the granule cell layer (F1,37=9.766, p=0.003), the 
polymorphic cell layer (F1,37=9.701, p=0.004) the CA1 (F1,37=79.237, p<0.0005), CA2 
(F1,37=5.802, p=0.021) and CA3 (F1,37=54.479, p<0.0005). There was also a main effect 
of fluoxetine in the granule cell layer (F1,37=62.289, p<0.0005), the polymorphic cell 
layer (F1,37=29.636, p<0.0005), the CA1 (F1,37=83.439, p<0.0005), the CA2 
(F1,37=17.538, p<0.0005) and the CA3 (F1,37=39.518, p<0.0005). There was an 
interaction effect between the two variables in the granule cell layer (F1,37=10.128, 
p=0.003), the polymorphic cell layer (F1,37=22.116, p<0.0005), the CA1 (F1,37=58.318, 
p<0.0005) and the CA3 (F1,37=25.015, p<0.0005) but not the CA2 (F1,37=2.602, 
p=0.115).  
 Post-hoc analysis with Tukey tests revealed that in the granular layer untreated 
post-septic animals (n=11) were significantly different from the three other groups 
(n=10 per group, p<0.0005).  The same differences were present in the polymorphic cell 
layer and the CA1 (p<0.0005). In CA2 untreated post-septic mice had significantly 
more microglia than untreated controls (p=0.032), fluoxetine treated controls 
(p<0.0005) and fluoxetine treated post-septic mice (p<0.0005). In CA3 untreated post-
septic mice were significantly different to the three other groups again (p<0.0005). 
These differences are illustrated in Figure 5.8.  
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Figure 5.8 Fluoxetine treatment reduces microglial activation in post-septic mice A) 
Representative micrographs (100x magnification) illustrating IBA1 expression in the 
CA1 region. Red circles highlight microglia with activated morphology B) Bar graph 
illustrating hippocampal IBA1 expression. */**/*** represents main effects, #/##/### 
show post-hoc differences at p<0.05/0.01/0.001. Error bars represent ±1 SEM. 
Saline/Water n=10, Sepsis/Water n=11, Saline/FLX n=10, Sepsis/FLX n=10. 
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5.3.7 BrdU 
 A two way between groups ANOVA was conducted in order to assess the 
effects of sepsis induction and fluoxetine treatment on BrdU levels within the 
subgranular zone of the dentate gyrus. Illustrated in Figure 5.9, there was a main effect 
of sepsis induction (F1,37=29.774, p<0.0005), fluoxetine treatment (F1,37=6.89, p=0.013) 
and an interaction between the two variables (F1,37=15.288, p<0.0005). Post-hoc 
analysis with a Tukey test revealed that there was a difference in BrdU expression 
between untreated post-septic animals and each of the other three groups (p<0.0005) but 
no other significant differences. 
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Figure 5.9 Fluoxetine promotes cell proliferation in post-septic mice. A) 
Representative micrographs (100x magnification) illustrating BrdU expression in the 
SGZ. B) Bar graph illustrating BrdU
+
 cells in the SGZ each experimental group. * 
represents main effect, ### represents post-hoc differences p<0.05/0.001. Error bars 
represent ±1 SEM. Saline/Water n=10, Sepsis/Water n=11, Saline/FLX n=10, 
Sepsis/FLX n=10. 
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5.4 Discussion 
 In previous chapters it has been shown that LPS induces long lasting affective 
changes which can be ameliorated with the pre-administration of anti-inflammatory 
agents. These results demonstrate that these behavioural deficits and the long-lasting 
neuroimmune changes which co-occur with them can be ameliorated by chronic 
treatment with the SSRI fluoxetine. Affective changes were evidenced in post-septic 
animals’ behaviour in the tail suspension test, elevated plus maze and novel object 
recognition test as had been seen in previous cohorts of animals. These behavioural 
changes occurred in conjunction with excessive microglial activation, altered IEG levels 
and cell proliferation as previously seen. Although fluoxetine has previously been used 
in other models of inflammatory depressive states, this is the first time that it has been 
used to treat the long-lasting behavioural deficits associated with LPS-induced sepsis.  
5.4.1 Fluoxetine Treatment Rescues Affective Behaviour in Post-Septic Mice 
   The tail suspension test is a well validated model of depressive-like 
behavioural despair. Although not previously used in models of sepsis associated 
encephalopathy, chronic fluoxetine has previously been shown to successfully reduce 
immobility times in a number of other inflammatory models of depressive-like 
symptoms – swiss albino mice submitted to chronic unpredictable mild stress (Dhingra 
& Bhankher, 2014), neonatal immune activation in NMRI mice (Doosti, et al., 2013) 
and acute LPS administration to CD-1 mice (Ji, et al., 2014). Fluoxetine in this model 
did not appear to affect immobility time in control mice. This is in line with some other 
experiments which show that non-depressed animals do not show reduced immobility 
time following fluoxetine administration (Doosti, et al., 2013; Wang, et al., 2011). 
Others however have shown reductions in immobility time even in control animals 
(Mutlu, et al., 2012; Wang, et al., 2013). Whether or not fluoxetine affects immobility in 
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control animals is therefore likely to vary according to both strain and dose (Tang, et al., 
2014). Using a genetic model of helplessness, mice specifically bred for their high or 
low scores in the tail suspension test, it was shown that chronic fluoxetine 
administration elicited anti-depressant effects in the helpless mice while not affecting 
behaviour in the non-helpless mice (Naudon, Yacoubi, Vaugeois, Leroux-Nicollet, & 
Costentin, 2002). Therefore in this context it appears that fluoxetine is effective in 
attenuating immobility time in the post-septic mice, without affecting behaviour in non-
septic animals.  
Anxiety-like responses were examined in the elevated plus maze. As before, 
post-septic animals explored open arms of the maze significantly less than non-septic 
controls, while this difference was not present among animals who had been treated 
with fluoxetine. Although anxiety disorders are highly comorbid with major depressive 
disorder (Kessler, et al., 2003), and fluoxetine has demonstrated anxiolytic effects in a 
variety of populations (Clark, et al., 2005; Faramarzi, et al., 2008; Shu, Huang, Fones 
Soon Leng, Strijckmans Crutel, & Kim, 2014) – as with the tail suspension test, a 
variety of effects have been reported in the elevated plus maze. Chronic and subchronic 
treatments with 20mg/kg fluoxetine has been shown to increase mice’s time spent in the 
open arms of the maze (Nollet, et al., 2012; Kurt, Arik, & Celik, 2000) and produce 
modest increases in the same measure among chronically stressed rats (Lapmanee, 
Charoenphandhu, & Charoenphandhu, 2013) while other groups have showed no effect 
of chronic fluoxetine on behaviour in the EPM (Griebel, Cohen, Perrault, & Sanger, 
1999; Robert, Drapier, Bentué-Ferre, Renault, & Reymann, 2011; Silva & Brandão, 
2000). Anxiogenic effects of fluoxetine have also been observed in the elevated plus 
maze following chronic treatments (Silva, Alves, & Santarem, 1999; Duran, et al., 
1999). 
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 Given the variety of models used to assess anxiety-like behaviour, and the 
different biological underpinnings of each of these models, it is not surprising that 
fluoxetine has shown conflicting effects across the literature. As with the tail suspension 
test, fluoxetine may differentially effect EPM behaviour depending on whether the 
animal in question is showing anxiety-like behaviour or not. For example, neonatal LPS 
administration leads to decreased time spent in the open arms and decreased open arm 
entries – both of which are dose-dependently ameliorated with fluoxetine (Majidi-
Zolbanin, Azarfarin, Samadi, Enayati, & Salari, 2013). While in the same experiment 
certain doses of fluoxetine were actually anxiogenic in nature in control animals. In the 
present work, prolonged microglial activation is likely to be responsible, at least in part, 
for increased anxiety like behaviour in post-septic mice. It therefore follows that 
attenuating this microglial activation also heLPS to ameliorate the anxiety behaviour 
that co-occurs with it. If anxiety-like behaviour is the result of another aetiology which 
is not affected by fluoxetine however responses may differ in that context. 
In the novel object task similar results were observed to those in previous 
chapters among the control animals submitted to sepsis. These animals did show 
preference for the novel object, but lower overall exploration – an effect which has been 
examined in the context of decreased motivation. This effect was attenuated in those 
animals treated with fluoxetine. For the first time, in those not treated with fluoxetine, 
there was actually a small effect of sepsis induction present on preference for the novel 
object. As there can be much variability between animals in behavioural testing 
(Lewejohann, Zipser, & Sachser, 2011), as well as some variation in the severity of 
sepsis suffered by each animals this cohort may have been more susceptible to a mild 
cognitive effect than previous cohorts.  
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As the novel object recognition task is primarily used as a measure of motivation 
here, it is difficult to compare it with other studies using fluoxetine in the same test. 
There is some evidence that chronic fluoxetine treatment can actually reduce preference 
for the novel object in similar NOR tasks (Carlini, et al., 2012; Valluzzi & Chan, 2007) 
although significantly different methodology was employed. Other studies have shown 
that fluoxetine has no effect in control animals, and can actually rescue performance in 
experimental models showing impaired cognitive/affective performance (LeGates, et 
al., 2012; Tellez, Rocha, Castillo, & Meneses, 2010). Here an effect of fluoxetine on 
object preference was not seen, but rather an amelioration of the decrease in overall 
exploration appeared present in post-septic animals. This suggests that  fluoxetine can 
be useful in restoring motivated behaviours and exploration in post-septic animals – in 
line with its other beneficial effects on various affective constructs.  
Surprisingly, in this experiment LPS-induced sepsis did not bring about any 
long-lasting changes to sucrose preference. In fact, there was actually a small effect of 
fluoxetine in the opposite direction – suggesting that here fluoxetine administration 
actually reduced sucrose preference levels. No group however had preference scores 
below 65% which is the often used percentage point for defining “anhedonia” (Briones, 
et al., 2012). This is particularly surprising given that fluoxetine has previously been 
reported to increase sucrose preference in a number of depressive models such as 
chronic unpredictable mild stress (Dhingra & Bhankher, 2014) and repeated LPS 
administration (Kubera, et al., 2013),  There have been other reports of chronic 
fluoxetine leading to decreased sucrose preference in some other models however. For 
example, Sprague Dawley rats given 10mg/kg chronic fluoxetine showed significantly 
decreased preference compared with controls (Brenes & Fornaguera, 2009) and chronic 
fluoxetine (7.5mg/kg) also failed to restore 1% sucrose consumption in a model of 
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interferon-α induced anhedonia (Sammut, Bethus, Goodall, & Muscat, 2002). It remains 
difficult to understand why LPS failed to alter sucrose preference as in previous 
chapters. As with the novel object presence it may be simply differences in individual 
cohorts’ responses to LPS-induced sepsis.  
5.4.2 Fluoxetine has Anti-Inflammatory Effects in Post-Septic Mice 
 Fluoxetine had a significant effect on microglial activation within the 
hippocampus. Chronic treatment led to an attenuation of microglial activation 
throughout the hippocampus – in line with other studies discussing fluoxetine’s anti-
inflammatory properties. Although fluoxetine failed to protect against mortality when 
administered after lethal doses of LPS (Roumestan, et al., 2007), these results indicate 
that it has utility in attenuating the long-lasting glial activation present in post-septic 
animals. These results are also important because the anti-inflammatory properties of 
fluoxetine are typically examined in the context of acute treatments, whereas here its 
potential to modulate inflammation over a chronic administration period is illustrated. 
This is in line with Alboni et al (2013) who showed that a 5mg/kg dose of fluoxetine 
reduced a broad range of inflammatory markers and led to an anti-inflammatory 
cytokine expression profile. 
 Chronic fluoxetine administration has previously been shown to promote anti-
inflammatory mRNA expression, particularly IL-4, while inhibiting pro-inflammatory 
signalling in rodents (Alboni, et al., 2013). As the IL-4 is upregulated by fluoxetine, and 
this in turn stimulates CD200 expression – an important deactivating signaller for 
microglia (Lyons, et al., 2007), this could represent one potential pathway through 
which fluoxetine inhibits microglial activation. In the present model such an effect may 
have contributed towards quiessing microglial activation following LPS-induced sepsis. 
Subchronic fluoxetine has also been shown to reduce microglial production of NADPH, 
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iNOS and ROS which attenuate oxidative stress associated with microglial activation 
(Chung, et al., 2010). In vitro studies also suggest that fluoxetine may inhibit microglial 
activation via mechanisms such as NF-κB, COX-2 and pro-inflammatory cytokine 
suppression (Lim, et al., 2009; Liu, et al., 2011; Obuchowicz, et al., 2014). Future work 
is needed however to ascertain whether the effects of fluoxetine when chronically 
administered may differ from its properties during in vitro application. 
 Post-septic animals showed reduced EGR-1 expression within the CA1 region 
and CA3 while fluoxetine treatment led to a robust increase in EGR-1 expression in 
both saline-treated and LPS-treated animals throughout the hippocampus. EGR-1 
expression can be modulated by BDNF via its downstream target ERK (Warren, et al., 
2011). Acute fluoxetine administration has previously been shown to lead to increased 
egr-1 expression in the cingulated and motor cortex (Van Waes, Beverley, Marinelli, & 
Steiner, 2010) as well as the central amygdale (Slattery, et al., 2005) with no effect in 
the hippocampus (Humblot, Thiriet, Gobaille, Aunis, & Zwiller, 1998). While 
hypothalamic egr-1 transcription appears to be affected by chronic fluoxetine (Conti, et 
al., 2007), the effects of chronic fluoxetine administration on hippocampal EGR-1 
expression have not previously been examined. These results also highlight once again 
the potential for regional differences to occur within the hippocampus following post-
septic encephalopathy with significant change present only within certain areas. 
 The serotonergic system has been shown to be involved in inducing egr-1 
expression, with lesions of the serotonin system inhibiting cocaine induced expression 
(Bhat, Cole, & Baraban, 1992). Fluoxetine also potentiates methylphenidate-induced 
egr-1 upregulation (Van Waes, Beverley, Marinelli, & Steiner, 2010), with serotonin 
possibly promoting increased transcription driven by dopaminergic signalling. As EGR-
1 here is measured at baseline levels and not in response to a stimulus it is unclear 
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whether such a synergistic effect could be taking place here. Another possibility is that 
elevated EGR-1 expression represents increased neuronal activity in the hippocampus 
due to increased neuronal proliferation and the incorporation of these cells into 
hippocampal networks. Although fluoxetine did not lead to increased proliferation in 
non-septic controls it may have affected survival or differentiation which are not 
measured here.  
5.4.3 Fluoxetine Promotes Adult Cell Proliferation in Post-Septic Mice 
 In contrast with PDTC treatment, fluoxetine administration restored cell 
proliferation following LPS-induced sepsis in the present experiment. Fluoxetine by 
itself did not appear to stimulate increased cell proliferation in control animals. This is 
in contrast to a number of other studies in rodents which have shown that fluoxetine can 
increase NPC proliferation even in control animals (Malberg, Eisch, Nestler, & Duman, 
2000; Nollet, et al., 2012; Wang, 2011). Others however have reported no change using 
BrdU as a marker of cell proliferation in non-depressed animals (Huang, Bannerman, & 
Flint, 2008; Marlatt, Lucassen, & van Praag, 2010; Tyler, 2014). Some of these 
differences are likely to stem from significant differences in protocols used to assess 
NPC proliferation with BrdU. In the present experiment a single BrdU injection 24 
hours before sampling labels. While this informs us that the rate of generation of cells is 
decreased in the post-septic hippocampus during a 24 hour period it does not inform us 
about their differentiation, survival, migration or incorporation into hippocampal 
networks. Many of the other studies showing increases in proliferation following 
fluoxetine treatment used either repeated administrations of BrdU and/or much longer 
time points between administration and sampling. They therefore mark a wider range of 
newborn cells, and so fluoxetine’s other effects – such as promoting survivability, may 
explain increased numbers of cells incorporating BrdU over longer periods of time. As 
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with the behavioural effects of fluoxetine there is also considerable strain differences in 
its neurogenic effects. Miller and colleagues (2008) for example showed that fluoxetine 
significantly increased proliferation in DBA/2J and 129S1 mice – but not A/J or SWR/J 
mice.  
Though fluoxetine has not been examined in the context of LPS induced sepsis it 
has been shown to be effective in restoring proliferation in another depressive model 
involving long lasting inflammation resulting from prenatal LPS exposure (Lin & 
Wang, 2014). The effect of fluoxetine in the present experiment may be attributable 
either to its direct promotion of cell proliferation, or to its attenuation of microglial 
suppression of proliferation. Fluoxetine upregulates levels of extracellular serotonin 
which in turn leads to increased NPC proliferation (Encinas, Vaahtokari, & Enikolopov, 
2006; Ohira & Miyakawa, 2011). Activated microglia on the other hand disrupt 
hippocampal neurogenesis during inflammatory states (Ekdahl, Claasen, Bonde, 
Kokaia, & Lindvall, 2003; Monje, et al,. 2003). This is in contrast to microglia which 
have polarised towards the M2 anti-inflammatory phenotype and may actually promote 
neurogenesis (Ekdahl, Kokaia, & Lindvall, 2009; Vukovic, Colditz, Blackmore, 
Ruitenberg, & Bartlett, 2012). If fluoxetine either reduces microglial activation, or 
polarises microglia towards a neuroprotective phenotype – for example by increasing 
IL-4 production, then this may be one potential mechanism through which it restores 
proliferation in the post-septic brain.   
5.4.4 Conclusion 
 In conclusion, it is clear that when fluoxetine is administered after sepsis 
induction it can help to improve many of the effects associated with post-septic 
encephalopathy. Although the mechanisms by which fluoxetine exerts its anti-
depressant effects are not yet well understood – in this instance it successfully 
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ameliorates ongoing microglial activation in the hippocampus and also promotes cell 
proliferation. As BDNF appears to be a key factor associated with both affective and 
inflammatory disorders it would be interesting to examine the levels of this 
neurotrophin in post-septic animals and its modulation by fluoxetine. These results, in 
conjunction with those of previous chapters, also illustrate the potential for variation in 
the symptoms experienced by post-septic animals – particularly in the case of 
behavioural effects. There is much potential for further investigation to be done 
regarding the link between fluoxetine, inflammation and affective behaviours in post-
septic encephalopathy. For example, little is known about changes key monoamine 
neurotransmitters such as serotonin in post-septic encephalopathy, and although 
changes to cell proiferation are present, no information is available regarding the 
survival and integration of these newborn cells in the hippocampus.  
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Chapter 6. Are Microglia Primed in the Post-Septic Hippocampus? 
Abstract 
Microglia are known to survey and adapt to their environment, changing their 
morphology and function as needed. The results in chapter three revealed that microglia 
appeared to take on an activated morphology in the hippocampus subsequent to LPS 
administration and that this persists for up to two months. These microglia did not 
however appear to be over-producing pro-inflammatory cytokines. As such it was 
suspected that LPS–induced sepsis may result in microglia assuming a primed 
phenotype. These microglia would exhibit exaggerated responses to a subsequent 
inflammatory response – particularly in terms of IL-1β expression. It was also 
hypothesised that behavioural responses to a low dose of LPS might also differ between 
post-septic and control mice.  
To test this sepsis was induced in mice as in prior experiments. After their 
recovery these mice were then tested for behavioural responses to a 100µg/kg dose of 
LPS, and brains were collected to examine markers of microglial activation at 4 hours 
post-treatment, as well as IL-1β expression and IEG activation at 2 and 9 hours post-
treatment. Post-septic and control mice showed no differences in behavioural responses 
to the acute low dose LPS in the open field and tail suspension tests. 
Immunohistochemistry revealed that prior sepsis induction did increase mice’s 
responses to a second dose of LPS in terms of microglial activation (F4/80, CD11b) and 
IEG expression (EGR-1, c-Fos) but not IL-1β expression. This effect was time and 
region specific. It is suggested that, as IL-1β expression was not elevated, these 
differences may be due to increased underlying inflammation in post-septic mice rather 
than the presence of primed microglia. 
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6.1 Introduction 
6.1.1 Microglia Phenotypes in the CNS 
 As previously described in chapter one, microglia may rapidly change their 
morphology and phenotype in response to a variety of signals within their 
microenvironment. Microglia in a resting (or ramified) state remain relatively immobile, 
but survey their surroundings via a large number of highly motile processes, completing 
a comprehensive screening of the entire brain parenchyma every couple of hours 
(Nimmerjahn, Kirchhoff, & Helmchen, 2005). These resting microglia are in direct 
contact with neurons, astrocytes and blood vessels (Nimmerjahn et al, 2005). A variety 
of signals can cause resting microglia to undergo morpho-functional change (Walker, et 
al., 2014). While pro-inflammatory factors influence microglial phenotype, inducing a 
shift from the ramified state to a deramified active state as previously discussed, several 
other CNS factors can also induce changes in microglial state. Microglia extend their 
processes in reaction to adenosine triphosphate (ATP) released from injured cells 
(Ohsawa, et al., 2010), microglial ramification is also induced by the presence of 
astrocytes in vitro (Wilms, Hartmann, & Sievers, 1997). In contrast, components of the 
extracellular matrix such as fibronectin and vitronectin can contribute to the 
deramification of resting microglia (Milner & Campbell, 2003).  
 Though microglia in the healthy adult brain are typically neuroprotective and 
support neuronal functioning (Streit, 2002), they have the potential to switch to 
deleterious, neurotoxic phenotypes in chronic inflammatory states. Apart from shifting 
between resting and activated phenotypes, microglia may also assume a “primed” 
phenotype during stress (Munhoz, et al., 2006), aging  (Henry, Huang, Wynne, & 
Godbout, 2009) or during inflammatory CNS diseases (Cunningham, 2012). These 
primed microglia are thought to exhibit an exaggerated response to subsequent immune 
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challenges, including an increased expression of pro-inflammatory cytokines such as 
IL-1β, IL-6 and TNF-α, increased IκBα expression as well as elevated production of 
iNOS and neuronal cell death (Cunningham, Wilcockson, Campion, Lunnon, & Perry, 
2005; Henry et al, 2009; Weber, Frank, Sobesky, Watkins, & Maier, 2013). 
Morphologically, primed microglia share similarities with activated microglia 
(deramification), although they do not express heightened levels of pro-inflammatory 
cytokines in the absence of immune challenges (Choi & Won, 2011; Perry & Teeling, 
2013). Their detection therefore relies on the examination of their response to secondary 
immune challenges.  
6.1.2 LPS-Induced Microglial Priming 
 Though priming can occur following a number of neuroinflammatory stimuli or 
conditions - LPS has been used in several experimental paradigms to study microglial 
priming both in vivo and in vitro. Typically, animals or macrophages which have either 
been treated with a large dose of LPS, are aged or are undergoing inflammatory diseases 
are given secondary, low doses of LPS or other immunostimulatory agents which elicit 
a more severe pro-inflammatory response than that seen in models which have not been 
primed (Perry & Teeling, 2013; Pestka & Zhou, 2006). Enhanced IL-1β production is 
the most typical marker of microglial priming, although IL-6 and TNFα production are 
also heightened (Islam & Pestka, 2006; Wynne, Henry, & Godbout, 2009). Recently it 
has also been reported that super low dose (0.5µg/kg) LPS priming can lead to 
significantly elevated mortality and TNFα production in mice later subjected to an 
extremely high dose (25mg/kg) of LPS (Deng, Maitra, Morris, & Li, 2013) 
The exaggerated inflammatory response exhibited by primed animals in 
response to subsequent immune activation is accompanied by a significantly altered 
behavioural and cognitive response. Aged mice subjected to a 0.33mg/kg dose of LPS 
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express significantly higher hippocampal levels of IL-1β transcription, IL-6 and IL-1β 
mRNA accompanied by an extended decrease in social behaviour and food intake than 
that seen in adult mice (Godbout, et al., 2005). The same dose has also been shown to 
increase depressive-like behaviours in the forced swim test and tail suspension test 
along with increased plasma IL-6, Indoleamine 2,3-dioxygenase (IDO) production and 
serotonin turnover rate compared with adult mice (Godbout, et al., 2007). Cognition is 
also impaired in this model with older mice showing deficits in a hippocampus-
dependent learning task along with exaggerated Il-1β, IL-6 and TNFα mRNA 
production in hippocampal neuronal cell layers (Chen, et al., 2008). Microglial priming 
has also been shown to be involved in producing delirium-like cognitive deficits in mice 
modelling prion disease (ME7 mice) subsequently administered a 100µg/kg dose of 
LPS (Murray, et al., 2012).  
As of yet there have been few studies into the precise mechanism which 
switches microglia to a primed phenotype. Excessive activation of the alternative 
complement system has been suggested as one cause of microglial priming – with mice 
knocked out for Crry (a key regulatory gene for the complement system) exhibiting 
chronic complement component 3 overactivation along with primed microglia in the 
CNS which over-express pro-inflammatory cytokines and iNOS in response to LPS 
challenge (Ramaglia, et al., 2012). It has also been suggested that super-low doses LPS 
may prime microglia by reducing levels of RelB - an NF-κB component which can 
suppress pro-inflammatory signalling (Deng, Maitra, Morris, & Li, 2013).  
6.1.3 Neuroprotective Effects of LPS-Activated Microglia  
 Though microglia primed by serious inflammatory insult can assume a primed 
phenotype, LPS-activated microglia may also play a protective role during subsequent 
injury or pathology. This may occur when relatively mild harmful stimuli (such as low 
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doses of LPS) precede a more harmful secondary insult – typically hypoxia/ischaemia 
or traumatic brain injury, and has been termed “preconditioning” (Shpargel, et al., 
2008). For example, in as study by Chen et al (2012) pre-treatment for four days with 
1mg/kg LPS i.p. induced microglial activation but protected mice from neuronal cell 
death following experimental brain injury with microglia ensheathing neurons in the 
CNS. Pre-treatment with LPS has also been shown to significantly attenuate cytokine 
production and apoptosis, as well as improve survival rates in mice subsequently 
subjected to septic peritonitis (Feterowski, Weighardt, Emmanuilidis, Hartung, & 
Holzmann, 2001). Aside from experimental brain injury models, LPS preconditioning 
has also been noted to attenuate cerebral ischemic damage in a number of models 
(Ahmed, et al., 2000; Dawson, Furuya, Gotoh, Nakao, & Hallenbeck, 1999; Tasaki, et 
al., 1997). This effect appears to be maximally beneficial 3-4 days post-LPS 
administration (Tasaki, et al., 1997) but is maintained as far as 14 days (Furuya, Zhu, 
Kawahara, Abe, & Kirino, 2005) and may be a result of microglia attenuation by low 
dose LPS treatment in the post-ischemic brain (Rosenzweig, et al., 2004).  
 Evidence from studies of preconditioning with LPS suggests that sustained 
microglial production of anti-inflammatory factors may be key in eliciting this 
neuroprotective effect. Yu et al (2010) illustrated that both IL-4 and IL-13 remain 
upregulated for much longer in the hippocampus of animals preconditioned with LPS 
before induction of ischemia relative to those who were not pre-treated with LPS. This 
effect was accompanied by a relative reduction in microglial and astrocytic activation as 
measured by GFAP and IBA-1 expression (Yu, et al., 2010). This may be due to altered 
TLR-4 signalling in response to secondary stimuli throughout the preconditioned brain 
with interferon regulatory factor (IRF)-3 and IRF-7 of particular importance (Stevens, et 
al., 2011). 
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6.1.4 LPS Tolerance 
 Related to the idea of microglial preconditioning is that of endotoxin tolerance. 
Endotoxin tolerance describes the desensitization of the immune system by prior low-
dose LPS exposure to subsequent LPS challenge leading to reduced production of 
inflammatory mediators and mortality (Ishiyama, et al., 2006). This tolerance involves 
the suppressed transcription of a broad number of LPS target genes (Mages, Dietrich, & 
Lang, 2008) as well as both a reduction in pro-inflammatory cytokine production and an 
accompanying increase in anti-inflammatory cytokine production (Soszynski, 2002). 
LPS tolerance also affects animals’ responses to LPS in terms of depressive-like 
behaviours, with tolerance to LPS-induced anhedonia exhibited by rats by the 7
th
 
consecutive day of endotoxin administration (Barr, et al., 2003). Early research 
characterised both an early phase tolerance, and a later phase tolerance which appears 
after several days and may persist for weeks following the initial insults (Greisman & 
Hornick, 1975). This phenomenon is measurable in septic patients, with leukocytes 
from these patients showing reduced LPS-reactivity (Cavaillon, Adrie, Fitting, & Adib-
Conguy, 2003).  
6.1.5 Aims 
 The aim of this chapter was therefore to investigate whether the administration 
of a septic dose of LPS would alter the neuroimmune response in the hippocampus to a 
subsequent low dose of LPS, and if so, whether this would affect the behavioural 
response to the second LPS treatment. Since a low dose of LPS given onto a 
background of existing neuroinflammation typically appears to prime an exaggerated 
inflammatory response it was hypothesised that this may occur within the context of the 
long-lasting neuroinflammation present following LPS-induced sepsis. Chosen for 
examination were microglial markers CD11b and F4/80 as well as immediate early gene 
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protein products c-FOS, EGR-1 and ARC, and finally the cytokine IL-1β given its 
importance as a marker of microglial priming. Locomotion and anxiety-like behaviour 
in the open field test as well as depressive-like behaviour in the tail suspension test were 
also assessed.  
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6.2 Methods and Materials 
6.2.1 Animals 
Male C57/bl6 mice were group housed in a 12:12 light dark cycle at 21±1˚C and 
50±10 humidity with food and water available ad libitum for 2 weeks before LPS 
administration. Animals remained housed in groups of 2–4 in polypropylene cages 
(33 cm long × 15 cm wide × 13 cm high) with wood chip bedding and environmental 
enrichment (shredded paper and cardboard tubes).  
6.2.2 Behavioural Priming Experiments 
Animals which had previously received septic doses of LPS (n=7) or vehicle 
(n=9) 3-4 months prior were treated i.p. in a counterbalanced fashion with either 0.9% 
sterile saline or 100µg/kg LPS. Two hours later these animals then underwent open field 
testing. Nine hours after treatment animals were tested in the tail suspension test as 
previously described. These timepoints were chosen due to the delay in the onset of 
depressive-like behaviours relative to sickness behaviour following acute LPS treatment 
(Dantzer, O'Connor, Freund, Johnson, & Kelley, 2008). All behavioural tests were 
conducted as previously described in chapter 2. The experimental timelines are shown 
in Figure 6.1. 
6.2.3 Assessment of microglial markers  
In order to assess whether treatment with a low dose of LPS elicited an 
exaggerated response in the hippocampus of post-septic animals compared with control 
animals, animals which had previously undergone treatment with 5mg/kg of LPS (n=7) 
or vehicle (n=9) were administered a 100µg/kg dose of LPS at ZT1-2 before being 
perfused 4 hours later at ZT5-6. Brains were then collected and processed 
immunohistochemically for microglial markers CD11b and F4/80 as previously 
described in chapter 2. 
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6.2.4 Assessment of neuroimmune parameters in the hippocampus 
Animals which had previously been administered either 5mg/kg of LPS (n=7) or 
vehicle (n=9) were injected i.p. with a 100µg/kg dose of LPS. Mice were then perfused 
either 2 or 9 hours later in order to coincide with behavioural timepoints. Brains were 
collected and processed for immunohistochemical analysis of c-Fos, Egr-1 and Arc as 
well as pro-inflammatory cytokine IL-1β as previously described. Four groups of 
animals were therefore examined – vehicle + 100µg/kg LPS (n=4) and post-septic + 
100µg/kg LPS (n=3) at 2 hours, and vehicle + 100µg/kg LPS (n=5) or post-septic + 
100µg/kg LPS (n=4) at 9 hours.  
6.2.5 Immunohistochemistry 
Hippocampal sections were divided in four sections to be stained for three 
immediate early gene markers (EGR-1, c-FOS and ARC) as well as the cytokine IL-1β. 
Immunohistochemistry followed a standard Avidin-Biotin Complex/Nickel DAB 
colourmetric protocol as previously described in chapter 3. Following two ten minute 
washes in 0.1 M PB and one ten minute wash in 0.1 M PB with 0.3% Triton X (PBX), 
sections were washed for 20 minutes in 0.1 M PB with 1.5% hydrogen peroxide to 
inactive peroxidises. After a further three ten minute washes (2 x PB, 1 x PBX) sections 
were blocked with 5% normal horse serum. Sections were then incubated with primary 
antibody in 2% normal horse serum overnight (EGR-1 1:3000, c-FOS 1:2000, ARC 
1:500, IL1-β 1:50). The following day sections were once again washed (2 x PB, 1 x 
PBX) before development with anti-rabbit biotinylated secondary antibody (1:400) for 
70 minutes. Following 3 subsequent ten minute washes (2 x PB, 1 x PBX) sections were 
developed in ABC for 90 minutes (0.4%; Vector Laboratories, Peterborough, 
Cambridgeshire, UK). After two more PB washes, and one ten minute wash in 0.1 M 
Sodium Acetate (Ph 6) sections were reacted with nickel-DAB to visualise the protein 
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products of interest. To control for inter-run variability all sections for individual anti-
bodies were reacted in the same run, for an equal amount of time. Photomicrographs of 
sections were taken using a digital camera connected to an Olympus BX-51 light 
microscope under constant light intensity. For ARC and c-FOS staining the number of 
clearly stained immunoreactive cells per area per section were counted via microscope, 
while for EGR-1 and IL1-β image analysis software (ImageJ 1.43, NIH, USA) was used 
to calculate integrated optical density for photomicrographs of sections of interest. For 
each method between 4 and 6 sections of the mid dorso-ventral level of the 
hippocampus were analysed. Hippocampal sections were assessed across five areas of 
interest – the dentate gyrus granule cell layer, the dentate gyrus polymorphic cell layer, 
CA1, CA2 and CA3 (Franklin & Paxinos, 1997).  
6.2.6 Statistical Analyses 
All results were analysed in IBM SPSS Statistics version 20. Two-way 
ANOVAs were run with timepoint and treatment as between groups variables, and t-
tests were run to follow up specific differences of interest. Alpha levels below 0.05 were 
considered significant for all tests. All data are presented as means ± standard error of 
the mean (SEM). Where data violated homogeneity of variances corrected p/t values are 
presented.  Scale bars on microphotographs represent 100µm for photos at 40x and 
100x magnification and 50µm for photos at 400x magnification. 
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Figure 6.1 Timeline of priming experiments.  
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6.3 Results 
6.3.1 EGR-1 
A two way ANOVA revealed that there was no significant interaction between 
prior sepsis induction and timepoint across any of the five areas examined (p>0.05 in all 
cases). As illustrated in Figure 6.2 there was a significant effect of prior sepsis induction 
in the dentate gyrus granule cell layer (F₁‚₁₂=16.462, p=0.016), the CA1 (F₁‚₁₂=4.892, 
p=0.047), and the CA2 regions (F₁‚₁₂=18.435, p=0.001). There was a significant effect 
of time in all regions (Dentate gyrus granule cell layer (F₁‚₁₂=22.786, p<0.0001, dentate 
gyrus polymorphic layer F₁‚₁₂=35.957, p<0.0001, CA1 F₁‚₁₂=22.948, p<0.0001, CA2 
F₁‚₁₂=39.927, p<0.0001, CA3 F₁‚₁₂=20.222, p=0.001).  
 To assess groupwise differences at each timepoint independent t-tests were 
carried out. These indicate that significant differences existed at 2 hours in the CA1 
region (t₅= 3.509, p=0.017) and the CA2 (t₅=3.187, p=0.024) with LPS-treated animals 
(n=3) showing significantly more activation in these areas than saline-treated animals 
(n=4) (IOD = 151.982 ± 2.139, 71.4724 ± 5.20502 and 124.1504 ± 6.52986 and 
54.6577 ± 2.51846 respectively). While at the 9 hour timepoint a significant difference 
was present in the CA2 region region (t₇=2.858, p=0.024) with LPS-treated animals 
(n=4) remaining higher compared to saline-treated (n=5) controls (47.6356±2.50181 
versus 34.6755±47.6356).  
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Figure 6.2 EGR-1 expression is heightened in post-septic mice following a secondary 
LPS challenge A) Representative photomicrographs of Egr-1 expression in 
hippocampal sections. B) Bar graph illustrating mean Egr-1 expression (IOD) in each 
hippocampal subsection at 2 or 9 hours post-treatment. Error bars represent 1x SEM, 
*/**/*** and #/##/### represents p<0.05/0.01/0.001 for main effects of time and LPS 
respectively. Control/2hours (n=4) and post-septic/2hours (n=3), and control/9hours 
(n=5) post-septic/9hours (n=4). 
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6.3.2 c-Fos 
 A two-way ANOVA revealed no significant interaction effect between prior 
sepsis induction and time in any area of the hippocampus – DgGr F1,12=0.224, p=0.63; 
DgPo F1,12=0.001, p=0.976; CA1 F1,12=1.326, p=0.272; CA2 F1,12=0.393, p=0.543; CA3 
F1,12=0.045, p=0.836.  As shown in Figure 6.3 a significant effect of prior sepsis 
induction was present in the dentate gyrus granule cell layer (F₁‚₁₂=6.476, p=0.026) with 
post-septic mice showing higher c-Fos expression and the Ca1 (F₁‚₁₂=7.311, p=0.019) 
with saline-treated controls showing higher c-Fos expression, but not the DgPo 
F1,12=0.793, p=0.391, the CA2 F1,12=3.242, p=0.097 or the CA3 F1,12=0.969, p=0.344. 
There was a significant effect of time in all areas apart from the DgGr (F₁‚₁₂=1.296, 
p=0.277) – DgPo (F1,12=19.225, p=0.001); CA1 (F₁‚₁₂=12.652, p=0.004); CA2 
(F₁‚₁₂=24.082, p<0.0005); CA3 (F₁‚₁₂=22.76, p<0.0005).  
 Independent T-tests revealed that at the two hour timepoint there was a 
significant difference in the number of immunoreactive cells in the granule cell layer of 
the dentate gyrus between saline-treated animals (n=4, 40±4.88) and LPS-treated 
animals (n=3, 73±3.54) t₅=5.083, p=0.004. At the nine hour timepoint there was a 
significant difference in the number of immunoreactive cells in the CA1 region region 
of saline animals (n=5, 12.5±1.41) and LPS animals (n=4, 3.08±1.01) t₇=5.163, 
p=0.001.   
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Figure 6.3 c-Fos expression is heightened in post-septic mice following a secondary 
LPS challenge A) Representative photomicrographs of c-Fos expression in 
hippocampal sections. B) Bar graph illustrating mean no. of c-Fos
+
 cells per 
hippocampal subsection at 2 or 9 hours post-treatment. Error bars represent 1x SEM, 
*/**/*** and #/##/### represents p<0.05/0.01/0.001 for main effects of time and LPS 
respectively. Control/2hours (n=4) and post-septic/2hours (n=3), and control/9hours 
(n=5) post-septic/9hours (n=4). 
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6.3.3 ARC 
 As illustrated in Figure 6.4 a two-way ANOVA revealed no significant 
interaction between timepoint and prior sepsis induction (F₁,₁₂=1.789, p=0.206). There 
was no significant effect of prior sepsis induction (F₁,₁₂=0.541, p=0.476) or timepoint 
(F₁,₁₂=0.646, p=0.437).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4 ARC expression is not altered in post-septic mice following a secondary 
LPS challenge A) Representative photomicrographs of Arc expression in hippocampal 
sections. B) Bar graph illustrating mean no. of Arc
+
 cells per Dentate Gyrus at 2 or 9 
hours post-treatment. Error bars represent 1x SEM, Control/2hours (n=4) and post-
septic/2hours (n=3), and control/9hours (n=5) post-septic/9hours (n=4. 
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6.3.4 IL-1β 
 A two-way ANOVA, illustrated in Figure 6.5, revealed no significant interaction 
between prior sepsis induction and time in any area of the hippocampus – DgGr 
F1,12=0.088, p=0.772; DgPo F1,12=2.4, p=0.147; CA1 F1,12=2.231, p=0.161; CA2 
F1,12=3.424, p=0.089; F1,12=0.664, CA3 p=0.431. There was also no main effect of 
treatment in any area of the hippocampus DgGr F1,12=0.002, p=0.963; DgPo 
F1,12=0.345, p=0.568; CA1 F1,12=0.347, p=0.567; CA2 F1,12=0.143, p=0.712; CA3 
F1,12=0.974, p=0.343. As illustrated in Figure 6.4 there was a main effect of time in the 
DgGr only F1,12=12.644, p=0.004; but not the DgPo F1,12=1.938, p=0.621; CA1 
F1,12=0.374, p=0.552; CA2 F1,12=1.208, p=0.293; CA3 F1,12=0.014, p=0.908. When 
groups were split by time there were no significant differences between saline and LPS-
treated animals in any area of the hippocampus at either time (Control/ 2hours n=4, and 
post-septic/2hours n=3, and control/9hours n=5 post-septic/9hours n=4).  
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Figure 6.5 Il-1β expression is heightened in post-septic mice following a secondary 
LPS challenge A) Representative photomicrographs of Il-1β expression in hippocampal 
sections. B) Bar graph illustrating mean IL-1β expression (IOD) in each hippocampal 
subsection at 2 or 9 hours post-treatment. Error bars represent 1x SEM, ** represents 
main effect of time (p<0.01). Control/2hours (n=4) and post-septic/2hours (n=3), and 
control/9hours (n=5) post-septic/9hours (n=4). 
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6.3.5 F4/80 
 As illustrated in Figure 6.6, F4/80 scores were significantly higher in post-septic 
animals (n=7) than controls (n=8) within the CA1 region (t13=2.765, p=0.016), the CA2 
t13=3.44, p=0.004 and the CA3 (t13=2.489, p=0.027). These differences were not 
statistically significant in the DgGr (t13=1.449, p=0.171) or the DgPo (t8.134=1.915, 
p=0.091).  
 
 
 
 
 
 
 
 
 
 
Figure 6.6 F4/80 expression is heightened in post-septic mice following a secondary 
LPS challenge A) Photomicrographs illustrating F4/80 expression across the 
hippocampus following a 100µg/kg dose to animals previously treated with a 5mg/kg 
dose or vehicle. B) Bar graph illustrating mean IOD scores for F4/80 across each area 
of the hippocampus. Error bars represent 1x SEM and */** indicates p<0.05/0.01 in 
independent t-tests. Control animals n=7, post-septic animals n=8.  
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6.3.6 CD11b 
 CD11b expression was significantly elevated in post-septic animals (n=7) 
compared to saline-treated animals (n=9) within the CA1 region (t14=2.23, p=0.043), the 
CA2 (t14=5.392, p<0.0005) and the CA3 (t8.31=2.342, p=0.046). These differences were 
not statistically significant within the DgGr (t8.157=2.252, p=0.054) or the DgPo 
(t14=1.698, p=0.143). This is illustrated in Figure 6.7.   
 
 
 
 
 
     
 
 
 
 
Figure 6.7 CD11b expression is heightened in post-septic mice following a secondary 
LPS challenge A) Photomicrographs illustrating CD11b expression across the 
hippocampus following a 100µg/kg dose to animals previously treated with a 5mg/kg 
dose or vehicle. B) Bar graph illustrating mean IOD scores for CD11b across each 
area of the hippocampus. Error bars represent 1x SEM and */*** indicates 
p<0.05/0.001 in independent t-tests. Control animals n=7, post-septic animals n=9.  
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6.3.7 Open Field Test 
 A mixed between-within ANOVA indicated that animals spent significantly less 
time moving after acute LPS administration (F1,14=154.042, p<0.0005), although there 
was no main effect of prior sepsis induction (F1,14=1.012, p=0.332) or interaction effect 
(F1.14=0.003, p=0.955). Both groups (control n=7, post-septic n=9) also spent 
significantly less time in the inner area of the arena following LPS administration 
(F1,14=7.412, p=0.017) although again there was no main effect of prior sepsis induction 
(F1,14=1.117, p=0.308) or interaction effect between the two variables (F1,14=0.797, 
p=0.387). Velocity was significantly reduced following LPS administration in both 
groups (F1,14=97.072, p<0.0005), with no effect of sepsis (F1,14=0.528, p=0.479) or 
interaction effect (F1,14=0.002, p=0.967). Distance moved was also significantly reduced 
by LPS administration (F1,14=97.851, p<0.0005) with no effect of sepsis (F1,1414=0.516, 
p=0.484) or interaction effect (F1,14=0.004, p=0.95). These results are illustrated in 
Figure 6.8. 
 
 
 
 
 
Figure 6.8 Post-septic mice show identical responses to secondary LPS challenge in 
the open field test A) Bar graph illustrating number of seconds moving during 300 
second trial 2 hours following treatment B) Bar graph illustrating number of seconds 
spent in the inner corridor of the arena during a 300 second trial hours following 
treatment. Error bars represent 1xSEM and */*** represent main effect of prior sepsis 
induction p<0.05/0.001. Control n=7, post-septic n=9 for both saline & 100µg/kg LPS 
treated groups. 
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6.3.8 Tail Suspension Test 
 As illustrated in Figure 6.9, in the tail suspension test there was a significant 
increase in time spent immobile nine hours following LPS administration in both groups 
(F1,14=16.923, p=0.001). Although there was a main effect of prior sepsis induction 
(F1,14=5.587, p=0.033), there was no interaction effect between the two variables 
(F1,14=0.212, p=0.653).  Independent t-tests showed that control animals (n=7) and post-
septic animals (n=9) did not differ significantly in their time spent immobile following 
either saline (t14=1.59, p=0.0135), or LPS administration (t14=2.02, p=0.063). 
 
 
 
 
 
 
 
 
 
 
Figure 6.9 Post-septic mice show identical responses to secondary LPS challenge in 
the tail suspension test. Bar graph illustrating a significant increase in time spent 
immobile 9 hours after treatment with 100µg/kg LPS than with vehicle. Error bars 
represent 1xSEM and *** represent main effect of acute LPS administration p<0.001. 
Control n=7, post-septic n=9 for both saline & 100µg/kg LPS treated groups. 
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6.4 Discussion 
 These experiments investigated whether animals which had previously survived 
sepsis would exhibit an altered behavioural and/or neuroimmune response to subsequent 
challenge with low dose LPS. In previous chapters a sustained inflammatory state is 
described in the post-septic hippocampus, accompanied by significant changes in 
depressive-like and anxiety-like behaviour. As other studies have shown that similar 
paradigms where low doses of LPS elicit primed responses in animal models of chronic 
neuroinflammatory states – such as exaggerated IL-1β expression and increased 
depressive-like behaviour (Godbout, et al., 2005; Perry & Teeling, 2013; Wynne et al., 
2009), it was hypothesised that such an effect may occur in post-septic animals. 
Therefore, post-septic and control animals’ responses to secondary insult with LPS in 
terms of IEG expression, microglial activation, pro-inflammatory cytokine expression 
and behavioural responses were examined.  
6.4.1 Are Neuroimmune Responses Primed Following LPS-Induced Sepsis? 
 Though there was no change in Arc expression, altered responses to LPS 
administration in terms of Egr-1 and c-Fos expression in the hippocampus of post-septic 
animals were noted – two common markers of neuronal activation. Interestingly, there 
was no change in Arc levels within the dentate gyrus at either timepoint or between 
treatment groups. These changes appeared to be particularly apparent in the granule cell 
layer and the CA1 region. In the dentate gyrus regions, post-septic animals exhibited 
higher levels of IEG expression in response to LPS administration at 2 hours while in 
the CA1 region Egr-1 expression was increased while c-Fos expression was lower in 
post-septic mice. By nine hours post-treatment post-septic animals actually show a 
significantly decreased level of c-Fos expression in comparison to control animals. 
There were also significant differences in IEG levels throughout the hippocampus when 
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animals were sampled at either 2 or 9 hours post-treatment. In both groups IEG 
expression was significantly higher at 2 hours post-LPS administration than at 9 hours 
throughout the hippocampus. This likely reflects the relatively rapid timeframe in which 
IEGs are expressed in response to CNS stimulation (Pérez-Cadahía, Drobic, & Davie, 
2011).  
 These differences in the expression patterns of IEGs following secondary LPS 
administration may show regional differences in the susceptibility of the hippocampus 
to the effects of inflammatory stimulus. Although related, these IEGs are functionally 
different, and as in response to behavioural training – may show differential temporal 
induction in the context of inflammatory stimuli also (Lonergan, Gafford, Jarome, & 
Helmstetter, 2010).  
 As previous chapters showed no change in c-Fos levels and decreased levels of 
Egr-1 and Arc in the post-septic hippocampus, it is interesting that the expression of 
these protein products is elevated upon subsequent LPS administration. Although c-Fos 
is known to be expressed throughout the brain in response to acute LPS administration 
(Wanner, et al., 2013) and Egr-1 is induced in murine macrophages in response to 
stimulation with LPS (Coleman, Bartiss, Sukhatme, Liu, & Rupprecht, 1992), neither 
marker has previously been used to examine response to secondary insults in models of 
chronic neuroinflammation. As with our previous experiments there is substantial 
variation in the response seen between different areas of the hippocampus. Here the 
granule cell layer of the dentate gyrus and the CA1, which is primarily composed of 
pyramidal cells (Mizuseki, Royer, Diba, & Buzsáki, 2012), appear particularly affected. 
As these proteins are primarily markers of neuronal activation they may represent a 
potentiated neural response to LPS rather than microglial priming per se.  
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 Microglial activation was examined at 4 hours post-LPS administration showing 
a significant upregulation of CD11b and F4/80 expression in the hippocampus of post-
septic versus control animals throughout the Cornus Ammonis region. Although this 
may reflect over-activation of microglia in post-septic animals a central hallmark of 
primed microglia – IL-1β over-expression was not present among post-septic animals.  
Primed microglia have previously been described as morphologically identical to 
activated microglia, only identifiable by the over-expression of pro-inflammatory 
cytokines in response to stimulation (Cunningham, Wilcockson, Campion, Lunnon, & 
Perry, 2005; Islam & Pestka, 2006; Wynne, Henry, & Godbout, 2009). It is therefore 
possible that elevated levels of CD11b and F4/80 are simply indicative of the chronic 
neuroinflammation present in post-septic animals regardless of acute LPS-
administration. The examination of other pro-inflammatory factors such as TNF-α or 
IL-6 for example may shed more light on the microglial response to subsequent LPS 
administration in the post-septic hippocampus.  
6.4.2 Are Behavioural Responses Primed Following LPS-induced Sepsis 
 As priming has previously been shown to lead to altered behavioural responses 
in terms of decreased social behaviour, food intake, and increased behavioural despair 
in the tail suspension test and forced swim test (Godbout, et al., 2005; Godbout, et al., 
2007) it was decide to examin behaviour in the open field test and tail suspension test at 
2 and 9 hours post-LPS respectively. Although there was a clear effect of acute LPS 
administration on behaviour in both the open field test and the tail suspension test these 
effects did not differ based on prior sepsis induction. In both groups animals 
significantly decreased their mobility and time spent in the central area of the open field 
test, and similarly exhibited increased immobility in the tail suspension test. Unlike in 
the prior experiments, post-septic mice did not show higher immobility than control 
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animals in the tail suspension following acute administration of either saline or LPS. As 
levels of immobility in control animals were relatively high compared with other 
instances of this experiment it is possible that the acute stress of injections and open 
field testing itself were a confounding factor. Immobility in the tail suspension test has 
previously been shown to be very sensitive to acute stressors, even in experimentally 
naïve animals (Dunn & Swiergiel, 2008) which may explain the heightened levels in 
this experiment. 
Given that animals showed such drastic reductions in movement it may be that 
this dose (100µg/kg) of LPS elicited reduced motility as part of a febrile response to 
LPS (Dantzer, 2001; Hart, 1988) rather than any true increase in anxiety-like or 
depressive-like behaviour which is thought to develop later than sickness behaviour 
(Dantzer, O'Connor, Freund, Johnson, & Kelley, 2008). LPS doses as low as 5µg/kg 
have been shown to significantly reduce mobility in mice (Silvia, et al., 2009), although 
this effect becomes much more potent at doses above 50µg/kg suggesting that any effect 
of prior sepsis induction on a behavioural response to LPS may be masked by the 
administration of a dose which is either too low or too high. It may therefore be useful 
to study behavioural priming following relatively low doses of inflammatory agents, or 
to use later timepoints than those examined here.  
6.4.3 Conclusion 
 It therefore appears that prior sepsis induction does not lead to a primed 
microglial or behavioural response to a 100µg/kg dose of LPS.  The responses elicited 
also do not seem indicative of LPS-tolerance or microglial pre-conditioning. Rather 
LPS induced high levels of sickness behaviours in both groups accompanied by 
microglial activation which likely appeared elevated in post-septic animals due to the 
altered level of activation already present before a secondary dose was administered. It 
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may also be that while there is no altered response in terms of affective behaviour, post-
septic animals might be more susceptible to a primed effect in terms of cognitive 
behaviours, not measured in this experiment, which are highly affected in post-septic 
patients (Iwashyna, Ely, Smith, & Langa, 2010).  
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Chapter 7. Disruption of Hippocampal Circadian Rhythmicity in Post-
Septic Mice 
Abstract 
 Circadian rhythms are present in organisms at almost every level from protein 
expression to behaviour and are essential for proper functioning. These near 24 hour 
cycles are severely disrupted during sepsis and are also affected in sufferers of mood 
disorders. Microglia themselves show circadian variation in their responses to 
inflammatory stimuli. It was hypothesised that post-septic mice may show variation in 
key circadian proteins which are important to maintaining rhythmicity in the 
hippocampus. The expression of these proteins (CLOCK, PER1 & PER2), as well as c-
Fos, was examined at 6 timepoints across a 24 hour cycle in post-septic and control 
mice. In order to assess the role of circadian factors in the microglial response to LPS a 
second experiment was also carried out. Here mice with a heterozygous knockout for 
circadian protein BMAL1 in macrophages were treated with 100µg/kg LPS before 
undergoing behavioural testing and then immunohistochemical analysis. 
 The first experiment revealed that post-septic mice showed dampened rhythms 
in the hippocampal expression of PER1 and PER2 across a 24 hour cycle – with some 
regional differences within the hippocampus. c-Fos and CLOCK expression did not 
oscillate across the 24 hour cycle and there were no differences between post-septic and 
control mice. The latter experiment revealed that mice with a knockdown for BMAL1 in 
macrophages showed subtle depressive-like behaviours in some tests but overall did not 
show large differences in response to LPS treatment. These results shed some light on 
the effects of LPS-induced sepsis on circadian rhythms in the mouse hippocampus. 
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7.1 Introduction 
As demonstrated in previous chapters, LPS-induced sepsis leads to prolonged 
microglial activation, alterations in hippocampal functioning and accompanying 
behavioural changes. The mechanisms through which these changes are brought about 
are not clear. One potential target for investigation is the disruption of circadian 
rhythmicity following sepsis induction. Circadian clocks are present both within the 
CNS and the periphery, regulating near 24 hour cycles of physiology and behaviour, 
with the master circadian pacemaker the suprachiasmatic nucleus (SCN) residing within 
the hypothalamus (Partch, Green, & Takahashi, 2014). Although the SCN itself does 
not directly control cognitive or affective behaviours, it synchronises clocks in other 
brain regions, such as the hippocampus, which are more directly involved in these 
processes (Cho, 2012).   
 Within the SCN circadian oscillations are driven by both positive and negative 
transcriptional and translational feedback loops which control the production of 
essential clock proteins (Kwon, Choe, Son, & Kim, 2011; Reppert & Weaver, 2002). A 
positive feedback mechanism occurs when the BMAL1:CLOCK and BMAL1:NPAS2 
dimers promotes the transcription of target genes Per1, Per2 and Per3 as well as Cry1 
and Cry2 (Debruyne, Weaver, & Reppert, 2007). PER:CRY protein dimers in turn 
negatively regulate their own transcription by translocating to the nucleus and 
interacting with CLOCK:BMAL1 to stop activation (Reppert & Weaver, 2002). Also 
important in regulating clock rhythmicity are REV-ERBα which represses Bmal1 
transcription and RORa and RORb which activate it (Liu, et al., 2008). Many circadian 
genes can also serve alternative functions outside of the SCN, for example Rev-Erbα 
can modulate aspects of macrophage function highlighting the interplay between the 
circadian and immune systems (Sato, et al., 2014).   
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7.1.1 Circadian Rhythms and Clock Gene Production in the Hippocampus 
It is thought that cell populations within areas such as the hippocampus may also 
function as circadian oscillators but that these are maintained in synchrony by the 
master clock within the SCN (Wang, et al., 2009). Although direct neural input from the 
SCN to the hippocampus has not yet been identified, hippocampal cells produce the 
clock gene proteins PER1, PER2, CRY1, CRY2, CLOCK and BMAL1 (Jilg, et al., 
2009). Some cell populations within the HPC even show endogenous clock gene 
rhythmicity. For example, pyramidal cells from the hippocampus display Per2 
rhythmicity in isolation from the SCN (Wang, et al., 2009). Evidence from 
electrophysiological study of CA1 pyramidal neurons in C57 mice and Wistar rats offer 
further insight into the role of circadian regulation in hippocampal function, showing 
that these neurons have significant diurnal variations in LTP (Chaudhury, Wang, & 
Colwell, 2005; Nakatsuka & Natsume, 2014). Circadian rhythms within the 
hippocampus are now known to control functions essential for memory formation and 
consolidation such as mitogen-activated protein kinase (MAPK) and cAMP signal 
transduction signalling (Eckel-Mahan, 2012), as well as dendritic spine formation and 
stabilisation following periods of learning via control of glucocorticoid levels (Liston, et 
al., 2013). Further evidencing the role of circadian genes in hippocampal function, mice 
knocked out for Per1 show severe deficits in hippocampal-dependent spatial learning 
(Jilg, et al., 2009). 
In humans circadian rhythms have also been shown to be important for 
regulating both cognitive and affective functioning (Wright, Lowry, & LeBourgeois, 
2012), both of which depend on the hippocampus. Aside from their role in normal 
functioning, circadian disturbances and clock gene abnormalities have been implicated 
in affective disorders such as major depression (McCarthy & Welsh, 2012) and diseases 
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involving significant cognitive impairment such as Alzheimer’s disease (Cermakian, 
Lamont, Boudreau, & Boivin, 2011). One hippocampal function important to both 
memory formation and emotion is the adult proliferation of NPCs within the 
subgranular zone of the hippocampus. Interestingly, there are molecular clocks present 
in these NPC cells and proliferation has been shown to be rhythmic, with the clock 
genes Per2 and Bmal1 of particular importance (Bouchard-Cannon, Mendoza-Viveros, 
Yuen, Kærn, & Cheng, 2013). The clock gene Bmal1 has also been shown to be 
essential to regulating the survival of newly proliferated NPCs within the SGZ, with 
Bmal1 KO mice actually showing increased survival of newborn cells (Rakai, Chrusch, 
Spanswick, Dyck, & Antle, 2014). Dysregulation of BMAL1 and PER2 proteins leads 
to significant alterations in proliferation and is also accompanied by cognitive deficits.  
7.1.2 Does the hippocampus exhibit independent rhythmicity or is it dependent on SCN 
input? 
 One important question regarding the hippocampal circadian clock is whether its 
rhythmicity is controlled purely by the SCN or whether it can maintain endogenous 
rhythms without SCN input. Although peripheral clocks within the brain and other 
organs are synchronised by neural or humeral signalling from the master timekeeper the 
SCN, some organs can maintain rhythmic oscillations despite SCN lesion (Tahara, et 
al., 2012). While these clocks may maintain their own individual rhythms without SCN 
input, genetic ablation of SCN function leads to desynchronicity between peripheral 
clocks in the absence of any zeitgeber (Husse, Leliavski, Tsang, Oster, & Eichele, 
2014). Clock genes Per2, Cry1 and Cry2 (Navigatore-Fonzo, Delgado, Golini, & 
Anzulovich, 2014) have shown endogenous rhythmicity within the hippocampus of rats 
kept in constant darkness and Jilg et al. (2009) illustrated that C3H mice express the 
majority of the central clock genes in the hippocampus also. As already noted, Per2 
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oscillates rhythmically in pyramidal cells cultured in isolation from SCN input (Wang, 
et al., 2009) but while Per1 (Abe, et al., 2002) has been shown to be strongly expressed 
in dentate gyrus tissue isolated from the SCN it was not rhythmic, and CA1, CA2 and 
CA3 tissue failed to show Per1 production at all. Although the oscillation of some 
factors may occur independent of SCN input, the rhythmic expression of MAP kinase 
and adenylyl cyclase as well as memory consolidation have been shown to depend on a 
functioning SCN (Phan, Chan, Sindreu, Eckel-Mahan, & Storm, 2011), and rhythmicity 
of PER2 expression in the DG has been shown to be abolished following SCN lesion 
(Lamont, Robinson, Stewart, & Amir, 2005). Therefore while some hippocampal cells 
populations may show rhythmic expression of clock genes in isolation from the SCN, 
proper hippocampal functioning still depends on SCN input. Despite this, the precise 
mechanism by which the SCN outputs to the hippocampus has yet to be defined. The 
hippocampus does show sensitivity to melatonin, a hormone under circadian control 
(Perreau-Lenz, et al., 2003) which can modulate serotonin signalling (Monnet, 2002), 
and subiculum synchronization by the SCN may also influence rhythmicity within the 
hippocampus (Cho, 2012).   
 One group of factors which may link the circadian system, the inflammatory 
response and cognitve/affective functioning are glucocorticoids – steroid hormones 
which are regulated by the circadian system, whose receptors are expressed in almost all 
tissue (Kadmiel & Cidlowski, 2013) and which are upregulated in response to life 
stressors (Sauro, Jorgensen, & Pedlow, 2003). Glucocorticoids may play a key role in 
the disruption to hippocampal rhythmicity during both psychiatric and inflammatory 
disorders, controlling both Per1 and Per2 oscillation in the dentate gyrus (Gilhooley, 
Pinnok, & Herbert, 2011) and CA1 (Conway-Campbell, et al., 2010) as well as Per2 
rhythmicity within the central amygdala (Segall, Milet, Tronche, & Amir, 2009). 
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Importantly in the context of the present research, glucocorticoids are also able to 
modulate adult neurogenesis, with over expression suppressing the proliferation of 
neural progenitor cells (Mirescu & Gould, 2006). Glucocorticoids are implicated in the 
pathophysiology of major depression (Anacker, Zunszain, Caravalho, & Pariante, 
2011), with cortisol for example showing flattened rhythms of expression in depressed 
women (Jarcho, Slavich, Tylova-Stein, Wolkowitz, & Burke, 2013). Cortisol rhythms 
are also dampened in chronic inflammatory conditions such as athlerosclerosis – with 
higher levels of inflammatory cytokines correlating with more disrupted rhythmicity 
(DeSantis, et al., 2012). Others have suggested that the increase in inflammatatory 
markers present in depression may drive HPA-axis hyperactivity (Carvalho, et al., 
2014) – an effect which could subsequently disrupt the expression of circadian genes in 
the hippocampus and other areas. 
7.1.3 Is There a Circadian Aspect to the Inflammatory Response? 
 Aside from its role in maintaining proper hippocampal functioning, the circadian 
system also shows significant bidirectional communication with various aspects of the 
immune system. As with peripheral macrophages (Keller, et al., 2009), microglia 
themselves actually contain their own molecular clock, with murine microglia 
rhythmically expressing Per1, Rev-erbα, Per2 and Bmal1 when isolated from mice 
(Hayashi, et al., 2013). These microglia also exhibit circadian expression of Cathepsin S 
which controls the diurnal changes in synaptic activity and spine density in neurons, 
illustrating yet another mechanism through which circadian oscillations can influence 
factors controlling cognition. Indeed, the immune response as a whole has been 
demonstrated to vary depending on the time of day at which a challenge occurs. 
Marpegan et al. (2009) showed a diurnal variation in mice’s susceptibility to LPS-
induced mortality and their immune responses to such a challenge. The authors found 
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that mice had significantly higher mortality following LPS administered at ZT11 rather 
than ZT19, a timepoint at which they also produced significantly higher levels of the 
cytokines IL-1β and IL-6 as well as chemokines MCP1 and MIP1α. Spengler et al. 
(2012) showed that the circadian protein CLOCK actually forms complexes with NF-κB 
subunit p65 and promotes its transcription independent of BMAL1. As NF-κB drives 
the innate immune response to LPS this explains in part the large diurnal variations 
mice exhibit in susceptibility to LPS challenge. This circadian regulation of the immune 
system is also present humans, with pro-inflammatory factors highest during night-time, 
and a shift towards an anti-inflammatory profile present during the day (Lange, 
Dimitrov, & Born, 2010). 
 As the circadian system appears to gate immune factors in healthy contexts as 
well as in response to pathogens researchers have also examined immune responses in 
situations of circadian disruption. This disruption can be achieved in animal models by 
altering the length of the light or dark periods of a normal 12:12 light:dark cycle, or by 
phase-shifting animals by advancing or delaying the onset of the light or dark part of 
their cycle – similar to what occurs during shift work and jet lag in humans. For 
example, Castanon-Cervantes et al. (2010) showed that four consecutive 6-hour phase 
advances in mice led to significant reductions in survival following LPS challenge as 
well as exaggerated inflammatory response in terms of serum cytokines IL-1β, IL-12 
and IL-13 with reduced IL-10 production. Chronic phase shifting has also been shown 
to alter circadian clock gene expression in natural killer (NK) cells , disrupting the 
expression of cytokine IFN-γ and altering their functional response to tumour challenge 
(Logan, et al., 2012). Destruction of clock functioning by bilateral SCN lesion leads to 
excessive immune responses to LPS (Guerrero-Vargas, et al., 2014). These studies 
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illustrate the necessity of proper circadian functioning for maintaining an appropriate 
and effective immune response to pathogens.  
7.1.4 How Does Inflammation Impact on Circadian Factors?  
 While the circadian system can control immune factors during normal 
functioning and in response to inflammatory challenge, the immune system can also 
exert effects on circadian parameters, even leading to desynchronicity in pathological 
states. A relatively low dose of LPS (50µg/kg) induces phase shifts, along with c-Fos 
activation in the SCN primarily through a TLR-4 dependent pathway (Paladino, Leone, 
Plano, & Golombek, 2010). Septic doses of LPS have also been shown to induce long-
lasting alterations in circadian parameters such as accelerated re-entrainment to six hour 
phase advances and exaggerated phase advances following photic stimulation 
(O'Callaghan, Anderson, Moynagh, & Coogan, 2012). These effects may be driven by 
the NF-κB pathway with the NF-κB subunit RelB having been shown to suppress 
circadian expression of BMAL1, and the suppression of light-induced phase advances 
by NF-κB inhibition with pyrrolidine dithiocarbamate (Bellet, Zocchi, & Sassone-Corsi, 
2012; Marpegan, et al., 2004). The cytokine TNFα and its receptor tnfr1, which are 
known to activate NF-κB also appear to be important in driving the circadian response 
to LPS stimulation (Paladino, Mul Fedele, Duhart, Marpegan, & Golombek, 2014). 
Inhibition of the NF-κB pathway with sulfasalazine blocks LPS-induced phase delays 
(Marpegán, Bekinschtein, Costas, & Golombek, 2005). These studies illustrate the bi-
directionality of the immune-circadian signalling and the potential for disruption in each 
system produce deleterious effects in the other. 
4.1.5 Linking Inflammatory Disorders, Psychiatric Illness and Circadian Parameters 
 In humans, circadian dysfunction is implicated in the pathogenesis and 
symptomatology of several immune diseases such as rheumatoid arthritis (Takagi, 
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Inada, & Naito, 2013; Yoshida, Hashimoto, Sakai, & Hashiramoto, 2014), and multiple 
sclerosis (Najafi, et al., 2013).  Many symptoms of immune disease are experienced in 
diurnal patterns, with some more apparent in early morning or late night – 
corresponding to rhythmic oscillations in immune factors within the body 
(Scheiermann, Kunisaki, & Frenette, 2013). These findings are important because 
disrupted circadian rhythmicity and subsequent sleep disturbance contribute towards 
impaired immune functioning in humans (Faraut, Boudjeltia, Vanhamme, & Kerkhofs, 
2012; Irwin, et al., 1996). Circadian disruption and sleep disturbances are also a factor 
in both the pathogenesis and symptomatology of numerous psychiatric illnesses 
(Jagannath, Peirson, & Foster, 2013). This includes diseases such as major depression 
(Souêtre, et al., 1989), anxiety disorders (Monti & Monti, 2000; Papadimitriou & 
Linkowski, 2005) and schizophrenia (Wulff, Dijk, Middleton, Foster, & Joyce, 2012). 
One particularly interesting study using a time of death analysis in post-mortem 
depressive patients illustrated that the rhythmicity of several key clock genes including 
Bmal1, Per1/2/3, and Rev-Erbα was blunted in cortical and limbic regions of depressive 
patients relative to controls (Li, et al., 2013). As these conditions also often involve 
inflammatory components (Najjar & Pearlman, 2014; Rosenblat, Cha, Mansur, & 
McIntyre, 2014) a link may also be present here between neuroinflammation and 
disrupted circadian rhythmicity. 
 This cross talk between the immune and circadian systems is particularly 
pertinent in the case of sepsis given that severe circadian disruption is present in the 
acute stages of sepsis, and data from animal models showing both that the severity of 
sepsis is affected by the circadian time at which sepsis is induced (Silver, Arjona, 
Walker, & Fikrig, 2012; Walker, Bozzi, & Fikrig, 2011) and that disruption of 
rhythmicity by Bmal1 deletion leads to increased mortality ad disease severity 
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(Cornonata, et al., 2014). Analysing melatonin metabolite 6-sulfatoxymelatonin (6-
SMT) in both ICU patients suffering from sepsis and non-septic ICU patients, 
Mundigler et al. (2002) showed that this circadian disruption was specific to sepsis and 
not simply an effect of environmental disruption such as noise, light or carer 
interactions. Interestingly, the authors followed up these authors 1-4 weeks after 
recovery from sepsis and found that they still failed to show circadian rhythmicity in 
aMT6s secretion. Another study of 6-SMT levels and lighting variability in septic 
patients showed again that rhythmicity is disrupted and also that light exposure in 
patient care rooms failed to entrain circadian rhythms (Verceles, et al., 2012), although 
the authors also highlight the importance of considering the modulatory effects many 
medications used during sepsis can have on melatonin secretion.  An antioxidant, 
melatonin administration has actually been shown to improve clinical outcomes in 
septic newborns (Gitto, et al., 2001) and a strong negative correlation exists between 
disease severity and nocturnal melatonin levels in severe sepsis (Perras, Kurowski, & 
Dodt, 2006). An in depth analysis spanning six days measuring heart rate as well as 
systolic, diastolic and mean blood pressure in a large sample (n=2690) found that while 
survivors tended to show circadian oscillations in these functions, rhythmicity was lost 
among non-survivors (Cheng, et al., 2014). 
7.1.6 Aims 
 Given these associations between inflammation, affective behaviours and 
circadian rhythms these experiments aimed to assess whether hippocampal rhythmicity 
may be altered in post-septic animals. Levels of PER1, PER2 and CLOCK protein 
products as well as the marker of neuronal activation c-Fos were examined, as these are 
all endogenously expressed in the mouse hippocampus (Jilg, et al., 2009), at six 
timepoints over a 24 hour cycle. As microglia also contain their own intrinsic clock 
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(Hayashi, et al., 2013) conducted behavioural and neuroimmunological investigation 
was also conducted with a circadian mutant mouse with a heterozygous knockout for 
Bmal1 in myeloid-lineage cells. It was hypothesised that these mice may exhibit an 
altered response to a low dose of LPS given the importance of correct clock functioning 
in gating an appropriate immune response.  
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7.2 Materials and methods 
7.2.1 Experiment 1. The effects of sepsis on hippocampal rhythmicity 
7.2.1.1 Animals 
For the purpose of all experiments male C57BL/6 mice (Charles River, Kent, 
UK) aged between 8 and 10 weeks were used. After two weeks of group housing 
following arrival to acclimatise to conditions, animals were singly housed in 
polypropylene cages (33cm long x 15 cm wide x 13cm high) with steel running wheels 
(11.5 cm diameter) in a 12:12 light:dark cycle for 2 weeks prior to LPS administration. 
Food and water were available ad libitum, temperature was 21 ±1°C and humidity was 
50 ±10%. All procedures were approved by the Research Ethics Committee, National 
University of Ireland Maynooth, and were licensed by the Department of Health and 
Children, Ireland under statutory instrument (S.I.) No. 543 of 2012 and the European 
directive 2010/63/EU.   
7.2.1.2 Drug Treatments 
 All saline and LPS injections were made up fresh on the treatment day, and 
given intraperitoneally in a final injection volume of 0.125ml.  0.9% sterile saline was 
made up fresh for control injections, while lipopolysaccharide (serotype0111.B4, Sigma 
Ireland; Qin et al, 2007) was made up to a 5mg/kg dose in sterile saline. Injections were 
given intraperitoneally between zeitgeber time (ZT) 06 and 08, where ZT0 is defined as 
lights on. Mortality and significant moribundity requiring euthanasia occurred within 
approximately 10% of animals following the induction of sepsis. 
7.2.1.3 Assessment of circadian clock gene expression 
 One month following either LPS (5mg/kg) or saline treatment animals were 
placed in DD (constant darkness) for two cycles following which they were sampled 
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every four hours across the third 24 hour DD cycle (n=3-4 per group). Brains were 
therefore collected at CT2, CT6, CT10, CT14, CT18 and CT22. Animals were 
administered sodium pentobarbital (0.1ml / animal) under dim red light (<1 lux) before 
being transcardially perfused with saline followed by 0.4% PFA as previously 
described. Brains were then cryoprotected in 30% sucrose and coronally sectioned at 
30µm as previously described. Immunohistochemical analysis was conducted as in 
previous chapters using the following antibodies – PER1 (1:500, goat, Santa Cruz), 
PER2 (1:1000, rabbit, Alpha Diagnostics), CLOCK (1:500, goat, Santa Cruz) and c-Fos 
(1:2000, rabbit, Santa Cruz). Between four and six section were analysed per mouse 
with the number of immunoreactive cells per area of interest counted as previously 
described. 
7.2.2 Experiment 2. Effects of myeloid-specific Bmal1 knockdown 
7.2.2.1 Animals 
Male mice (n=11) with heterozygous BMAL1 deletion in the myeloid cell 
lineage (Bmal1
+/-
) and wild-type counterparts (n=10) were received from Trinity 
College Dublin and were group housed for 2 weeks in a 12:12 light:dark cycle at 
21±1˚C with 50±10% humidity and food and water available ad libitum. These animals 
were produced via a cross between LysMCre animals and floxed bmal1 mice, as per 
(Gibbs, et al., 2012). At age 8 weeks, they were taken to the testing area 3 days before 
experimental testing begun to allow for habituation and control for stress induced by 
moving. Experimental timelines for these mice are shown in Figure 7.1. 
7.2.2.2 Behavioural phenotyping 
Animals were given either a sterile saline or 100µg/kg dose of LPS (0.125ml) 
between ZT2.5 and ZT3.5 and were two hours later (ZT4.5-5.5) introduced to a novel 
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arena (diameter 60cm) and allowed to explore for five minutes during which time 
distance, velocity and time in the inner and outer corridors were recorded. They were 
then returned to their homecage and one hour later they were introduced to an elevated 
plus maze. Animals were tested in the elevated plus maze for 5 minutes – recording 
their time spent in the open and closed arms, as well as number of entries to the open 
and closed arms. 24 hours after treatment animals were tested in the tail suspension test.  
Five weeks later, when animals were deemed to be ready to be re-tested, the 
same experiments were carried out, but those who were treated with saline the first time 
were given LPS, and vice versa. For the elevated plus maze, in order to combat one-trial 
tolerance (Schneider, Ho, Spanagel, & Pawlak, 2011), when the animals were re-tested 
the environment was changed significantly by the introduction of novel light sources 
and extra-maze stimuli, as well as a altered direction of the maze. 
The forced swim test was carried out a week after the previous experiments, this 
time in the animal house itself. There was no treatment prior to testing, rather animals 
were tested only for a between-groups effect. During the light phase of their light:dark 
cycle mice were placed singly in a 2 litre clear plexiglass beaker (12.5cm x 23.5cm) 
filled to a height of 12cm with 1.25l water (27±1°C), such that their tails could not 
touch the bottom of the beaker. Each test lasted six minutes, with the immobility being 
marked in the final four minutes only. Immobility was defined as an absence of 
movement, except slight leg movements to stay afloat. Animals were then lightly dried 
and placed under a warm lamp before being returned to their home cage.  
The sucrose preference test was carried out one week after the forced swim test. 
Following procedures set out in (Strekalova, Spanagel, Bartsch, Henn, & Gass, 2004) 
animals housed either in twos or threes were given ad libitum access to two water 
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bottles at 10am, one containing tap water, the other containing a 1% sucrose in tap 
water solution. Both bottles and bottle tops were washed before being filled, they were 
then sealed to prevent leakage, tested for liquid availability and weighed before being 
placed in the cage. Twelve hours later, the placement of the bottles was reversed to 
control for any side-preference in drinking. After 24 hours had passed, both bottles were 
then weighed again. Where liquid was found to have leaked in a cage data for that 
animal was not considered. 
7.2.2.3 Assessment of BMAL-1 expression in microglia 
 One week after the sucrose preference test animals were transcardially perfused 
and brains were processed as previously described. For double staining with BMAL1 
and IBA-1 brains were first stained using standard NiDAB protocol for BMAL1(rabbit, 
1:500, sc-48790) as previously described. Following three washes with 0.1M PB, 
sections were then blocked for one hour in 0.1M 0.03% PBX containing 5% NGS 
before being incubated overnight at 4˚C in 0.1M 0.03% PBX containing 2% NGS and a 
1:3000 dilution of IBA-1 (Rabbit, Wako). The following day, sections were washed and 
incubated with anti-rabbit secondary as previously described before colour development 
with NovaRed (Vector labs, SK-4800). This staining was carried out using a VECTOR 
NovaRED peroxidise substrate kit according to manufacturer’s instructions. Sections 
were then washed in 0.1M PB before being mounted, dehydrated, delipified and 
coverslipped. For analysis, the number of microglia within a single field of view in the 
dorsal CA1 area was calculated via an Olympus BX-51 light microscope at 40x 
magnification. This was repeated for 4 sections per animal. The number of microglia 
which were also stained positive for BMAL1 were then analysed and this was used to 
calculate the percentage values used for statistical analysis. 
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7.2.3 Statistical Analysis 
 All statistical analysis was conducted in IBM SPSS version 20. For the 
assessment of clock gene rhythmicity data were analysed using two-way ANOVAs with 
time and treatment as between groups factors. To examine the level of BMAL1 in 
microglia independent t-tests were utilised with genotype as the independent variable. 
For behavioural tests with LPS two-way ANOVAs were conducted with genotype as a 
between groups factor and treatment as a within groups factor, while for testing in naïve 
animals independent t-tests were used to examine the effects of genotype. P values of < 
0.05 were accepted as significant for all tests. Where statistical assumptions were 
violated corrected values are presented. All data are presented as means ± standard error 
of the mean (SEM). * represents p<0.05, ** represents p<0.01 and *** represents 
p<0.001. Scale bars on microphotographs represent 100µm for photos at 40x and 100x 
magnification and 50µm for photos at 400x magnification. 
  
 
 
 
 
 
 
 
Figure 7.1 Timeline for circadian experiments. 
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7.3 Results 
7.3.1 Effect of Sepsis on Hippocampal Clock Gene Expression 
7.3.1.1 PER1 
 Two-way ANOVAs were conducted for each hippocampal subregion with n=3 
mice per group per timepoint for each area. As shown in Figure 7.2, there was no main 
effect of treatment (F1,24=0.04, p=0.843), timepoint (F5,24=1.46, p=0.239) or interaction 
effect (F5,24=1.331, p=0.285) in the granule cell layer. In the polymorphic cell layer 
there was no effect of treatment (F1,24=1.238, p=0.277), or interaction effect 
(F5,24=0.139), or timepoint  (F5,24=2.559, p=0.054). In the CA1 region there was a main 
effect of treatment (F1,24=5.288, p=0.03), time (F5,24=13.301, p<0.0005) and an 
interaction effect (F5,24=5.312, p=0.002). In the CA2 region there was no main effect of 
treatment (F1,24=1.104, p=0.304), although there was a main effect of time (F5,24=2.976, 
p=0.031) and an interaction effect (F5,24=2.846, p=0.037). Lastly, in the CA3 region 
there was no main effect of treatment (F1,24=0.346, p=0.562) although there was a main 
effect of time (F5,24=4.747, p=0.004) and no interaction effect (F5,24=1.813, p=0.148). 
Where analysed as a whole there was no main effect of treatment (F1,24=1.091, p=0.307) 
although there was a main effect of time (F5,24=7.16, p<0.0005) and interaction effect 
present (F5,24=3.19, p=0.024).  
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Figure 7.2 PER1 expression across a 24-hour cycle. Line graphs illustrating mean 
PER1 expression in DgGr, CA1 and CA3 at each of the six timepoints. Error bars 
represent 1xSEM. N=3 per group per timepoint.  
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7.3.1.2 PER2 
 Two-way ANOVAs were conducted for each hippocampal subregion with n=3 
mice per group per timepoint for each area. There was no significant effect of timepoint 
in the granule cell layer (F5,24=0.647, p=0.666) although there was a main effect of 
treatment (F1,24=5.694, p=0.025) but no interaction (F5,24=0.768, p=0.582). In the 
polymorphic cell layer there was a main effect of time (F5,24=4.642, p=0.004), but not 
treatment (F1,24=0.784, p=0.385) and no interaction effect (F5,24=0.906, p=0.493). In the 
CA1 region there was a main effect of time (F5,24=3.021, p=0.03) and a main effect of 
treatment (F1,24=4.471, p=0.045) but no significant interaction (F5,24=0.218, p=0.952). In 
the CA2 region there was no main effect of time (F5,24=1.928, p=0.128), a main effect of 
treatment (F1,24=9356, p=0.008) but no interaction (F5,24=0.354, p=0.874). In the CA3 
region there was no main effect of time (F5,24=1.656, p=0.184), treatment (F1,24=0.129, 
p=0.723) or interaction between the variables (F5,24=0.996, p=0.441). When analysed as 
a whole there was a main effect of timepoint (F5,24=2.959, p=0.032), and treatment 
(F1,24=6.235, p=0.02) but no interaction effect (F5,24=0.334, p=0.887). These results are 
illustrated in Figure 7.3. 
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Figure 7.3 PER2 expression across a 24-hour cycle. Line graphs illustrating mean 
PER2 expression in DgGr, CA1 and CA3 at each of the six timepoints. Error bars 
represent 1xSEM. N=3 per group per timepoint.  
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7.3.1.3. CLOCK 
 Two-way ANOVAs were conducted for each hippocampal subregion with n=3 
mice per group per timepoint for each area. As illustrated in Figure 7.4, there was no 
significant effect of treatment (F1,24=0.401, p=0.533), timepoint (F5,24=0.585, p=0.712) 
or interaction effect (F5,24=0.026, p=1.00) in the granule cell layer. In the polymorphic 
cell layer there was also no main effect of treatment (F1,24<0.0005, p=0.992), timepoint, 
(F5,24=0.381, p=0.857) or interaction effect (F5,24=0.198, p=0.96). In the CA1 region 
there was no main effect of treatment (F1,24=0.001, p=0.979), timepoint (F5,24=0.918, 
p=0.486) or interaction effect (F5,24=0.027, p=1.00). In the CA2 region there was no 
main effect of treatment (F1,24=0.003, p=0.96), timepoint (F5,24=0.496, p=0.496) and no 
interaction effect (F5,24=0.321, p=0.895). In the CA3 region there was no main effect of 
treatment (F1,24=0.002, p=0.962), timepoint (F5,24=0.253, p=0.934) or interaction effect 
(F5,24=0.146, p=0.979). Analysed as a whole there was also no main effect of treatment 
(F1,24=0.023, p=0.88), timepoint, (F5,24=0.569, p=0.723) or interaction effect 
(F5,24=0.114, p=0.988).  
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Figure 7.4 CLOCK expression across a 24-hour cycle. Line graphs illustrating mean 
CLOCK expression in DgGr, CA1 and CA3 at each of the six timepoints. Error bars 
represent 1xSEM. N=3 per group per timepoint.  
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7.3.1.4. C-Fos 
 Shown in Figure 7.5, two-way ANOVAs showed that there was no main effect 
of timepoint (n=3/group/timepoint, F5,24=0.282, p=0.918), treatment (F1,24=0.125, 
p=0.727) or interaction effect in the granule cell layer (F5,24=0.336, p=0.886). In the 
polymorphic cell layer there was also no main effect of timepoint (F5,24=0.882, p=.508), 
treatment, (F1,24=0.076, p=0.786) or interaction effect (F5,24=076, p=0.587). In the CA1 
region there was no main effect of timepoint (F5,24=0.499, p=0.774), treatment 
(F1,24=0.094, p=0.762) or interaction effect (F5,24=0.259, p=0.931). In the CA2 region 
there was no main effect of timepoint (F5,24=0.959, p=0.462), treatment (F1,24=1.749, 
p=0.198) or interaction effect (F5,24=1.197, p=0.341). In the CA3 region there was also 
no main effect of timepoint (F5,24=0.386, p=0.386), treatment (F1,24=0.227, p=0.638) or 
interaction effect (F5,24=0.345, p=0.88). Lastly, when analysed as a whole there was no 
main effect of timepoint (F5,24=0.484, p=0.785), treatment (F1,24=0.092, p=0.764) or 
interaction effect (F5,24=0.284, p=0.917). 
 Figures 7.6 illustrates the rhythmic expression of these proteins in each group 
while Figure 7.7 features representative micrographs of peak and trough expression for 
each protein across the entire hippocampus.  
  
259 
 
 
 
 
Figure 7.5 c-Fos expression across a 24-hour cycle. Line graphs illustrating mean c-
Fos expression in DgGr, CA1 and CA3 at each of the six timepoints. Error bars 
represent 1xSEM. N=3 per group per timepoint. 
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Figure 7.6 Clock gene expression at peak and trough timepoints in the post-septic hippocampus.  
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Figure 7.7 Post-septic mice show alterations in the rhythmic expression of hippocampal clock genes. Values represent 
mean expression for the total of all five areas. Error bars represent 1x SEM. N=3 per group per timepoint. 
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7.3.2 Experiment Two - Behavioural response of Bmal1
+/-
 mice to LPS 
7.3.2.1 Open Field Test 
A mixed between-within ANOVA indicated a main effect of LPS treatment 
(n=21 per treatment) on the distance moved in the open field test (F₁,₁₉=80.092, 
p<0.0005) as shown in Figure 7.8. There was no main effect of genotype (n=10 wild-
type, 11 BMAL1 
+/- 
mice) F₁,₁₉=1.005, p=0.329. There was also no treatment x 
genotype interaction (F₁,₁₉=0.38, p=0.545). LPS produced a significant reduction in 
animals’ velocity in the arena (F₁,₁₉=78.955, p<0.0005). There was no main effect of 
genotype on velocity (F₁,₁₉=1.054, p=0.318). There was no treatment x genotype 
interaction (F₁,₁₉=0.11., p=0.744). LPS also significantly reduced time spent in the 
inner corridor of the arena (F₁,₁₉=6.054, p=0.024). There was no main effect of 
genotype (F₁,₁₉=2.357, p=0.141). There was no interaction effect between the two 
variables (F₁,₁₉=0.183, p=0.674). 
 
 
 
 
 
 
  
Figure 7.8 Altered open field exploration following LPS administration in BMAL1
+/-
 
mice Bar graphs illustrating distance moved and time spent in the inner portion of the 
open field test. Error bars represent 1xSEM and */*** represents main effect of LPS 
administration p<0.05/0/001. N=10 for wild-type mice, n=11 for BMAL1
+/- 
mice, n=21 
for saline and LPS treatments. 
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7.3.1.2 Elevated Plus Maze 
Shown in Figure 7.9, there was a main effect of treatment (n=21 per treatment) 
on the number of open arm entries in the elevated plus maze (F₁,₁₉=24.056, p<0.0005). 
There was no main effect of genotype (F₁,₁₉= 0.156, p=0.697). There was no interaction 
effect between treatment and genotype (n=10 wild-type, 11 BMAL1 
+/- 
mice) 
F₁,₁₉=0.896, p=0.356. There was also a main effect of treatment on the number of 
closed arm entries (F₁,₁₉=37.039, p=0.0092). There was no main effect of genotype 
(F₁,₁₉=1.884, p=0.186). There was no interaction effect between the two variables 
(F₁,₁₉=3.156, p=0.092). There was a main effect of treatment on time spent in the open 
arms of the maze (F₁,₁₉=8.576, p=0.009). There was no main effect of genotype 
(F₁,₁₉=0.958, p=0.34). There was no interaction effect between the two variables 
(F₁,₁₉=0.073, p=0.789). There was a main effect of treatment on time spent in the 
closed arms of the maze (F₁,₁₉=8.318, p=0.01). There was no main effect of genotype 
(F₁,₁₉=0.009, p=0.925). There was no interaction effect between the variables 
(F₁,₁₉=0.159, p=0.695).  
 
 
 
 
 
 
Figure 75 Altered elevated plus maze exploration following LPS administration in 
BMAL1
+/-
 mice. Error bars represent 1xSEM and */** represents main effect of LPS 
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administration p<0.05/0/01. N=10 for wild-type mice, n=11 for BMAL1
+/- 
mice, n=21 
for saline and LPS treatments. 
7.3.1.3 Tail Suspension Test 
In the tail suspension test, as shown in Figure 7.10, there was a significant main effect 
of LPS treatment (n=20 for saline, 19 for LPS, F₁,₁₇=5.776, p=0.028). There was no 
effect of genotype (n=10 for wildtype, n=10 for 
BMAL1+/-
, F₁,₁₇=2.413, p=0.139). There 
was no interaction effect between the two variables (F₁,₁₇=1.493, p=0.238). Dependent 
t-tests revealed a significant effect of treatment in the wild type animals (t₈=2.417, 
p=0.042), but not the KO animals (t₉ = 0.886, p = 0.399). 
 
 
 
 
 
 
 
 
 
Figure 7.10 BMAL1
+/-
 mice are less affected by LPS administration in the tail 
suspension test. Bar graph illustrating time spent immobile by both genotypes following 
LPS or saline administration. Error bars represent 1xSEM and * represents main effect 
of LPS administration p<0.05. N=10 for wild-type mice, n=11 for BMAL1
+/- 
mice, n=21 
for saline and LPS treatments. 
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7.3.3 Baseline behaviour of BMAL1
+/-
 mice 
7.3.3.1 Forced Swim Test 
An independent t-test revealed a significant difference in baseline depressive-like 
behaviour between wild type (n=10) and Bmal1
+/-
 (n=11) mice. As illustrated in Figure 
7.11, the wild type mice spent an average of 86±10.50 seconds immobile, while the KO 
mice spent 119.27±6.27 seconds immobile (t₁₉=2.78, p=0.012). This may explain an 
absence of main effect of LPS on the Bmal1
+/-
 group in the tail suspension test, since 
these animals begin with a higher baseline.  
 
 
 
 
 
 
 
 
 
 
Figure 7.11 BMAL1
+/-
 mice show increased behavioural despair in the forced swim 
test. Bar graph illustrating time spent immobile by both genotypes.  Error bars 
represent 1x SEM and * represents main effect of genotype p<0.05. N=10 for wild-type 
mice, n=11 for BMAL1
+/- 
mice. 
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7.3.3.2 Sucrose Preference Test 
 An independent t-test, illustrated in Figure 7.8, indicated no difference between 
wild type (n=10) and knock out (n=11) animals in terms of sucrose preference 
(t10=0.006, p=0.995). As illustrated in Figure 7.12, wild type mice had a mean 
preference of 72.32±2.98% while Bmal1
+/-
 animals had a mean preference of 
72.29±4.44%.  
 
 
 
 
 
 
 
 
 
 
Figure 7.12 BMAL1
+/-
 mice show no anhedonia in the sucrose preference test. Bar 
graph illustrating sucrose preference percent for both genotypes. Error bars represent 
1x SEM and * represents p<0.05. N=10 for wild-type mice, n=11 for BMAL1
+/-
. 
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7.3.4 Immunohistochemical analysis 
 Immunohistochemical analysis of the number of microglia expressing BMAL1 
within the cell nucleus was conducted by double staining with IBA-1 (NovaRED) and 
BMAL1 (DAB) antibodies. An independent t-test revealed no significant differences in 
the number of microglia within one field of view of the CA1 region – 40.575±1.5% for 
WT animals, 38±2.15% for Bmal1
+/-
  mice, (t19=0.961, p=0.349). Microglial 
morphology in both groups appeared to be normal. An independent t-test revealed that 
there was a lower percent of microglia positive for BMAL1 within the nucleus in 
Bmal1
+/-
 mice (n=11, 12.78±1.42%) than WT mice (n=10, 19.51±1.61%), t19=3.152, 
p=0.005. Photomicrographs in Figure 7.13 illustrates the field of view utilised to assess 
BMAL1 co-localisation with IBA-1 as well as higher magnifications exampling both 
microglia with and without BMAL1 expression. 
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Figure 7.13 BMAL1 expression in microglia according to genotype A) 
Photomicrographs (100x, 400x) illustrating co-localised BMAL1 and IBA-1 staining in 
the CA1 region of WT and Bmal1
+/-
 mice scale bars represent 100µm (100x) and 50µm 
(400x) B) Bar graph illustrating the percentage of microglia expressing BMAL1 within 
their cell bodies. Error bars represent 1x SEM, ** represents main effect of genotype 
p<0.01. N=10 for wild-type mice, n=11 for BMAL1
+/- 
mice. 
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7.4 Discussion 
 This chapter describes the long-lasting effects of sepsis on circadian rhythmicity 
within the hippocampus as well as whether genetic disruption of microglial clocks via 
heterozygous Bmal1 deletion in myeloid-lineage cells affects the behavioural response 
to LPS. It is shown that, despite high variation, the clock gene protein products PER1 
and PER2 appear to be rhythmically expressed within the hippocampus, while CLOCK 
and c-Fos are not rhythmic in their expression. In the post-septic animal the magnitude 
of this rhythmicity is attenuated. In the second set of experiments it is shown that the 
sickness behaviour exhibited by Bmal1
+/-
 mice following acute low dose LPS 
administration is not significantly different to that of wild type animals, although certain 
aspects of depression-like behaviour may be elevated at baseline.  
7.4.1 PER1 and PER2 expression in the post-septic hippocampus 
 Both PER1 and PER2 expression appeared to be rhythmic in the hippocampus 
of untreated mice in the present experiment. There were some regional differences in 
PER1 expression, with the strongest rhythmicity occurring within the CA1 region. 
Despite variations in the magnitude of rhythmicity among subfields, the temporal 
pattern of peak and trough expression was relatively even across each area. PER2 on the 
other hand seemed to be equally rhythmic throughout all hippocampal subfields, again 
with all areas showing similar temporal patterns. This synchronised expression of clock 
genes across each area of the hippocampus is in line with other data on hippocampal 
clock gene expression in C3H/J mice, although the temporal pattern is not (Jilg, et al., 
2009; Feillet, Mendoza, Albrecht, Pévet, & Challet, 2008). The differences in 
rhythmicity between C3H and C57BL/6 mice may be due to the high levels of 
melatonin production in the former, compared with low levels of production the latter 
(Dinet, Ansari, Torres-Farfan, & Korf, 2007; von Gall, et al., 2000). These two strains 
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also show different behavioural patterns of rhythmicity over a 24 hour cycle without 
intervention. Although even following administration of melatonin to C57BL/6 mice, 
which express functional melatonin receptors despite not producing the hormone 
(Dubovich, Hudson, Sumaya, Masana, & Manna, 2005), differences persist (Adamah-
Biassi, Stepien, Hudson, & Dubovich, 2013) suggesting that other mechanisms may 
also contribute to different temporal patterns of clock gene expression within the 
hippocampus of these strains.  
 Though the amplitude of both PER1 and PER2 rhythmicity is dampened in the 
post-septic hippocampus, the phase does not seem to be altered. LPS has previously 
been shown to elicit short-term suppression of clock gene expression in SCN and liver 
(Okada, et al., 2008), but the long-lasting effects of sepsis on hippocampal clock gene 
protein products has not previously been examined. It is possible that this is either a 
downstream effect of disruption to SCN rhythmicity or output, or that endogenous clock 
gene production in the hippocampus itself is altered following sepsis-induction. As 
discussed, it is as of yet unclear precisely which aspects of hippocampal rhythmicity are 
endogenous and which are under SCN control. Although no definite SCN to 
hippocampus pathway is known, the SCN does output to areas which in turn affect 
hippocampal function (Ruby, et al., 2008) – and as the current experiment utilise a 
whole-system model, in which SCN rhythmicity is affected (O'Callaghan, et al., 2012) it 
is unlikely that circadian oscillations in the hippocampus are perturbed in isolation. 
 Disruption of PER1 and PER2 rhythms may have significant consequences for 
hippocampal functioning in post-septic mice. Bouchard-Cannon et al (2013) showed 
that Per2 was essential for gating the entrance of quiescent neural precursor cells to the 
neurogenesis cycle, thereby controlling the production of newborn hippocampal 
neurons. Per2 KO mice also show subtle deficits in LTP, hippocampal phosphorylated-
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CREB levels, and long-term, but not short-term, recall of trace fear memories (Wang, et 
al., 2009). In Bouchard-Cannon et al’s (2013) experiment Per2 KO mice do not 
however show any deficits in hippocampal-dependent behavioural tasks indicating that 
Per2 disruption may not, by itself, be sufficient to impair most hippocampal-dependent 
function. Similarly to Per2 ablation, knock out of Per1 also leads to alterations in a 
number of parameters within the mouse hippocampus. This includes the cessation of 
rhythmic pCREB production, as well as altered gene expression and reduced LTP 
magnitude (Rawashdeh, et al., 2014). Per1 KO mice also show significant deficits in the 
hippocampal-dependent radial arm maze (Jilg, et al., 2009). Although mice knocked out 
completely for Per1 or Per2 show these significant changes in hippocampal 
functioning, disruption of these genes’ rhythmic expression may also be sufficient to 
affect hippocampal neurogenesis and other hippocampal function in post-septic mice. 
As the expression of BDNF, a key neurotrophin in depressive-like behaviour, and its 
receptor TrkB are under circadian control (Martin-Fairey & Nunez, 2014), disruption of 
this rhythmicity due to altered PER1/PER2 expression could represent one mechanism 
through which hippocampal circadian proteins contribute to affective changes in post-
septic mice.  
7.4.2 CLOCK Expression in the Post-Septic Hippocampus 
 CLOCK protein product did not appear to be rhythmically expressed in the 
hippocampus of either post-septic or control mice. This is in contrast to C3H mice 
which show rhythmic expression of CLOCK with peaks during the subjective night 
(Jilg, et al., 2009). Previous examination of CLOCK within the hippocampus of young 
C57BL/6 mice showed it to be rhythmically expressed in the dentate gyrus but not CA1 
or CA3 (Wyse & Coogan, 2010), while BMAL1 was expressed rhythmically in the CA1 
region and CA3. A lack of diurnal variation in CLOCK is somewhat surprising since it 
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is a core part of the activating transcriptional CLOCK:BMAL1 heterodimer. The large 
degree of inter-animal variation in CLOCK expression, even among non-septic mice, 
and relatively low number of mice per group/timepoint may have contributed to this 
lack of effect. Alternatively, if hippocampal circadian rhythmicity is controlled only by 
synchronization via the SCN rather than endogenous signalling then CLOCK may be 
functionally redundant, at least in terms of circadian rhythmicity, in the hippocampus. 
CLOCK may still however fulfil a non-circadian role within the hippocampus (Uz, et 
al., 2005), such as its action during cocaine sensitization (McClung, et al., 2005), which 
does not require rhythmic expression. Unlike Per1 and Per2, CLOCK has not been 
directly implicated in controlling LTP or other aspects of hippocampal functioning, 
although it is a positive regulator of both Per genes when heterodimerised with BMAL1 
(Gerstner, 2012).  
7.4.3. c-Fos Expression in the Post-Septic Hippocampus 
 Though c-Fos expression appears rhythmic in the hippocampus of C3H mice 
(Pantazopoulos, Dolatshad, & Davis, 2011) it did not appear to be rhythmically 
expressed in any area of the C57BL/6 hippocampus in the present experiment. As c-Fos 
is most commonly used as a marker of neuronal activation (Benito & Barco, 2014) this 
likely implies that there is no change in basal activity within hippocampal neurons 
across the circadian cycle. Although other important hippocampal processes show 
diurnal oscillations such as adenylyl cyclase activity (Phan, et al., 2011), as well as 
MAPK and cAMP pathway signalling (Eckel-Mahan, 2012), BDNF expression (Schaaf, 
Duurland, de Kloet, & Vreugdenhil, 2000), and an increased magnitude in stimulus-
induced LTP during the subjective night versus the subjective day (Chaudhury, Wang, 
& Colwell, 2005) – it is possible that basal neuronal activity in the absence of stimuli 
does not change significantly over the circadian cycle. Munn and Bilkey (2012) showed 
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that a majority of 48 CA1 place cells, entrained to environmental entry and food 
availability, demonstrating circadian oscillations in their firing rate in freely moving 
Sprague-Dawley rats, although some exhibited antiphase rhythmicity and several were 
also arrhythmic. These animals also differ from C57BL/6 mice in that they show 
circadian oscillation in melatonin levels (Price, et al., 2005), and place cells were not 
examined in isolation in the present experiment. It may be that certain cell populations 
within the hippocampus show rhythmic activity but when analysed as a whole these 
areas do not show robust oscillations in c-Fos levels. 
 Overall, the data from this experiment indicates that both PER1 and PER2 
expression oscillate rhythmically within the hippocampus of control animals, although 
CLOCK does not, and c-Fos production indicates that there is no change in basal 
neuronal activity across a 24 hour cycle. LPS-induced sepsis appears to reduce the 
magnitude of rhythmicity in PER1 and PER2 expression although no phase shifting 
occurs. Post-septic animals also do not show alterations in overall c-Fos expression, in 
line with results from previous chapters. These changes do not however result in deficits 
in hippocampal-dependent cognitive tasks suggesting that disruption in Per1/2 
rhythmicity may not be necessary for learning and memory – despite their involvement 
in LTP (Rawashdeh, et al., 2014; Wang, et al., 2009). Zueger et al. (2006) showed, 
contrary to some other findings, that Per1 and Per2 KO mice could still learn normally 
in the hippocampal-dependent Morris watermaze and contextual fear condition 
paradigms however showing that rather than being necessary for memory formation 
Per1/2 may more subtley modulate hippocampal functioning – for example by 
controlling diurnal variations in time to learn and successful performance  of such tasks.  
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7.4.4 Phenotyping an Immune-circadian Mutant 
 In the second set of experiments it was examined whether a heterozygous knock 
out for BMAL1 in myeloid cells would exhibit different responses to LPS treatment 
than wild-type animals. BMAL1 has been suggested to be one of the most important 
factor in modulating the circadian aspect of immune responses (Curtis, Bellet, Sassone-
Corsi, & O'Neill, 2014). Myeloid-specific deletion of Bmal1 has previously been shown 
to alter chemokine expression and predispose mice to pathologies involving both acute 
and chronic inflammation (Ngyuyen, et al., 2013). Bmal1 is also the only clock gene 
whose knockout leads to complete arhythmicity, although this can be remedied in part 
by artificial promotion of the constitutive expression of Bmal2 (Shi, et al., 2010).  It was 
therefore hypothesised that these mice may exhibit an exaggerated sickness response to 
a low dose of LPS. As CLOCK is a driver of NF-κB transcription (Spengler, et al., 
2012) and BMAL1:CLOCK dimers suppresses Clock transcription, it is possible that 
the repression of BMAL1 could lead to increased susceptibility to excessive 
inflammation. 
When examining microglia within the hippocampus of these knockout mice, it 
was found that there were no gross changes to microglia number or morphology. This 
indicates that despite heterozygous Bmal1 deletion in myeloid cells, microglia can still 
develop at a normal rate and without any overt morphological phenotypes. It was found 
that, despite a significant reduction in the amount of BMAL1 expressed in hippocampal 
microglia, it was still present in ~10% of cells. This represents roughly half the 
expression of BMAL1 protein in microglia as in wildtype counterparts. When 
administered LPS both groups of mice showed similar behavioural changes, indicating 
that there was no increased susceptibility to LPS-induced sickness behaviour in the KO 
mice. It was noted however that BMAL1 deficient animals appeared to have higher 
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baseline depressive and anxious-like behaviour in the tail suspension test and the open 
field test. It was therefore  decided to examined their behaviour in the forced swim test 
and sucrose preference test without an acute LPS or saline treatment. Here, KO mice 
showed increased behavioural despair but there was no effect on anhedonia. A lack of 
exaggerated reaction to LPS may therefore be explained by animals’ elevated baseline 
propensity of some depressive-like behaviours. Another possibility is that these mice 
may only exhibit altered responses to LPS when examined at specific timepoints. For 
example, BMAL1 deletion in peritoneal exudates cells, the majority of which are 
macrophages, leads to a loss of gating in response to LPS, although the magnitude of 
the response is not more exaggerated overall (Gibbs, et al., 2011). BMAL1 appears to 
be anti-inflammatory (Curtis, Bellet, Sassone-Corsi, & O'Neill, 2014) and its levels vary 
according to the circadian cycle. Therefore if LPS is administered at a time when 
BMAL1 expression is at trough expression in control animals there may appear to be no 
effect. If LPS were administered when BMAL1 levels are at peak circadian expression 
in wild-type animals then an effect of BMAL1 knockdown may be more apparent. As 
this mouse has heterozygous Bmal1 knockout in all myeloid lineage cells are affected in 
this mouse any effect, or lack thereof, cannot be attributed specifically to hippocampal 
microglia but likely involves many other myeloid lineage cells.  
That both the Bmal1
+/-
  mice and post-septic wildtype C57BL/6 mice show 
elevated depressive-like behaviours illustrates the interplay between the circadian and 
immune systems, and the role of both in the pathophysiology of depressive disorders  
(Salgado-Delgado, Osorio, Saderi, & Escobar, 2011; Patel, 2013). While the link 
between the circadian and inflammatory systems is bi-directional (Cermakian, et al., 
2013), inflammation appears to be associated with pre-disposing, or even causative, 
factors for depression such as stress and obesity (Berk, et al., 2013) rather than a result 
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of depressive disorders themselves. The results of the present experiments highlight the 
ability of sepsis to produce long-lasting changes in hippocampal circadian rhythmicity 
in addition to prolonged microglial activation. These factors are particularly important 
for post-septic patients given that circadian disruption is present during severe illness 
(Verceles, et al., 2012) and long-term sleep impairment, as well as depressive 
symptoms, are experienced in the aftermath critical illness (Weinhouse & Schwab, 
2006). 
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Chapter 8. General Discussion 
The goal of this thesis has been to characterise to as full an extent as possible the 
long-lasting effects of a septic dose of LPS in mice. In Chapters 2, and 3 involved an in 
depth exploration of this model of post-septic encephalopathy – establishing the 
affective changes present in these animals and the neuroinflammatory state of the 
hippocampus. In contrast to the intense microglial activation seen at 24 hours post-
sepsis, a pattern emerges across Chapters 3, 4 and 5 of a persistent but low-grade 
microglial activation within the hippocampus which appears to impact on other factors 
within this region. Despite no increase in cytokine levels, post-septic mice show subtle 
differences in plasticity-related protein products (ARC, EGR-1) and cell proliferation in 
the SGZ. There is also a reduction of c-FOS and EGR-1 expression in the amygdala 
indicating that neuronal activation in this structure may be altered. These post-septic 
mice do not show any overt changes in locomotion or cognition across any behavioural 
tasks, yet reliably exhibit depressive-like and anxiety-like behaviours and respond well 
to anti-depressant treatment. 
 Building on these findings it was then explored how these changes might be 
modulated either by disruption of the NF-κB pathway prior to sepsis induction, or by 
the administration of the SSRI fluoxetine. In light of the findings that post-septic mice 
appear to show elevated microglial activation without an over-production of cytokines, 
it was then explored whether these animals might be exhibiting microglial priming. This 
did not appear to be the case. Also examined were the effects of sepsis on circadian 
clock gene expression. Circadian parameters are often disturbed in patients with sepsis, 
and post-septic mice here also appear to show disruption to their circadian system. 
These later experiments provide insight into some of the processes which may be at 
play in the post-septic brain and provide further evidence to support the relationship 
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between excessive microglial activity in the post-septic hippocampus and the 
behavioural changes observed. 
 Unexpectedly, our results differed quite significantly both from other 
experiments modelling post-septic encephalopathy, and from what one might expect 
given the array of deficits seen in post-septic patients. Despite finding significant 
neuroinflammatory changes within the dorsal hippocampus of our post-septic mice, 
these animals did not show the cognitive deficits across a range of tasks that one would 
expect with this pathology. It could be that the level of inflammation present in our 
model was not sufficient to produce cognitive deficits – findings from CLP models 
report more aggressive inflammatory changes with oxidative stress (Comim, et al., 
2011) and Aβ accumulation (Schwalm, et al., 2014) which likely lead to more potent 
disruption of hippocampal processes and resulting cognitive function. The hippocampus 
is also highly plastic and capable of significant functional recovery after insult 
(Hoffman, et al., 2011) which may be at play here given the length of time between 
sepsis-induction and behavioural testing. Although suppressed, adult hippocampal cell 
proliferation is not absent in post-septic mice, which could contribute to a recovery 
process (Zhang & Chopp, 2009). This also raises the possibility that the affective 
changes present post-sepsis are modulated, at least in part, by brain areas outside the 
hippocampus which have less potential for recovery.  
 These findings remain valuable, however, and contribute new information to a 
relatively small field of study regarding a very poorly understood disorder. While it has 
previously been shown that a single intraperitoneal injection of LPS can induce long 
lasting inflammation and cognitive symptoms (Semmler, et al., 2007), this is the first 
time that it has been shown that the same treatment can result in chronic behavioural 
changes typical of a depressive state. These experiments are also the first to show that 
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these animals have a deficiency in adult hippocampal cell production – something 
which may be implicated in both cognitive and affective dysfunction (Christian, Song, 
& Ming, 2014). This provides a clue to what may underlie cognitive changes in human 
post-septic patients and suggests an avenue of therapeutic investigation for a syndrome 
with no treatment currently available. It is shown here that treatment with an SSRI can 
stimulate cell proliferation in the SGZ as well as reverse depressive-like behaviour in a 
model of post-septic encephalopathy, and it would be very valuable to investigate if this 
may also be the case for patients. This is also interesting because fluoxetine’s effect on 
neurogenesis had not previously been studied in the context of a large dose of LPS.     
When viewing the present work in its entirety it becomes apparent that systemic 
LPS administration will not always produce exactly the same effects in every 
experiment – a factor that is already known in terms of the intraperitoneal 
administration of other substances (Gaines Das & North, 2007). Reviewing the data 
from the present experiments it can be seen that there are some cases where null results 
occur where significant results were present in other cohorts (e.g. the sucrose preference 
test in Chapter 5 versus Chapters 3 and 4), and in examining the health ratings of 
animals after LPS administration it can be seen that there is some individual variance in 
the severity of sepsis experienced. It may therefore be advisable to interpret some 
findings from this model with caution where they occur in isolation or where sample 
sises are not large. It is important to note that there is also considerable variability when 
cecal ligation and puncture is used to model sepsis, particularly when performed by 
different experimenters (Cuenca, Delano, Kelly-Scumpia, Moldawer, & Efron, 2010). 
Behavioural testing is also generally prone to high levels of variability, even with inbred 
mouse strains (Hånell & Marklund, 2014). Of course the human condition of post-septic 
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encephalopathy is also highly heterogeneous and not all sufferers of sepsis will develop 
encephalopathy (Papadopoulos, et al., 2000).  
 Also shown is the importance of considering the hippocampus, as much as 
possible, in terms of its various subregions rather than as a unitary structure. In several 
of the comparative studies of post-septic rodents the hippocampus is considered as a 
homogenous region (Bossù, et al., 2012; Cassol-Jr, et al., 2010; Michels, et al., 2014; 
Weberpals, et al., 2009). Aside from the functional distinctions proposed between the 
dorsal and ventral hippocampus (Fanselow & Dong, 2010), it is shown here there is 
differential susceptibility of the different hippocampus subregions following sepsis. In 
all three chapters (2, 7 and 8) where IBA1 staining was examined, for example, there 
seemed to be a greater degree of microglial activation in the CA1 region than CA3 
regions. Egr-1 staining throughout these experiments reveals a similar pattern with 
larger effects in the CA1 region than CA3 – although in this case the difference could 
also be a function of the sparser staining overall in this subregion. This differential 
susceptibility is also reflected in the hippocampus’ vulnerability to both exogenous and 
endogenous oxidative stress with the CA1 the most prone to injury (Vornov, Park, & 
Thomas, 1998). As discussed in Chapter 1, these subregions are different in terms of 
their cellular anatomy, function and connectivity – and the demonstration of their 
variation in susceptibility provides further reason for their separate consideration in 
research on post-septic encephalopathy. 
  As this work involves the characterisation of a model of a human syndrome, it 
is also prudent here to evaluate whether this post-septic model is relatable to the human 
condition of post-septic encephalopathy. Recent work has shed some doubt on the 
utility of such models, at least in terms of the acute effects of sepsis, with  mouse 
models displaying many differences to the immunological response exhibited by 
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humans and translatability of clinical findings have generally been poor (Dyson & 
Singer, 2009;  Seok, et al., 2013; Zofaghari, Pinto, Dyson, & Singer, 2013).  
Specifically the LPS-induced model induces a more rapid and extreme upregulation of 
pro-inflammatory cytokines than is seen in human sepsis (Rittirsch, Hoesel, & Ward, 
2007), although some other aspects of the pathology (e.g. apoptosis of immune cells, 
lymphocyte gene expression and phenotypic shifting of T cells for example) appear to 
be better reproduced (Hotchkiss, Monneret, & Payen, 2013). It is difficult to know to 
what extent this model may reflect the neurological changes present in post-septic 
patients given the lack of understanding of this condition’s aetiology (Ziaja, 2013). In 
terms of modelling post-septic encephalopathy the most striking difference may be that, 
as reviewed in the introduction, while post-septic patients often display cognitive 
difficulties and only sometimes show affective symptoms, our results indicate that 
following LPS-administration post-septic animals show primarily affective changes. It 
could therefore be suggested that these post-septic animals may reflect a subset of post-
septic patients which experience affective symptoms – or it could be that this model 
more closely reflects some of the changes present in affective disorders themselves, as 
has been discussed in Chapter 7. As sepsis in human populations typically occurs either 
very early or very late in life, one suggestion to increase the relevancy of septic animal 
models to human conditions is to induce sepsis in aged mice (Fink, 2014).  
 The human applications of the data from these experiments is therefore limited 
by our understanding of what specifically drives the lasting cognitive and emotional 
deficits in post-septic patients. With due caution, however, these results may still inform 
investigative and therapeutic approaches in post-septic people. The experiments in this 
thesis have illustrated that post-septic mice reliably show long-lasting microglial 
activation, and interventions which reduce this activation appear beneficial in terms of 
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behaviour. New technology is now beginning to allow for the in vivo imaging of 
microglia and macrophages in humans (Venneti, Lopresti & Wiley, 2013). Therefore 
one avenue of investigation informed by the present results may be to assess whether or 
not post-septic patients show ongoing microglial activation and whether interventions 
which target this inflammation are beneficial to these patients’ cognitive and emotional 
states. These treatments would need to be adjusted to specific patients’ needs and 
backgrounds but could include for example and SSRI as used here, or more traditional 
anti-inflammatories. 
The present experiments are limited in certain aspects however. One of the main 
limitations of these experiments is the use of only immunohistochemistry when 
analysing the inflammatory state of the hippocampus. Although immunohistochemistry 
is a powerful technique, allowing for the examination of the spatial, functional and 
morphological examination of many protein products (Frevert, Johnson, & Stahl, 2014), 
it is not without pitfalls. The most significant problem with immunohistochemistry is 
that of antibody specificity – the potential for one’s antibody to bind to unintended 
targets and therefore produce staining which is misleading (Rhodes & Trimmer, 2006). 
This danger can be mitigated to some extent by verifying antibody specificity by 
comparison with other techniques such as in situ hybridization and testing negative 
controls which omit the primary or secondary antibody (Rhodes & Trimmer, 2006). It 
has been shown however that even antibodies which pass these controls may still 
produce staining in KO models – indicating that true antibody verification may not be 
possible without examining its staining in a KO animal (Baek, Darlington, Smith, & 
Ashton, 2013). Although it is not possible within the present study to generate a 
knockout of every gene examined, analysis of hippocampal tissue with other techniques 
such as western blotting or ELISAs may help to confirm the present findings. It is also 
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worth noting that results which were positive in Chapter 3 were generally repeatable in 
later experiments – although there have been some discrepancies, for example in the 
margin of effects between hippocampal subregions. 
 Another limitation which becomes apparent in light of the behavioural results 
obtained is that analysis of the hipoccampus was done primarily at the dorsal to mid 
level, rather than at the ventral level. Initially this was done to allow for comparison 
with other studies of the post-septic brain (Bossù, et al., 2012; Fan, et al., 2012; Qin, et 
al., 2007; Semmler, et al., 2007; Weberpals, et al., 2009) many of which also reported 
changes in cognitive measures among post-septic rodents and examine dorsal 
hippocampal functioning. Here however affective rather than cognitive changes were 
found when post-septic behaviour was examined. As discussed in the introduction, these 
changes are usually associated with the ventral hippocampus – as well as other areas 
such as the amygdala and prefrontal cortex. Given the number of proteins and 
experimental conditions examined,  it was not feasible to quantify the changes in all of 
these areas – although altered amygdala IEG production is noted. Also, despite the 
attribution of cognition to the dorsal hippocampus and emotion to the ventral 
hippocampus, there is evidence that neither function is isolated to a specific area (Beer 
et al, 2014; Keinath, et al., 2014; Tanti & Belzung, 2012). In addition, the mid region - 
included for analysis in the present experiments - appears to be more or less equally 
involved in both types of processing (Kheirbek, et al., 2013), and there is of course a 
high degree of interconnectivity between different levels of the hippocampus (Amaral & 
Lavenex, 2007). Therefore, although correlative observations regarding changes in the 
dorsal hippocampus and related behaviours can be made, it is not prudent to infer 
causality as other areas are likely also involved. 
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  With these points in mind, future work could evolve from these findings in 
numerous directions. In order to better understand how this model relates to the human 
condition, it would be very useful to examine post-mortem brain tissue of post-septic 
patients. Post-mortem analysis of patients who died during sepsis shows a pathology 
involving ischaemia, haemorrhaging, as well as occasional involvement of micro-
abscesses, microglial and neuronal apoptosis, elevated microglial activation, cytokine 
levels and vascular iNOS expression (Sharshar, et al., 2002; Sharshar, et al., 2003; 
Sharshar, et al., 2004). Little work has looked specifically at the hippocampus, although 
one case study found hippocampal neuronal loss and ischemic lesions in a patient who 
died while experiencing post-septic encephalopathy (Finelli & Uphoff, 2004). No 
similar examination has been done in patients who died after recovering from sepsis 
which would provide data with which to compare neurological findings in animal 
models. Although such findings may be complicated by comorbidities and medication. 
Another easier approach would be to further characterise the neurological changes 
present in post-septic mice – for example, investigating whether the abscesses, 
hippocampal volume reduction and ischaemia present in human septic encephalopathy 
are also present in the current model, or investigating electrophysiological changes 
given the EEG changes present in post-septic patients (Semmler, et al., 2013). There is 
much still to investigate regarding the microglial activation present within post-septic 
mice. For example, it is not clear how microglia persist in an activated morphology 
despite no measurable increase in pro-inflammatory cytokine production. Potential 
study could examine the time course of microglial morphofunctional change from the 
acute stages of sepsis to the 2 month timepoint examined here, perhaps with more 
attention to anti-inflammatory cytokines and microglial “off” signals such as CD200 
(Biber, Neumann, Inoue, & Boddeke, 2007). Greater knowledge of how closely this 
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model mirrors the human condition will lead to improved potential for treatment 
development. 
 The other potential direction for future research stemming from this work would 
be to use the model in the investigation of inflammation and mood disorders. Although 
the aetiology of the various mood disorders are not much better understood than post-
septic encephalopathy, there is a much broader literature, both in terms of human 
studies and animal models, which provides a context for the interpretation of findings. 
As has been discussed both acute (Wang Z. , et al., 2014) and chronic (Kubera, et al., 
2013) LPS administration are already used to model depression in rodents – although 
this research provides a different perspective using a single peripheral administration to 
produce long-lasting effects. Many interesting avenues could be pursued focusing on 
this aspect of the model. Mechanistic work could be done examining the role of 
microglia in modulating signalling along hippocampal and amygdala pathways 
important to mood (Benson, et al., 2014). Other factors implicated in the pathology of 
mood disorders which have not been investigated in the present model include 
monoaminergic neurotransmission (Sperner-Untwerger, Kohl, & Fuchs, 2014), 
glucorticoid signalling (Pandey, Rizavi, Ren, Dwivedi, & Palkovits, 2013) and 
hippocampal volume (Videbech & Ravnkilde, 2004). As the development of mood 
disorders is commonly preceded by significant psychological stress (Horesh & Iancu, 
2010) another interesting approach could be to combine this inflammatory model with 
an established behavioural model such as chronic unpredictable mild stress.  
  In conclusion, this work has provided a detailed characterization of the long-
lasting effects of a septic dose of LPS on behaviour, cognition and the 
neuroinflammatory state of the hippocampus in mice. Further work needs to be done 
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however to describe the mechanisms which lead to these changes and also to assess how 
closely this model mirrors the human syndrome. 
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